<?xml version="1.0"?>
<!DOCTYPE BlastOutput PUBLIC "-//NCBI//NCBI BlastOutput/EN" "http://www.ncbi.nlm.nih.gov/dtd/NCBI_BlastOutput.dtd">
<BlastOutput>
  <BlastOutput_program>blastp</BlastOutput_program>
  <BlastOutput_version>BLASTP 2.12.0+</BlastOutput_version>
  <BlastOutput_reference>Stephen F. Altschul, Thomas L. Madden, Alejandro A. Sch&amp;auml;ffer, Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997), &quot;Gapped BLAST and PSI-BLAST: a new generation of protein database search programs&quot;, Nucleic Acids Res. 25:3389-3402.</BlastOutput_reference>
  <BlastOutput_db>/project/bowmanlab/borowsky.jonathan/installations/pdbaa</BlastOutput_db>
  <BlastOutput_query-ID>Query_1</BlastOutput_query-ID>
  <BlastOutput_query-def>1A28_1|Chains A, B|PROGESTERONE RECEPTOR|Homo sapiens (9606)</BlastOutput_query-def>
  <BlastOutput_query-len>256</BlastOutput_query-len>
  <BlastOutput_param>
    <Parameters>
      <Parameters_matrix>BLOSUM62</Parameters_matrix>
      <Parameters_expect>10</Parameters_expect>
      <Parameters_gap-open>11</Parameters_gap-open>
      <Parameters_gap-extend>1</Parameters_gap-extend>
      <Parameters_filter>F</Parameters_filter>
    </Parameters>
  </BlastOutput_param>
<BlastOutput_iterations>
<Iteration>
  <Iteration_iter-num>1</Iteration_iter-num>
  <Iteration_query-ID>Query_1</Iteration_query-ID>
  <Iteration_query-def>1A28_1|Chains A, B|PROGESTERONE RECEPTOR|Homo sapiens (9606)</Iteration_query-def>
  <Iteration_query-len>256</Iteration_query-len>
<Iteration_hits>
<Hit>
  <Hit_num>1</Hit_num>
  <Hit_id>pdb|4OAR|A</Hit_id>
  <Hit_def>Progesterone receptor with bound ulipristal acetate and a peptide from the co-repressor SMRT [Homo sapiens]</Hit_def>
  <Hit_accession>4OAR_A</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>522.702</Hsp_bit-score>
      <Hsp_score>1345</Hsp_score>
      <Hsp_evalue>0</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>3</Hsp_hit-from>
      <Hsp_hit-to>258</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>256</Hsp_identity>
      <Hsp_positive>256</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>256</Hsp_align-len>
      <Hsp_qseq>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_hseq>
      <Hsp_midline>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>2</Hit_num>
  <Hit_id>pdb|3G8O|A</Hit_id>
  <Hit_def>Progesterone Receptor with bound Pyrrolidine 1 [Homo sapiens] &gt;pdb|3G8O|B Progesterone Receptor with bound Pyrrolidine 1 [Homo sapiens]</Hit_def>
  <Hit_accession>3G8O_A</Hit_accession>
  <Hit_len>263</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>522.702</Hsp_bit-score>
      <Hsp_score>1345</Hsp_score>
      <Hsp_evalue>0</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>8</Hsp_hit-from>
      <Hsp_hit-to>263</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>256</Hsp_identity>
      <Hsp_positive>256</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>256</Hsp_align-len>
      <Hsp_qseq>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_hseq>
      <Hsp_midline>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>3</Hit_num>
  <Hit_id>pdb|1A28|A</Hit_id>
  <Hit_def>Hormone-Bound Human Progesterone Receptor Ligand-Binding Domain [Homo sapiens] &gt;pdb|1A28|B Hormone-Bound Human Progesterone Receptor Ligand-Binding Domain [Homo sapiens] &gt;pdb|2OVH|A Progesterone Receptor with Bound Asoprisnil and a Peptide from the Co-Repressor SMRT [Homo sapiens] &gt;pdb|2OVM|A Progesterone Receptor with Bound Asoprisnil and a Peptide from the Co-Repressor NCoR [Homo sapiens] &gt;pdb|3HQ5|A Progesterone Receptor bound to an Alkylpyrrolidine ligand. [Homo sapiens] &gt;pdb|3HQ5|B Progesterone Receptor bound to an Alkylpyrrolidine ligand. [Homo sapiens]</Hit_def>
  <Hit_accession>1A28_A</Hit_accession>
  <Hit_len>256</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>522.702</Hsp_bit-score>
      <Hsp_score>1345</Hsp_score>
      <Hsp_evalue>0</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>256</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>256</Hsp_identity>
      <Hsp_positive>256</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>256</Hsp_align-len>
      <Hsp_qseq>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_hseq>
      <Hsp_midline>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>4</Hit_num>
  <Hit_id>pdb|1SQN|A</Hit_id>
  <Hit_def>Progesterone Receptor Ligand Binding Domain with bound Norethindrone [Homo sapiens] &gt;pdb|1SQN|B Progesterone Receptor Ligand Binding Domain with bound Norethindrone [Homo sapiens]</Hit_def>
  <Hit_accession>1SQN_A</Hit_accession>
  <Hit_len>261</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>522.316</Hsp_bit-score>
      <Hsp_score>1344</Hsp_score>
      <Hsp_evalue>0</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>6</Hsp_hit-from>
      <Hsp_hit-to>261</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>256</Hsp_identity>
      <Hsp_positive>256</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>256</Hsp_align-len>
      <Hsp_qseq>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_hseq>
      <Hsp_midline>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>5</Hit_num>
  <Hit_id>pdb|1E3K|A</Hit_id>
  <Hit_def>Human Progesteron Receptor Ligand Binding Domain in complex with the ligand metribolone (R1881) [Homo sapiens] &gt;pdb|1E3K|B Human Progesteron Receptor Ligand Binding Domain in complex with the ligand metribolone (R1881) [Homo sapiens] &gt;pdb|3D90|A Crystal structure of the human progesterone receptor ligand-binding domain bound to levonorgestrel [Homo sapiens] &gt;pdb|3D90|B Crystal structure of the human progesterone receptor ligand-binding domain bound to levonorgestrel [Homo sapiens]</Hit_def>
  <Hit_accession>1E3K_A</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>522.316</Hsp_bit-score>
      <Hsp_score>1344</Hsp_score>
      <Hsp_evalue>0</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>3</Hsp_hit-from>
      <Hsp_hit-to>258</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>256</Hsp_identity>
      <Hsp_positive>256</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>256</Hsp_align-len>
      <Hsp_qseq>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_hseq>
      <Hsp_midline>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>6</Hit_num>
  <Hit_id>pdb|2W8Y|A</Hit_id>
  <Hit_def>RU486 bound to the progesterone receptor in a destabilized agonistic conformation [Homo sapiens] &gt;pdb|2W8Y|B RU486 bound to the progesterone receptor in a destabilized agonistic conformation [Homo sapiens] &gt;pdb|3ZR7|A Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators [Homo sapiens] &gt;pdb|3ZR7|B Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators [Homo sapiens] &gt;pdb|3ZRA|A Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators [Homo sapiens] &gt;pdb|3ZRA|B Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators [Homo sapiens] &gt;pdb|3ZRB|A Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators [Homo sapiens] &gt;pdb|3ZRB|B Structural basis for agonism and antagonism for a set of chemically related progesterone receptor modulators [Homo sapiens] &gt;pdb|4A2J|A PR X-Ray structures in agonist conformations reveal two different mechanisms for partial agonism in 11beta-substituted steroids [Homo sapiens] &gt;pdb|4A2J|B PR X-Ray structures in agonist conformations reveal two different mechanisms for partial agonism in 11beta-substituted steroids [Homo sapiens] &gt;pdb|4APU|A PR X-Ray structures in agonist conformations reveal two different mechanisms for partial agonism in 11beta-substituted steroids [Homo sapiens] &gt;pdb|4APU|B PR X-Ray structures in agonist conformations reveal two different mechanisms for partial agonism in 11beta-substituted steroids [Homo sapiens]</Hit_def>
  <Hit_accession>2W8Y_A</Hit_accession>
  <Hit_len>260</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>522.316</Hsp_bit-score>
      <Hsp_score>1344</Hsp_score>
      <Hsp_evalue>0</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>5</Hsp_hit-from>
      <Hsp_hit-to>260</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>256</Hsp_identity>
      <Hsp_positive>256</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>256</Hsp_align-len>
      <Hsp_qseq>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_hseq>
      <Hsp_midline>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>7</Hit_num>
  <Hit_id>pdb|1SR7|A</Hit_id>
  <Hit_def>Progesterone Receptor Hormone Binding Domain with Bound Mometasone Furoate [Homo sapiens] &gt;pdb|1SR7|B Progesterone Receptor Hormone Binding Domain with Bound Mometasone Furoate [Homo sapiens] &gt;pdb|1ZUC|A Progesterone receptor ligand binding domain in complex with the nonsteroidal agonist tanaproget [Homo sapiens] &gt;pdb|1ZUC|B Progesterone receptor ligand binding domain in complex with the nonsteroidal agonist tanaproget [Homo sapiens]</Hit_def>
  <Hit_accession>1SR7_A</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>521.931</Hsp_bit-score>
      <Hsp_score>1343</Hsp_score>
      <Hsp_evalue>0</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>4</Hsp_hit-from>
      <Hsp_hit-to>259</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>256</Hsp_identity>
      <Hsp_positive>256</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>256</Hsp_align-len>
      <Hsp_qseq>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_hseq>
      <Hsp_midline>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>8</Hit_num>
  <Hit_id>pdb|3KBA|A</Hit_id>
  <Hit_def>Progesterone receptor bound to sulfonamide pyrrolidine partial agonist [Homo sapiens] &gt;pdb|3KBA|B Progesterone receptor bound to sulfonamide pyrrolidine partial agonist [Homo sapiens]</Hit_def>
  <Hit_accession>3KBA_A</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>516.153</Hsp_bit-score>
      <Hsp_score>1328</Hsp_score>
      <Hsp_evalue>0</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>253</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>253</Hsp_identity>
      <Hsp_positive>253</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>253</Hsp_align-len>
      <Hsp_qseq>IQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>IQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_hseq>
      <Hsp_midline>IQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>9</Hit_num>
  <Hit_id>pdb|4FN9|A</Hit_id>
  <Hit_def>X-ray Crystal structure of the Ancestral 3-keto steroid receptor - Progesterone complex [unidentified] &gt;pdb|4FN9|B X-ray Crystal structure of the Ancestral 3-keto steroid receptor - Progesterone complex [unidentified] &gt;pdb|4FNE|A X-ray Crystal structure of the Ancestral 3-keto steroid receptor - DOC complex [Danio rerio]</Hit_def>
  <Hit_accession>4FN9_A</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>372.859</Hsp_bit-score>
      <Hsp_score>956</Hsp_score>
      <Hsp_evalue>1.59361e-131</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>6</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>169</Hsp_identity>
      <Hsp_positive>212</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PSLISILQAIEPEVVYAGYDNTQPDTTNYLLSSLNRLAEKQLVSVVKWAKALPGFRNLHLDDQMTLIQYSWMGLMAFAMGWRSYKHTNGQMLYFAPDLIFNEQRMQQSAMYDLCQGMQQISQEFVRLQVTQEEFLCMKALLLLSTVPKEGLKSQASFDEMRMNYIKELNRAIAKKENNSAQNWQRFYQLTKLLDSMHDLVGGLLQFCFYTFVQSQALSVEFPEMLVEIISAQLPKVLAGMAKPLLFHKK</Hsp_hseq>
      <Hsp_midline>P LI++L +IEP+V+YAG+DNT+PDT++ LL+SLN+L E+QL+SVVKW+K+LPGFRNLH+DDQ+TLIQYSWM LM F +GWRSYKH +GQMLYFAPDLI NEQRM++S+ Y LC  M QI QEFV+LQV+QEEFLCMK LLLL+T+P EGL+SQ  F+EMR +YI+EL +AI  ++     + QRFYQLTKLLD++HDLV  L  +C  TF+QS+ALSVEFPEM+ E+I+AQLPK+LAGM KPLLFHKK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>10</Hit_num>
  <Hit_id>pdb|4LTW|A</Hit_id>
  <Hit_def>Ancestral Ketosteroid Receptor-Progesterone-Mifepristone Complex</Hit_def>
  <Hit_accession>4LTW_A</Hit_accession>
  <Hit_len>252</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>372.089</Hsp_bit-score>
      <Hsp_score>954</Hsp_score>
      <Hsp_evalue>3.37675e-131</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>4</Hsp_hit-from>
      <Hsp_hit-to>252</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>169</Hsp_identity>
      <Hsp_positive>212</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PSLISILQAIEPEVVYAGYDNTQPDTTNYLLSSLNRLAEKQLVSVVKWAKALPGFRNLHLDDQMTLIQYSWMGLMAFAMGWRSYKHTNGQMLYFAPDLIFNEQRMQQSAMYDLCQGMQQISQEFVRLQVTQEEFLCMKALLLLSTVPKEGLKSQASFDEMRMNYIKELNRAIAKKENNSAQNWQRFYQLTKLLDSMHDLVGGLLQFCFYTFVQSQALSVEFPEMLVEIISAQLPKVLAGMAKPLLFHKK</Hsp_hseq>
      <Hsp_midline>P LI++L +IEP+V+YAG+DNT+PDT++ LL+SLN+L E+QL+SVVKW+K+LPGFRNLH+DDQ+TLIQYSWM LM F +GWRSYKH +GQMLYFAPDLI NEQRM++S+ Y LC  M QI QEFV+LQV+QEEFLCMK LLLL+T+P EGL+SQ  F+EMR +YI+EL +AI  ++     + QRFYQLTKLLD++HDLV  L  +C  TF+QS+ALSVEFPEM+ E+I+AQLPK+LAGM KPLLFHKK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>11</Hit_num>
  <Hit_id>pdb|2Q1H|A</Hit_id>
  <Hit_def>Ancestral Corticoid Receptor in Complex with Aldosterone [unidentified] &gt;pdb|2Q1V|A Ancestral corticoid receptor in complex with cortisol [unidentified]</Hit_def>
  <Hit_accession>2Q1H_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>357.451</Hsp_bit-score>
      <Hsp_score>916</Hsp_score>
      <Hsp_evalue>1.99718e-125</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>4</Hsp_hit-from>
      <Hsp_hit-to>250</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>163</Hsp_identity>
      <Hsp_positive>210</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>247</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>LISILEAIEPEVVYAGYDNSQPDTTNYLLSSLNRLAGKQMVSVVKWAKALPGFRNLHLDDQMTLIQYSWMSLMAFSLGWRSYKHTNGQMLYFAPDLIFNEERMQQSAMYDLCQGMRQISQEFVRLQVTYEEFLCMKVLLLLSTVPKDGLKSQASFDEMRMNYIKELRRAIAKKENNSSQNWQRFYQLTKLLDSMHDLVGGLLQFCFYTFVQSQALSVEFPEMLVEIISDQLPKVMAGMAKPLLFHKK</Hsp_hseq>
      <Hsp_midline>LI++L +IEP+V+YAG+DN++PDT++ LL+SLN+L  +Q++SVVKW+K+LPGFRNLH+DDQ+TLIQYSWMSLM F LGWRSYKH +GQMLYFAPDLI NE+RM++S+ Y LC  M QI QEFV+LQV+ EEFLCMKVLLLL+T+P +GL+SQ  F+EMR +YI+EL +AI  ++     + QRFYQLTKLLD++HDLV  L  +C  TF+QS+ALSVEFPEM+ E+I+ QLPK++AGM KPLLFHKK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>12</Hit_num>
  <Hit_id>pdb|2Q3Y|A</Hit_id>
  <Hit_def>Ancestral Corticiod Receptor in Complex with DOC [unidentified]</Hit_def>
  <Hit_accession>2Q3Y_A</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>354.755</Hsp_bit-score>
      <Hsp_score>909</Hsp_score>
      <Hsp_evalue>2.16836e-124</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>255</Hsp_query-to>
      <Hsp_hit-from>4</Hsp_hit-from>
      <Hsp_hit-to>249</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>162</Hsp_identity>
      <Hsp_positive>208</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>246</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHK</Hsp_qseq>
      <Hsp_hseq>LISILEAIEPEVVYAGYDNSQPDTTNYLLSSLNRLAGKQMVSVVKWAKALPGFRNLHLDDQMTLIQYSWMSLMAFSLGWRSYKHTNGQMLYFAPDLIFNEERMQQSAMYDLCQGMRQISQEFVRLQVTYEEFLCMKVLLLLSTVPKDGLKSQASFDEMRMNYIKELRRAIARNENNSSQNWQRFYQLTKLLDSMHDLVGGLLQFCFYTFVQSQALSVEFPEMLVEIISDQLPKVMAGMAKPLLFHK</Hsp_hseq>
      <Hsp_midline>LI++L +IEP+V+YAG+DN++PDT++ LL+SLN+L  +Q++SVVKW+K+LPGFRNLH+DDQ+TLIQYSWMSLM F LGWRSYKH +GQMLYFAPDLI NE+RM++S+ Y LC  M QI QEFV+LQV+ EEFLCMKVLLLL+T+P +GL+SQ  F+EMR +YI+EL +AI   +     + QRFYQLTKLLD++HDLV  L  +C  TF+QS+ALSVEFPEM+ E+I+ QLPK++AGM KPLLFHK</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>13</Hit_num>
  <Hit_id>pdb|3RY9|A</Hit_id>
  <Hit_def>Crystal Structure of the Resurrected Ancestral Glucocorticoid Receptor 1 in complex with DOC [Leucoraja erinacea] &gt;pdb|3RY9|B Crystal Structure of the Resurrected Ancestral Glucocorticoid Receptor 1 in complex with DOC [Leucoraja erinacea]</Hit_def>
  <Hit_accession>3RY9_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>349.362</Hsp_bit-score>
      <Hsp_score>895</Hsp_score>
      <Hsp_evalue>2.8071e-122</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>2</Hsp_hit-from>
      <Hsp_hit-to>250</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>161</Hsp_identity>
      <Hsp_positive>207</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PTMISILEAIEPDVIYAGYDSTLPDTTNRLLSSLNRLGGRQMISAVKWAKALPGFRNLHLDDQMTLLQYSWMSLMAFSLGWRSYQHTNGNMLYFAPDLIFNEERMQQSSMYELCKGMHKISLEFVRLQVSYEEYLCMKVLLLLSTVPKDGLKSQAAFDEIRMSYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHDLVGGLLQFCFYTFVESKTLSVEFPEMLVEIISNQLPKVMAGMAKPLLFHQK</Hsp_hseq>
      <Hsp_midline>P +I++L +IEPDVIYAG+D+T PDT++ LL+SLN+LG RQ++S VKW+K+LPGFRNLH+DDQ+TL+QYSWMSLM F LGWRSY+H +G MLYFAPDLI NE+RM++SS Y LC  M +I  EFV+LQVS EE+LCMKVLLLL+T+P +GL+SQ  F+E+R SYI+EL KAI  R+     + QRFYQLTKLLD++HDLV  L  +C  TF++S+ LSVEFPEM+ E+I+ QLPK++AGM KPLLFH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>14</Hit_num>
  <Hit_id>pdb|6W9M|A</Hit_id>
  <Hit_def>Structure of the Ancestral Glucocorticoid Receptor 2 ligand binding domain in complex with vamorolone and SHP coregulator fragment [synthetic construct]</Hit_def>
  <Hit_accession>6W9M_A</Hit_accession>
  <Hit_len>251</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>315.464</Hsp_bit-score>
      <Hsp_score>807</Hsp_score>
      <Hsp_evalue>8.45297e-109</Hsp_evalue>
      <Hsp_query-from>7</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>3</Hsp_hit-from>
      <Hsp_hit-to>251</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>149</Hsp_identity>
      <Hsp_positive>200</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>250</Hsp_align-len>
      <Hsp_qseq>IPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>FPTLISLLEVIEPEVLYSGYDSTLPDTSTRLMSTLNRLGGRQVVSAVKWAKALPGFRNLHLDDQMTLLQYSWMSLMAFSLGWRSYKQSNGNMLCFAPDLVINEERMQLPYMYDQCQQMLKISSEFVRLQVSYDEYLCMKVLLLLSTVPKDGLKSQAVFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEMVGGLLQFCFYTFV-NKSLSVEFPEMLAEIISNQLPKFKAGSVKPLLFHQK</Hsp_hseq>
      <Hsp_midline> P LI+LL  IEP+V+Y+G+D+T PDTS+ L+++LN+LG RQ++S VKW+K+LPGFRNLH+DDQ+TL+QYSWMSLM F LGWRSYK  +G ML FAPDL++NE+RM+    Y  C  M +I  EFV+LQVS +E+LCMKVLLLL+T+P +GL+SQ  F+E+R +YI+EL KAI  R+     + QRFYQLTKLLD++H++V  L  +C  TF+ +++LSVEFPEM++E+I+ QLPK  AG VKPLLFH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>15</Hit_num>
  <Hit_id>pdb|3GN8|A</Hit_id>
  <Hit_def>X-ray Crystal Structure of AncGR2 in Complex with Dexamethasone [Homo sapiens] &gt;pdb|3GN8|B X-ray Crystal Structure of AncGR2 in Complex with Dexamethasone [Homo sapiens] &gt;pdb|6W9K|A Structure of the Ancestral Glucocorticoid Receptor 2 ligand binding domain in complex with Prednisolone and PGC1a coregulator fragment [synthetic construct]</Hit_def>
  <Hit_accession>3GN8_A</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>315.079</Hsp_bit-score>
      <Hsp_score>806</Hsp_score>
      <Hsp_evalue>9.93024e-109</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>2</Hsp_hit-from>
      <Hsp_hit-to>249</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>149</Hsp_identity>
      <Hsp_positive>200</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PTLISLLEVIEPEVLYSGYDSTLPDTSTRLMSTLNRLGGRQVVSAVKWAKALPGFRNLHLDDQMTLLQYSWMSLMAFSLGWRSYKQSNGNMLCFAPDLVINEERMQLPYMYDQCQQMLKISSEFVRLQVSYDEYLCMKVLLLLSTVPKDGLKSQAVFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEMVGGLLQFCFYTFV-NKSLSVEFPEMLAEIISNQLPKFKAGSVKPLLFHQK</Hsp_hseq>
      <Hsp_midline>P LI+LL  IEP+V+Y+G+D+T PDTS+ L+++LN+LG RQ++S VKW+K+LPGFRNLH+DDQ+TL+QYSWMSLM F LGWRSYK  +G ML FAPDL++NE+RM+    Y  C  M +I  EFV+LQVS +E+LCMKVLLLL+T+P +GL+SQ  F+E+R +YI+EL KAI  R+     + QRFYQLTKLLD++H++V  L  +C  TF+ +++LSVEFPEM++E+I+ QLPK  AG VKPLLFH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>16</Hit_num>
  <Hit_id>pdb|6NWK|A</Hit_id>
  <Hit_def>Structure of the Ancestral Glucocorticoid Receptor 2 ligand binding domain in complex with dexamethasone and PGC1a coregulator fragment [Homo sapiens] &gt;pdb|6NWL|A Structure of the Ancestral Glucocorticoid Receptor 2 ligand binding domain in complex with hydrocortisone and PGC1a coregulator fragment [Homo sapiens] &gt;pdb|6W9L|A Structure of the Ancestral Glucocorticoid Receptor 2 ligand binding domain in complex with deacetylated deflazacort and PGC1a coregulator fragment [synthetic construct]</Hit_def>
  <Hit_accession>6NWK_A</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>315.079</Hsp_bit-score>
      <Hsp_score>806</Hsp_score>
      <Hsp_evalue>1.02615e-108</Hsp_evalue>
      <Hsp_query-from>7</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>249</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>149</Hsp_identity>
      <Hsp_positive>200</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>250</Hsp_align-len>
      <Hsp_qseq>IPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>FPTLISLLEVIEPEVLYSGYDSTLPDTSTRLMSTLNRLGGRQVVSAVKWAKALPGFRNLHLDDQMTLLQYSWMSLMAFSLGWRSYKQSNGNMLCFAPDLVINEERMQLPYMYDQCQQMLKISSEFVRLQVSYDEYLCMKVLLLLSTVPKDGLKSQAVFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEMVGGLLQFCFYTFV-NKSLSVEFPEMLAEIISNQLPKFKAGSVKPLLFHQK</Hsp_hseq>
      <Hsp_midline> P LI+LL  IEP+V+Y+G+D+T PDTS+ L+++LN+LG RQ++S VKW+K+LPGFRNLH+DDQ+TL+QYSWMSLM F LGWRSYK  +G ML FAPDL++NE+RM+    Y  C  M +I  EFV+LQVS +E+LCMKVLLLL+T+P +GL+SQ  F+E+R +YI+EL KAI  R+     + QRFYQLTKLLD++H++V  L  +C  TF+ +++LSVEFPEM++E+I+ QLPK  AG VKPLLFH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>17</Hit_num>
  <Hit_id>pdb|4E2J|A</Hit_id>
  <Hit_def>X-Ray Crystal Structure of the Ancestral Glucocorticoid Receptor 2 ligand binding domain in complex with mometasone furoate and TIF-2 coactivator fragment [Neolamprologus pulcher] &gt;pdb|4E2J|B X-Ray Crystal Structure of the Ancestral Glucocorticoid Receptor 2 ligand binding domain in complex with mometasone furoate and TIF-2 coactivator fragment [Neolamprologus pulcher]</Hit_def>
  <Hit_accession>4E2J_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>313.538</Hsp_bit-score>
      <Hsp_score>802</Hsp_score>
      <Hsp_evalue>3.77672e-108</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>255</Hsp_query-to>
      <Hsp_hit-from>4</Hsp_hit-from>
      <Hsp_hit-to>250</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>148</Hsp_identity>
      <Hsp_positive>199</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>248</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHK</Hsp_qseq>
      <Hsp_hseq>PTLISLLEVIEPEVLYSGYDSTLPDTSTRLMSTLNRLGGRQVVSAVKWAKALPGFRNLHLDDQMTLLQYSWMSLMAFSLGWRSYKQSNGNMLCFAPDLVINEERMQLPYMYDQCQQMLKISSEFVRLQVSYDEYLCMKVLLLLSTVPKDGLKSQAVFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEMVGGLLQFCFYTFV-NKSLSVEFPEMLAEIISNQLPKFKAGSVKPLLFHQ</Hsp_hseq>
      <Hsp_midline>P LI+LL  IEP+V+Y+G+D+T PDTS+ L+++LN+LG RQ++S VKW+K+LPGFRNLH+DDQ+TL+QYSWMSLM F LGWRSYK  +G ML FAPDL++NE+RM+    Y  C  M +I  EFV+LQVS +E+LCMKVLLLL+T+P +GL+SQ  F+E+R +YI+EL KAI  R+     + QRFYQLTKLLD++H++V  L  +C  TF+ +++LSVEFPEM++E+I+ QLPK  AG VKPLLFH+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>18</Hit_num>
  <Hit_id>pdb|5UFS|A</Hit_id>
  <Hit_def>X-Ray Crystal Structure of the Ancestral Glucocorticoid Receptor 2 ligand binding domain in complex with triamcinolone acetonide and SHP coregulator fragment [unidentified] &gt;pdb|5UFS|B X-Ray Crystal Structure of the Ancestral Glucocorticoid Receptor 2 ligand binding domain in complex with triamcinolone acetonide and SHP coregulator fragment [unidentified]</Hit_def>
  <Hit_accession>5UFS_A</Hit_accession>
  <Hit_len>248</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>313.153</Hsp_bit-score>
      <Hsp_score>801</Hsp_score>
      <Hsp_evalue>5.22795e-108</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>255</Hsp_query-to>
      <Hsp_hit-from>2</Hsp_hit-from>
      <Hsp_hit-to>248</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>148</Hsp_identity>
      <Hsp_positive>199</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>248</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHK</Hsp_qseq>
      <Hsp_hseq>PTLISLLEVIEPEVLYSGYDSTLPDTSTRLMSTLNRLGGRQVVSAVKWAKALPGFRNLHLDDQMTLLQYSWMSLMAFSLGWRSYKQSNGNMLCFAPDLVINEERMQLPYMYDQCQQMLKISSEFVRLQVSYDEYLCMKVLLLLSTVPKDGLKSQAVFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEMVGGLLQFCFYTFV-NKSLSVEFPEMLAEIISNQLPKFKAGSVKPLLFHQ</Hsp_hseq>
      <Hsp_midline>P LI+LL  IEP+V+Y+G+D+T PDTS+ L+++LN+LG RQ++S VKW+K+LPGFRNLH+DDQ+TL+QYSWMSLM F LGWRSYK  +G ML FAPDL++NE+RM+    Y  C  M +I  EFV+LQVS +E+LCMKVLLLL+T+P +GL+SQ  F+E+R +YI+EL KAI  R+     + QRFYQLTKLLD++H++V  L  +C  TF+ +++LSVEFPEM++E+I+ QLPK  AG VKPLLFH+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>19</Hit_num>
  <Hit_id>pdb|3RLL|A</Hit_id>
  <Hit_def>Crystal structure of the T877A androgen receptor ligand binding domain in complex with (S)-N-(4-Cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanonaphthalen-1-yloxy)-2-hydroxy-2-methylpropanamide [Homo sapiens]</Hit_def>
  <Hit_accession>3RLL_A</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>309.301</Hsp_bit-score>
      <Hsp_score>791</Hsp_score>
      <Hsp_evalue>1.67259e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>254</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>247</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>194</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>247</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFH</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFAFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFH</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>20</Hit_num>
  <Hit_id>pdb|2OZ7|A</Hit_id>
  <Hit_def>Crystal structure of the human androgen receptor T877A mutant ligand-binding domain with cyproterone acetate [Homo sapiens]</Hit_def>
  <Hit_accession>2OZ7_A</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>309.301</Hsp_bit-score>
      <Hsp_score>791</Hsp_score>
      <Hsp_evalue>1.77159e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>249</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>195</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFAFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>21</Hit_num>
  <Hit_id>pdb|5JJM|B</Hit_id>
  <Hit_def>Crystal Structure of Homodimeric Androgen Receptor Ligand-Binding Domain bound to DHT and LxxLL peptide [Homo sapiens]</Hit_def>
  <Hit_accession>5JJM_B</Hit_accession>
  <Hit_len>252</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>309.301</Hsp_bit-score>
      <Hsp_score>791</Hsp_score>
      <Hsp_evalue>1.89956e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>4</Hsp_hit-from>
      <Hsp_hit-to>252</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>195</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVXAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>22</Hit_num>
  <Hit_id>pdb|2AX6|A</Hit_id>
  <Hit_def>Crystal Structure Of The Androgen Receptor Ligand Binding Domain T877A Mutant In Complex With Hydroxyflutamide [Homo sapiens] &gt;pdb|2AX7|A Crystal Structure Of The Androgen Receptor Ligand Binding Domain T877A Mutant In Complex With S-1 [Homo sapiens]</Hit_def>
  <Hit_accession>2AX6_A</Hit_accession>
  <Hit_len>256</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>309.301</Hsp_bit-score>
      <Hsp_score>791</Hsp_score>
      <Hsp_evalue>2.27481e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>8</Hsp_hit-from>
      <Hsp_hit-to>256</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>195</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFAFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>23</Hit_num>
  <Hit_id>pdb|5JJM|A</Hit_id>
  <Hit_def>Crystal Structure of Homodimeric Androgen Receptor Ligand-Binding Domain bound to DHT and LxxLL peptide [Homo sapiens] &gt;pdb|5JJM|C Crystal Structure of Homodimeric Androgen Receptor Ligand-Binding Domain bound to DHT and LxxLL peptide [Homo sapiens] &gt;pdb|5JJM|D Crystal Structure of Homodimeric Androgen Receptor Ligand-Binding Domain bound to DHT and LxxLL peptide [Homo sapiens]</Hit_def>
  <Hit_accession>5JJM_A</Hit_accession>
  <Hit_len>252</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>309.301</Hsp_bit-score>
      <Hsp_score>791</Hsp_score>
      <Hsp_evalue>2.33821e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>4</Hsp_hit-from>
      <Hsp_hit-to>252</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>195</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>24</Hit_num>
  <Hit_id>pdb|3RLJ|A</Hit_id>
  <Hit_def>Crystal structure of the androgen receptor ligand binding domain in complex with SARM S-22 [Homo sapiens]</Hit_def>
  <Hit_accession>3RLJ_A</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>308.916</Hsp_bit-score>
      <Hsp_score>790</Hsp_score>
      <Hsp_evalue>2.37342e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>254</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>247</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>194</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>247</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFH</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFH</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>25</Hit_num>
  <Hit_id>pdb|2Z4J|A</Hit_id>
  <Hit_def>Crystal structure of AR LBD with SHP peptide NR Box 2 [Homo sapiens]</Hit_def>
  <Hit_accession>2Z4J_A</Hit_accession>
  <Hit_len>248</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>308.916</Hsp_bit-score>
      <Hsp_score>790</Hsp_score>
      <Hsp_evalue>2.37677e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>254</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>247</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>194</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>247</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFH</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFH</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>26</Hit_num>
  <Hit_id>pdb|1XOW|A</Hit_id>
  <Hit_def>Crystal structure of the human androgen receptor ligand binding domain bound with an androgen receptor NH2-terminal peptide, AR20-30, and R1881 [Homo sapiens] &gt;pdb|1XQ3|A Crystal structure of the human androgen receptor ligand binding domain bound with R1881 [Homo sapiens] &gt;pdb|2AO6|A Crystal structure of the human androgen receptor ligand binding domain bound with TIF2(iii) 740-753 peptide and R1881 [Homo sapiens] &gt;pdb|2YHD|A Human androgen receptor in complex with AF2 small molecule inhibitor [Homo sapiens] &gt;pdb|3B5R|A Crystal structure of the androgen receptor ligand binding domain in complex with SARM C-31 [Homo sapiens] &gt;pdb|3B65|A Crystal structure of the androgen receptor ligand binding domain in complex with SARM S-24 [Homo sapiens] &gt;pdb|3B66|A Crystal structure of the androgen receptor ligand binding domain in complex with SARM S-21 [Homo sapiens] &gt;pdb|3B67|A Crystal structure of the androgen receptor ligand binding domain in complex with SARM C-23 [Homo sapiens] &gt;pdb|3B68|A Crystal structure of the androgen receptor ligand binding domain in complex with SARM S-4 [Homo sapiens] &gt;pdb|3V4A|A Structure of ar lbd with activator peptide and sarm inhibitor 2 [Homo sapiens]</Hit_def>
  <Hit_accession>1XOW_A</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>308.916</Hsp_bit-score>
      <Hsp_score>790</Hsp_score>
      <Hsp_evalue>2.40626e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>249</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>195</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>27</Hit_num>
  <Hit_id>pdb|4OGH|A</Hit_id>
  <Hit_def>Crystal structure of T877A-AR-LBD [Homo sapiens] &gt;pdb|4OH5|A Crystal structure of T877A-AR-LBD bound with co-regulator peptide [Homo sapiens] &gt;pdb|4OH6|A Crystal structure of T877A-AR-LBD bound with co-regulator peptide [Homo sapiens] &gt;pdb|4OHA|A Crystal structure of T877A-AR-LBD bound with co-regulator peptide [Homo sapiens] &gt;pdb|4OIL|A Crystal structure of T877A-AR-LBD bound with co-regulator peptide [Homo sapiens] &gt;pdb|4OIU|A Crystal structure of T877A-AR-LBD bound with co-regulator peptide [Homo sapiens] &gt;pdb|4OJ9|A Crystal structure of T877A-AR-LBD bound with co-regulator peptide [Homo sapiens]</Hit_def>
  <Hit_accession>4OGH_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>308.916</Hsp_bit-score>
      <Hsp_score>790</Hsp_score>
      <Hsp_evalue>2.4096e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>2</Hsp_hit-from>
      <Hsp_hit-to>250</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>194</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSAMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFAFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+  MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>28</Hit_num>
  <Hit_id>pdb|5VO4|A</Hit_id>
  <Hit_def>Crystal Structure Of The Androgen Receptor Ligand Binding Domain In Complex With 5-(2-fluoro-4-hydroxyphenyl)-1-methyl-1H-pyrrole-2-carbonitrile [Homo sapiens]</Hit_def>
  <Hit_accession>5VO4_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>308.916</Hsp_bit-score>
      <Hsp_score>790</Hsp_score>
      <Hsp_evalue>2.7176e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>2</Hsp_hit-from>
      <Hsp_hit-to>250</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>195</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>29</Hit_num>
  <Hit_id>pdb|2HVC|A</Hit_id>
  <Hit_def>The Crystal Structure of Ligand-binding Domain (LBD) of human Androgen Receptor in Complex with a selective modulator LGD2226 [Homo sapiens]</Hit_def>
  <Hit_accession>2HVC_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>308.916</Hsp_bit-score>
      <Hsp_score>790</Hsp_score>
      <Hsp_evalue>2.74748e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>254</Hsp_query-to>
      <Hsp_hit-from>3</Hsp_hit-from>
      <Hsp_hit-to>249</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>194</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>247</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFH</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFH</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>30</Hit_num>
  <Hit_id>pdb|2AX9|A</Hit_id>
  <Hit_def>Crystal Structure Of The Androgen Receptor Ligand Binding Domain In Complex With R-3 [Homo sapiens] &gt;pdb|2AXA|A Crystal Structure Of The Androgen Receptor Ligand Binding Domain In Complex With S-1 [Homo sapiens] &gt;pdb|2YLO|A Targeting The Binding Function 3 Site Of The Androgen Receptor Through In Silico Molecular Modeling [Homo sapiens] &gt;pdb|2YLP|A Targeting The Binding Function 3 Site Of The Androgen Receptor Through In Silico Molecular Modeling [Homo sapiens] &gt;pdb|2YLQ|A Targeting The Binding Function 3 Site Of The Androgen Receptor Through In Silico Molecular Modeling [Homo sapiens] &gt;pdb|3ZQT|A Targeting The Binding Function 3 Site Of The Androgen Receptor Through In Silico Molecular Modeling [Escherichia coli BL21(DE3)] &gt;pdb|4HLW|A Targeting the Binding Function 3 (BF3) Site of the Human Androgen Receptor Through Virtual Screening. 2. Development of 2-((2-phenoxyethyl) thio)-1H-benzoimidazole derivatives. [Homo sapiens]</Hit_def>
  <Hit_accession>2AX9_A</Hit_accession>
  <Hit_len>256</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>308.916</Hsp_bit-score>
      <Hsp_score>790</Hsp_score>
      <Hsp_evalue>2.98992e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>8</Hsp_hit-from>
      <Hsp_hit-to>256</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>195</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>31</Hit_num>
  <Hit_id>pdb|3L3X|A</Hit_id>
  <Hit_def>Crystal structure of DHT-bound androgen receptor in complex with the first motif of steroid receptor coactivator 3 [Homo sapiens] &gt;pdb|3L3Z|A Crystal structure of DHT-bound androgen receptor in complex with the third motif of steroid receptor coactivator 3 [Homo sapiens]</Hit_def>
  <Hit_accession>3L3X_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>308.916</Hsp_bit-score>
      <Hsp_score>790</Hsp_score>
      <Hsp_evalue>3.06497e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>254</Hsp_query-to>
      <Hsp_hit-from>3</Hsp_hit-from>
      <Hsp_hit-to>249</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>194</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>247</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFH</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFH</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>32</Hit_num>
  <Hit_id>pdb|1T5Z|A</Hit_id>
  <Hit_def>Crystal Structure of the Androgen Receptor Ligand Binding Domain (LBD) with DHT and a peptide derived from its physiological coactivator ARA70 [Homo sapiens] &gt;pdb|1T63|A Crystal Structure of the Androgen Receptor Ligand Binding Domain with DHT and a peptide derived from its physiological coactivator GRIP1 NR box3 [Homo sapiens] &gt;pdb|1T65|A Crystal structure of the androgen receptor ligand binding domain with DHT and a peptide derived form its physiological coactivator GRIP1 NR box 2 bound in a non-helical conformation [Homo sapiens] &gt;pdb|2PIO|A Androgen receptor LBD with small molecule [Homo sapiens] &gt;pdb|2PIP|L Androgen receptor LBD with small molecule [Homo sapiens] &gt;pdb|2PIQ|A androgen receptor LBD with small molecule [Homo sapiens] &gt;pdb|2PIR|A Androgen receptor LBD with small molecule [Homo sapiens] &gt;pdb|2PIT|A Androgen receptor LBD with small molecule [Homo sapiens] &gt;pdb|2PIU|A Androgen receptor LBD with small molecule [Homo sapiens] &gt;pdb|2PIV|A Androgen receptor with small molecule [Homo sapiens] &gt;pdb|2PIW|A Androgen receptor with small molecule [Homo sapiens] &gt;pdb|2PIX|A AR LBD with small molecule [Homo sapiens] &gt;pdb|2PKL|A Androgen receptor LBD with small molecule [Homo sapiens] &gt;pdb|2QPY|A AR LBD with small molecule [Mus musculus]</Hit_def>
  <Hit_accession>1T5Z_A</Hit_accession>
  <Hit_len>251</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>308.916</Hsp_bit-score>
      <Hsp_score>790</Hsp_score>
      <Hsp_evalue>3.27728e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>3</Hsp_hit-from>
      <Hsp_hit-to>251</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>195</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>33</Hit_num>
  <Hit_id>pdb|1XJ7|A</Hit_id>
  <Hit_def>Complex Androgen Receptor LBD and RAC3 peptide [Homo sapiens] &gt;pdb|2Q7I|A The Wild Type Androgen Receptor Ligand Binding Domain Bound with Testosterone and an AR 20-30 Peptide [Homo sapiens] &gt;pdb|2Q7J|A The Wild Type Androgen Receptor Ligand Binding Domain Bound with Testosterone and a TIF2 box 3 Coactivator Peptide 740-753 [Homo sapiens]</Hit_def>
  <Hit_accession>1XJ7_A</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>308.916</Hsp_bit-score>
      <Hsp_score>790</Hsp_score>
      <Hsp_evalue>3.30335e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>9</Hsp_hit-from>
      <Hsp_hit-to>257</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>195</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>34</Hit_num>
  <Hit_id>pdb|1E3G|A</Hit_id>
  <Hit_def>Human Androgen Receptor Ligand Binding in complex with the ligand metribolone (R1881) [Homo sapiens]</Hit_def>
  <Hit_accession>1E3G_A</Hit_accession>
  <Hit_len>263</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>309.301</Hsp_bit-score>
      <Hsp_score>791</Hsp_score>
      <Hsp_evalue>3.40162e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>15</Hsp_hit-from>
      <Hsp_hit-to>263</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>195</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>35</Hit_num>
  <Hit_id>pdb|1I38|A</Hit_id>
  <Hit_def>Crystal Structure Of The Rat Androgen Receptor Ligand Binding Domain T877a Mutant Complex With Dihydrotestosterone [Rattus norvegicus] &gt;pdb|1XNN|A Crystal Structure Of The Rat Androgen Receptor Ligand Binding Domain T877a Mutant Complex With (3a-Alpha-,4- Alpha 7-Alpha-,7a-Alpha-)-3a,4,7,7a-Tetrahydro-2-(4-Nitro- 1-Naphthalenyl)-4,7-Ethano-1h-Isoindole-1,3(2h)-Dione. [Rattus norvegicus]</Hit_def>
  <Hit_accession>1I38_A</Hit_accession>
  <Hit_len>260</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>308.916</Hsp_bit-score>
      <Hsp_score>790</Hsp_score>
      <Hsp_evalue>3.50219e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>12</Hsp_hit-from>
      <Hsp_hit-to>260</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>195</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFAFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>36</Hit_num>
  <Hit_id>pdb|5T8E|A</Hit_id>
  <Hit_def>Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part II: Optimization of 4-(pyrrolidin-1-yl)benzonitrile derivatives [Homo sapiens] &gt;pdb|5T8J|A Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part II: Optimization of 4-(pyrrolidin-1-yl)benzonitrile derivatives [Homo sapiens]</Hit_def>
  <Hit_accession>5T8E_A</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>308.916</Hsp_bit-score>
      <Hsp_score>790</Hsp_score>
      <Hsp_evalue>3.6099e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>10</Hsp_hit-from>
      <Hsp_hit-to>258</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>195</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>37</Hit_num>
  <Hit_id>pdb|4OEA|A</Hit_id>
  <Hit_def>Crystal structure of AR-LBD [Homo sapiens] &gt;pdb|4OED|A Crystal structure of AR-LBD bound with co-regulator peptide [Homo sapiens] &gt;pdb|4OEY|A Crystal structure of AR-LBD bound with co-regulator peptide [Homo sapiens] &gt;pdb|4OEZ|A Crystal structure of AR-LBD bound with co-regulator peptide [Homo sapiens] &gt;pdb|4OFR|A Crystal structure of AR-LBD bound with co-regulator peptide [Homo sapiens] &gt;pdb|4OFU|A Crystal structure of AR-LBD bound with co-regulator peptide [Homo sapiens]</Hit_def>
  <Hit_accession>4OEA_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>308.531</Hsp_bit-score>
      <Hsp_score>789</Hsp_score>
      <Hsp_evalue>4.20872e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>2</Hsp_hit-from>
      <Hsp_hit-to>250</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>194</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSAMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+  MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>38</Hit_num>
  <Hit_id>pdb|2AM9|A</Hit_id>
  <Hit_def>Crystal structure of human androgen receptor ligand binding domain in complex with testosterone [Homo sapiens] &gt;pdb|2AMA|A Crystal structure of human androgen receptor ligand binding domain in complex with dihydrotestosterone [Homo sapiens] &gt;pdb|2AMB|A Crystal structure of human androgen receptor ligand binding domain in complex with tetrahydrogestrinone [Homo sapiens] &gt;pdb|2PNU|A Crystal structure of human androgen receptor ligand-binding domain in complex with EM-5744 [Homo sapiens] &gt;pdb|3V49|A Structure of ar lbd with activator peptide and sarm inhibitor 1 [Homo sapiens]</Hit_def>
  <Hit_accession>2AM9_A</Hit_accession>
  <Hit_len>266</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>308.916</Hsp_bit-score>
      <Hsp_score>790</Hsp_score>
      <Hsp_evalue>4.38946e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>18</Hsp_hit-from>
      <Hsp_hit-to>266</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>195</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>39</Hit_num>
  <Hit_id>pdb|4QL8|A</Hit_id>
  <Hit_def>Crystal structure of Androgen Receptor in complex with the ligand [Homo sapiens]</Hit_def>
  <Hit_accession>4QL8_A</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>308.531</Hsp_bit-score>
      <Hsp_score>789</Hsp_score>
      <Hsp_evalue>4.59728e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>11</Hsp_hit-from>
      <Hsp_hit-to>259</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>195</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>40</Hit_num>
  <Hit_id>pdb|1I37|A</Hit_id>
  <Hit_def>Crystal Structure Of The Rat Androgen Receptor Ligand Binding Domain Complex With Dihydrotestosterone [Rattus norvegicus] &gt;pdb|2IHQ|A Crystal Structure of the Rat Androgen Receptor Ligand Binding Domian Complex with an N-Aryl-Hydroxybicyclohydantoin [Rattus norvegicus] &gt;pdb|2NW4|A Crystal Structure of the Rat Androgen Receptor Ligand Binding Domain Complex with BMS-564929 [Rattus norvegicus] &gt;pdb|3G0W|A Crystal structure of the rat androgen receptor ligand binding domain complex with an n-aryl-oxazolidin 2-imine inhibitor [Rattus norvegicus]</Hit_def>
  <Hit_accession>1I37_A</Hit_accession>
  <Hit_len>260</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>308.531</Hsp_bit-score>
      <Hsp_score>789</Hsp_score>
      <Hsp_evalue>4.70474e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>12</Hsp_hit-from>
      <Hsp_hit-to>260</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>195</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>41</Hit_num>
  <Hit_id>pdb|4K7A|A</Hit_id>
  <Hit_def>Crystal structure of the androgen receptor ligand binding domain in complex with minoxidil [Homo sapiens]</Hit_def>
  <Hit_accession>4K7A_A</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>308.145</Hsp_bit-score>
      <Hsp_score>788</Hsp_score>
      <Hsp_evalue>4.74019e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>254</Hsp_query-to>
      <Hsp_hit-from>2</Hsp_hit-from>
      <Hsp_hit-to>248</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>193</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>247</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFH</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSAMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFH</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+  MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>42</Hit_num>
  <Hit_id>pdb|1T73|A</Hit_id>
  <Hit_def>Crystal structure of the androgen receptor ligand binding domain in complex with a FxxFF motif [Pan troglodytes] &gt;pdb|1T74|A Crystal structure of the androgen receptor ligand binding domain in complex with a WxxLF motif [Pan troglodytes] &gt;pdb|1T76|A Crystal structure of the androgen receptor ligand binding domain in complex with a WxxVW motif [Pan troglodytes] &gt;pdb|1T79|A Crystal structure of the androgen receptor ligand binding domain in complex with a FxxLW motif [Pan troglodytes] &gt;pdb|1T7F|A Crystal structure of the androgen receptor ligand binding domain in complex with a LxxLL motif [Pan troglodytes] &gt;pdb|1T7M|A Crystal structure of the androgen receptor ligand binding domain in complex with a FxxYF motif [Pan troglodytes] &gt;pdb|1T7R|A Crystal structure of the androgen receptor ligand binding domain in complex with a FxxLF motif [Pan troglodytes] &gt;pdb|1T7T|A Crystal structure of the androgen receptor ligand binding domain in complex with 5-alpha dihydrotestosterone [Pan troglodytes]</Hit_def>
  <Hit_accession>1T73_A</Hit_accession>
  <Hit_len>269</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>308.916</Hsp_bit-score>
      <Hsp_score>790</Hsp_score>
      <Hsp_evalue>4.96707e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>21</Hsp_hit-from>
      <Hsp_hit-to>269</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>195</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>43</Hit_num>
  <Hit_id>pdb|5CJ6|A</Hit_id>
  <Hit_def>Crystal Structure of a Selective Androgen Receptor Modulator Bound to the Ligand Binding Domain of the Human Androgen Receptor [Homo sapiens]</Hit_def>
  <Hit_accession>5CJ6_A</Hit_accession>
  <Hit_len>283</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>308.916</Hsp_bit-score>
      <Hsp_score>790</Hsp_score>
      <Hsp_evalue>7.38377e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>33</Hsp_hit-from>
      <Hsp_hit-to>281</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>195</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>44</Hit_num>
  <Hit_id>pdb|5V8Q|A</Hit_id>
  <Hit_def>Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs): Part III [Homo sapiens]</Hit_def>
  <Hit_accession>5V8Q_A</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>307.76</Hsp_bit-score>
      <Hsp_score>787</Hsp_score>
      <Hsp_evalue>8.84087e-106</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>249</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>194</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACARKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I   +K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>45</Hit_num>
  <Hit_id>pdb|1GS4|A</Hit_id>
  <Hit_def>Structural basis for the glucocorticoid response in a mutant human androgen receptor (ARccr) derived from an androgen-independent prostate cancer [Homo sapiens]</Hit_def>
  <Hit_accession>1GS4_A</Hit_accession>
  <Hit_len>248</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>306.99</Hsp_bit-score>
      <Hsp_score>785</Hsp_score>
      <Hsp_evalue>1.57617e-105</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>254</Hsp_query-to>
      <Hsp_hit-from>2</Hsp_hit-from>
      <Hsp_hit-to>248</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>136</Hsp_identity>
      <Hsp_positive>193</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>247</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFH</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALHSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFAFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFH</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++L +SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>46</Hit_num>
  <Hit_id>pdb|2Q7K|A</Hit_id>
  <Hit_def>The Androgen Receptor Prostate Cancer Mutant H874Y Ligand Binding Domain Bound with Testosterone and an AR 20-30 Peptide [Homo sapiens] &gt;pdb|2Q7L|A The Androgen Receptor Prostate Cancer Mutant H874Y Ligand Binding Domain Bound with Testosterone and a TIF2 box3 Coactivator Peptide 740-753 [Homo sapiens]</Hit_def>
  <Hit_accession>2Q7K_A</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>306.605</Hsp_bit-score>
      <Hsp_score>784</Hsp_score>
      <Hsp_evalue>3.21052e-105</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>9</Hsp_hit-from>
      <Hsp_hit-to>257</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>136</Hsp_identity>
      <Hsp_positive>195</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELYQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYSWM LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++L+ +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>47</Hit_num>
  <Hit_id>pdb|4OJB|A</Hit_id>
  <Hit_def>Crystal structure of W741L-AR-LBD [Homo sapiens] &gt;pdb|4OK1|A Crystal structure of W741L-AR-LBD bound with co-regulator peptide [Homo sapiens] &gt;pdb|4OKB|A Crystal structure of W741L-AR-LBD bound with co-regulator peptide [Homo sapiens] &gt;pdb|4OKT|A Crystal structure of W741L-AR-LBD bound with co-regulator peptide [Homo sapiens] &gt;pdb|4OKW|A Crystal structure of W741L-AR-LBD bound with co-regulator peptide [Homo sapiens] &gt;pdb|4OKX|A Crystal structure of W741L-AR-LBD bound with co-regulator peptide [Homo sapiens] &gt;pdb|4OLM|A Crystal structure of W741L-AR-LBD bound with co-regulator peptide [Homo sapiens]</Hit_def>
  <Hit_accession>4OJB_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>303.908</Hsp_bit-score>
      <Hsp_score>777</Hsp_score>
      <Hsp_evalue>2.30241e-104</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>2</Hsp_hit-from>
      <Hsp_hit-to>250</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>136</Hsp_identity>
      <Hsp_positive>193</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSLMGLMVFAMGWRSFTNVNSAMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYS M LMVF +GWRS+ +V+  MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>48</Hit_num>
  <Hit_id>pdb|2AX8|A</Hit_id>
  <Hit_def>Crystal Structure Of The Androgen Receptor Ligand Binding Domain W741L Mutant In Complex With S-1 [Homo sapiens]</Hit_def>
  <Hit_accession>2AX8_A</Hit_accession>
  <Hit_len>256</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>303.908</Hsp_bit-score>
      <Hsp_score>777</Hsp_score>
      <Hsp_evalue>2.82399e-104</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>8</Hsp_hit-from>
      <Hsp_hit-to>256</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>136</Hsp_identity>
      <Hsp_positive>194</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSLMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</Hsp_hseq>
      <Hsp_midline>P  +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYS M LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>49</Hit_num>
  <Hit_id>pdb|1Z95|A</Hit_id>
  <Hit_def>Crystal Structure of the Androgen Receptor Ligand-binding Domain W741L Mutant Complex with R-bicalutamide [Homo sapiens]</Hit_def>
  <Hit_accession>1Z95_A</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>302.753</Hsp_bit-score>
      <Hsp_score>774</Hsp_score>
      <Hsp_evalue>6.83582e-104</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>254</Hsp_query-to>
      <Hsp_hit-from>2</Hsp_hit-from>
      <Hsp_hit-to>246</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>135</Hsp_identity>
      <Hsp_positive>192</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>245</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFH</Hsp_qseq>
      <Hsp_hseq>FLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSLMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFH</Hsp_hseq>
      <Hsp_midline> +N+L +IEP V+ AGHDN +PD+ ++LL+SLN+LGERQL+ VVKW+K+LPGFRNLH+DDQ+ +IQYS M LMVF +GWRS+ +V+ +MLYFAPDL+ NE RM +S  YS C+ M  + QEF  LQ++ +EFLCMK LLL + IP++GL++Q  F+E+R +YI+EL + I  ++K   S S+RFYQLTKLLD++  + ++LH +  +  I+S  +SV+FPEMM+E+I+ Q+PKIL+G VKP+ FH</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>50</Hit_num>
  <Hit_id>pdb|3VHV|A</Hit_id>
  <Hit_def>Mineralocorticoid receptor ligand-binding domain with non-steroidal antagonist [Homo sapiens]</Hit_def>
  <Hit_accession>3VHV_A</Hit_accession>
  <Hit_len>260</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>302.368</Hsp_bit-score>
      <Hsp_score>773</Hsp_score>
      <Hsp_evalue>1.32501e-103</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>10</Hsp_hit-from>
      <Hsp_hit-to>260</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>142</Hsp_identity>
      <Hsp_positive>192</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>251</Hsp_align-len>
      <Hsp_qseq>LIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>LTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPGFKNLPLEDQITLIQYSWMSLLSFALSWRSYKHTNSQFLYFAPDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMRTNYIKELRKMVTKCPNNSGQSWQRFYQLTKLLDSMHDLVSDLLEFCFYTFRESHALKVEFPAMLVEIISDQLPKVESGNVKPLYFHRK</Hsp_hseq>
      <Hsp_midline>L P  + +L +IEP+++YAG+D++KPDT+ +LL++LN+L  +Q++ VVKW+K LPGF+NL ++DQITLIQYSWMSL+ F L WRSYKH + Q LYFAPDL+ NE++M +S+ Y LC  M QI  +FV+LQ++ EE+  MKVLLLL+TIP +GL+SQ  FEEMR++YI+EL K +         S QRFYQLTKLLD++HDLV  L  +C  TF +S AL VEFP M+ E+I+ QLPK+ +G VKPL FH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>51</Hit_num>
  <Hit_id>pdb|3WFF|A</Hit_id>
  <Hit_def>Mineralocorticoid receptor ligand-binding domain with compound 2b [Homo sapiens] &gt;pdb|3WFG|A Mineralocorticoid receptor ligand-binding domain with compuond 2e [Homo sapiens] &gt;pdb|4PF3|A Mineralocorticoid receptor ligand-binding domain with compuond 37a [Homo sapiens]</Hit_def>
  <Hit_accession>3WFF_A</Hit_accession>
  <Hit_len>275</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>302.753</Hsp_bit-score>
      <Hsp_score>774</Hsp_score>
      <Hsp_evalue>1.56712e-103</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>25</Hsp_hit-from>
      <Hsp_hit-to>275</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>142</Hsp_identity>
      <Hsp_positive>192</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>251</Hsp_align-len>
      <Hsp_qseq>LIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>LTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPGFKNLPLEDQITLIQYSWMSLLSFALSWRSYKHTNSQFLYFAPDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMRTNYIKELRKMVTKCPNNSGQSWQRFYQLTKLLDSMHDLVSDLLEFCFYTFRESHALKVEFPAMLVEIISDQLPKVESGNVKPLYFHRK</Hsp_hseq>
      <Hsp_midline>L P  + +L +IEP+++YAG+D++KPDT+ +LL++LN+L  +Q++ VVKW+K LPGF+NL ++DQITLIQYSWMSL+ F L WRSYKH + Q LYFAPDL+ NE++M +S+ Y LC  M QI  +FV+LQ++ EE+  MKVLLLL+TIP +GL+SQ  FEEMR++YI+EL K +         S QRFYQLTKLLD++HDLV  L  +C  TF +S AL VEFP M+ E+I+ QLPK+ +G VKPL FH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>52</Hit_num>
  <Hit_id>pdb|2OAX|A</Hit_id>
  <Hit_def>Crystal structure of the S810L mutant mineralocorticoid receptor associated with SC9420 [Homo sapiens] &gt;pdb|2OAX|B Crystal structure of the S810L mutant mineralocorticoid receptor associated with SC9420 [Homo sapiens] &gt;pdb|2OAX|C Crystal structure of the S810L mutant mineralocorticoid receptor associated with SC9420 [Homo sapiens] &gt;pdb|2OAX|D Crystal structure of the S810L mutant mineralocorticoid receptor associated with SC9420 [Homo sapiens] &gt;pdb|2OAX|E Crystal structure of the S810L mutant mineralocorticoid receptor associated with SC9420 [Homo sapiens] &gt;pdb|2OAX|F Crystal structure of the S810L mutant mineralocorticoid receptor associated with SC9420 [Homo sapiens]</Hit_def>
  <Hit_accession>2OAX_A</Hit_accession>
  <Hit_len>256</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>301.982</Hsp_bit-score>
      <Hsp_score>772</Hsp_score>
      <Hsp_evalue>1.97657e-103</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>256</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>141</Hsp_identity>
      <Hsp_positive>191</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>256</Hsp_align-len>
      <Hsp_qseq>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>GSSRALTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPGFKNLPLEDQITLIQYSWMCLLSFALSWRSYKHTNSQFLYFAPDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMRTNYIKELRKMVTKAPNNSGQSWQRFYQLTKLLDSMHDLVSDLLEFCFYTFRESHALKVEFPAMLVEIISDQLPKVESGNAKPLYFHRK</Hsp_hseq>
      <Hsp_midline>G    L P  + +L +IEP+++YAG+D++KPDT+ +LL++LN+L  +Q++ VVKW+K LPGF+NL ++DQITLIQYSWM L+ F L WRSYKH + Q LYFAPDL+ NE++M +S+ Y LC  M QI  +FV+LQ++ EE+  MKVLLLL+TIP +GL+SQ  FEEMR++YI+EL K +         S QRFYQLTKLLD++HDLV  L  +C  TF +S AL VEFP M+ E+I+ QLPK+ +G  KPL FH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>53</Hit_num>
  <Hit_id>pdb|3MNO|A</Hit_id>
  <Hit_def>Crystal structure of the agonist form of mouse glucocorticoid receptor stabilized by (A611V, F608S) mutations at 1.55A [Mus musculus]</Hit_def>
  <Hit_accession>3MNO_A</Hit_accession>
  <Hit_len>261</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>301.597</Hsp_bit-score>
      <Hsp_score>771</Hsp_score>
      <Hsp_evalue>3.39555e-103</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>11</Hsp_hit-from>
      <Hsp_hit-to>261</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>142</Hsp_identity>
      <Hsp_positive>193</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>252</Hsp_align-len>
      <Hsp_qseq>QLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>QLTPTLVSLLEVIEPEVLYAGYDSSVPDSAWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMSLMVFALGWRSYRQASGNLLCFAPDLIINEQRMTLPCMYDQCKHMLFISTELQRLQVSYEEYLCMKTLLLLSSVPKEGLKSQELFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHDVVENLLSYCFQTFL-DKSMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK</Hsp_hseq>
      <Hsp_midline>QL P L++LL  IEP+V+YAG+D++ PD++  ++T+LN LG RQ+++ VKW+K++PGFRNLH+DDQ+TL+QYSWMSLMVF LGWRSY+  SG +L FAPDLI+NEQRM     Y  C  M  I  E  +LQVS EE+LCMK LLLL+++P EGL+SQ  F+E+R +YI+EL KAI  R+     + QRFYQLTKLLD++HD+V+ L  YC  TF+  +++S+EFPEM++E+I  Q+PK   G +K LLFH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>54</Hit_num>
  <Hit_id>pdb|2AA6|A</Hit_id>
  <Hit_def>Mineralocorticoid Receptor S810L Mutant with Bound Progesterone [Homo sapiens] &gt;pdb|2AA6|B Mineralocorticoid Receptor S810L Mutant with Bound Progesterone [Homo sapiens] &gt;pdb|2AAX|A Mineralocorticoid Receptor Double Mutant with Bound Cortisone [Homo sapiens] &gt;pdb|2AAX|B Mineralocorticoid Receptor Double Mutant with Bound Cortisone [Homo sapiens] &gt;pdb|2AB2|A Mineralocorticoid Receptor Double Mutant with Bound Spironolactone [Homo sapiens] &gt;pdb|2AB2|B Mineralocorticoid Receptor Double Mutant with Bound Spironolactone [Homo sapiens]</Hit_def>
  <Hit_accession>2AA6_A</Hit_accession>
  <Hit_len>275</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>301.597</Hsp_bit-score>
      <Hsp_score>771</Hsp_score>
      <Hsp_evalue>5.09987e-103</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>25</Hsp_hit-from>
      <Hsp_hit-to>275</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>141</Hsp_identity>
      <Hsp_positive>191</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>251</Hsp_align-len>
      <Hsp_qseq>LIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>LTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPGFKNLPLEDQITLIQYSWMSLLSFALSWRSYKHTNSQFLYFAPDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMRTNYIKELRKMVTKCPNNSGQSWQRFYQLTKLLDSMHDLVSDLLEFCFYTFRESHALKVEFPAMLVEIISDQLPKVESGNAKPLYFHRK</Hsp_hseq>
      <Hsp_midline>L P  + +L +IEP+++YAG+D++KPDT+ +LL++LN+L  +Q++ VVKW+K LPGF+NL ++DQITLIQYSWMSL+ F L WRSYKH + Q LYFAPDL+ NE++M +S+ Y LC  M QI  +FV+LQ++ EE+  MKVLLLL+TIP +GL+SQ  FEEMR++YI+EL K +         S QRFYQLTKLLD++HDLV  L  +C  TF +S AL VEFP M+ E+I+ QLPK+ +G  KPL FH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>55</Hit_num>
  <Hit_id>pdb|1Y9R|A</Hit_id>
  <Hit_def>Crystal structure of the human mineralocorticoid receptor ligand-binding domain bound to deoxycorticosterone and harboring the S810L mutation responsible for a severe form of hypertension [Homo sapiens] &gt;pdb|1Y9R|B Crystal structure of the human mineralocorticoid receptor ligand-binding domain bound to deoxycorticosterone and harboring the S810L mutation responsible for a severe form of hypertension [Homo sapiens] &gt;pdb|1YA3|A Crystal structure of the human mineralocorticoid receptor ligand-binding domain bound to progesterone and harboring the S810L mutation responsible for a severe form of hypertension [Homo sapiens] &gt;pdb|1YA3|B Crystal structure of the human mineralocorticoid receptor ligand-binding domain bound to progesterone and harboring the S810L mutation responsible for a severe form of hypertension [Homo sapiens] &gt;pdb|1YA3|C Crystal structure of the human mineralocorticoid receptor ligand-binding domain bound to progesterone and harboring the S810L mutation responsible for a severe form of hypertension [Homo sapiens]</Hit_def>
  <Hit_accession>1Y9R_A</Hit_accession>
  <Hit_len>255</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>300.827</Hsp_bit-score>
      <Hsp_score>769</Hsp_score>
      <Hsp_evalue>5.11006e-103</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>5</Hsp_hit-from>
      <Hsp_hit-to>255</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>140</Hsp_identity>
      <Hsp_positive>190</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>251</Hsp_align-len>
      <Hsp_qseq>LIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>LTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPGFKNLPLEDQITLIQYSWMCLLSFALSWRSYKHTNSQFLYFAPDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMRTNYIKELRKMVTKAPNNSGQSWQRFYQLTKLLDSMHDLVSDLLEFCFYTFRESHALKVEFPAMLVEIISDQLPKVESGNAKPLYFHRK</Hsp_hseq>
      <Hsp_midline>L P  + +L +IEP+++YAG+D++KPDT+ +LL++LN+L  +Q++ VVKW+K LPGF+NL ++DQITLIQYSWM L+ F L WRSYKH + Q LYFAPDL+ NE++M +S+ Y LC  M QI  +FV+LQ++ EE+  MKVLLLL+TIP +GL+SQ  FEEMR++YI+EL K +         S QRFYQLTKLLD++HDLV  L  +C  TF +S AL VEFP M+ E+I+ QLPK+ +G  KPL FH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>56</Hit_num>
  <Hit_id>pdb|4UDB|A</Hit_id>
  <Hit_def>MR in complex with desisobutyrylciclesonide [Homo sapiens]</Hit_def>
  <Hit_accession>4UDB_A</Hit_accession>
  <Hit_len>272</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>301.212</Hsp_bit-score>
      <Hsp_score>770</Hsp_score>
      <Hsp_evalue>5.99251e-103</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>20</Hsp_hit-from>
      <Hsp_hit-to>272</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>141</Hsp_identity>
      <Hsp_positive>191</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>253</Hsp_align-len>
      <Hsp_qseq>IQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>FQGTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPGFKNLPLEDQITLIQYSWMSLLSFALSWRSYKHTNSQFLYFAPDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMRTNYIKELRKMVTKSPNNSGQSWQRFYQLTKLLDSMHDLVSDLLEFCFYTFRESHALKVEFPAMLVEIISDQLPKVESGNAKPLYFHRK</Hsp_hseq>
      <Hsp_midline> Q  P  + +L +IEP+++YAG+D++KPDT+ +LL++LN+L  +Q++ VVKW+K LPGF+NL ++DQITLIQYSWMSL+ F L WRSYKH + Q LYFAPDL+ NE++M +S+ Y LC  M QI  +FV+LQ++ EE+  MKVLLLL+TIP +GL+SQ  FEEMR++YI+EL K +         S QRFYQLTKLLD++HDLV  L  +C  TF +S AL VEFP M+ E+I+ QLPK+ +G  KPL FH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>57</Hit_num>
  <Hit_id>pdb|3VHU|A</Hit_id>
  <Hit_def>Mineralocorticoid receptor ligand-binding domain with spironolactone [Homo sapiens]</Hit_def>
  <Hit_accession>3VHU_A</Hit_accession>
  <Hit_len>294</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>301.982</Hsp_bit-score>
      <Hsp_score>772</Hsp_score>
      <Hsp_evalue>7.5723e-103</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>44</Hsp_hit-from>
      <Hsp_hit-to>294</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>141</Hsp_identity>
      <Hsp_positive>191</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>251</Hsp_align-len>
      <Hsp_qseq>LIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>LTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPGFKNLPLEDQITLIQYSWMSLLSFALSWRSYKHTNSQFLYFAPDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMRTNYIKELRKMVTKCPNNSGQSWQRFYQLTKLLDSMHDLVSDLLEFCFYTFRESHALKVEFPAMLVEIISDQLPKVESGNAKPLYFHRK</Hsp_hseq>
      <Hsp_midline>L P  + +L +IEP+++YAG+D++KPDT+ +LL++LN+L  +Q++ VVKW+K LPGF+NL ++DQITLIQYSWMSL+ F L WRSYKH + Q LYFAPDL+ NE++M +S+ Y LC  M QI  +FV+LQ++ EE+  MKVLLLL+TIP +GL+SQ  FEEMR++YI+EL K +         S QRFYQLTKLLD++HDLV  L  +C  TF +S AL VEFP M+ E+I+ QLPK+ +G  KPL FH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>58</Hit_num>
  <Hit_id>pdb|2ABI|A</Hit_id>
  <Hit_def>Crystal structure of the human mineralocorticoid receptor ligand-binding domain bound to deoxycorticosterone [Homo sapiens] &gt;pdb|2ABI|B Crystal structure of the human mineralocorticoid receptor ligand-binding domain bound to deoxycorticosterone [Homo sapiens] &gt;pdb|2ABI|C Crystal structure of the human mineralocorticoid receptor ligand-binding domain bound to deoxycorticosterone [Homo sapiens]</Hit_def>
  <Hit_accession>2ABI_A</Hit_accession>
  <Hit_len>256</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>300.442</Hsp_bit-score>
      <Hsp_score>768</Hsp_score>
      <Hsp_evalue>7.83523e-103</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>256</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>141</Hsp_identity>
      <Hsp_positive>190</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>256</Hsp_align-len>
      <Hsp_qseq>GQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>GSSRALTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPGFKNLPLEDQITLIQYSWMCLSSFALSWRSYKHTNSQFLYFAPDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMRTNYIKELRKMVTKAPNNSGQSWQRFYQLTKLLDSMHDLVSDLLEFCFYTFRESHALKVEFPAMLVEIISDQLPKVESGNAKPLYFHRK</Hsp_hseq>
      <Hsp_midline>G    L P  + +L +IEP+++YAG+D++KPDT+ +LL++LN+L  +Q++ VVKW+K LPGF+NL ++DQITLIQYSWM L  F L WRSYKH + Q LYFAPDL+ NE++M +S+ Y LC  M QI  +FV+LQ++ EE+  MKVLLLL+TIP +GL+SQ  FEEMR++YI+EL K +         S QRFYQLTKLLD++HDLV  L  +C  TF +S AL VEFP M+ E+I+ QLPK+ +G  KPL FH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>59</Hit_num>
  <Hit_id>pdb|5HCV|A</Hit_id>
  <Hit_def>Identification of Spirooxindole and Dibenzoxazepine Motifs as Potent Mineralocorticoid Receptor Antagonists [Homo sapiens] &gt;pdb|5HCV|B Identification of Spirooxindole and Dibenzoxazepine Motifs as Potent Mineralocorticoid Receptor Antagonists [Homo sapiens] &gt;pdb|5HCV|C Identification of Spirooxindole and Dibenzoxazepine Motifs as Potent Mineralocorticoid Receptor Antagonists [Homo sapiens]</Hit_def>
  <Hit_accession>5HCV_A</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>300.056</Hsp_bit-score>
      <Hsp_score>767</Hsp_score>
      <Hsp_evalue>9.97615e-103</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>7</Hsp_hit-from>
      <Hsp_hit-to>257</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>141</Hsp_identity>
      <Hsp_positive>190</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>251</Hsp_align-len>
      <Hsp_qseq>LIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>LTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPGFKNLPLEDQITLIQYSWMSLSSFALSWRSYKHTNSQFLYFAPDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMRTNYIKELRKMVTKCPNNSGQSWQRFYQLTKLLDSMHDLVSDLLEFCFYTFRESHALKVEFPAMLVEIISDQLPKVESGNAKPLYFHRK</Hsp_hseq>
      <Hsp_midline>L P  + +L +IEP+++YAG+D++KPDT+ +LL++LN+L  +Q++ VVKW+K LPGF+NL ++DQITLIQYSWMSL  F L WRSYKH + Q LYFAPDL+ NE++M +S+ Y LC  M QI  +FV+LQ++ EE+  MKVLLLL+TIP +GL+SQ  FEEMR++YI+EL K +         S QRFYQLTKLLD++HDLV  L  +C  TF +S AL VEFP M+ E+I+ QLPK+ +G  KPL FH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>60</Hit_num>
  <Hit_id>pdb|2A3I|A</Hit_id>
  <Hit_def>Structural and Biochemical Mechanisms for the Specificity of Hormone Binding and Coactivator Assembly by Mineralocorticoid Receptor [Homo sapiens]</Hit_def>
  <Hit_accession>2A3I_A</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>300.056</Hsp_bit-score>
      <Hsp_score>767</Hsp_score>
      <Hsp_evalue>1.00407e-102</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>3</Hsp_hit-from>
      <Hsp_hit-to>253</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>141</Hsp_identity>
      <Hsp_positive>190</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>251</Hsp_align-len>
      <Hsp_qseq>LIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>LTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPGFKNLPLEDQITLIQYSWMSLSSFALSWRSYKHTNSQFLYFAPDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMRTNYIKELRKMVTKCPNNSGQSWQRFYQLTKLLDSMHDLVSDLLEFCFYTFRESHALKVEFPAMLVEIISDQLPKVESGNAKPLYFHRK</Hsp_hseq>
      <Hsp_midline>L P  + +L +IEP+++YAG+D++KPDT+ +LL++LN+L  +Q++ VVKW+K LPGF+NL ++DQITLIQYSWMSL  F L WRSYKH + Q LYFAPDL+ NE++M +S+ Y LC  M QI  +FV+LQ++ EE+  MKVLLLL+TIP +GL+SQ  FEEMR++YI+EL K +         S QRFYQLTKLLD++HDLV  L  +C  TF +S AL VEFP M+ E+I+ QLPK+ +G  KPL FH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>61</Hit_num>
  <Hit_id>pdb|4UDA|A</Hit_id>
  <Hit_def>MR in complex with dexamethasone [Homo sapiens] &gt;pdb|6L88|A Crystal structure of mineralocorticoid receptor ligand binding domain in complex with esaxerenone [Homo sapiens] &gt;pdb|6L88|B Crystal structure of mineralocorticoid receptor ligand binding domain in complex with esaxerenone [Homo sapiens] &gt;pdb|6L88|C Crystal structure of mineralocorticoid receptor ligand binding domain in complex with esaxerenone [Homo sapiens] &gt;pdb|6L88|D Crystal structure of mineralocorticoid receptor ligand binding domain in complex with esaxerenone [Homo sapiens]</Hit_def>
  <Hit_accession>4UDA_A</Hit_accession>
  <Hit_len>251</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>299.671</Hsp_bit-score>
      <Hsp_score>766</Hsp_score>
      <Hsp_evalue>1.0814e-102</Hsp_evalue>
      <Hsp_query-from>8</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>3</Hsp_hit-from>
      <Hsp_hit-to>251</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>140</Hsp_identity>
      <Hsp_positive>189</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>249</Hsp_align-len>
      <Hsp_qseq>PPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>PSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPGFKNLPLEDQITLIQYSWMSLSSFALSWRSYKHTNSQFLYFAPDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMRTNYIKELRKMVTKSPNNSGQSWQRFYQLTKLLDSMHDLVSDLLEFCFYTFRESHALKVEFPAMLVEIISDQLPKVESGNAKPLYFHRK</Hsp_hseq>
      <Hsp_midline>P  + +L +IEP+++YAG+D++KPDT+ +LL++LN+L  +Q++ VVKW+K LPGF+NL ++DQITLIQYSWMSL  F L WRSYKH + Q LYFAPDL+ NE++M +S+ Y LC  M QI  +FV+LQ++ EE+  MKVLLLL+TIP +GL+SQ  FEEMR++YI+EL K +         S QRFYQLTKLLD++HDLV  L  +C  TF +S AL VEFP M+ E+I+ QLPK+ +G  KPL FH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>62</Hit_num>
  <Hit_id>pdb|2AA2|A</Hit_id>
  <Hit_def>Mineralocorticoid Receptor with Bound Aldosterone [Homo sapiens] &gt;pdb|2AA5|A Mineralocorticoid Receptor with Bound Progesterone [Homo sapiens] &gt;pdb|2AA5|B Mineralocorticoid Receptor with Bound Progesterone [Homo sapiens] &gt;pdb|2AA7|A Mineralocorticoid Receptor with Bound Deoxycorticosterone [Homo sapiens]</Hit_def>
  <Hit_accession>2AA2_A</Hit_accession>
  <Hit_len>275</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>300.442</Hsp_bit-score>
      <Hsp_score>768</Hsp_score>
      <Hsp_evalue>1.33382e-102</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>25</Hsp_hit-from>
      <Hsp_hit-to>275</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>141</Hsp_identity>
      <Hsp_positive>190</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>251</Hsp_align-len>
      <Hsp_qseq>LIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>LTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPGFKNLPLEDQITLIQYSWMSLSSFALSWRSYKHTNSQFLYFAPDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMRTNYIKELRKMVTKCPNNSGQSWQRFYQLTKLLDSMHDLVSDLLEFCFYTFRESHALKVEFPAMLVEIISDQLPKVESGNAKPLYFHRK</Hsp_hseq>
      <Hsp_midline>L P  + +L +IEP+++YAG+D++KPDT+ +LL++LN+L  +Q++ VVKW+K LPGF+NL ++DQITLIQYSWMSL  F L WRSYKH + Q LYFAPDL+ NE++M +S+ Y LC  M QI  +FV+LQ++ EE+  MKVLLLL+TIP +GL+SQ  FEEMR++YI+EL K +         S QRFYQLTKLLD++HDLV  L  +C  TF +S AL VEFP M+ E+I+ QLPK+ +G  KPL FH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>63</Hit_num>
  <Hit_id>pdb|3MNE|A</Hit_id>
  <Hit_def>Crystal structure of the agonist form of mouse glucocorticoid receptor stabilized by F608S mutation at 1.96A [Mus musculus]</Hit_def>
  <Hit_accession>3MNE_A</Hit_accession>
  <Hit_len>261</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>300.056</Hsp_bit-score>
      <Hsp_score>767</Hsp_score>
      <Hsp_evalue>1.37549e-102</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>11</Hsp_hit-from>
      <Hsp_hit-to>261</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>141</Hsp_identity>
      <Hsp_positive>192</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>252</Hsp_align-len>
      <Hsp_qseq>QLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>QLTPTLVSLLEVIEPEVLYAGYDSSVPDSAWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMSLMAFALGWRSYRQASGNLLCFAPDLIINEQRMTLPCMYDQCKHMLFISTELQRLQVSYEEYLCMKTLLLLSSVPKEGLKSQELFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHDVVENLLSYCFQTFL-DKSMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK</Hsp_hseq>
      <Hsp_midline>QL P L++LL  IEP+V+YAG+D++ PD++  ++T+LN LG RQ+++ VKW+K++PGFRNLH+DDQ+TL+QYSWMSLM F LGWRSY+  SG +L FAPDLI+NEQRM     Y  C  M  I  E  +LQVS EE+LCMK LLLL+++P EGL+SQ  F+E+R +YI+EL KAI  R+     + QRFYQLTKLLD++HD+V+ L  YC  TF+  +++S+EFPEM++E+I  Q+PK   G +K LLFH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>64</Hit_num>
  <Hit_id>pdb|5L7E|A</Hit_id>
  <Hit_def>MCR IN COMPLEX WITH ligand [Homo sapiens] &gt;pdb|5L7G|A MCR IN COMPLEX WITH ligand [Homo sapiens] &gt;pdb|5L7H|A MCR IN COMPLEX WITH ligand [Homo sapiens] &gt;pdb|6GEV|A Mineralocorticoid receptor in complex with (s)-13 [Homo sapiens] &gt;pdb|6GGG|A Mineralocorticoid receptor in complex with (s)-13 [Homo sapiens]</Hit_def>
  <Hit_accession>5L7E_A</Hit_accession>
  <Hit_len>305</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>301.212</Hsp_bit-score>
      <Hsp_score>770</Hsp_score>
      <Hsp_evalue>2.09963e-102</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>20</Hsp_hit-from>
      <Hsp_hit-to>272</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>141</Hsp_identity>
      <Hsp_positive>191</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>253</Hsp_align-len>
      <Hsp_qseq>IQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>FQGTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPGFKNLPLEDQITLIQYSWMSLLSFALSWRSYKHTNSQFLYFAPDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMRTNYIKELRKMVTKSPNNSGQSWQRFYQLTKLLDSMHDLVSDLLEFCFYTFRESHALKVEFPAMLVEIISDQLPKVESGNAKPLYFHRK</Hsp_hseq>
      <Hsp_midline> Q  P  + +L +IEP+++YAG+D++KPDT+ +LL++LN+L  +Q++ VVKW+K LPGF+NL ++DQITLIQYSWMSL+ F L WRSYKH + Q LYFAPDL+ NE++M +S+ Y LC  M QI  +FV+LQ++ EE+  MKVLLLL+TIP +GL+SQ  FEEMR++YI+EL K +         S QRFYQLTKLLD++HDLV  L  +C  TF +S AL VEFP M+ E+I+ QLPK+ +G  KPL FH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>65</Hit_num>
  <Hit_id>pdb|3MNP|A</Hit_id>
  <Hit_def>Crystal structure of the agonist form of mouse glucocorticoid receptor stabilized by (A611V, V708A, E711G) mutations at 1.50A [Mus musculus]</Hit_def>
  <Hit_accession>3MNP_A</Hit_accession>
  <Hit_len>261</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>298.901</Hsp_bit-score>
      <Hsp_score>764</Hsp_score>
      <Hsp_evalue>2.98841e-102</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>11</Hsp_hit-from>
      <Hsp_hit-to>261</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>141</Hsp_identity>
      <Hsp_positive>191</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>252</Hsp_align-len>
      <Hsp_qseq>QLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>QLTPTLVSLLEVIEPEVLYAGYDSSVPDSAWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMFLMVFALGWRSYRQASGNLLCFAPDLIINEQRMTLPCMYDQCKHMLFISTELQRLQVSYEEYLCMKTLLLLSSVPKEGLKSQELFDEIRMTYIKELGKAIAKRGGNSSQNWQRFYQLTKLLDSMHDVVENLLSYCFQTFL-DKSMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK</Hsp_hseq>
      <Hsp_midline>QL P L++LL  IEP+V+YAG+D++ PD++  ++T+LN LG RQ+++ VKW+K++PGFRNLH+DDQ+TL+QYSWM LMVF LGWRSY+  SG +L FAPDLI+NEQRM     Y  C  M  I  E  +LQVS EE+LCMK LLLL+++P EGL+SQ  F+E+R +YI+EL KAI  R      + QRFYQLTKLLD++HD+V+ L  YC  TF+  +++S+EFPEM++E+I  Q+PK   G +K LLFH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>66</Hit_num>
  <Hit_id>pdb|4P6X|A</Hit_id>
  <Hit_def>Crystal Structure of cortisol-bound glucocorticoid receptor ligand binding domain [Homo sapiens] &gt;pdb|4P6X|C Crystal Structure of cortisol-bound glucocorticoid receptor ligand binding domain [Homo sapiens] &gt;pdb|4P6X|E Crystal Structure of cortisol-bound glucocorticoid receptor ligand binding domain [Homo sapiens] &gt;pdb|4P6X|G Crystal Structure of cortisol-bound glucocorticoid receptor ligand binding domain [Homo sapiens] &gt;pdb|4P6X|I Crystal Structure of cortisol-bound glucocorticoid receptor ligand binding domain [Homo sapiens] &gt;pdb|4P6X|K Crystal Structure of cortisol-bound glucocorticoid receptor ligand binding domain [Homo sapiens]</Hit_def>
  <Hit_accession>4P6X_A</Hit_accession>
  <Hit_len>255</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>298.516</Hsp_bit-score>
      <Hsp_score>763</Hsp_score>
      <Hsp_evalue>4.03282e-102</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>5</Hsp_hit-from>
      <Hsp_hit-to>255</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>139</Hsp_identity>
      <Hsp_positive>191</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>252</Hsp_align-len>
      <Hsp_qseq>QLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>QLTPTLVSLLEVIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMALMAFALGWRSYRQSSANLLYFAPDLIINEQRMTLPCMYDQCKHMLYVSSELHRLQVSYEEYLCMKVLLLLSTIPKDGLKSQALFDAIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEVVENLLNYCFQTFL-DKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK</Hsp_hseq>
      <Hsp_midline>QL P L++LL  IEP+V+YAG+D++ PD++  ++T+LN LG RQ+++ VKW+K++PGFRNLH+DDQ+TL+QYSWM+LM F LGWRSY+  S  +LYFAPDLI+NEQRM     Y  C  M  +  E  +LQVS EE+LCMKVLLLL+TIP +GL+SQ  F+ +R +YI+EL KAI  R+     + QRFYQLTKLLD++H++V+ L  YC  TF+  + +S+EFPEM++E+I  Q+PK   G +K LLFH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>67</Hit_num>
  <Hit_id>pdb|4P6W|A</Hit_id>
  <Hit_def>Crystal Structure of mometasone furoate-bound glucocorticoid receptor ligand binding domain [Homo sapiens]</Hit_def>
  <Hit_accession>4P6W_A</Hit_accession>
  <Hit_len>252</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>298.516</Hsp_bit-score>
      <Hsp_score>763</Hsp_score>
      <Hsp_evalue>4.15342e-102</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>2</Hsp_hit-from>
      <Hsp_hit-to>252</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>139</Hsp_identity>
      <Hsp_positive>191</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>252</Hsp_align-len>
      <Hsp_qseq>QLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>QLTPTLVSLLEVIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMALMAFALGWRSYRQSSANLLYFAPDLIINEQRMTLPCMYDQCKHMLYVSSELHRLQVSYEEYLCMKVLLLLSTIPKDGLKSQELFDEIRMTYIKELGAAIVAREGNSSQNWQRFYQLTKLLDSMHEVVENLLNYCFQTFL-DKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK</Hsp_hseq>
      <Hsp_midline>QL P L++LL  IEP+V+YAG+D++ PD++  ++T+LN LG RQ+++ VKW+K++PGFRNLH+DDQ+TL+QYSWM+LM F LGWRSY+  S  +LYFAPDLI+NEQRM     Y  C  M  +  E  +LQVS EE+LCMKVLLLL+TIP +GL+SQ  F+E+R +YI+EL  AI  R+     + QRFYQLTKLLD++H++V+ L  YC  TF+  + +S+EFPEM++E+I  Q+PK   G +K LLFH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>68</Hit_num>
  <Hit_id>pdb|5MWP|A</Hit_id>
  <Hit_def>The structure of MR in complex with AZD9977. [Homo sapiens] &gt;pdb|5MWY|A The structure of MR in complex with eplerenone. [Homo sapiens] &gt;pdb|6GG8|A Mineralocorticoid receptor in complex with (s)-13 [Homo sapiens]</Hit_def>
  <Hit_accession>5MWP_A</Hit_accession>
  <Hit_len>305</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>300.056</Hsp_bit-score>
      <Hsp_score>767</Hsp_score>
      <Hsp_evalue>4.86588e-102</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>20</Hsp_hit-from>
      <Hsp_hit-to>272</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>141</Hsp_identity>
      <Hsp_positive>190</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>253</Hsp_align-len>
      <Hsp_qseq>IQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>FQGTPSPVMVLENIEPEIVYAGYDSSKPDTAENLLSTLNRLAGKQMIQVVKWAKVLPGFKNLPLEDQITLIQYSWMSLSSFALSWRSYKHTNSQFLYFAPDLVFNEEKMHQSAMYELCQGMHQISLQFVRLQLTFEEYTIMKVLLLLSTIPKDGLKSQAAFEEMRTNYIKELRKMVTKSPNNSGQSWQRFYQLTKLLDSMHDLVSDLLEFCFYTFRESHALKVEFPAMLVEIISDQLPKVESGNAKPLYFHRK</Hsp_hseq>
      <Hsp_midline> Q  P  + +L +IEP+++YAG+D++KPDT+ +LL++LN+L  +Q++ VVKW+K LPGF+NL ++DQITLIQYSWMSL  F L WRSYKH + Q LYFAPDL+ NE++M +S+ Y LC  M QI  +FV+LQ++ EE+  MKVLLLL+TIP +GL+SQ  FEEMR++YI+EL K +         S QRFYQLTKLLD++HDLV  L  +C  TF +S AL VEFP M+ E+I+ QLPK+ +G  KPL FH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>69</Hit_num>
  <Hit_id>pdb|5NFT|A</Hit_id>
  <Hit_def>Glucocorticoid Receptor in complex with AZD5423 [Homo sapiens] &gt;pdb|6EL7|A Glucocorticoid Receptor in complex with compound 31 [Homo sapiens] &gt;pdb|6EL9|A Glucocorticoid Receptor in complex with AZD9567 [Homo sapiens]</Hit_def>
  <Hit_accession>5NFT_A</Hit_accession>
  <Hit_len>280</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>298.516</Hsp_bit-score>
      <Hsp_score>763</Hsp_score>
      <Hsp_evalue>9.15574e-102</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>30</Hsp_hit-from>
      <Hsp_hit-to>280</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>138</Hsp_identity>
      <Hsp_positive>191</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>252</Hsp_align-len>
      <Hsp_qseq>QLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>QLTPTLVSLLEVIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQMIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMSLMAFALGWRSYRQSSANLLCFAPDLIINEQRMTLPDMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQALFDEIRMTYIKELGKAIVKREGNSSQNSQRFYQLTKLLDSMHEVVENLLNYCFQTFL-DKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK</Hsp_hseq>
      <Hsp_midline>QL P L++LL  IEP+V+YAG+D++ PD++  ++T+LN LG RQ+++ VKW+K++PGFRNLH+DDQ+TL+QYSWMSLM F LGWRSY+  S  +L FAPDLI+NEQRM     Y  C  M  +  E  +LQVS EE+LCMK LLLL+++P +GL+SQ  F+E+R +YI+EL KAI  R+     +SQRFYQLTKLLD++H++V+ L  YC  TF+  + +S+EFPEM++E+I  Q+PK   G +K LLFH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>70</Hit_num>
  <Hit_id>pdb|4CSJ|A</Hit_id>
  <Hit_def>The discovery of potent selective glucocorticoid receptor modulators, suitable for inhalation [Homo sapiens] &gt;pdb|4UDD|A GR in complex with desisobutyrylciclesonide [Homo sapiens] &gt;pdb|5G3J|A Discovery of New Selective Glucocorticoid Receptor Agonist Leads [Homo sapiens] &gt;pdb|5G5W|A Structure guided design and discovery of Indazole ethers as highly potent, non-steroidal Glucocorticoid receptor modulators [Homo sapiens] &gt;pdb|5NFP|A Glucocorticoid Receptor in complex with budesonide [Homo sapiens] &gt;pdb|6EL6|A Glucocorticoid Receptor in complex with compound 4 [Homo sapiens]</Hit_def>
  <Hit_accession>4CSJ_A</Hit_accession>
  <Hit_len>280</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>295.049</Hsp_bit-score>
      <Hsp_score>754</Hsp_score>
      <Hsp_evalue>2.37229e-100</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>30</Hsp_hit-from>
      <Hsp_hit-to>280</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>190</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>252</Hsp_align-len>
      <Hsp_qseq>QLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>QLTPTLVSLLEVIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQMIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMSLMAFALGWRSYRQSSANLLCFAPDLIINEQRMTLPDMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEVVENLLNYCFQTFL-DKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK</Hsp_hseq>
      <Hsp_midline>QL P L++LL  IEP+V+YAG+D++ PD++  ++T+LN LG RQ+++ VKW+K++PGFRNLH+DDQ+TL+QYSWMSLM F LGWRSY+  S  +L FAPDLI+NEQRM     Y  C  M  +  E  +LQVS EE+LCMK LLLL+++P +GL+SQ  F+E+R +YI+EL KAI  R+     + QRFYQLTKLLD++H++V+ L  YC  TF+  + +S+EFPEM++E+I  Q+PK   G +K LLFH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>71</Hit_num>
  <Hit_id>pdb|1NHZ|A</Hit_id>
  <Hit_def>Crystal Structure of the Antagonist Form of Glucocorticoid Receptor [Homo sapiens] &gt;pdb|1P93|A CRYSTAL STRUCTURE OF THE AGONIST FORM OF GLUCOCORTICOID RECEPTOR [Homo sapiens] &gt;pdb|1P93|B CRYSTAL STRUCTURE OF THE AGONIST FORM OF GLUCOCORTICOID RECEPTOR [Homo sapiens] &gt;pdb|1P93|C CRYSTAL STRUCTURE OF THE AGONIST FORM OF GLUCOCORTICOID RECEPTOR [Homo sapiens] &gt;pdb|1P93|D CRYSTAL STRUCTURE OF THE AGONIST FORM OF GLUCOCORTICOID RECEPTOR [Homo sapiens] &gt;pdb|4UDC|A GR in complex with dexamethasone [Homo sapiens]</Hit_def>
  <Hit_accession>1NHZ_A</Hit_accession>
  <Hit_len>280</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>294.664</Hsp_bit-score>
      <Hsp_score>753</Hsp_score>
      <Hsp_evalue>3.08315e-100</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>30</Hsp_hit-from>
      <Hsp_hit-to>280</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>190</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>252</Hsp_align-len>
      <Hsp_qseq>QLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>QLTPTLVSLLEVIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMSLMAFALGWRSYRQSSANLLCFAPDLIINEQRMTLPDMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEVVENLLNYCFQTFL-DKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK</Hsp_hseq>
      <Hsp_midline>QL P L++LL  IEP+V+YAG+D++ PD++  ++T+LN LG RQ+++ VKW+K++PGFRNLH+DDQ+TL+QYSWMSLM F LGWRSY+  S  +L FAPDLI+NEQRM     Y  C  M  +  E  +LQVS EE+LCMK LLLL+++P +GL+SQ  F+E+R +YI+EL KAI  R+     + QRFYQLTKLLD++H++V+ L  YC  TF+  + +S+EFPEM++E+I  Q+PK   G +K LLFH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>72</Hit_num>
  <Hit_id>pdb|3H52|A</Hit_id>
  <Hit_def>Crystal structure of the antagonist form of human glucocorticoid receptor [Homo sapiens] &gt;pdb|3H52|B Crystal structure of the antagonist form of human glucocorticoid receptor [Homo sapiens] &gt;pdb|3H52|C Crystal structure of the antagonist form of human glucocorticoid receptor [Homo sapiens] &gt;pdb|3H52|D Crystal structure of the antagonist form of human glucocorticoid receptor [Homo sapiens]</Hit_def>
  <Hit_accession>3H52_A</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>293.508</Hsp_bit-score>
      <Hsp_score>750</Hsp_score>
      <Hsp_evalue>3.48083e-100</Hsp_evalue>
      <Hsp_query-from>6</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>5</Hsp_hit-from>
      <Hsp_hit-to>254</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>136</Hsp_identity>
      <Hsp_positive>189</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>251</Hsp_align-len>
      <Hsp_qseq>LIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>LTPTLVSLLEVIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMSLMAFALGWRSYRQSSANLLCFAPDLIINEQRMTLPDMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQALFDAIRMTYIKELGKAIVKREGNSSQNSQRFYQLTKLLDSMHEVVENLLNYCFQTFL-DKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK</Hsp_hseq>
      <Hsp_midline>L P L++LL  IEP+V+YAG+D++ PD++  ++T+LN LG RQ+++ VKW+K++PGFRNLH+DDQ+TL+QYSWMSLM F LGWRSY+  S  +L FAPDLI+NEQRM     Y  C  M  +  E  +LQVS EE+LCMK LLLL+++P +GL+SQ  F+ +R +YI+EL KAI  R+     +SQRFYQLTKLLD++H++V+ L  YC  TF+  + +S+EFPEM++E+I  Q+PK   G +K LLFH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>73</Hit_num>
  <Hit_id>pdb|3BQD|A</Hit_id>
  <Hit_def>Doubling the Size of the Glucocorticoid Receptor Ligand Binding Pocket by Deacylcortivazol [Homo sapiens]</Hit_def>
  <Hit_accession>3BQD_A</Hit_accession>
  <Hit_len>255</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>293.508</Hsp_bit-score>
      <Hsp_score>750</Hsp_score>
      <Hsp_evalue>4.06024e-100</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>5</Hsp_hit-from>
      <Hsp_hit-to>255</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>190</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>252</Hsp_align-len>
      <Hsp_qseq>QLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>QLTPTLVSLLEVIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMSLMAFALGWRSYRQSSANLLCFAPDLIINEQRMTLPCMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEVVENLLNYCFQTFL-DKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK</Hsp_hseq>
      <Hsp_midline>QL P L++LL  IEP+V+YAG+D++ PD++  ++T+LN LG RQ+++ VKW+K++PGFRNLH+DDQ+TL+QYSWMSLM F LGWRSY+  S  +L FAPDLI+NEQRM     Y  C  M  +  E  +LQVS EE+LCMK LLLL+++P +GL+SQ  F+E+R +YI+EL KAI  R+     + QRFYQLTKLLD++H++V+ L  YC  TF+  + +S+EFPEM++E+I  Q+PK   G +K LLFH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>74</Hit_num>
  <Hit_id>pdb|1M2Z|A</Hit_id>
  <Hit_def>Crystal structure of a dimer complex of the human glucocorticoid receptor ligand-binding domain bound to dexamethasone and a TIF2 coactivator motif [Homo sapiens] &gt;pdb|1M2Z|D Crystal structure of a dimer complex of the human glucocorticoid receptor ligand-binding domain bound to dexamethasone and a TIF2 coactivator motif [Homo sapiens]</Hit_def>
  <Hit_accession>1M2Z_A</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>293.508</Hsp_bit-score>
      <Hsp_score>750</Hsp_score>
      <Hsp_evalue>4.20361e-100</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>7</Hsp_hit-from>
      <Hsp_hit-to>257</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>137</Hsp_identity>
      <Hsp_positive>190</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>252</Hsp_align-len>
      <Hsp_qseq>QLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>QLTPTLVSLLEVIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMSLMAFALGWRSYRQSSANLLCFAPDLIINEQRMTLPCMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEVVENLLNYCFQTFL-DKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK</Hsp_hseq>
      <Hsp_midline>QL P L++LL  IEP+V+YAG+D++ PD++  ++T+LN LG RQ+++ VKW+K++PGFRNLH+DDQ+TL+QYSWMSLM F LGWRSY+  S  +L FAPDLI+NEQRM     Y  C  M  +  E  +LQVS EE+LCMK LLLL+++P +GL+SQ  F+E+R +YI+EL KAI  R+     + QRFYQLTKLLD++H++V+ L  YC  TF+  + +S+EFPEM++E+I  Q+PK   G +K LLFH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>75</Hit_num>
  <Hit_id>pdb|5UC3|A</Hit_id>
  <Hit_def>Structure of the dominant negative mutant Glucocorticoid Receptor alpha (L733K/N734P) complexed with RU-486 [Homo sapiens] &gt;pdb|5UC3|B Structure of the dominant negative mutant Glucocorticoid Receptor alpha (L733K/N734P) complexed with RU-486 [Homo sapiens]</Hit_def>
  <Hit_accession>5UC3_A</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>291.582</Hsp_bit-score>
      <Hsp_score>745</Hsp_score>
      <Hsp_evalue>2.09506e-99</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>7</Hsp_hit-from>
      <Hsp_hit-to>257</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>136</Hsp_identity>
      <Hsp_positive>189</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>252</Hsp_align-len>
      <Hsp_qseq>QLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>QLTPTLVSLLEVIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMFLMAFALGWRSYRQSSANLLCFAPDLIINEQRMTLPCMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEVVENLKPYCFQTFL-DKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK</Hsp_hseq>
      <Hsp_midline>QL P L++LL  IEP+V+YAG+D++ PD++  ++T+LN LG RQ+++ VKW+K++PGFRNLH+DDQ+TL+QYSWM LM F LGWRSY+  S  +L FAPDLI+NEQRM     Y  C  M  +  E  +LQVS EE+LCMK LLLL+++P +GL+SQ  F+E+R +YI+EL KAI  R+     + QRFYQLTKLLD++H++V+ L  YC  TF+  + +S+EFPEM++E+I  Q+PK   G +K LLFH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>76</Hit_num>
  <Hit_id>pdb|4LSJ|A</Hit_id>
  <Hit_def>Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Bound to a Dibenzoxapine Sulfonamide [Homo sapiens]</Hit_def>
  <Hit_accession>4LSJ_A</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>291.582</Hsp_bit-score>
      <Hsp_score>745</Hsp_score>
      <Hsp_evalue>2.36473e-99</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>8</Hsp_hit-from>
      <Hsp_hit-to>258</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>136</Hsp_identity>
      <Hsp_positive>189</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>252</Hsp_align-len>
      <Hsp_qseq>QLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>QLTPTLVSLLEVIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMYLMAFALGWRSYRQSSANLLCFAPDLIINEQRMTLPGMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEVVENLLNYCFQTFL-DKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK</Hsp_hseq>
      <Hsp_midline>QL P L++LL  IEP+V+YAG+D++ PD++  ++T+LN LG RQ+++ VKW+K++PGFRNLH+DDQ+TL+QYSWM LM F LGWRSY+  S  +L FAPDLI+NEQRM     Y  C  M  +  E  +LQVS EE+LCMK LLLL+++P +GL+SQ  F+E+R +YI+EL KAI  R+     + QRFYQLTKLLD++H++V+ L  YC  TF+  + +S+EFPEM++E+I  Q+PK   G +K LLFH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>77</Hit_num>
  <Hit_id>pdb|3E7C|A</Hit_id>
  <Hit_def>Glucocorticoid Receptor LBD bound to GSK866 [Homo sapiens] &gt;pdb|3E7C|B Glucocorticoid Receptor LBD bound to GSK866 [Homo sapiens]</Hit_def>
  <Hit_accession>3E7C_A</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>291.582</Hsp_bit-score>
      <Hsp_score>745</Hsp_score>
      <Hsp_evalue>2.5227e-99</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>7</Hsp_hit-from>
      <Hsp_hit-to>257</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>136</Hsp_identity>
      <Hsp_positive>189</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>252</Hsp_align-len>
      <Hsp_qseq>QLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>QLTPTLVSLLEVIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMYLMAFALGWRSYRQSSANLLCFAPDLIINEQRMTLPGMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEVVENLLNYCFQTFL-DKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK</Hsp_hseq>
      <Hsp_midline>QL P L++LL  IEP+V+YAG+D++ PD++  ++T+LN LG RQ+++ VKW+K++PGFRNLH+DDQ+TL+QYSWM LM F LGWRSY+  S  +L FAPDLI+NEQRM     Y  C  M  +  E  +LQVS EE+LCMK LLLL+++P +GL+SQ  F+E+R +YI+EL KAI  R+     + QRFYQLTKLLD++H++V+ L  YC  TF+  + +S+EFPEM++E+I  Q+PK   G +K LLFH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>78</Hit_num>
  <Hit_id>pdb|3CLD|A</Hit_id>
  <Hit_def>Ligand binding domain of the glucocorticoid receptor complexed with fluticazone furoate [Homo sapiens] &gt;pdb|3CLD|B Ligand binding domain of the glucocorticoid receptor complexed with fluticazone furoate [Homo sapiens] &gt;pdb|3K22|A Glucocorticoid Receptor with Bound alaninamide 10 with TIF2 peptide [Homo sapiens] &gt;pdb|3K22|B Glucocorticoid Receptor with Bound alaninamide 10 with TIF2 peptide [Homo sapiens] &gt;pdb|3K23|A Glucocorticoid Receptor with Bound D-prolinamide 11 [Homo sapiens] &gt;pdb|3K23|B Glucocorticoid Receptor with Bound D-prolinamide 11 [Homo sapiens] &gt;pdb|3K23|C Glucocorticoid Receptor with Bound D-prolinamide 11 [Homo sapiens]</Hit_def>
  <Hit_accession>3CLD_A</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>291.197</Hsp_bit-score>
      <Hsp_score>744</Hsp_score>
      <Hsp_evalue>3.00989e-99</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>9</Hsp_hit-from>
      <Hsp_hit-to>259</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>136</Hsp_identity>
      <Hsp_positive>189</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>252</Hsp_align-len>
      <Hsp_qseq>QLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>QLTPTLVSLLEVIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMYLMAFALGWRSYRQSSANLLCFAPDLIINEQRMTLPGMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEVVENLLNYCFQTFL-DKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK</Hsp_hseq>
      <Hsp_midline>QL P L++LL  IEP+V+YAG+D++ PD++  ++T+LN LG RQ+++ VKW+K++PGFRNLH+DDQ+TL+QYSWM LM F LGWRSY+  S  +L FAPDLI+NEQRM     Y  C  M  +  E  +LQVS EE+LCMK LLLL+++P +GL+SQ  F+E+R +YI+EL KAI  R+     + QRFYQLTKLLD++H++V+ L  YC  TF+  + +S+EFPEM++E+I  Q+PK   G +K LLFH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>79</Hit_num>
  <Hit_id>pdb|4MDD|A</Hit_id>
  <Hit_def>Crystal Structure of the Glucocorticoid Receptor Bound to a Non-steroidal Antagonist Reveals Repositioning and Partial Disordering of Activation Function Helix 12 [Homo sapiens] &gt;pdb|4MDD|B Crystal Structure of the Glucocorticoid Receptor Bound to a Non-steroidal Antagonist Reveals Repositioning and Partial Disordering of Activation Function Helix 12 [Homo sapiens] &gt;pdb|6DXK|A Glucocorticoid Receptor in complex with Compound 11 [Homo sapiens] &gt;pdb|6DXK|B Glucocorticoid Receptor in complex with Compound 11 [Homo sapiens]</Hit_def>
  <Hit_accession>4MDD_A</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>290.812</Hsp_bit-score>
      <Hsp_score>743</Hsp_score>
      <Hsp_evalue>5.25009e-99</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>256</Hsp_query-to>
      <Hsp_hit-from>8</Hsp_hit-from>
      <Hsp_hit-to>258</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>134</Hsp_identity>
      <Hsp_positive>188</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>252</Hsp_align-len>
      <Hsp_qseq>QLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</Hsp_qseq>
      <Hsp_hseq>QSTPTLVSALETIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMYLMAFALGWRSYRQSSANLLCFAPDLIINEQRMTLPDMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQALFDAIRMTYIKELGKAIVKREGNSSQNSQRFYQLTKLLDSMHEVVENLLNYCFQTFL-DKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK</Hsp_hseq>
      <Hsp_midline>Q  P L++ L +IEP+V+YAG+D++ PD++  ++T+LN LG RQ+++ VKW+K++PGFRNLH+DDQ+TL+QYSWM LM F LGWRSY+  S  +L FAPDLI+NEQRM     Y  C  M  +  E  +LQVS EE+LCMK LLLL+++P +GL+SQ  F+ +R +YI+EL KAI  R+     +SQRFYQLTKLLD++H++V+ L  YC  TF+  + +S+EFPEM++E+I  Q+PK   G +K LLFH+K</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>80</Hit_num>
  <Hit_id>pdb|5UC1|A</Hit_id>
  <Hit_def>Structural Analysis of Glucocorticoid Receptor beta Ligand Binding Domain Complexed with Glucocorticoid Antagonist RU-486: Implication of Helix 12 in Antagonism [Heterocephalus glaber] &gt;pdb|5UC1|B Structural Analysis of Glucocorticoid Receptor beta Ligand Binding Domain Complexed with Glucocorticoid Antagonist RU-486: Implication of Helix 12 in Antagonism [Heterocephalus glaber]</Hit_def>
  <Hit_accession>5UC1_A</Hit_accession>
  <Hit_len>222</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>248.054</Hsp_bit-score>
      <Hsp_score>632</Hsp_score>
      <Hsp_evalue>9.59722e-83</Hsp_evalue>
      <Hsp_query-from>5</Hsp_query-from>
      <Hsp_query-to>210</Hsp_query-to>
      <Hsp_hit-from>7</Hsp_hit-from>
      <Hsp_hit-to>212</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>118</Hsp_identity>
      <Hsp_positive>155</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>206</Hsp_align-len>
      <Hsp_qseq>QLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQL</Hsp_qseq>
      <Hsp_hseq>QLTPTLVSLLEVIEPEVLYAGYDGTVPDTTWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMSLMAFALGWRSYRQSSGNVLCFAPDLIINEQRMGLPYMYDQCKQMLFVSSELKRLQVSYEEYLCMKTLLLFSSVPKEGLKSQELFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHENVTWL</Hsp_hseq>
      <Hsp_midline>QL P L++LL  IEP+V+YAG+D T PDT+  ++T+LN LG RQ+++ VKW+K++PGFRNLH+DDQ+TL+QYSWMSLM F LGWRSY+  SG +L FAPDLI+NEQRM     Y  C  M  +  E  +LQVS EE+LCMK LLL +++P EGL+SQ  F+E+R +YI+EL KAI  R+     + QRFYQLTKLLD++H+ V  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>81</Hit_num>
  <Hit_id>pdb|6CBZ|B</Hit_id>
  <Hit_def>Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Estradiol and GRIP Peptide [Homo sapiens]</Hit_def>
  <Hit_accession>6CBZ_B</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.8265</Hsp_bit-score>
      <Hsp_score>242</Hsp_score>
      <Hsp_evalue>5.64389e-24</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>11</Hsp_hit-from>
      <Hsp_hit-to>204</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>61</Hsp_identity>
      <Hsp_positive>114</Hsp_positive>
      <Hsp_gaps>13</Hsp_gaps>
      <Hsp_align-len>199</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLIL--NEQRMKES--SFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKMVEGMVEIFDMLLA---TSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L  N+ +M E     + + L        F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>82</Hit_num>
  <Hit_id>pdb|5ACC|A</Hit_id>
  <Hit_def>A Novel Oral Selective Estrogen Receptor Down-regulator, AZD9496, drives Tumour Growth Inhibition in Estrogen Receptor positive and ESR1 Mutant Models [Homo sapiens] &gt;pdb|5FQR|A Selective estrogen receptor downregulator antagonists: Tetrahydroisoquinoline phenols 2. [Homo sapiens]</Hit_def>
  <Hit_accession>5ACC_A</Hit_accession>
  <Hit_len>248</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.4413</Hsp_bit-score>
      <Hsp_score>241</Hsp_score>
      <Hsp_evalue>7.18236e-24</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>9</Hsp_hit-from>
      <Hsp_hit-to>202</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>83</Hit_num>
  <Hit_id>pdb|3UU7|B</Hit_id>
  <Hit_def>Crystal structure of hERa-LBD (Y537S) in complex with bisphenol-A [Homo sapiens] &gt;pdb|4TV1|A Crystal structure of hERa-LBD (Y537S) in complex with propylparaben [Homo sapiens]</Hit_def>
  <Hit_accession>3UU7_B</Hit_accession>
  <Hit_len>251</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.4413</Hsp_bit-score>
      <Hsp_score>241</Hsp_score>
      <Hsp_evalue>7.2367e-24</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>14</Hsp_hit-from>
      <Hsp_hit-to>207</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>84</Hit_num>
  <Hit_id>pdb|4MG8|A</Hit_id>
  <Hit_def>Crystal structure of hERa-LBD (Y537S) in complex with alpha-zearalanol [Homo sapiens]</Hit_def>
  <Hit_accession>4MG8_A</Hit_accession>
  <Hit_len>255</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.4413</Hsp_bit-score>
      <Hsp_score>241</Hsp_score>
      <Hsp_evalue>7.27763e-24</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>18</Hsp_hit-from>
      <Hsp_hit-to>211</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>85</Hit_num>
  <Hit_id>pdb|5FQP|A</Hit_id>
  <Hit_def>Selective estrogen receptor downregulator antagonists: Tetrahydroisoquinoline phenols 1. [Homo sapiens] &gt;pdb|5FQS|A Selective estrogen receptor downregulator antagonists: Tetrahydroisoquinoline phenols 3. [Homo sapiens] &gt;pdb|5FQT|A Selective estrogen receptor downregulator antagonists: Tetrahydroisoquinoline phenols 4. [Homo sapiens] &gt;pdb|5FQV|A Selective estrogen receptor downregulator antagonists: Tetrahydroisoquinoline phenols 5. [Homo sapiens]</Hit_def>
  <Hit_accession>5FQP_A</Hit_accession>
  <Hit_len>248</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.4413</Hsp_bit-score>
      <Hsp_score>241</Hsp_score>
      <Hsp_evalue>7.41005e-24</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>9</Hsp_hit-from>
      <Hsp_hit-to>202</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>86</Hit_num>
  <Hit_id>pdb|3UU7|A</Hit_id>
  <Hit_def>Crystal structure of hERa-LBD (Y537S) in complex with bisphenol-A [Homo sapiens] &gt;pdb|3UUD|B Crystal structure of hERa-LBD (Y537S) in complex with estradiol [Homo sapiens] &gt;pdb|4TV1|B Crystal structure of hERa-LBD (Y537S) in complex with propylparaben [Homo sapiens]</Hit_def>
  <Hit_accession>3UU7_A</Hit_accession>
  <Hit_len>251</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.4413</Hsp_bit-score>
      <Hsp_score>241</Hsp_score>
      <Hsp_evalue>7.62282e-24</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>14</Hsp_hit-from>
      <Hsp_hit-to>207</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>87</Hit_num>
  <Hit_id>pdb|5W9C|A</Hit_id>
  <Hit_def>Estrogen Receptor Alpha Ligand Binding Domain C381S, C417S, C530S in Complex with 4-hydroxytamoxifen &gt;pdb|5W9C|B Estrogen Receptor Alpha Ligand Binding Domain C381S, C417S, C530S in Complex with 4-hydroxytamoxifen &gt;pdb|5W9C|C Estrogen Receptor Alpha Ligand Binding Domain C381S, C417S, C530S in Complex with 4-hydroxytamoxifen &gt;pdb|5W9C|D Estrogen Receptor Alpha Ligand Binding Domain C381S, C417S, C530S in Complex with 4-hydroxytamoxifen &gt;pdb|6VJD|A Estrogen Receptor Alpha Ligand Binding Domain in Complex with Lasofoxifene [Homo sapiens] &gt;pdb|6VJD|B Estrogen Receptor Alpha Ligand Binding Domain in Complex with Lasofoxifene [Homo sapiens] &gt;pdb|6VJD|C Estrogen Receptor Alpha Ligand Binding Domain in Complex with Lasofoxifene [Homo sapiens] &gt;pdb|6VJD|D Estrogen Receptor Alpha Ligand Binding Domain in Complex with Lasofoxifene [Homo sapiens] &gt;pdb|6VNN|A Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative That Increases Receptor Resonance Time in the Nucleus of Breast Cancer Cells [Homo sapiens] &gt;pdb|6VNN|B Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative That Increases Receptor Resonance Time in the Nucleus of Breast Cancer Cells [Homo sapiens] &gt;pdb|6VNN|C Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative That Increases Receptor Resonance Time in the Nucleus of Breast Cancer Cells [Homo sapiens] &gt;pdb|6VNN|D Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative That Increases Receptor Resonance Time in the Nucleus of Breast Cancer Cells [Homo sapiens]</Hit_def>
  <Hit_accession>5W9C_A</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.4413</Hsp_bit-score>
      <Hsp_score>241</Hsp_score>
      <Hsp_evalue>8.04576e-24</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>10</Hsp_hit-from>
      <Hsp_hit-to>203</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>88</Hit_num>
  <Hit_id>pdb|4MG7|B</Hit_id>
  <Hit_def>Crystal structure of hERa-LBD (Y537S) in complex with ferutinine [Homo sapiens] &gt;pdb|4MG8|B Crystal structure of hERa-LBD (Y537S) in complex with alpha-zearalanol [Homo sapiens] &gt;pdb|4MG9|B Crystal structure of hERa-LBD (Y537S) in complex with butylparaben [Homo sapiens] &gt;pdb|4MGA|B Crystal structure of hERa-LBD (Y537S) in complex with 4-tert-octylphenol [Homo sapiens] &gt;pdb|4MGC|A Crystal structure of hERa-LBD (Y537S) in complex with benzophenone-2 [Homo sapiens] &gt;pdb|4MGC|B Crystal structure of hERa-LBD (Y537S) in complex with benzophenone-2 [Homo sapiens] &gt;pdb|4TUZ|B Crystal structure of hERa-LBD (Y537S) in complex with alpha-zearalenol [Homo sapiens]</Hit_def>
  <Hit_accession>4MG7_B</Hit_accession>
  <Hit_len>255</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.4413</Hsp_bit-score>
      <Hsp_score>241</Hsp_score>
      <Hsp_evalue>8.32973e-24</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>18</Hsp_hit-from>
      <Hsp_hit-to>211</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>89</Hit_num>
  <Hit_id>pdb|6CHW|A</Hit_id>
  <Hit_def>Estrogen Receptor Alpha Y537S covalently bound to antagonist H3B-5942. [Homo sapiens]</Hit_def>
  <Hit_accession>6CHW_A</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>8.58585e-24</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>10</Hsp_hit-from>
      <Hsp_hit-to>203</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>90</Hit_num>
  <Hit_id>pdb|5AAU|A</Hit_id>
  <Hit_def>Optimization of a novel binding motif to to (E)-3-(3,5-difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H- pyrido(3,4-b)indol-1-yl)phenyl)acrylic acid (AZD9496), a potent and orally bioavailable selective estrogen receptor downregulator and antagonist [Homo sapiens] &gt;pdb|5AAU|B Optimization of a novel binding motif to to (E)-3-(3,5-difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H- pyrido(3,4-b)indol-1-yl)phenyl)acrylic acid (AZD9496), a potent and orally bioavailable selective estrogen receptor downregulator and antagonist [Homo sapiens]</Hit_def>
  <Hit_accession>5AAU_A</Hit_accession>
  <Hit_len>252</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.4413</Hsp_bit-score>
      <Hsp_score>241</Hsp_score>
      <Hsp_evalue>8.62582e-24</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>13</Hsp_hit-from>
      <Hsp_hit-to>206</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>91</Hit_num>
  <Hit_id>pdb|3HM1|A</Hit_id>
  <Hit_def>Crystal structure of human Estrogen Receptor Alpha Ligand-Binding Domain in complex with a Glucocorticoid Receptor Interacting Protein 1 Nr Box II Peptide and estrone ((8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one) [Homo sapiens] &gt;pdb|3HM1|B Crystal structure of human Estrogen Receptor Alpha Ligand-Binding Domain in complex with a Glucocorticoid Receptor Interacting Protein 1 Nr Box II Peptide and estrone ((8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one) [Homo sapiens]</Hit_def>
  <Hit_accession>3HM1_A</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.4413</Hsp_bit-score>
      <Hsp_score>241</Hsp_score>
      <Hsp_evalue>8.98113e-24</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>18</Hsp_hit-from>
      <Hsp_hit-to>211</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>92</Hit_num>
  <Hit_id>pdb|5UFW|A</Hit_id>
  <Hit_def>Estrogen Receptor Alpha Ligand Binding Domain in Complex with OP1154 [Homo sapiens] &gt;pdb|5UFW|B Estrogen Receptor Alpha Ligand Binding Domain in Complex with OP1154 [Homo sapiens] &gt;pdb|5UFX|A Estrogen Receptor Alpha Ligand Binding Domain in Complex with OP1074 [Homo sapiens] &gt;pdb|5UFX|B Estrogen Receptor Alpha Ligand Binding Domain in Complex with OP1074 [Homo sapiens] &gt;pdb|5W9D|A Estrogen Receptor Alpha Ligand Binding Domain C381S, C417S, C530S Mutant in Complex with Endoxifen [Homo sapiens] &gt;pdb|5W9D|B Estrogen Receptor Alpha Ligand Binding Domain C381S, C417S, C530S Mutant in Complex with Endoxifen [Homo sapiens] &gt;pdb|6C42|A Estrogen Receptor Alpha Ligand Binding Domain in Complex with OP1156 [Homo sapiens] &gt;pdb|6C42|B Estrogen Receptor Alpha Ligand Binding Domain in Complex with OP1156 [Homo sapiens]</Hit_def>
  <Hit_accession>5UFW_A</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>9.02079e-24</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>10</Hsp_hit-from>
      <Hsp_hit-to>203</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>93</Hit_num>
  <Hit_id>pdb|1PCG|A</Hit_id>
  <Hit_def>Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions [Homo sapiens] &gt;pdb|1PCG|B Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions [Homo sapiens] &gt;pdb|2I0J|A Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of Benign Prostatic Hyperplasia [Homo sapiens] &gt;pdb|2I0J|B Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of Benign Prostatic Hyperplasia [Homo sapiens] &gt;pdb|2I0J|C Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of Benign Prostatic Hyperplasia [Homo sapiens] &gt;pdb|2I0J|D Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of Benign Prostatic Hyperplasia [Homo sapiens]</Hit_def>
  <Hit_accession>1PCG_A</Hit_accession>
  <Hit_len>244</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>9.24761e-24</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>12</Hsp_hit-from>
      <Hsp_hit-to>205</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>94</Hit_num>
  <Hit_id>pdb|5DX3|B</Hit_id>
  <Hit_def>Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Stapled Peptide SRC2-P3 and Estradiol [Homo sapiens]</Hit_def>
  <Hit_accession>5DX3_B</Hit_accession>
  <Hit_len>261</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.4413</Hsp_bit-score>
      <Hsp_score>241</Hsp_score>
      <Hsp_evalue>9.44381e-24</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>215</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>61</Hsp_identity>
      <Hsp_positive>114</Hsp_positive>
      <Hsp_gaps>13</Hsp_gaps>
      <Hsp_align-len>199</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLIL--NEQRMKES--SFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKMVEGMVEIFDMLLA---TSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L  N+ +M E     + + L        F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>95</Hit_num>
  <Hit_id>pdb|1QKT|A</Hit_id>
  <Hit_def>Mutant Estrogen Nuclear Receptor Ligand Binding Domain Complexed With Estradiol [Homo sapiens] &gt;pdb|2AYR|A A SERM Designed for the Treatment of Uterine Leiomyoma with Unique Tissue Specificity for Uterus and Ovaries in Rats [Homo sapiens] &gt;pdb|2POG|A Benzopyrans as Selective Estrogen Receptor b Agonists (SERBAs). Part 2: Structure Activity Relationship Studies on the Benzopyran Scaffold. [Homo sapiens] &gt;pdb|2POG|B Benzopyrans as Selective Estrogen Receptor b Agonists (SERBAs). Part 2: Structure Activity Relationship Studies on the Benzopyran Scaffold. [Homo sapiens] &gt;pdb|2Q70|A Estrogen receptor alpha ligand-binding domain complxed to a benzopyran ligand [Homo sapiens] &gt;pdb|2Q70|B Estrogen receptor alpha ligand-binding domain complxed to a benzopyran ligand [Homo sapiens] &gt;pdb|2QE4|A Estrogen receptor alpha ligand-binding domain in complex with a benzopyran agonist [Homo sapiens] &gt;pdb|2QE4|B Estrogen receptor alpha ligand-binding domain in complex with a benzopyran agonist [Homo sapiens] &gt;pdb|2R6W|A Estrogen receptor alpha ligand-binding domain complexed to a SERM [Homo sapiens] &gt;pdb|2R6W|B Estrogen receptor alpha ligand-binding domain complexed to a SERM [Homo sapiens] &gt;pdb|2R6Y|A Estrogen receptor alpha ligand-binding domain in complex with a SERM [Homo sapiens] &gt;pdb|2R6Y|B Estrogen receptor alpha ligand-binding domain in complex with a SERM [Homo sapiens]</Hit_def>
  <Hit_accession>1QKT_A</Hit_accession>
  <Hit_len>248</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>9.6106e-24</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>12</Hsp_hit-from>
      <Hsp_hit-to>205</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>96</Hit_num>
  <Hit_id>pdb|5DXE|A</Hit_id>
  <Hit_def>Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Stapled Peptide SRC2-P4 and Estradiol [Homo sapiens] &gt;pdb|5DXE|B Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Stapled Peptide SRC2-P4 and Estradiol [Homo sapiens] &gt;pdb|5DXG|A Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Stapled Peptide SRC2-P5 [Homo sapiens] &gt;pdb|5DXG|B Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Stapled Peptide SRC2-P5 [Homo sapiens]</Hit_def>
  <Hit_accession>5DXE_A</Hit_accession>
  <Hit_len>261</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.4413</Hsp_bit-score>
      <Hsp_score>241</Hsp_score>
      <Hsp_evalue>9.74222e-24</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>215</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>97</Hit_num>
  <Hit_id>pdb|5AAV|B</Hit_id>
  <Hit_def>Optimization of a novel binding motif to to (E)-3-(3,5-difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H- pyrido(3,4-b)indol-1-yl)phenyl)acrylic acid (AZD9496), a potent and orally bioavailable selective estrogen receptor downregulator and antagonist [Homo sapiens]</Hit_def>
  <Hit_accession>5AAV_B</Hit_accession>
  <Hit_len>252</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>9.87339e-24</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>13</Hsp_hit-from>
      <Hsp_hit-to>206</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>98</Hit_num>
  <Hit_id>pdb|5AAV|A</Hit_id>
  <Hit_def>Optimization of a novel binding motif to to (E)-3-(3,5-difluoro-4-((1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-2,3,4,9-tetrahydro-1H- pyrido(3,4-b)indol-1-yl)phenyl)acrylic acid (AZD9496), a potent and orally bioavailable selective estrogen receptor downregulator and antagonist [Homo sapiens] &gt;pdb|6SQ0|A ERa_L536S (L536S/C381S/C471S,C530S) in complex with a bridged tetracyclic indole (compound 8) [Homo sapiens] &gt;pdb|6SQ0|B ERa_L536S (L536S/C381S/C471S,C530S) in complex with a bridged tetracyclic indole (compound 8) [Homo sapiens] &gt;pdb|6SUO|A ERa_L536S (L536S/C381S/C471S,C530S) in complex with a tricyclic indole (compound 6) [Homo sapiens] &gt;pdb|6SUO|B ERa_L536S (L536S/C381S/C471S,C530S) in complex with a tricyclic indole (compound 6) [Homo sapiens] &gt;pdb|6ZOQ|A Chain A, Estrogen receptor [Homo sapiens] &gt;pdb|6ZOQ|B Chain B, Estrogen receptor [Homo sapiens] &gt;pdb|6ZOR|A Chain A, Estrogen receptor [Homo sapiens] &gt;pdb|6ZOR|B Chain B, Estrogen receptor [Homo sapiens] &gt;pdb|6ZOS|A Chain A, Estrogen receptor [Homo sapiens] &gt;pdb|6ZOS|B Chain B, Estrogen receptor [Homo sapiens]</Hit_def>
  <Hit_accession>5AAV_A</Hit_accession>
  <Hit_len>252</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>1.00807e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>13</Hsp_hit-from>
      <Hsp_hit-to>206</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>99</Hit_num>
  <Hit_id>pdb|5T92|A</Hit_id>
  <Hit_def>ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH (2E)-3-{4-[(1R)-2-(4-fluorophenyl)-6-hydroxy-1-methy l-1,2,3,4- tetrahydroisoquinolin-1-yl]phenyl}prop-2-enoic acid [Homo sapiens] &gt;pdb|5T92|B ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH (2E)-3-{4-[(1R)-2-(4-fluorophenyl)-6-hydroxy-1-methy l-1,2,3,4- tetrahydroisoquinolin-1-yl]phenyl}prop-2-enoic acid [Homo sapiens] &gt;pdb|5T97|A ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH (2E)-3-(4-{(1R)-6-hydroxy-1-methyl-2-[4-(propan-2 -yl)phenyl]-1,2,3,4- tetrahydroisoquinolin-1-yl}phenyl)prop-2-enoic acid [Homo sapiens] &gt;pdb|5T97|B ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH (2E)-3-(4-{(1R)-6-hydroxy-1-methyl-2-[4-(propan-2 -yl)phenyl]-1,2,3,4- tetrahydroisoquinolin-1-yl}phenyl)prop-2-enoic acid [Homo sapiens] &gt;pdb|6B0F|A ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH LSZ102 [Homo sapiens] &gt;pdb|6B0F|B ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH LSZ102 [Homo sapiens]</Hit_def>
  <Hit_accession>5T92_A</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>1.01603e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>16</Hsp_hit-from>
      <Hsp_hit-to>209</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>100</Hit_num>
  <Hit_id>pdb|1ZKY|A</Hit_id>
  <Hit_def>Human Estrogen Receptor Alpha Ligand-Binding Domain In Complex With OBCP-3M and A Glucocorticoid Receptor Interacting Protein 1 Nr Box II Peptide [Homo sapiens] &gt;pdb|1ZKY|B Human Estrogen Receptor Alpha Ligand-Binding Domain In Complex With OBCP-3M and A Glucocorticoid Receptor Interacting Protein 1 Nr Box II Peptide [Homo sapiens] &gt;pdb|2B1V|A Human estrogen receptor alpha ligand-binding domain in complex with OBCP-1M and a glucocorticoid receptor interacting protein 1 NR box II peptide [Homo sapiens] &gt;pdb|2B1V|B Human estrogen receptor alpha ligand-binding domain in complex with OBCP-1M and a glucocorticoid receptor interacting protein 1 NR box II peptide [Homo sapiens] &gt;pdb|2B1Z|A Human estrogen receptor alpha ligand-binding domain in complex with 17methyl-17alpha-dihydroequilenin and a glucoc interacting protein 1 NR box II peptide [Homo sapiens] &gt;pdb|2B1Z|B Human estrogen receptor alpha ligand-binding domain in complex with 17methyl-17alpha-dihydroequilenin and a glucoc interacting protein 1 NR box II peptide [Homo sapiens] &gt;pdb|2B23|A Human estrogen receptor alpha ligand-binding domain and a glucocorticoid receptor-interacting protein 1 NR box II peptide [Homo sapiens] &gt;pdb|2B23|B Human estrogen receptor alpha ligand-binding domain and a glucocorticoid receptor-interacting protein 1 NR box II peptide [Homo sapiens] &gt;pdb|2FAI|A Human Estrogen Receptor Alpha Ligand-Binding Domain In Complex With OBCP-2M and A Glucocorticoid Receptor Interacting Protein 1 NR Box II Peptide [Homo sapiens] &gt;pdb|2FAI|B Human Estrogen Receptor Alpha Ligand-Binding Domain In Complex With OBCP-2M and A Glucocorticoid Receptor Interacting Protein 1 NR Box II Peptide [Homo sapiens] &gt;pdb|2G44|A Human Estrogen Receptor Alpha Ligand-Binding Domain In Complex With OBCP-1M-G and A Glucocorticoid Receptor Interacting Protein 1 NR Box II Peptide [Homo sapiens] &gt;pdb|2G44|B Human Estrogen Receptor Alpha Ligand-Binding Domain In Complex With OBCP-1M-G and A Glucocorticoid Receptor Interacting Protein 1 NR Box II Peptide [Homo sapiens] &gt;pdb|2G5O|A Human estrogen receptor alpha ligand-binding domain in complex with 2-(but-1-enyl)-17beta-estradiol and a glucocorticoid receptor interacting protein 1 NR BOX II Peptide [Homo sapiens] &gt;pdb|2G5O|B Human estrogen receptor alpha ligand-binding domain in complex with 2-(but-1-enyl)-17beta-estradiol and a glucocorticoid receptor interacting protein 1 NR BOX II Peptide [Homo sapiens]</Hit_def>
  <Hit_accession>1ZKY_A</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.4413</Hsp_bit-score>
      <Hsp_score>241</Hsp_score>
      <Hsp_evalue>1.02225e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>18</Hsp_hit-from>
      <Hsp_hit-to>211</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>101</Hit_num>
  <Hit_id>pdb|2YAT|A</Hit_id>
  <Hit_def>Crystal structure of estradiol derived metal chelate and estrogen receptor-ligand binding domain complex [Homo sapiens]</Hit_def>
  <Hit_accession>2YAT_A</Hit_accession>
  <Hit_len>252</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>1.03998e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>16</Hsp_hit-from>
      <Hsp_hit-to>209</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>102</Hit_num>
  <Hit_id>pdb|1UOM|A</Hit_id>
  <Hit_def>The Structure of Estrogen Receptor in Complex with a Selective and Potent Tetrahydroisochiolin Ligand. [Homo sapiens] &gt;pdb|1XQC|A X-ray structure of ERalpha LBD bound to a tetrahydroisoquinoline SERM ligand at 2.05A resolution [Homo sapiens] &gt;pdb|1XQC|B X-ray structure of ERalpha LBD bound to a tetrahydroisoquinoline SERM ligand at 2.05A resolution [Homo sapiens] &gt;pdb|1XQC|C X-ray structure of ERalpha LBD bound to a tetrahydroisoquinoline SERM ligand at 2.05A resolution [Homo sapiens] &gt;pdb|1XQC|D X-ray structure of ERalpha LBD bound to a tetrahydroisoquinoline SERM ligand at 2.05A resolution [Homo sapiens]</Hit_def>
  <Hit_accession>1UOM_A</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>1.05913e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>16</Hsp_hit-from>
      <Hsp_hit-to>209</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>103</Hit_num>
  <Hit_id>pdb|6CHZ|A</Hit_id>
  <Hit_def>Estrogen Receptor Alpha Y537S bound to antagonist H3B-9224. [Homo sapiens]</Hit_def>
  <Hit_accession>6CHZ_A</Hit_accession>
  <Hit_len>263</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.4413</Hsp_bit-score>
      <Hsp_score>241</Hsp_score>
      <Hsp_evalue>1.09916e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>24</Hsp_hit-from>
      <Hsp_hit-to>217</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>104</Hit_num>
  <Hit_id>pdb|3Q95|B</Hit_id>
  <Hit_def>Crystal structure of human estrogen receptor alpha LBD in complex with GRIP peptide and estriol [Homo sapiens]</Hit_def>
  <Hit_accession>3Q95_B</Hit_accession>
  <Hit_len>260</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>1.11679e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>21</Hsp_hit-from>
      <Hsp_hit-to>214</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>105</Hit_num>
  <Hit_id>pdb|6OWC|A</Hit_id>
  <Hit_def>Mutant estrogen receptor alpha (ERa) Y537S covalently bound to H3B-6545. [Homo sapiens] &gt;pdb|6OWC|B Mutant estrogen receptor alpha (ERa) Y537S covalently bound to H3B-6545. [Homo sapiens]</Hit_def>
  <Hit_accession>6OWC_A</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>1.14404e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>19</Hsp_hit-from>
      <Hsp_hit-to>212</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>106</Hit_num>
  <Hit_id>pdb|3UUC|A</Hit_id>
  <Hit_def>Crystal structure of hERa-LBD (wt) in complex with bisphenol-C [Homo sapiens] &gt;pdb|3UUC|B Crystal structure of hERa-LBD (wt) in complex with bisphenol-C [Homo sapiens] &gt;pdb|3UUC|C Crystal structure of hERa-LBD (wt) in complex with bisphenol-C [Homo sapiens] &gt;pdb|3UUC|D Crystal structure of hERa-LBD (wt) in complex with bisphenol-C [Homo sapiens]</Hit_def>
  <Hit_accession>3UUC_A</Hit_accession>
  <Hit_len>251</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>1.17946e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>14</Hsp_hit-from>
      <Hsp_hit-to>207</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>107</Hit_num>
  <Hit_id>pdb|6VJ1|A</Hit_id>
  <Hit_def>Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with RU39411 [Homo sapiens] &gt;pdb|6VJ1|B Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with RU39411 [Homo sapiens] &gt;pdb|6VJ1|D Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with RU39411 [Homo sapiens] &gt;pdb|6VJ1|E Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with RU39411 [Homo sapiens] &gt;pdb|6VPK|A Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with a Methylated Lasofoxifene Derivative that Enhances Estrogen Receptor Alpha Nuclear Resonance Time [Homo sapiens] &gt;pdb|6VPK|B Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with a Methylated Lasofoxifene Derivative that Enhances Estrogen Receptor Alpha Nuclear Resonance Time [Homo sapiens] &gt;pdb|6VPK|C Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with a Methylated Lasofoxifene Derivative that Enhances Estrogen Receptor Alpha Nuclear Resonance Time [Homo sapiens] &gt;pdb|6VPK|D Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with a Methylated Lasofoxifene Derivative that Enhances Estrogen Receptor Alpha Nuclear Resonance Time [Homo sapiens] &gt;pdb|6VVP|A Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with a Methylated Lasofoxifene Derivative that Possesses Selective Estrogen Receptor Degrader Activities [Homo sapiens] &gt;pdb|6VVP|B Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with a Methylated Lasofoxifene Derivative that Possesses Selective Estrogen Receptor Degrader Activities [Homo sapiens] &gt;pdb|6VVP|C Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with a Methylated Lasofoxifene Derivative that Possesses Selective Estrogen Receptor Degrader Activities [Homo sapiens] &gt;pdb|6VVP|D Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with a Methylated Lasofoxifene Derivative that Possesses Selective Estrogen Receptor Degrader Activities [Homo sapiens] &gt;pdb|7KCA|A Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Raloxifene [Homo sapiens] &gt;pdb|7KCA|B Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Raloxifene [Homo sapiens]</Hit_def>
  <Hit_accession>6VJ1_A</Hit_accession>
  <Hit_len>263</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>1.20661e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>24</Hsp_hit-from>
      <Hsp_hit-to>217</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>108</Hit_num>
  <Hit_id>pdb|7KCD|A</Hit_id>
  <Hit_def>Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative That Increases Receptor Resonance Time in the Nucleus of Breast Cancer Cells [Homo sapiens] &gt;pdb|7KCD|B Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative That Increases Receptor Resonance Time in the Nucleus of Breast Cancer Cells [Homo sapiens] &gt;pdb|7KCD|C Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative That Increases Receptor Resonance Time in the Nucleus of Breast Cancer Cells [Homo sapiens] &gt;pdb|7KCD|D Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative That Increases Receptor Resonance Time in the Nucleus of Breast Cancer Cells [Homo sapiens]</Hit_def>
  <Hit_accession>7KCD_A</Hit_accession>
  <Hit_len>262</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>1.20894e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>23</Hsp_hit-from>
      <Hsp_hit-to>216</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>109</Hit_num>
  <Hit_id>pdb|4MG5|A</Hit_id>
  <Hit_def>Crystal structure of hERa-LBD (Y537S) in complex with chlordecone [Homo sapiens] &gt;pdb|4MG5|B Crystal structure of hERa-LBD (Y537S) in complex with chlordecone [Homo sapiens] &gt;pdb|4MG6|A Crystal structure of hERa-LBD (Y537S) in complex with benzylbutylphtalate [Homo sapiens] &gt;pdb|4MG6|B Crystal structure of hERa-LBD (Y537S) in complex with benzylbutylphtalate [Homo sapiens] &gt;pdb|4MGA|A Crystal structure of hERa-LBD (Y537S) in complex with 4-tert-octylphenol [Homo sapiens] &gt;pdb|4MGB|B Crystal structure of hERa-LBD (Y537S) in complex with TCBPA [Homo sapiens] &gt;pdb|4MGD|B Crystal structure of hERa-LBD (Y537S) in complex with HPTE [Homo sapiens] &gt;pdb|4TUZ|A Crystal structure of hERa-LBD (Y537S) in complex with alpha-zearalenol [Homo sapiens] &gt;pdb|5JMM|B Crystal structure of hERa-LBD (Y537S) in complex with biochanin A [Homo sapiens]</Hit_def>
  <Hit_accession>4MG5_A</Hit_accession>
  <Hit_len>255</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>1.22313e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>18</Hsp_hit-from>
      <Hsp_hit-to>211</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>110</Hit_num>
  <Hit_id>pdb|1ERR|A</Hit_id>
  <Hit_def>Human Estrogen Receptor Ligand-binding Domain In Complex With Raloxifene [Homo sapiens] &gt;pdb|1ERR|B Human Estrogen Receptor Ligand-binding Domain In Complex With Raloxifene [Homo sapiens]</Hit_def>
  <Hit_accession>1ERR_A</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>1.22648e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>15</Hsp_hit-from>
      <Hsp_hit-to>208</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>111</Hit_num>
  <Hit_id>pdb|4MG7|A</Hit_id>
  <Hit_def>Crystal structure of hERa-LBD (Y537S) in complex with ferutinine [Homo sapiens] &gt;pdb|4MG9|A Crystal structure of hERa-LBD (Y537S) in complex with butylparaben [Homo sapiens] &gt;pdb|4MGB|A Crystal structure of hERa-LBD (Y537S) in complex with TCBPA [Homo sapiens] &gt;pdb|4MGD|A Crystal structure of hERa-LBD (Y537S) in complex with HPTE [Homo sapiens] &gt;pdb|5JMM|A Crystal structure of hERa-LBD (Y537S) in complex with biochanin A [Homo sapiens]</Hit_def>
  <Hit_accession>4MG7_A</Hit_accession>
  <Hit_len>255</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>1.23589e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>18</Hsp_hit-from>
      <Hsp_hit-to>211</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>112</Hit_num>
  <Hit_id>pdb|3UUA|B</Hit_id>
  <Hit_def>Crystal structure of hERa-LBD (Y537S) in complex with bisphenol-AF [Homo sapiens] &gt;pdb|3UUD|A Crystal structure of hERa-LBD (Y537S) in complex with estradiol [Homo sapiens]</Hit_def>
  <Hit_accession>3UUA_B</Hit_accession>
  <Hit_len>251</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>1.26844e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>14</Hsp_hit-from>
      <Hsp_hit-to>207</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>113</Hit_num>
  <Hit_id>pdb|1L2I|A</Hit_id>
  <Hit_def>Human Estrogen Receptor alpha Ligand-binding Domain in Complex with (R,R)-5,11-cis-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol and a Glucocorticoid Receptor Interacting Protein 1 NR box II Peptide [Homo sapiens] &gt;pdb|1L2I|B Human Estrogen Receptor alpha Ligand-binding Domain in Complex with (R,R)-5,11-cis-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol and a Glucocorticoid Receptor Interacting Protein 1 NR box II Peptide [Homo sapiens]</Hit_def>
  <Hit_accession>1L2I_A</Hit_accession>
  <Hit_len>261</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>1.27563e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>215</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>114</Hit_num>
  <Hit_id>pdb|6PSJ|A</Hit_id>
  <Hit_def>Bazedoxifene in Complex with Y537S Estrogen Receptor Alpha Ligand Binding Domain [Homo sapiens] &gt;pdb|6PSJ|B Bazedoxifene in Complex with Y537S Estrogen Receptor Alpha Ligand Binding Domain [Homo sapiens] &gt;pdb|6V87|A Estrogen Receptor Alpha Ligand Binding Domain Y537S in Complex with 4-Hydroxytamoxifen [Homo sapiens] &gt;pdb|6V87|B Estrogen Receptor Alpha Ligand Binding Domain Y537S in Complex with 4-Hydroxytamoxifen [Homo sapiens] &gt;pdb|6V8T|A Estrogen Receptor Alpha Ligand Binding Domain Y537S in Complex with LSZ102 [Homo sapiens] &gt;pdb|6V8T|B Estrogen Receptor Alpha Ligand Binding Domain Y537S in Complex with LSZ102 [Homo sapiens] &gt;pdb|6VGH|A Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant In Complex with Lasofoxifene [Homo sapiens] &gt;pdb|6VGH|B Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant In Complex with Lasofoxifene [Homo sapiens]</Hit_def>
  <Hit_accession>6PSJ_A</Hit_accession>
  <Hit_len>262</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>1.2865e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>23</Hsp_hit-from>
      <Hsp_hit-to>216</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>115</Hit_num>
  <Hit_id>pdb|5AK2|A</Hit_id>
  <Hit_def>Oxyphenylpropenoic acids as Oral Selective Estrogen Receptor Down- Regulators. [Homo sapiens] &gt;pdb|5AK2|B Oxyphenylpropenoic acids as Oral Selective Estrogen Receptor Down- Regulators. [Homo sapiens]</Hit_def>
  <Hit_accession>5AK2_A</Hit_accession>
  <Hit_len>268</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>1.31036e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>29</Hsp_hit-from>
      <Hsp_hit-to>222</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>116</Hit_num>
  <Hit_id>pdb|6VMU|A</Hit_id>
  <Hit_def>Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative with Selective Estrogen Receptor Degrader Properties [Homo sapiens] &gt;pdb|6VMU|B Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative with Selective Estrogen Receptor Degrader Properties [Homo sapiens] &gt;pdb|6VMU|C Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative with Selective Estrogen Receptor Degrader Properties [Homo sapiens] &gt;pdb|6VMU|D Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative with Selective Estrogen Receptor Degrader Properties [Homo sapiens]</Hit_def>
  <Hit_accession>6VMU_A</Hit_accession>
  <Hit_len>263</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>1.32453e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>24</Hsp_hit-from>
      <Hsp_hit-to>217</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>117</Hit_num>
  <Hit_id>pdb|7KBS|A</Hit_id>
  <Hit_def>Estrogen Receptor Alpha Ligand Binding Domain in Complex with Raloxifene [Homo sapiens] &gt;pdb|7KBS|B Estrogen Receptor Alpha Ligand Binding Domain in Complex with Raloxifene [Homo sapiens]</Hit_def>
  <Hit_accession>7KBS_A</Hit_accession>
  <Hit_len>263</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>1.32453e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>24</Hsp_hit-from>
      <Hsp_hit-to>217</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>118</Hit_num>
  <Hit_id>pdb|2BJ4|B</Hit_id>
  <Hit_def>ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A PHAGE-DISPLAY DERIVED PEPTIDE ANTAGONIST [Homo sapiens] &gt;pdb|2JFA|B ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH AN AFFINITY-SELECTED COREPRESSOR PEPTIDE [Homo sapiens]</Hit_def>
  <Hit_accession>2BJ4_B</Hit_accession>
  <Hit_len>252</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>1.34836e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>34</Hsp_hit-from>
      <Hsp_hit-to>227</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>119</Hit_num>
  <Hit_id>pdb|5T1Z|A</Hit_id>
  <Hit_def>Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Ethoxytriphenylethylene and GRIP Peptide [Homo sapiens] &gt;pdb|5T1Z|B Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Ethoxytriphenylethylene and GRIP Peptide [Homo sapiens]</Hit_def>
  <Hit_accession>5T1Z_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>1.36569e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>11</Hsp_hit-from>
      <Hsp_hit-to>204</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLEMAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>120</Hit_num>
  <Hit_id>pdb|2IOG|A</Hit_id>
  <Hit_def>Chain A, Estrogen receptor [Homo sapiens]</Hit_def>
  <Hit_accession>2IOG_A</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>1.37112e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>7</Hsp_hit-from>
      <Hsp_hit-to>200</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>121</Hit_num>
  <Hit_id>pdb|5GS4|A</Hit_id>
  <Hit_def>Crystal structure of estrogen receptor alpha in complex with a stabilized peptide antagonist [Homo sapiens] &gt;pdb|5GTR|A estrogen receptor alpha in complex with a stabilized peptide antagonist 6 [Homo sapiens]</Hit_def>
  <Hit_accession>5GS4_A</Hit_accession>
  <Hit_len>243</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>1.37424e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>11</Hsp_hit-from>
      <Hsp_hit-to>204</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>122</Hit_num>
  <Hit_id>pdb|3UUA|A</Hit_id>
  <Hit_def>Crystal structure of hERa-LBD (Y537S) in complex with bisphenol-AF [Homo sapiens]</Hit_def>
  <Hit_accession>3UUA_A</Hit_accession>
  <Hit_len>251</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>1.37835e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>14</Hsp_hit-from>
      <Hsp_hit-to>207</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>123</Hit_num>
  <Hit_id>pdb|6CBZ|A</Hit_id>
  <Hit_def>Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Estradiol and GRIP Peptide [Homo sapiens]</Hit_def>
  <Hit_accession>6CBZ_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>1.37995e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>11</Hsp_hit-from>
      <Hsp_hit-to>204</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>124</Hit_num>
  <Hit_id>pdb|6PIT|B</Hit_id>
  <Hit_def>Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with SRC2 Stapled Peptide 41A and Estradiol [Homo sapiens]</Hit_def>
  <Hit_accession>6PIT_B</Hit_accession>
  <Hit_len>262</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>1.41225e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>23</Hsp_hit-from>
      <Hsp_hit-to>216</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>125</Hit_num>
  <Hit_id>pdb|1SJ0|A</Hit_id>
  <Hit_def>Human Estrogen Receptor Alpha Ligand-binding Domain in Complex with the Antagonist Ligand 4-D [Homo sapiens] &gt;pdb|1XP1|A Human Estrogen Receptor Alpha Ligand-binding Domain In Complex With Compound 15 [Homo sapiens] &gt;pdb|1XP6|A Human Estrogen Receptor Alpha Ligand-binding Domain In Complex With Compound 16 [Homo sapiens] &gt;pdb|1XP9|A Human Estrogen Receptor Alpha Ligand-binding Domain In Complex With Compound 18 [Homo sapiens] &gt;pdb|1XPC|A Human Estrogen Receptor Alpha Ligand-binding Domain In Complex With Compound 19 [Homo sapiens] &gt;pdb|1YIM|A Human estrogen receptor alpha ligand-binding domain in complex with compound 4 [Homo sapiens] &gt;pdb|1YIN|A Human estrogen receptor alpha ligand-binding domain in complex with compound 3F [Homo sapiens]</Hit_def>
  <Hit_accession>1SJ0_A</Hit_accession>
  <Hit_len>248</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>1.45665e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>9</Hsp_hit-from>
      <Hsp_hit-to>202</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>126</Hit_num>
  <Hit_id>pdb|6VIG|A</Hit_id>
  <Hit_def>Estrogen Receptor Alpha Ligand Binding Domain in Complex with RU39411 [Homo sapiens] &gt;pdb|6VIG|B Estrogen Receptor Alpha Ligand Binding Domain in Complex with RU39411 [Homo sapiens] &gt;pdb|6VIG|C Estrogen Receptor Alpha Ligand Binding Domain in Complex with RU39411 [Homo sapiens] &gt;pdb|6VIG|D Estrogen Receptor Alpha Ligand Binding Domain in Complex with RU39411 [Homo sapiens] &gt;pdb|6VPF|A Estrogen Receptor Alpha Ligand Binding Domain in Complex with the Selective Estrogen Receptor Modulator Clomiphene [Homo sapiens] &gt;pdb|6VPF|B Estrogen Receptor Alpha Ligand Binding Domain in Complex with the Selective Estrogen Receptor Modulator Clomiphene [Homo sapiens] &gt;pdb|6VPF|C Estrogen Receptor Alpha Ligand Binding Domain in Complex with the Selective Estrogen Receptor Modulator Clomiphene [Homo sapiens] &gt;pdb|6VPF|D Estrogen Receptor Alpha Ligand Binding Domain in Complex with the Selective Estrogen Receptor Modulator Clomiphene [Homo sapiens]</Hit_def>
  <Hit_accession>6VIG_A</Hit_accession>
  <Hit_len>263</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>97.0561</Hsp_bit-score>
      <Hsp_score>240</Hsp_score>
      <Hsp_evalue>1.49986e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>24</Hsp_hit-from>
      <Hsp_hit-to>217</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>127</Hit_num>
  <Hit_id>pdb|1GWQ|A</Hit_id>
  <Hit_def>HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE [Homo sapiens] &gt;pdb|1GWQ|B HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE [Homo sapiens]</Hit_def>
  <Hit_accession>1GWQ_A</Hit_accession>
  <Hit_len>248</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>1.56658e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>15</Hsp_hit-from>
      <Hsp_hit-to>208</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>128</Hit_num>
  <Hit_id>pdb|6D0F|A</Hit_id>
  <Hit_def>Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with 3OHTPE and GRIP Peptide [Homo sapiens] &gt;pdb|6D0F|B Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with 3OHTPE and GRIP Peptide [Homo sapiens]</Hit_def>
  <Hit_accession>6D0F_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>1.5795e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>11</Hsp_hit-from>
      <Hsp_hit-to>204</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>129</Hit_num>
  <Hit_id>pdb|1ERE|A</Hit_id>
  <Hit_def>Human Estrogen Receptor Ligand-Binding Domain In Complex With 17beta-Estradiol [Homo sapiens] &gt;pdb|1ERE|B Human Estrogen Receptor Ligand-Binding Domain In Complex With 17beta-Estradiol [Homo sapiens] &gt;pdb|1ERE|C Human Estrogen Receptor Ligand-Binding Domain In Complex With 17beta-Estradiol [Homo sapiens] &gt;pdb|1ERE|D Human Estrogen Receptor Ligand-Binding Domain In Complex With 17beta-Estradiol [Homo sapiens] &gt;pdb|1ERE|E Human Estrogen Receptor Ligand-Binding Domain In Complex With 17beta-Estradiol [Homo sapiens] &gt;pdb|1ERE|F Human Estrogen Receptor Ligand-Binding Domain In Complex With 17beta-Estradiol [Homo sapiens] &gt;pdb|2OUZ|A Crystal Structure of Estrogen Receptor alpha-lasofoxifene complex [Homo sapiens]</Hit_def>
  <Hit_accession>1ERE_A</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>1.60657e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>15</Hsp_hit-from>
      <Hsp_hit-to>208</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>130</Hit_num>
  <Hit_id>pdb|4IU7|A</Hit_id>
  <Hit_def>Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 2b [Homo sapiens] &gt;pdb|4IU7|B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 2b [Homo sapiens] &gt;pdb|4IUI|A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY derivative, 4a [Homo sapiens] &gt;pdb|4IUI|B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY derivative, 4a [Homo sapiens] &gt;pdb|4IV2|A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY-derivative, 5a [Homo sapiens] &gt;pdb|4IV2|B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY-derivative, 5a [Homo sapiens] &gt;pdb|4IV4|A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 5b [Homo sapiens] &gt;pdb|4IV4|B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 5b [Homo sapiens] &gt;pdb|4IVW|A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 6b [Homo sapiens] &gt;pdb|4IVW|B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 6b [Homo sapiens] &gt;pdb|4IVY|A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY-derivative, 7a [Homo sapiens] &gt;pdb|4IVY|B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY-derivative, 7a [Homo sapiens] &gt;pdb|4IW6|A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 7b [Homo sapiens] &gt;pdb|4IW6|B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 7b [Homo sapiens] &gt;pdb|4IW8|A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY-derivative, 9a [Homo sapiens] &gt;pdb|4IW8|B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Dynamic WAY-derivative, 9a [Homo sapiens] &gt;pdb|4IWC|A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with a Dynamic Thiophene-derivative [Homo sapiens] &gt;pdb|4IWC|B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with a Dynamic Thiophene-derivative [Homo sapiens] &gt;pdb|4IWF|A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with a Dynamic Oxime-derivative [Homo sapiens] &gt;pdb|4IWF|B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with a Dynamic Oxime-derivative [Homo sapiens]</Hit_def>
  <Hit_accession>4IU7_A</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>1.61779e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>13</Hsp_hit-from>
      <Hsp_hit-to>206</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>131</Hit_num>
  <Hit_id>pdb|1G50|A</Hit_id>
  <Hit_def>Crystal Structure Of A Wild Type Her Alpha Lbd At 2.9 Angstrom Resolution [Homo sapiens] &gt;pdb|1G50|B Crystal Structure Of A Wild Type Her Alpha Lbd At 2.9 Angstrom Resolution [Homo sapiens] &gt;pdb|1G50|C Crystal Structure Of A Wild Type Her Alpha Lbd At 2.9 Angstrom Resolution [Homo sapiens]</Hit_def>
  <Hit_accession>1G50_A</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>1.61779e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>12</Hsp_hit-from>
      <Hsp_hit-to>205</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>132</Hit_num>
  <Hit_id>pdb|4DMA|A</Hit_id>
  <Hit_def>Crystal structure of ERa LBD in complex with RU100132 [Homo sapiens] &gt;pdb|4DMA|B Crystal structure of ERa LBD in complex with RU100132 [Homo sapiens]</Hit_def>
  <Hit_accession>4DMA_A</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>1.61779e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>13</Hsp_hit-from>
      <Hsp_hit-to>206</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>133</Hit_num>
  <Hit_id>pdb|7JHD|A</Hit_id>
  <Hit_def>Chain A, Estrogen receptor [Homo sapiens] &gt;pdb|7JHD|B Chain B, Estrogen receptor [Homo sapiens]</Hit_def>
  <Hit_accession>7JHD_A</Hit_accession>
  <Hit_len>251</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>1.6617e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>12</Hsp_hit-from>
      <Hsp_hit-to>205</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>134</Hit_num>
  <Hit_id>pdb|4PP6|A</Hit_id>
  <Hit_def>Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Resveratrol [Homo sapiens] &gt;pdb|4PP6|B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Resveratrol [Homo sapiens] &gt;pdb|4PPP|A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Fluoro-Resveratrol [Homo sapiens] &gt;pdb|4PPP|B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Fluoro-Resveratrol [Homo sapiens] &gt;pdb|4PPS|A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with an A-CD ring estrogen derivative [Homo sapiens] &gt;pdb|4PPS|B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with an A-CD ring estrogen derivative [Homo sapiens]</Hit_def>
  <Hit_accession>4PP6_A</Hit_accession>
  <Hit_len>244</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.2857</Hsp_bit-score>
      <Hsp_score>238</Hsp_score>
      <Hsp_evalue>1.69088e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>11</Hsp_hit-from>
      <Hsp_hit-to>204</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>135</Hit_num>
  <Hit_id>pdb|1GWR|A</Hit_id>
  <Hit_def>HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-OESTRADIOL AND TIF2 NRBOX3 PEPTIDE [Homo sapiens] &gt;pdb|1GWR|B HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 17BETA-OESTRADIOL AND TIF2 NRBOX3 PEPTIDE [Homo sapiens]</Hit_def>
  <Hit_accession>1GWR_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.2857</Hsp_bit-score>
      <Hsp_score>238</Hsp_score>
      <Hsp_evalue>1.70718e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>11</Hsp_hit-from>
      <Hsp_hit-to>204</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>136</Hit_num>
  <Hit_id>pdb|2IOK|A</Hit_id>
  <Hit_def>Human estrogen receptor alpha ligand-binding domain in complex with compound 1D [Homo sapiens] &gt;pdb|2IOK|B Human estrogen receptor alpha ligand-binding domain in complex with compound 1D [Homo sapiens]</Hit_def>
  <Hit_accession>2IOK_A</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>1.79833e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>15</Hsp_hit-from>
      <Hsp_hit-to>208</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>137</Hit_num>
  <Hit_id>pdb|3Q95|A</Hit_id>
  <Hit_def>Crystal structure of human estrogen receptor alpha LBD in complex with GRIP peptide and estriol [Homo sapiens]</Hit_def>
  <Hit_accession>3Q95_A</Hit_accession>
  <Hit_len>260</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>1.79914e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>21</Hsp_hit-from>
      <Hsp_hit-to>214</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>138</Hit_num>
  <Hit_id>pdb|1QKU|A</Hit_id>
  <Hit_def>WILD TYPE ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL [Homo sapiens] &gt;pdb|1QKU|B WILD TYPE ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL [Homo sapiens] &gt;pdb|1QKU|C WILD TYPE ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL [Homo sapiens]</Hit_def>
  <Hit_accession>1QKU_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.2857</Hsp_bit-score>
      <Hsp_score>238</Hsp_score>
      <Hsp_evalue>1.82672e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>15</Hsp_hit-from>
      <Hsp_hit-to>208</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>139</Hit_num>
  <Hit_id>pdb|3HLV|A</Hit_id>
  <Hit_def>Crystal structure of human Estrogen Receptor Alpha Ligand-Binding Domain in complex with a Glucocorticoid Receptor Interacting Protein 1 Nr Box II Peptide and 16-alpha-hydroxy-estrone ((8S,9R,13S,14R,16R)-3,16-dihydroxy-13-methyl-7,8,9,11,12,14,15, 16-octahydro-6H-cyclopenta[a]phenanthren-17-one [Homo sapiens] &gt;pdb|3HLV|B Crystal structure of human Estrogen Receptor Alpha Ligand-Binding Domain in complex with a Glucocorticoid Receptor Interacting Protein 1 Nr Box II Peptide and 16-alpha-hydroxy-estrone ((8S,9R,13S,14R,16R)-3,16-dihydroxy-13-methyl-7,8,9,11,12,14,15, 16-octahydro-6H-cyclopenta[a]phenanthren-17-one [Homo sapiens]</Hit_def>
  <Hit_accession>3HLV_A</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.2857</Hsp_bit-score>
      <Hsp_score>238</Hsp_score>
      <Hsp_evalue>1.93659e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>18</Hsp_hit-from>
      <Hsp_hit-to>211</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>140</Hit_num>
  <Hit_id>pdb|6PIT|A</Hit_id>
  <Hit_def>Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with SRC2 Stapled Peptide 41A and Estradiol [Homo sapiens]</Hit_def>
  <Hit_accession>6PIT_A</Hit_accession>
  <Hit_len>262</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>1.94708e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>23</Hsp_hit-from>
      <Hsp_hit-to>216</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>141</Hit_num>
  <Hit_id>pdb|2QA8|B</Hit_id>
  <Hit_def>Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Mutant 537S Complexed with Genistein [Homo sapiens] &gt;pdb|2QZO|A Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with WAY-169916 [Homo sapiens]</Hit_def>
  <Hit_accession>2QA8_B</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>2.00281e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>19</Hsp_hit-from>
      <Hsp_hit-to>212</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>142</Hit_num>
  <Hit_id>pdb|1R5K|A</Hit_id>
  <Hit_def>Human Estrogen Receptor alpha Ligand-Binding Domain In Complex With GW5638 [Homo sapiens] &gt;pdb|1R5K|B Human Estrogen Receptor alpha Ligand-Binding Domain In Complex With GW5638 [Homo sapiens] &gt;pdb|1R5K|C Human Estrogen Receptor alpha Ligand-Binding Domain In Complex With GW5638 [Homo sapiens] &gt;pdb|3ERD|A HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DIETHYLSTILBESTROL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE [Homo sapiens] &gt;pdb|3ERD|B HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DIETHYLSTILBESTROL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE [Homo sapiens] &gt;pdb|3ERT|A Human Estrogen Receptor Alpha Ligand-Binding Domain In Complex With 4- Hydroxytamoxifen [Homo sapiens]</Hit_def>
  <Hit_accession>1R5K_A</Hit_accession>
  <Hit_len>261</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>2.03346e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>215</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>143</Hit_num>
  <Hit_id>pdb|3L03|A</Hit_id>
  <Hit_def>Crystal Structure of human Estrogen Receptor alpha Ligand-Binding Domain in complex with a Glucocorticoid Receptor Interacting Protein 1 Nr Box II peptide and Estetrol (Estra-1,3,5(10)-triene-3,15 alpha,16alpha,17beta-tetrol) [Homo sapiens] &gt;pdb|3L03|B Crystal Structure of human Estrogen Receptor alpha Ligand-Binding Domain in complex with a Glucocorticoid Receptor Interacting Protein 1 Nr Box II peptide and Estetrol (Estra-1,3,5(10)-triene-3,15 alpha,16alpha,17beta-tetrol) [Homo sapiens]</Hit_def>
  <Hit_accession>3L03_A</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.2857</Hsp_bit-score>
      <Hsp_score>238</Hsp_score>
      <Hsp_evalue>2.03973e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>18</Hsp_hit-from>
      <Hsp_hit-to>211</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>144</Hit_num>
  <Hit_id>pdb|1A52|A</Hit_id>
  <Hit_def>Estrogen Receptor Alpha Ligand-Binding Domain Complexed To Estradiol [Homo sapiens] &gt;pdb|1A52|B Estrogen Receptor Alpha Ligand-Binding Domain Complexed To Estradiol [Homo sapiens]</Hit_def>
  <Hit_accession>1A52_A</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>2.04477e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>19</Hsp_hit-from>
      <Hsp_hit-to>212</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHERLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>145</Hit_num>
  <Hit_id>pdb|4ZN7|A</Hit_id>
  <Hit_def>Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with Diethylstilbestrol [Homo sapiens] &gt;pdb|4ZN7|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with Diethylstilbestrol [Homo sapiens] &gt;pdb|4ZN9|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with Oxabicyclic Heptene Sulfonate (OBHS) [Homo sapiens] &gt;pdb|4ZN9|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with Oxabicyclic Heptene Sulfonate (OBHS) [Homo sapiens] &gt;pdb|4ZNH|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 2-Fluoro-substituted OBHS derivative [Homo sapiens] &gt;pdb|4ZNH|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 2-Fluoro-substituted OBHS derivative [Homo sapiens] &gt;pdb|4ZNS|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 3-Fluoro-substituted OBHS derivative [Homo sapiens] &gt;pdb|4ZNS|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 3-Fluoro-substituted OBHS derivative [Homo sapiens] &gt;pdb|4ZNT|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 3-Bromo-substituted OBHS derivative [Homo sapiens] &gt;pdb|4ZNT|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 3-Bromo-substituted OBHS derivative [Homo sapiens] &gt;pdb|4ZNU|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 2-Methyl-substituted OBHS derivative [Homo sapiens] &gt;pdb|4ZNU|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 2-Methyl-substituted OBHS derivative [Homo sapiens] &gt;pdb|4ZNV|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 2-Methoxy-substituted OBHS derivative [Homo sapiens] &gt;pdb|4ZNV|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 2-Methoxy-substituted OBHS derivative [Homo sapiens] &gt;pdb|4ZNW|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 4-Bromo-substituted OBHS derivative [Homo sapiens] &gt;pdb|4ZNW|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 4-Bromo-substituted OBHS derivative [Homo sapiens]</Hit_def>
  <Hit_accession>4ZN7_A</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>2.06239e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>15</Hsp_hit-from>
      <Hsp_hit-to>208</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>146</Hit_num>
  <Hit_id>pdb|6SBO|A</Hit_id>
  <Hit_def>Estrogen receptor mutant L536S [Homo sapiens] &gt;pdb|6SBO|B Estrogen receptor mutant L536S [Homo sapiens]</Hit_def>
  <Hit_accession>6SBO_A</Hit_accession>
  <Hit_len>260</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>2.10168e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>21</Hsp_hit-from>
      <Hsp_hit-to>214</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>147</Hit_num>
  <Hit_id>pdb|2QZO|B</Hit_id>
  <Hit_def>Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with WAY-169916 [Homo sapiens]</Hit_def>
  <Hit_accession>2QZO_B</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.2857</Hsp_bit-score>
      <Hsp_score>238</Hsp_score>
      <Hsp_evalue>2.10935e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>19</Hsp_hit-from>
      <Hsp_hit-to>212</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>148</Hit_num>
  <Hit_id>pdb|5DI7|A</Hit_id>
  <Hit_def>Crystal Structure of the ER-alpha Ligand-binding Domain in complex with an methyl-substituted A-CD ring estrogen derivative (1S,3aR,5S,7aS)-5-(4-hydroxy-2-methylphenyl)-7a-methyloctahydro-1H-inden-1-ol [Homo sapiens] &gt;pdb|5DI7|B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with an methyl-substituted A-CD ring estrogen derivative (1S,3aR,5S,7aS)-5-(4-hydroxy-2-methylphenyl)-7a-methyloctahydro-1H-inden-1-ol [Homo sapiens] &gt;pdb|5DID|A Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a difluoro-substituted A-CD ring estrogen derivative (1S,3aR,5S,7aS)-5-(2,3-difluoro-4-hydroxyphenyl)-7a-methyloctahydro-1H-inden-1-ol [Homo sapiens] &gt;pdb|5DID|B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a difluoro-substituted A-CD ring estrogen derivative (1S,3aR,5S,7aS)-5-(2,3-difluoro-4-hydroxyphenyl)-7a-methyloctahydro-1H-inden-1-ol [Homo sapiens] &gt;pdb|5DIE|A Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a trifluoro-substituted A-CD ring estrogen derivative (1S,3aR,5S,7aS)-7a-methyl-5-(2,3,5-trifluoro-4-hydroxyphenyl)octahydro-1H-inden-1-ol [Homo sapiens] &gt;pdb|5DIE|B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a trifluoro-substituted A-CD ring estrogen derivative (1S,3aR,5S,7aS)-7a-methyl-5-(2,3,5-trifluoro-4-hydroxyphenyl)octahydro-1H-inden-1-ol [Homo sapiens] &gt;pdb|5DIG|A Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a trifluoromethyl-substituted A-CD ring estrogen derivative (1S,3aR,5S,7aS)-5-[4-hydroxy-2-(trifluoromethyl)phenyl]-7a-methyloctahydro-1H-inden-1-ol [Homo sapiens] &gt;pdb|5DIG|B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a trifluoromethyl-substituted A-CD ring estrogen derivative (1S,3aR,5S,7aS)-5-[4-hydroxy-2-(trifluoromethyl)phenyl]-7a-methyloctahydro-1H-inden-1-ol [Homo sapiens] &gt;pdb|5DK9|A Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a phenylamino-substituted ethyl triaryl-ethylene derivative 4,4&apos;-{2-[3-(phenylamino)phenyl]but-1-ene-1,1-diyl}diphenol [Homo sapiens] &gt;pdb|5DK9|B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a phenylamino-substituted ethyl triaryl-ethylene derivative 4,4&apos;-{2-[3-(phenylamino)phenyl]but-1-ene-1,1-diyl}diphenol [Homo sapiens] &gt;pdb|5DKB|A Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 3-methylphenylamino-substituted ethyl triaryl-ethylene derivative 4,4&apos;-(2-{3-[(3-methylphenyl)amino]phenyl}but-1-ene-1,1-diyl)diphenol [Homo sapiens] &gt;pdb|5DKB|B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 3-methylphenylamino-substituted ethyl triaryl-ethylene derivative 4,4&apos;-(2-{3-[(3-methylphenyl)amino]phenyl}but-1-ene-1,1-diyl)diphenol [Homo sapiens] &gt;pdb|5DKE|A Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 3-naphthyl-substituted, methyl, cis-diaryl-ethylene compound 4,4&apos;-[2-(naphthalen-2-yl)prop-1-ene-1,1-diyl]diphenol [Homo sapiens] &gt;pdb|5DKE|B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 3-naphthyl-substituted, methyl, cis-diaryl-ethylene compound 4,4&apos;-[2-(naphthalen-2-yl)prop-1-ene-1,1-diyl]diphenol [Homo sapiens] &gt;pdb|5DKG|A Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a t-butyl-substituted, methyl, triaryl-ethylene derivative 4,4&apos;-[2-(4-tert-butylphenyl)prop-1-ene-1,1-diyl]diphenol [Homo sapiens] &gt;pdb|5DKG|B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a t-butyl-substituted, methyl, triaryl-ethylene derivative 4,4&apos;-[2-(4-tert-butylphenyl)prop-1-ene-1,1-diyl]diphenol [Homo sapiens] &gt;pdb|5DKS|A Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 2-naphthylamino-substituted, ethyl, triaryl-ethylene derivative 4,4&apos;-{2-[3-(naphthalen-1-ylamino)phenyl]but-1-ene-1,1-diyl}diphenol [Homo sapiens] &gt;pdb|5DKS|B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 2-naphthylamino-substituted, ethyl, triaryl-ethylene derivative 4,4&apos;-{2-[3-(naphthalen-1-ylamino)phenyl]but-1-ene-1,1-diyl}diphenol [Homo sapiens] &gt;pdb|5DL4|A Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a phenylamino-substituted, methyl, triaryl-ethylene derivative 4,4&apos;-{2-[3-(phenylamino)phenyl]prop-1-ene-1,1-diyl}diphenol [Homo sapiens] &gt;pdb|5DL4|B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a phenylamino-substituted, methyl, triaryl-ethylene derivative 4,4&apos;-{2-[3-(phenylamino)phenyl]prop-1-ene-1,1-diyl}diphenol [Homo sapiens] &gt;pdb|5DLR|A Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a triaryl-ethylene compound 4,4&apos;-(2-phenylethene-1,1-diyl)diphenol [Homo sapiens] &gt;pdb|5DLR|B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a triaryl-ethylene compound 4,4&apos;-(2-phenylethene-1,1-diyl)diphenol [Homo sapiens] &gt;pdb|5DMC|A Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a nitrile-substituted triaryl-ethylene derivative 3,3-bis(4-hydroxyphenyl)-2-phenylprop-2-enenitrile [Homo sapiens] &gt;pdb|5DMC|B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a nitrile-substituted triaryl-ethylene derivative 3,3-bis(4-hydroxyphenyl)-2-phenylprop-2-enenitrile [Homo sapiens] &gt;pdb|5DMF|A Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 4-fluorophenylamino-substituted, methyl triaryl-ethylene derivative 4,4&apos;-(2-{3-[(4-fluorophenyl)amino]phenyl}prop-1-ene-1,1-diyl)diphenol [Homo sapiens] &gt;pdb|5DMF|B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 4-fluorophenylamino-substituted, methyl triaryl-ethylene derivative 4,4&apos;-(2-{3-[(4-fluorophenyl)amino]phenyl}prop-1-ene-1,1-diyl)diphenol [Homo sapiens] &gt;pdb|5DP0|A Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 4-fluorophenylamino-substituted triaryl-ethylene derivative 4,4&apos;-(2-{3-[(4-fluorophenyl)amino]phenyl}ethene-1,1-diyl)diphenol [Homo sapiens] &gt;pdb|5DP0|B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 4-fluorophenylamino-substituted triaryl-ethylene derivative 4,4&apos;-(2-{3-[(4-fluorophenyl)amino]phenyl}ethene-1,1-diyl)diphenol [Homo sapiens] &gt;pdb|5DRJ|A Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dichloro-substituted, 3-methyl 2,5-diarylthiophene-core ligand 4,4&apos;-(3-methylthiene-2,5-diyl)bis(3-chlorophenol) [Homo sapiens] &gt;pdb|5DRJ|B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dichloro-substituted, 3-methyl 2,5-diarylthiophene-core ligand 4,4&apos;-(3-methylthiene-2,5-diyl)bis(3-chlorophenol) [Homo sapiens] &gt;pdb|5DRM|A Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dichloro-substituted, 2,5-diarylthiophene-core ligand 4,4&apos;-thiene-2,5-diylbis(3-chlorophenol) [Homo sapiens] &gt;pdb|5DRM|B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dichloro-substituted, 2,5-diarylthiophene-core ligand 4,4&apos;-thiene-2,5-diylbis(3-chlorophenol) [Homo sapiens] &gt;pdb|5DTV|A Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dimethyl-substituted, 3,4-diarylthiophene dioxide core ligand [Homo sapiens] &gt;pdb|5DTV|B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dimethyl-substituted, 3,4-diarylthiophene dioxide core ligand [Homo sapiens] &gt;pdb|5DU5|A Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dichloro-substituted, 3,4-diarylthiophene dioxide core ligand [Homo sapiens] &gt;pdb|5DU5|B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dichloro-substituted, 3,4-diarylthiophene dioxide core ligand [Homo sapiens] &gt;pdb|5DUE|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a para-Hydroxyl-substituted, Sulfoxide-bridged Oxabicyclic Heptene Sulfonate (SOBHS)-2 Analog 4-hydroxyphenyl (1S,2S,4S,5S,6R,7S)-5,6-bis(4-hydroxy-2-methylphenyl)-7-thiabicyclo[2.2.1]heptane-2-sulfonate 7-oxide [Homo sapiens] &gt;pdb|5DUE|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a para-Hydroxyl-substituted, Sulfoxide-bridged Oxabicyclic Heptene Sulfonate (SOBHS)-2 Analog 4-hydroxyphenyl (1S,2S,4S,5S,6R,7S)-5,6-bis(4-hydroxy-2-methylphenyl)-7-thiabicyclo[2.2.1]heptane-2-sulfonate 7-oxide [Homo sapiens] &gt;pdb|5DUG|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Sulfoxide-bridged Oxabicyclic Heptene Sulfonate (SOBHS)-2 analog phenyl (1S,2S,4S,7S)-5,6-bis(4-hydroxy-2-methylphenyl)-7-thiabicyclo[2.2.1]hept-5-ene-2-sulfonate 7-oxide [Homo sapiens] &gt;pdb|5DUG|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Sulfoxide-bridged Oxabicyclic Heptene Sulfonate (SOBHS)-2 analog phenyl (1S,2S,4S,7S)-5,6-bis(4-hydroxy-2-methylphenyl)-7-thiabicyclo[2.2.1]hept-5-ene-2-sulfonate 7-oxide [Homo sapiens] &gt;pdb|5DUH|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Sulfoxide-bridged Oxabicyclic Heptene Sulfonate (SOBHS)-3 analog phenyl (1S,2S,4S,7S)-5,6-bis(4-hydroxy-3-methylphenyl)-7-thiabicyclo[2.2.1]hept-5-ene-2-sulfonate 7-oxide [Homo sapiens] &gt;pdb|5DUH|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Sulfoxide-bridged Oxabicyclic Heptene Sulfonate (SOBHS)-3 analog phenyl (1S,2S,4S,7S)-5,6-bis(4-hydroxy-3-methylphenyl)-7-thiabicyclo[2.2.1]hept-5-ene-2-sulfonate 7-oxide [Homo sapiens] &gt;pdb|5DVS|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a 2-Methyl-substituted Triaryl-imine 4,4&apos;-[(2-methylphenyl)carbonimidoyl]diphenol [Homo sapiens] &gt;pdb|5DVS|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a 2-Methyl-substituted Triaryl-imine 4,4&apos;-[(2-methylphenyl)carbonimidoyl]diphenol [Homo sapiens] &gt;pdb|5DVV|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Triaryl-imine analog 4,4&apos;-(phenylcarbonimidoyl)diphenol [Homo sapiens] &gt;pdb|5DVV|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Triaryl-imine analog 4,4&apos;-(phenylcarbonimidoyl)diphenol [Homo sapiens] &gt;pdb|5DWE|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a 2-Chloro-substituted Triaryl-imine analog 4,4&apos;-[(2-chlorophenyl)carbonimidoyl]diphenol [Homo sapiens] &gt;pdb|5DWE|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a 2-Chloro-substituted Triaryl-imine analog 4,4&apos;-[(2-chlorophenyl)carbonimidoyl]diphenol [Homo sapiens] &gt;pdb|5DWG|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Triaryl-substituted Imine Analog, 4-{(E)-(4-hydroxyphenyl)[(2-methylphenyl)imino]methyl}benzene-1,3-diol [Homo sapiens] &gt;pdb|5DWG|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Triaryl-substituted Imine Analog, 4-{(E)-(4-hydroxyphenyl)[(2-methylphenyl)imino]methyl}benzene-1,3-diol [Homo sapiens] &gt;pdb|5DWI|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Resorcinyl 2-Chloro-substituted Diaryl-imine analog 4-[(E)-[(2-chlorophenyl)imino](4-hydroxyphenyl)methyl]benzene-1,3-diol [Homo sapiens] &gt;pdb|5DWI|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Resorcinyl 2-Chloro-substituted Diaryl-imine analog 4-[(E)-[(2-chlorophenyl)imino](4-hydroxyphenyl)methyl]benzene-1,3-diol [Homo sapiens] &gt;pdb|5DWJ|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Resorcinyl 4-Fluoro-substituted Diaryl-imine analog 4-[(E)-[(4-fluorophenyl)imino](4-hydroxyphenyl)methyl]benzene-1,3-diol [Homo sapiens] &gt;pdb|5DWJ|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Resorcinyl 4-Fluoro-substituted Diaryl-imine analog 4-[(E)-[(4-fluorophenyl)imino](4-hydroxyphenyl)methyl]benzene-1,3-diol [Homo sapiens] &gt;pdb|5DXK|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-[(9s)-bicyclo[3.3.1]non-9-ylmethanediyl]diphenol [Homo sapiens] &gt;pdb|5DXK|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-[(9s)-bicyclo[3.3.1]non-9-ylmethanediyl]diphenol [Homo sapiens] &gt;pdb|5DXM|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 3-[(E)-(1s,5s)-bicyclo[3.3.1]non-9-ylidene(4-hydroxyphenyl)methyl]phenol [Homo sapiens] &gt;pdb|5DXM|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 3-[(E)-(1s,5s)-bicyclo[3.3.1]non-9-ylidene(4-hydroxyphenyl)methyl]phenol [Homo sapiens] &gt;pdb|5DXP|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4-[(E)-(1s,5s)-bicyclo[3.3.1]non-9-ylidene(phenyl)methyl]phenol [Homo sapiens] &gt;pdb|5DXP|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4-[(E)-(1s,5s)-bicyclo[3.3.1]non-9-ylidene(phenyl)methyl]phenol [Homo sapiens] &gt;pdb|5DXQ|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-[(1s,5s)-bicyclo[3.3.1]non-9-ylidenemethanediyl]diphenol [Homo sapiens] &gt;pdb|5DXQ|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-[(1s,5s)-bicyclo[3.3.1]non-9-ylidenemethanediyl]diphenol [Homo sapiens] &gt;pdb|5DXR|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-{[(3R)-3-methylcyclohexylidene]methanediyl}diphenol [Homo sapiens] &gt;pdb|5DXR|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-{[(3R)-3-methylcyclohexylidene]methanediyl}diphenol [Homo sapiens] &gt;pdb|5DY8|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-{[(3S)-3-ethylcyclohexylidene]methanediyl}diphenol [Homo sapiens] &gt;pdb|5DY8|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-{[(3S)-3-ethylcyclohexylidene]methanediyl}diphenol [Homo sapiens] &gt;pdb|5DYB|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-(3,4-dihydronaphthalen-2(1H)-ylidenemethanediyl)diphenol [Homo sapiens] &gt;pdb|5DYB|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-(3,4-dihydronaphthalen-2(1H)-ylidenemethanediyl)diphenol [Homo sapiens] &gt;pdb|5DYD|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-{[(3S)-3-(methylsulfanyl)cyclohexylidene]methanediyl}diphenol [Homo sapiens] &gt;pdb|5DYD|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-{[(3S)-3-(methylsulfanyl)cyclohexylidene]methanediyl}diphenol [Homo sapiens] &gt;pdb|5DZ0|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-[(4-methylcyclohexylidene)methanediyl]diphenol [Homo sapiens] &gt;pdb|5DZ0|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-[(4-methylcyclohexylidene)methanediyl]diphenol [Homo sapiens] &gt;pdb|5DZ1|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-[(4-ethylcyclohexylidene)methanediyl]diphenol [Homo sapiens] &gt;pdb|5DZ1|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-[(4-ethylcyclohexylidene)methanediyl]diphenol [Homo sapiens] &gt;pdb|5DZ3|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-{[4-(fluoromethyl)cyclohexylidene]methanediyl}diphenol [Homo sapiens] &gt;pdb|5DZ3|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-{[4-(fluoromethyl)cyclohexylidene]methanediyl}diphenol [Homo sapiens] &gt;pdb|5DZH|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-{[4-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol [Homo sapiens] &gt;pdb|5DZH|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-{[4-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol [Homo sapiens] &gt;pdb|5DZI|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-{[(3S)-3-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol [Homo sapiens] &gt;pdb|5DZI|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-{[(3S)-3-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol [Homo sapiens] &gt;pdb|5E0W|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-{[(3S)-3-(4-hydroxyphenyl)cyclohexylidene]methanediyl}diphenol [Homo sapiens] &gt;pdb|5E0W|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-{[(3S)-3-(4-hydroxyphenyl)cyclohexylidene]methanediyl}diphenol [Homo sapiens] &gt;pdb|5E0X|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-{[(3S)-3-(4-methoxyphenyl)cyclohexylidene]methanediyl}diphenol [Homo sapiens] &gt;pdb|5E0X|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-{[(3S)-3-(4-methoxyphenyl)cyclohexylidene]methanediyl}diphenol [Homo sapiens] &gt;pdb|5E14|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-{[(3R)-3-phenylcyclohexylidene]methanediyl}diphenol [Homo sapiens] &gt;pdb|5E14|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-{[(3R)-3-phenylcyclohexylidene]methanediyl}diphenol [Homo sapiens] &gt;pdb|5E15|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-{[4-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol [Homo sapiens] &gt;pdb|5E15|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-{[4-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol [Homo sapiens] &gt;pdb|5E19|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative methyl {4-[bis(4-hydroxyphenyl)methylidene]cyclohexyl}acetate [Homo sapiens] &gt;pdb|5E19|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative methyl {4-[bis(4-hydroxyphenyl)methylidene]cyclohexyl}acetate [Homo sapiens] &gt;pdb|5E1C|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative dimethyl {(1S)-3-[bis(4-hydroxyphenyl)methylidene]cyclohexyl}propanedioate [Homo sapiens] &gt;pdb|5E1C|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative dimethyl {(1S)-3-[bis(4-hydroxyphenyl)methylidene]cyclohexyl}propanedioate [Homo sapiens] &gt;pdb|5EGV|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex the 3,4-diaryl-furan derivative 3-chloranyl-4-[4-(2-chloranyl-4-oxidanyl-phenyl)furan-3-yl]phenol [Homo sapiens] &gt;pdb|5EGV|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex the 3,4-diaryl-furan derivative 3-chloranyl-4-[4-(2-chloranyl-4-oxidanyl-phenyl)furan-3-yl]phenol [Homo sapiens] &gt;pdb|5EHJ|A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-[(4aR,8aR)-octahydronaphthalen-2(1H)-ylidenemethanediyl]diphenol [Homo sapiens] &gt;pdb|5EHJ|B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4&apos;-[(4aR,8aR)-octahydronaphthalen-2(1H)-ylidenemethanediyl]diphenol [Homo sapiens] &gt;pdb|5EI1|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the imidazopyridine derivative 2-(4-hydroxyphenyl)-3-iodanyl-imidazo[1,2-a]pyridin-6-ol [Homo sapiens] &gt;pdb|5EI1|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the imidazopyridine derivative 2-(4-hydroxyphenyl)-3-iodanyl-imidazo[1,2-a]pyridin-6-ol [Homo sapiens] &gt;pdb|5EIT|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the imidazopyridine derivative 2-(4-hydroxyphenyl)-3-(trifluoromethyl)imidazo[1,2-a]pyridin-6-ol [Homo sapiens] &gt;pdb|5EIT|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the imidazopyridine derivative 2-(4-hydroxyphenyl)-3-(trifluoromethyl)imidazo[1,2-a]pyridin-6-ol [Homo sapiens] &gt;pdb|5KCC|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with Oxabicyclic Heptene Sulfonamide (OBHS-N) [Homo sapiens] &gt;pdb|5KCC|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with Oxabicyclic Heptene Sulfonamide (OBHS-N) [Homo sapiens] &gt;pdb|5KCD|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-methyl Substituted OBHS-N derivative [Homo sapiens] &gt;pdb|5KCD|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-methyl Substituted OBHS-N derivative [Homo sapiens] &gt;pdb|5KCE|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-methyl, 2-chlorobenzyl OBHS-N derivative [Homo sapiens] &gt;pdb|5KCE|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-methyl, 2-chlorobenzyl OBHS-N derivative [Homo sapiens] &gt;pdb|5KCF|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-ethyl, 4-methoxybenzyl OBHS-N derivative [Homo sapiens] &gt;pdb|5KCF|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-ethyl, 4-methoxybenzyl OBHS-N derivative [Homo sapiens] &gt;pdb|5KCT|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-ethyl, 4-chlorobenzyl OBHS-N derivative [Homo sapiens] &gt;pdb|5KCT|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-ethyl, 4-chlorobenzyl OBHS-N derivative [Homo sapiens] &gt;pdb|5KCU|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-ethyl, alpha-naphthyl OBHS-N derivative [Homo sapiens] &gt;pdb|5KCU|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-ethyl, alpha-naphthyl OBHS-N derivative [Homo sapiens] &gt;pdb|5KCW|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-trifluoroethyl OBHS-N derivative [Homo sapiens] &gt;pdb|5KCW|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-trifluoroethyl OBHS-N derivative [Homo sapiens] &gt;pdb|5KD9|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-trifluoroethyl 4-chlorobenzyl OBHS-N derivative [Homo sapiens] &gt;pdb|5KD9|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-trifluoroethyl 4-chlorobenzyl OBHS-N derivative [Homo sapiens] &gt;pdb|5KR9|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with Coumestrol [Homo sapiens] &gt;pdb|5KR9|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with Coumestrol [Homo sapiens] &gt;pdb|5KRA|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with DDT and DDE [Homo sapiens] &gt;pdb|5KRA|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with DDT and DDE [Homo sapiens] &gt;pdb|5KRA|E Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with DDT and DDE [Homo sapiens] &gt;pdb|5KRA|F Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with DDT and DDE [Homo sapiens] &gt;pdb|5KRC|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with Zearalenone [Homo sapiens] &gt;pdb|5KRC|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with Zearalenone [Homo sapiens] &gt;pdb|5KRF|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Dynamic WAY derivative, 1a [Homo sapiens] &gt;pdb|5KRF|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Dynamic WAY derivative, 1a [Homo sapiens] &gt;pdb|5KRH|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 16-benzylidene estrone [Homo sapiens] &gt;pdb|5KRH|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 16-benzylidene estrone [Homo sapiens] &gt;pdb|5KRI|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 16b-benzyl 17b-estradiol [Homo sapiens] &gt;pdb|5KRI|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 16b-benzyl 17b-estradiol [Homo sapiens] &gt;pdb|5KRJ|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an a-naphthyl Substituted OBHS derivative [Homo sapiens] &gt;pdb|5KRJ|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an a-naphthyl Substituted OBHS derivative [Homo sapiens] &gt;pdb|5KRK|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4&apos;-((5-bromo-2,3-dihydro-1H-inden-1-ylidene)methylene)diphenol [Homo sapiens] &gt;pdb|5KRK|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4&apos;-((5-bromo-2,3-dihydro-1H-inden-1-ylidene)methylene)diphenol [Homo sapiens] &gt;pdb|5KRL|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the A-CD ring estrogen, (1S,7aS)-5-(2-chloro-4-hydroxyphenyl)-7a-methyl-2,3,3a,4,7,7a-hexahydro-1H-inden-1-ol [Homo sapiens] &gt;pdb|5KRL|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the A-CD ring estrogen, (1S,7aS)-5-(2-chloro-4-hydroxyphenyl)-7a-methyl-2,3,3a,4,7,7a-hexahydro-1H-inden-1-ol [Homo sapiens] &gt;pdb|5KRM|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the A-CD ring estrogen, (1S,7aS)-5-(2,5-difluoro-4-hydroxyphenyl)-7a-methyl-2,3,3a,4,7,7a-hexahydro-1H-inden-1-ol [Homo sapiens] &gt;pdb|5KRM|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the A-CD ring estrogen, (1S,7aS)-5-(2,5-difluoro-4-hydroxyphenyl)-7a-methyl-2,3,3a,4,7,7a-hexahydro-1H-inden-1-ol [Homo sapiens] &gt;pdb|5KRO|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Methyl(phenyl)amino-substituted Estrogen, (8R,9S,13S,14S,17S)-13-methyl-17-(methyl(phenyl)amino)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol [Homo sapiens] &gt;pdb|5KRO|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Methyl(phenyl)amino-substituted Estrogen, (8R,9S,13S,14S,17S)-13-methyl-17-(methyl(phenyl)amino)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol [Homo sapiens] &gt;pdb|5TLD|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the phenylamino-substituted estrogen, (8R,9S,13S,14S,17S)-13-methyl-17-(phenylamino)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol [Homo sapiens] &gt;pdb|5TLD|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the phenylamino-substituted estrogen, (8R,9S,13S,14S,17S)-13-methyl-17-(phenylamino)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol [Homo sapiens] &gt;pdb|5TLF|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Constrained WAY Derivative, 4-(2-(3-methylbut-2-en-1-yl)-7-(trifluoromethyl)-2H-indazol-3-yl)benzene-1,3-diol [Homo sapiens] &gt;pdb|5TLF|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Constrained WAY Derivative, 4-(2-(3-methylbut-2-en-1-yl)-7-(trifluoromethyl)-2H-indazol-3-yl)benzene-1,3-diol [Homo sapiens] &gt;pdb|5TLG|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with (E)-4,4&apos;&apos;-dihydroxy-3&apos;-((hydroxyiminio)methyl)-[1,1&apos;:2&apos;,1&apos;&apos;-terphenyl]-4&apos;-olate [Homo sapiens] &gt;pdb|5TLG|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with (E)-4,4&apos;&apos;-dihydroxy-3&apos;-((hydroxyiminio)methyl)-[1,1&apos;:2&apos;,1&apos;&apos;-terphenyl]-4&apos;-olate [Homo sapiens] &gt;pdb|5TLL|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with (E)-2-chloro-4&apos;-hydroxy-4-((hydroxyiminio)methyl)-[1,1&apos;-biphenyl]-3-olate [Homo sapiens] &gt;pdb|5TLL|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with (E)-2-chloro-4&apos;-hydroxy-4-((hydroxyiminio)methyl)-[1,1&apos;-biphenyl]-3-olate [Homo sapiens] &gt;pdb|5TLM|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4&apos;,4&apos;&apos;-(thiophene-2,3,5-triyl)triphenol [Homo sapiens] &gt;pdb|5TLM|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4&apos;,4&apos;&apos;-(thiophene-2,3,5-triyl)triphenol [Homo sapiens] &gt;pdb|5TLO|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with a Squaric Acid-linked Dimeric Estrogen [Homo sapiens] &gt;pdb|5TLO|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with a Squaric Acid-linked Dimeric Estrogen [Homo sapiens] &gt;pdb|5TLP|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-BSC Analog, 3-fluorophenyl (1R,2R,4S)-5-(4-hydroxyphenyl)-6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate and 3-methyl-6-phenyl-3H-imidazo[4,5-b]pyridin-2-amine [Homo sapiens] &gt;pdb|5TLP|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-BSC Analog, 3-fluorophenyl (1R,2R,4S)-5-(4-hydroxyphenyl)-6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate and 3-methyl-6-phenyl-3H-imidazo[4,5-b]pyridin-2-amine [Homo sapiens] &gt;pdb|5TLT|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with octane-1,8-diyl bis(2,3-bis(4-hydroxyphenyl)pentanoate) [Homo sapiens] &gt;pdb|5TLT|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with octane-1,8-diyl bis(2,3-bis(4-hydroxyphenyl)pentanoate) [Homo sapiens] &gt;pdb|5TLU|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the PEG-linked Dimeric Estrogen, EE2-(eg)6-EE2-amine [Homo sapiens] &gt;pdb|5TLU|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the PEG-linked Dimeric Estrogen, EE2-(eg)6-EE2-amine [Homo sapiens] &gt;pdb|5TLV|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4&apos;-(thiophene-2,3-diyl)bis(3-fluorophenol) [Homo sapiens] &gt;pdb|5TLV|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4&apos;-(thiophene-2,3-diyl)bis(3-fluorophenol) [Homo sapiens] &gt;pdb|5TLX|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 3,4-bis(4-hydroxyphenyl)thiophene 1,1-dioxide [Homo sapiens] &gt;pdb|5TLX|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 3,4-bis(4-hydroxyphenyl)thiophene 1,1-dioxide [Homo sapiens] &gt;pdb|5TLY|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 3,4-bis(2-fluoro-4-hydroxyphenyl)thiophene 1,1-dioxide [Homo sapiens] &gt;pdb|5TLY|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 3,4-bis(2-fluoro-4-hydroxyphenyl)thiophene 1,1-dioxide [Homo sapiens] &gt;pdb|5TM1|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 2,5-bis(2-fluoro-4-hydroxyphenyl)thiophene 1-oxide [Homo sapiens] &gt;pdb|5TM1|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 2,5-bis(2-fluoro-4-hydroxyphenyl)thiophene 1-oxide [Homo sapiens] &gt;pdb|5TM2|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 2,5-bis(2-chloro-4-hydroxyphenyl)thiophene 1-oxide [Homo sapiens] &gt;pdb|5TM2|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 2,5-bis(2-chloro-4-hydroxyphenyl)thiophene 1-oxide [Homo sapiens] &gt;pdb|5TM3|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 2,3-bis(2-chloro-4-hydroxyphenyl)thiophene 1-oxide [Homo sapiens] &gt;pdb|5TM3|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 2,3-bis(2-chloro-4-hydroxyphenyl)thiophene 1-oxide [Homo sapiens] &gt;pdb|5TM4|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC Analog, 5-(4-((1R,4S,6R)-6-((3-chlorophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenoxy)pentanoic acid [Homo sapiens] &gt;pdb|5TM4|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC Analog, 5-(4-((1R,4S,6R)-6-((3-chlorophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenoxy)pentanoic acid [Homo sapiens] &gt;pdb|5TM5|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compound, 5-(4-((1R,4S,6R)-6-((4-bromophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenoxy)pentanoic acid [Homo sapiens] &gt;pdb|5TM5|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compound, 5-(4-((1R,4S,6R)-6-((4-bromophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenoxy)pentanoic acid [Homo sapiens] &gt;pdb|5TM6|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compound, 6-(4-((1R,4S,6R)-6-((4-bromophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenoxy)hexanoic acid [Homo sapiens] &gt;pdb|5TM6|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compound, 6-(4-((1R,4S,6R)-6-((4-bromophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenoxy)hexanoic acid [Homo sapiens] &gt;pdb|5TM7|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compound, 7-(4-((1R,4S,6R)-6-((3-chlorophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenoxy)heptanoic acid [Homo sapiens] &gt;pdb|5TM7|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compound, 7-(4-((1R,4S,6R)-6-((3-chlorophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenoxy)heptanoic acid [Homo sapiens] &gt;pdb|5TM8|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compound, 7-(4-((1R,4S,6R)-6-((4-bromophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenoxy)heptanoic acid [Homo sapiens] &gt;pdb|5TM8|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compound, 7-(4-((1R,4S,6R)-6-((4-bromophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenoxy)heptanoic acid [Homo sapiens] &gt;pdb|5TM9|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC Analog, (E)-3-(4-((1R,4S,6R)-6-((3-chlorophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenyl)acrylic acid [Homo sapiens] &gt;pdb|5TM9|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC Analog, (E)-3-(4-((1R,4S,6R)-6-((3-chlorophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenyl)acrylic acid [Homo sapiens] &gt;pdb|5TML|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compound, (E)-6-(4-((1R,4S,6R)-6-((3-chlorophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenyl)hex-5-enoic acid [Homo sapiens] &gt;pdb|5TML|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compound, (E)-6-(4-((1R,4S,6R)-6-((3-chlorophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenyl)hex-5-enoic acid [Homo sapiens] &gt;pdb|5TMM|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC analog, (E)-6-(4-((1R,4S,6R)-6-((4-bromophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenyl)hex-5-enoic acid [Homo sapiens] &gt;pdb|5TMM|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC analog, (E)-6-(4-((1R,4S,6R)-6-((4-bromophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenyl)hex-5-enoic acid [Homo sapiens] &gt;pdb|5TMO|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Arene Core OBHS derivative, phenyl 4,4&apos;&apos;-dihydroxy-[1,1&apos;:2&apos;,1&apos;&apos;-terphenyl]-4&apos;-sulfonate [Homo sapiens] &gt;pdb|5TMO|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Arene Core OBHS derivative, phenyl 4,4&apos;&apos;-dihydroxy-[1,1&apos;:2&apos;,1&apos;&apos;-terphenyl]-4&apos;-sulfonate [Homo sapiens] &gt;pdb|5TMQ|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Arene Core OBHS derivative, 4-bromophenyl 4,4&apos;&apos;-dihydroxy-[1,1&apos;:2&apos;,1&apos;&apos;-terphenyl]-4&apos;-sulfonate [Homo sapiens] &gt;pdb|5TMQ|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Arene Core OBHS derivative, 4-bromophenyl 4,4&apos;&apos;-dihydroxy-[1,1&apos;:2&apos;,1&apos;&apos;-terphenyl]-4&apos;-sulfonate [Homo sapiens] &gt;pdb|5TMR|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Cyclofenil-ASC derivative, ethyl (E)-3-(4-(cyclohexylidene(4-hydroxyphenyl)methyl)phenyl)acrylate [Homo sapiens] &gt;pdb|5TMR|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Cyclofenil-ASC derivative, ethyl (E)-3-(4-(cyclohexylidene(4-hydroxyphenyl)methyl)phenyl)acrylate [Homo sapiens] &gt;pdb|5TMS|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Cyclofenil-ASC derivative, ethyl (E)-3-(4-(bicyclo[3.3.1]nonan-9-ylidene(4-hydroxyphenyl)methyl)phenyl)acrylate [Homo sapiens] &gt;pdb|5TMS|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Cyclofenil-ASC derivative, ethyl (E)-3-(4-(bicyclo[3.3.1]nonan-9-ylidene(4-hydroxyphenyl)methyl)phenyl)acrylate [Homo sapiens] &gt;pdb|5TMT|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4&apos;-((1,3-dihydro-2H-inden-2-ylidene)methylene)diphenol [Homo sapiens] &gt;pdb|5TMT|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4&apos;-((1,3-dihydro-2H-inden-2-ylidene)methylene)diphenol [Homo sapiens] &gt;pdb|5TMU|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4&apos;-(cycloheptylidenemethylene)diphenol [Homo sapiens] &gt;pdb|5TMU|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4&apos;-(cycloheptylidenemethylene)diphenol [Homo sapiens] &gt;pdb|5TMV|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS analog, 4-iodophenyl (1S,2R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate [Homo sapiens] &gt;pdb|5TMV|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS analog, 4-iodophenyl (1S,2R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate [Homo sapiens] &gt;pdb|5TMW|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS derivative, 4-acetamidophenyl (1S,2R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate [Homo sapiens] &gt;pdb|5TMW|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS derivative, 4-acetamidophenyl (1S,2R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate [Homo sapiens] &gt;pdb|5TMZ|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the estradiol derivative, (8S,9S,13S,14S,17S)-16-(3-methoxybenzyl)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol [Homo sapiens] &gt;pdb|5TMZ|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the estradiol derivative, (8S,9S,13S,14S,17S)-16-(3-methoxybenzyl)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol [Homo sapiens] &gt;pdb|5TN1|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the estradiol derivative, (8S,9S,13S,14S,E)-17-((4-isopropylphenyl)imino)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol [Homo sapiens] &gt;pdb|5TN1|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the estradiol derivative, (8S,9S,13S,14S,E)-17-((4-isopropylphenyl)imino)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol [Homo sapiens] &gt;pdb|5TN3|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the estradiol derivative, (8S,9S,13S,14S)-17-((4-isopropylphenyl)amino)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol [Homo sapiens] &gt;pdb|5TN3|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the estradiol derivative, (8S,9S,13S,14S)-17-((4-isopropylphenyl)amino)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol [Homo sapiens] &gt;pdb|5TN4|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the ACD-ring estrogen, (S)-5-(4-hydroxy-3,5-dimethylphenyl)-2,3-dihydro-1H-inden-1-ol [Homo sapiens] &gt;pdb|5TN4|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the ACD-ring estrogen, (S)-5-(4-hydroxy-3,5-dimethylphenyl)-2,3-dihydro-1H-inden-1-ol [Homo sapiens] &gt;pdb|5TN5|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the AC-ring estrogen, (1S,3aS,5S,7aS)-5-(4-hydroxyphenyl)-7a-methyloctahydro-1H-inden-1-ol [Homo sapiens] &gt;pdb|5TN5|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the AC-ring estrogen, (1S,3aS,5S,7aS)-5-(4-hydroxyphenyl)-7a-methyloctahydro-1H-inden-1-ol [Homo sapiens] &gt;pdb|5TN6|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Spiro BC-estradiol, (1S,1&apos;S,3a&apos;S,7a&apos;S)-7a&apos;-methyl-1&apos;,2,2&apos;,3,3&apos;,3a&apos;,4&apos;,6&apos;,7&apos;,7a&apos;-decahydro-1,5&apos;-spirobi[indene]-1&apos;,5-diol [Homo sapiens] &gt;pdb|5TN6|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Spiro BC-estradiol, (1S,1&apos;S,3a&apos;S,7a&apos;S)-7a&apos;-methyl-1&apos;,2,2&apos;,3,3&apos;,3a&apos;,4&apos;,6&apos;,7&apos;,7a&apos;-decahydro-1,5&apos;-spirobi[indene]-1&apos;,5-diol [Homo sapiens] &gt;pdb|5TN7|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with (E)-3&apos;-fluoro-4&apos;-hydroxy-3-((hydroxyiminio)methyl)-[1,1&apos;-biphenyl]-4-olate [Homo sapiens] &gt;pdb|5TN7|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with (E)-3&apos;-fluoro-4&apos;-hydroxy-3-((hydroxyiminio)methyl)-[1,1&apos;-biphenyl]-4-olate [Homo sapiens] &gt;pdb|5TN8|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with (E)-4&apos;-hydroxy-3-((hydroxyiminio)methyl)-[1,1&apos;-biphenyl]-4-olate [Homo sapiens] &gt;pdb|5TN8|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with (E)-4&apos;-hydroxy-3-((hydroxyiminio)methyl)-[1,1&apos;-biphenyl]-4-olate [Homo sapiens] &gt;pdb|5U2B|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the phenylamino-substituted estrogen, (8R,9S,13S,14S,17S)-13-methyl-17-(phenylamino)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol, without a coactivator peptide [Homo sapiens] &gt;pdb|5U2B|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the phenylamino-substituted estrogen, (8R,9S,13S,14S,17S)-13-methyl-17-(phenylamino)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol, without a coactivator peptide [Homo sapiens] &gt;pdb|5U2B|C Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the phenylamino-substituted estrogen, (8R,9S,13S,14S,17S)-13-methyl-17-(phenylamino)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol, without a coactivator peptide [Homo sapiens] &gt;pdb|5U2B|D Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the phenylamino-substituted estrogen, (8R,9S,13S,14S,17S)-13-methyl-17-(phenylamino)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol, without a coactivator peptide [Homo sapiens] &gt;pdb|5U2B|E Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the phenylamino-substituted estrogen, (8R,9S,13S,14S,17S)-13-methyl-17-(phenylamino)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol, without a coactivator peptide [Homo sapiens] &gt;pdb|5U2B|F Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the phenylamino-substituted estrogen, (8R,9S,13S,14S,17S)-13-methyl-17-(phenylamino)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol, without a coactivator peptide [Homo sapiens] &gt;pdb|5U2D|A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with Oxabicyclic Heptene Sulfonate (OBHS) [Homo sapiens] &gt;pdb|5U2D|B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with Oxabicyclic Heptene Sulfonate (OBHS) [Homo sapiens] &gt;pdb|6CZN|A Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Z2OHTPE and a glucocorticoid receptor-interacting protein 1 NR box II peptide [Homo sapiens] &gt;pdb|6CZN|B Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Z2OHTPE and a glucocorticoid receptor-interacting protein 1 NR box II peptide [Homo sapiens]</Hit_def>
  <Hit_accession>5DI7_A</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.2857</Hsp_bit-score>
      <Hsp_score>238</Hsp_score>
      <Hsp_evalue>2.13501e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>18</Hsp_hit-from>
      <Hsp_hit-to>211</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>149</Hit_num>
  <Hit_id>pdb|2QXS|A</Hit_id>
  <Hit_def>Crystal Structure of Antagonizing Mutant 536S of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to Raloxifene [Homo sapiens] &gt;pdb|2QXS|B Crystal Structure of Antagonizing Mutant 536S of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to Raloxifene [Homo sapiens]</Hit_def>
  <Hit_accession>2QXS_A</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.2857</Hsp_bit-score>
      <Hsp_score>238</Hsp_score>
      <Hsp_evalue>2.15354e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>19</Hsp_hit-from>
      <Hsp_hit-to>212</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>150</Hit_num>
  <Hit_id>pdb|4Q13|A</Hit_id>
  <Hit_def>Apo Estrogen Receptor Alpha Ligand Binding Domain D538G Mutant with a glucocorticoid receptor-interacting protein 1 NR box II peptide [Homo sapiens] &gt;pdb|4Q13|B Apo Estrogen Receptor Alpha Ligand Binding Domain D538G Mutant with a glucocorticoid receptor-interacting protein 1 NR box II peptide [Homo sapiens]</Hit_def>
  <Hit_accession>4Q13_A</Hit_accession>
  <Hit_len>261</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.2857</Hsp_bit-score>
      <Hsp_score>238</Hsp_score>
      <Hsp_evalue>2.18638e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>215</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>151</Hit_num>
  <Hit_id>pdb|5DX3|A</Hit_id>
  <Hit_def>Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Stapled Peptide SRC2-P3 and Estradiol [Homo sapiens] &gt;pdb|5DXB|B Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Stapled Peptide SRC2-P1 and Estradiol [Homo sapiens] &gt;pdb|5WGD|A Estrogen Receptor Alpha Ligand Binding Domain in Complex with Estradiol and SRC2-LP1 [Homo sapiens] &gt;pdb|5WGD|B Estrogen Receptor Alpha Ligand Binding Domain in Complex with Estradiol and SRC2-LP1 [Homo sapiens] &gt;pdb|5WGQ|A Estrogen Receptor Alpha Ligand Binding Domain in Complex with Estradiol and SRC2-BCP1 [Homo sapiens] &gt;pdb|5WGQ|B Estrogen Receptor Alpha Ligand Binding Domain in Complex with Estradiol and SRC2-BCP1 [Homo sapiens]</Hit_def>
  <Hit_accession>5DX3_A</Hit_accession>
  <Hit_len>261</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.2857</Hsp_bit-score>
      <Hsp_score>238</Hsp_score>
      <Hsp_evalue>2.25538e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>215</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>152</Hit_num>
  <Hit_id>pdb|2BJ4|A</Hit_id>
  <Hit_def>ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A PHAGE-DISPLAY DERIVED PEPTIDE ANTAGONIST [Homo sapiens] &gt;pdb|2JF9|A ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A TAMOXIFEN-SPECIFIC PEPTIDE ANTAGONIST [Homo sapiens] &gt;pdb|2JF9|B ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A TAMOXIFEN-SPECIFIC PEPTIDE ANTAGONIST [Homo sapiens] &gt;pdb|2JF9|C ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH A TAMOXIFEN-SPECIFIC PEPTIDE ANTAGONIST [Homo sapiens] &gt;pdb|2JFA|A ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH AN AFFINITY-SELECTED COREPRESSOR PEPTIDE [Homo sapiens]</Hit_def>
  <Hit_accession>2BJ4_A</Hit_accession>
  <Hit_len>252</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.2857</Hsp_bit-score>
      <Hsp_score>238</Hsp_score>
      <Hsp_evalue>2.26594e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>34</Hsp_hit-from>
      <Hsp_hit-to>227</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>153</Hit_num>
  <Hit_id>pdb|5HYR|A</Hit_id>
  <Hit_def>Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Stapled Peptide SRC2-SP2 and Estradiol [Homo sapiens] &gt;pdb|5HYR|B Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Stapled Peptide SRC2-SP2 and Estradiol [Homo sapiens]</Hit_def>
  <Hit_accession>5HYR_A</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.2857</Hsp_bit-score>
      <Hsp_score>238</Hsp_score>
      <Hsp_evalue>2.33971e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>14</Hsp_hit-from>
      <Hsp_hit-to>207</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>154</Hit_num>
  <Hit_id>pdb|5DXB|A</Hit_id>
  <Hit_def>Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Stapled Peptide SRC2-P1 and Estradiol [Homo sapiens]</Hit_def>
  <Hit_accession>5DXB_A</Hit_accession>
  <Hit_len>261</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.2857</Hsp_bit-score>
      <Hsp_score>238</Hsp_score>
      <Hsp_evalue>2.37525e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>215</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>155</Hit_num>
  <Hit_id>pdb|2YJA|B</Hit_id>
  <Hit_def>Stapled Peptides binding to Estrogen Receptor alpha. [Homo sapiens] &gt;pdb|3DT3|A Human Estrogen receptor alpha LBD with GW368 [Homo sapiens] &gt;pdb|3DT3|B Human Estrogen receptor alpha LBD with GW368 [Homo sapiens]</Hit_def>
  <Hit_accession>2YJA_B</Hit_accession>
  <Hit_len>255</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.2857</Hsp_bit-score>
      <Hsp_score>238</Hsp_score>
      <Hsp_evalue>2.42583e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>19</Hsp_hit-from>
      <Hsp_hit-to>212</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>156</Hit_num>
  <Hit_id>pdb|4Q50|A</Hit_id>
  <Hit_def>The Estrogen Receptor Alpha Ligand Binding Domain D538G Mutant in Complex with 4-hydroxytamoxifen [Homo sapiens] &gt;pdb|4Q50|B The Estrogen Receptor Alpha Ligand Binding Domain D538G Mutant in Complex with 4-hydroxytamoxifen [Homo sapiens] &gt;pdb|4Q50|C The Estrogen Receptor Alpha Ligand Binding Domain D538G Mutant in Complex with 4-hydroxytamoxifen [Homo sapiens] &gt;pdb|4Q50|D The Estrogen Receptor Alpha Ligand Binding Domain D538G Mutant in Complex with 4-hydroxytamoxifen [Homo sapiens] &gt;pdb|4Q50|E The Estrogen Receptor Alpha Ligand Binding Domain D538G Mutant in Complex with 4-hydroxytamoxifen [Homo sapiens] &gt;pdb|4Q50|F The Estrogen Receptor Alpha Ligand Binding Domain D538G Mutant in Complex with 4-hydroxytamoxifen [Homo sapiens] &gt;pdb|4Q50|G The Estrogen Receptor Alpha Ligand Binding Domain D538G Mutant in Complex with 4-hydroxytamoxifen [Homo sapiens] &gt;pdb|4Q50|H The Estrogen Receptor Alpha Ligand Binding Domain D538G Mutant in Complex with 4-hydroxytamoxifen [Homo sapiens]</Hit_def>
  <Hit_accession>4Q50_A</Hit_accession>
  <Hit_len>260</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.2857</Hsp_bit-score>
      <Hsp_score>238</Hsp_score>
      <Hsp_evalue>2.42971e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>21</Hsp_hit-from>
      <Hsp_hit-to>214</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>157</Hit_num>
  <Hit_id>pdb|2P15|A</Hit_id>
  <Hit_def>Crystal structure of the ER alpha ligand binding domain with the agonist ortho-trifluoromethylphenylvinyl estradiol [Homo sapiens] &gt;pdb|2P15|B Crystal structure of the ER alpha ligand binding domain with the agonist ortho-trifluoromethylphenylvinyl estradiol [Homo sapiens] &gt;pdb|2Q6J|A Crystal Structure of Estrogen Receptor alpha Complexed to a B-N Substituted Ligand [Homo sapiens] &gt;pdb|2Q6J|B Crystal Structure of Estrogen Receptor alpha Complexed to a B-N Substituted Ligand [Homo sapiens] &gt;pdb|2QA6|A Crystal Structure of Estrogen Receptor Alpha mutant 537S Complexed with 4-(6-hydroxy-1H-indazol-3-yl)benzene-1,3-diol [Homo sapiens] &gt;pdb|2QA6|B Crystal Structure of Estrogen Receptor Alpha mutant 537S Complexed with 4-(6-hydroxy-1H-indazol-3-yl)benzene-1,3-diol [Homo sapiens] &gt;pdb|2QAB|A Crystal Structure of Estrogen Receptor Alpha Ligand Binding Domain Mutant 537S Complexed with an Ethyl Indazole Compound [Homo sapiens] &gt;pdb|2QAB|B Crystal Structure of Estrogen Receptor Alpha Ligand Binding Domain Mutant 537S Complexed with an Ethyl Indazole Compound [Homo sapiens] &gt;pdb|2QGT|A Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to an Ether Estradiol Compound [Homo sapiens] &gt;pdb|2QGT|B Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to an Ether Estradiol Compound [Homo sapiens] &gt;pdb|2QGW|A Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with a Chloro-Indazole Compound [Homo sapiens] &gt;pdb|2QGW|B Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with a Chloro-Indazole Compound [Homo sapiens] &gt;pdb|2QH6|A Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with an Oxabicyclic diarylethylene Compound [Homo sapiens] &gt;pdb|2QH6|B Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with an Oxabicyclic diarylethylene Compound [Homo sapiens] &gt;pdb|2QR9|A Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with an Oxabicyclic Derivative Compound [Homo sapiens] &gt;pdb|2QR9|B Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with an Oxabicyclic Derivative Compound [Homo sapiens] &gt;pdb|2QSE|A Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain complexed with Burned Meat Compound 4-OH-PhIP [Homo sapiens] &gt;pdb|2QSE|B Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain complexed with Burned Meat Compound 4-OH-PhIP [Homo sapiens] &gt;pdb|2QXM|A Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to Burned Meat Compound PhIP [Homo sapiens] &gt;pdb|2QXM|B Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to Burned Meat Compound PhIP [Homo sapiens]</Hit_def>
  <Hit_accession>2P15_A</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.2857</Hsp_bit-score>
      <Hsp_score>238</Hsp_score>
      <Hsp_evalue>2.43874e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>19</Hsp_hit-from>
      <Hsp_hit-to>212</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>158</Hit_num>
  <Hit_id>pdb|2QA8|A</Hit_id>
  <Hit_def>Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Mutant 537S Complexed with Genistein [Homo sapiens]</Hit_def>
  <Hit_accession>2QA8_A</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.2857</Hsp_bit-score>
      <Hsp_score>238</Hsp_score>
      <Hsp_evalue>2.43874e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>19</Hsp_hit-from>
      <Hsp_hit-to>212</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>159</Hit_num>
  <Hit_id>pdb|4PXM|A</Hit_id>
  <Hit_def>The Estrogen Receptor Alpha Ligand Binding Domain D538G Mutant in Complex with Estradiol and a glucocorticoid receptor-interacting protein 1 NR box II peptide [Homo sapiens] &gt;pdb|4PXM|B The Estrogen Receptor Alpha Ligand Binding Domain D538G Mutant in Complex with Estradiol and a glucocorticoid receptor-interacting protein 1 NR box II peptide [Homo sapiens]</Hit_def>
  <Hit_accession>4PXM_A</Hit_accession>
  <Hit_len>271</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.2857</Hsp_bit-score>
      <Hsp_score>238</Hsp_score>
      <Hsp_evalue>2.73802e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>32</Hsp_hit-from>
      <Hsp_hit-to>225</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>160</Hit_num>
  <Hit_id>pdb|2OCF|A</Hit_id>
  <Hit_def>Human estrogen receptor alpha ligand-binding domain in complex with estradiol and the E2#23 FN3 monobody [Homo sapiens]</Hit_def>
  <Hit_accession>2OCF_A</Hit_accession>
  <Hit_len>298</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>96.6709</Hsp_bit-score>
      <Hsp_score>239</Hsp_score>
      <Hsp_evalue>3.45191e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>18</Hsp_hit-from>
      <Hsp_hit-to>211</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>111</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLEXAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>161</Hit_num>
  <Hit_id>pdb|2EWP|A</Hit_id>
  <Hit_def>Crystal structure of Estrogen Related Receptor-3 (ERR-gamma) ligand binding domaind with tamoxifen analog GSK5182 [Homo sapiens] &gt;pdb|2EWP|B Crystal structure of Estrogen Related Receptor-3 (ERR-gamma) ligand binding domaind with tamoxifen analog GSK5182 [Homo sapiens] &gt;pdb|2EWP|C Crystal structure of Estrogen Related Receptor-3 (ERR-gamma) ligand binding domaind with tamoxifen analog GSK5182 [Homo sapiens] &gt;pdb|2EWP|D Crystal structure of Estrogen Related Receptor-3 (ERR-gamma) ligand binding domaind with tamoxifen analog GSK5182 [Homo sapiens] &gt;pdb|2EWP|E Crystal structure of Estrogen Related Receptor-3 (ERR-gamma) ligand binding domaind with tamoxifen analog GSK5182 [Homo sapiens]</Hit_def>
  <Hit_accession>2EWP_A</Hit_accession>
  <Hit_len>226</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>4.76407e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>152</Hsp_query-to>
      <Hsp_hit-from>5</Hsp_hit-from>
      <Hsp_hit-to>145</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>87</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>143</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNT</Hsp_qseq>
      <Hsp_hseq>IVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDE--LVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANS</Hsp_hseq>
      <Hsp_midline>+++ L+  EP+ IYA  D T PD+    LT+L  L +R+L+ ++ W+K +PGF  L + DQ++L+Q +WM +++ G+ +RS        L +A D I++E + K +    L   + Q+ +++  +++ +EEF+ +K + L N+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>162</Hit_num>
  <Hit_id>pdb|1KV6|A</Hit_id>
  <Hit_def>X-ray structure of the orphan nuclear receptor ERR3 ligand-binding domain in the constitutively active conformation [Homo sapiens] &gt;pdb|1KV6|B X-ray structure of the orphan nuclear receptor ERR3 ligand-binding domain in the constitutively active conformation [Homo sapiens] &gt;pdb|2GP7|A Estrogen Related Receptor-gamma ligand binding domain [Homo sapiens] &gt;pdb|2GP7|B Estrogen Related Receptor-gamma ligand binding domain [Homo sapiens] &gt;pdb|2GP7|C Estrogen Related Receptor-gamma ligand binding domain [Homo sapiens] &gt;pdb|2GP7|D Estrogen Related Receptor-gamma ligand binding domain [Homo sapiens] &gt;pdb|2GPO|A Estrogen Related Receptor-gamma ligand binding domain complexed with a synthetic peptide from RIP140 [Homo sapiens] &gt;pdb|2GPP|A Estrogen Related Receptor-gamma ligand binding domain complexed with a RIP140 peptide and synthetic ligand GSK4716 [Homo sapiens] &gt;pdb|2GPP|B Estrogen Related Receptor-gamma ligand binding domain complexed with a RIP140 peptide and synthetic ligand GSK4716 [Homo sapiens] &gt;pdb|2GPU|A Estrogen Related Receptor-gamma ligand binding domain complexed with 4-hydroxy-tamoxifen [Homo sapiens] &gt;pdb|2GPV|A Estrogen Related Receptor-gamma ligand binding domain complexed with 4-hydroxy-tamoxifen and a SMRT peptide [Homo sapiens] &gt;pdb|2GPV|B Estrogen Related Receptor-gamma ligand binding domain complexed with 4-hydroxy-tamoxifen and a SMRT peptide [Homo sapiens] &gt;pdb|2GPV|C Estrogen Related Receptor-gamma ligand binding domain complexed with 4-hydroxy-tamoxifen and a SMRT peptide [Homo sapiens] &gt;pdb|2GPV|D Estrogen Related Receptor-gamma ligand binding domain complexed with 4-hydroxy-tamoxifen and a SMRT peptide [Homo sapiens] &gt;pdb|2GPV|E Estrogen Related Receptor-gamma ligand binding domain complexed with 4-hydroxy-tamoxifen and a SMRT peptide [Homo sapiens] &gt;pdb|2GPV|F Estrogen Related Receptor-gamma ligand binding domain complexed with 4-hydroxy-tamoxifen and a SMRT peptide [Homo sapiens]</Hit_def>
  <Hit_accession>1KV6_A</Hit_accession>
  <Hit_len>230</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>4.96848e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>152</Hsp_query-to>
      <Hsp_hit-from>9</Hsp_hit-from>
      <Hsp_hit-to>149</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>87</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>143</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNT</Hsp_qseq>
      <Hsp_hseq>IVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDE--LVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANS</Hsp_hseq>
      <Hsp_midline>+++ L+  EP+ IYA  D T PD+    LT+L  L +R+L+ ++ W+K +PGF  L + DQ++L+Q +WM +++ G+ +RS        L +A D I++E + K +    L   + Q+ +++  +++ +EEF+ +K + L N+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>163</Hit_num>
  <Hit_id>pdb|1S9P|A</Hit_id>
  <Hit_def>crystal structure of the ligand-binding domain of the estrogen-related receptor gamma in complex with diethylstilbestrol [Mus musculus] &gt;pdb|1S9P|B crystal structure of the ligand-binding domain of the estrogen-related receptor gamma in complex with diethylstilbestrol [Mus musculus] &gt;pdb|1S9P|C crystal structure of the ligand-binding domain of the estrogen-related receptor gamma in complex with diethylstilbestrol [Mus musculus] &gt;pdb|1S9P|D crystal structure of the ligand-binding domain of the estrogen-related receptor gamma in complex with diethylstilbestrol [Mus musculus] &gt;pdb|6K3N|A Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with BPA-monoF [Homo sapiens]</Hit_def>
  <Hit_accession>1S9P_A</Hit_accession>
  <Hit_len>227</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>5.01987e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>152</Hsp_query-to>
      <Hsp_hit-from>6</Hsp_hit-from>
      <Hsp_hit-to>146</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>87</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>143</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNT</Hsp_qseq>
      <Hsp_hseq>IVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDE--LVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANS</Hsp_hseq>
      <Hsp_midline>+++ L+  EP+ IYA  D T PD+    LT+L  L +R+L+ ++ W+K +PGF  L + DQ++L+Q +WM +++ G+ +RS        L +A D I++E + K +    L   + Q+ +++  +++ +EEF+ +K + L N+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>164</Hit_num>
  <Hit_id>pdb|6I62|A</Hit_id>
  <Hit_def>Crystal structure of human ERRg LBD in complex with HPTE [Homo sapiens] &gt;pdb|6I63|A Crystal structure of human ERRg LBD in complex with bisphenol-A [Homo sapiens]</Hit_def>
  <Hit_accession>6I62_A</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>5.73544e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>152</Hsp_query-to>
      <Hsp_hit-from>16</Hsp_hit-from>
      <Hsp_hit-to>156</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>87</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>143</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNT</Hsp_qseq>
      <Hsp_hseq>IVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDE--LVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANS</Hsp_hseq>
      <Hsp_midline>+++ L+  EP+ IYA  D T PD+    LT+L  L +R+L+ ++ W+K +PGF  L + DQ++L+Q +WM +++ G+ +RS        L +A D I++E + K +    L   + Q+ +++  +++ +EEF+ +K + L N+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>165</Hit_num>
  <Hit_id>pdb|3OS8|A</Hit_id>
  <Hit_def>Estrogen Receptor [Homo sapiens] &gt;pdb|3OS8|B Estrogen Receptor [Homo sapiens]</Hit_def>
  <Hit_accession>3OS8_A</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>95.1301</Hsp_bit-score>
      <Hsp_score>235</Hsp_score>
      <Hsp_evalue>6.06686e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>20</Hsp_hit-from>
      <Hsp_hit-to>213</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>110</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTRHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKXVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L   DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>166</Hit_num>
  <Hit_id>pdb|5YSO|A</Hit_id>
  <Hit_def>Crystal structure of Estrogen Related Receptor-3 (ERR-gamma) ligand binding domain with DN200434 [Homo sapiens] &gt;pdb|5YSO|B Crystal structure of Estrogen Related Receptor-3 (ERR-gamma) ligand binding domain with DN200434 [Homo sapiens] &gt;pdb|5YSO|C Crystal structure of Estrogen Related Receptor-3 (ERR-gamma) ligand binding domain with DN200434 [Homo sapiens] &gt;pdb|6A6K|A Crystal structure of Estrogen-related Receptor-3 (ERR-gamma) ligand binding domain with DN201000 [Homo sapiens] &gt;pdb|6A6K|B Crystal structure of Estrogen-related Receptor-3 (ERR-gamma) ligand binding domain with DN201000 [Homo sapiens] &gt;pdb|6A6K|C Crystal structure of Estrogen-related Receptor-3 (ERR-gamma) ligand binding domain with DN201000 [Homo sapiens]</Hit_def>
  <Hit_accession>5YSO_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>6.22916e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>152</Hsp_query-to>
      <Hsp_hit-from>17</Hsp_hit-from>
      <Hsp_hit-to>157</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>87</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>143</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNT</Hsp_qseq>
      <Hsp_hseq>IVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDE--LVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANS</Hsp_hseq>
      <Hsp_midline>+++ L+  EP+ IYA  D T PD+    LT+L  L +R+L+ ++ W+K +PGF  L + DQ++L+Q +WM +++ G+ +RS        L +A D I++E + K +    L   + Q+ +++  +++ +EEF+ +K + L N+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>167</Hit_num>
  <Hit_id>pdb|4XI3|A</Hit_id>
  <Hit_def>Estrogen Receptor Alpha Ligand Binding Domain in Complex with Bazedoxifene [Homo sapiens] &gt;pdb|4XI3|B Estrogen Receptor Alpha Ligand Binding Domain in Complex with Bazedoxifene [Homo sapiens] &gt;pdb|4XI3|C Estrogen Receptor Alpha Ligand Binding Domain in Complex with Bazedoxifene [Homo sapiens] &gt;pdb|4XI3|D Estrogen Receptor Alpha Ligand Binding Domain in Complex with Bazedoxifene [Homo sapiens]</Hit_def>
  <Hit_accession>4XI3_A</Hit_accession>
  <Hit_len>243</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>6.26864e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>10</Hsp_hit-from>
      <Hsp_hit-to>203</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>110</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTSHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L   DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>168</Hit_num>
  <Hit_id>pdb|1X7E|A</Hit_id>
  <Hit_def>Crystal Structure Of Estrogen Receptor Alpha Complexed With Way-244 [Homo sapiens] &gt;pdb|1X7E|B Crystal Structure Of Estrogen Receptor Alpha Complexed With Way-244 [Homo sapiens] &gt;pdb|1X7R|A Crystal Structure Of Estrogen Receptor Alpha Complexed With Genistein [Homo sapiens]</Hit_def>
  <Hit_accession>1X7E_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>6.32073e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>11</Hsp_hit-from>
      <Hsp_hit-to>204</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>57</Hsp_identity>
      <Hsp_positive>108</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPVK--LLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H     L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>169</Hit_num>
  <Hit_id>pdb|6I61|A</Hit_id>
  <Hit_def>Crystal structure of human ERRg LBD in complex with bisphenol-B [Homo sapiens] &gt;pdb|6I64|A Crystal structure of human ERRg LBD in complex with bisphenol-E [Homo sapiens] &gt;pdb|6I65|A Crystal structure of human ERRg LBD in complex with 4-iso-propylphenol [Homo sapiens] &gt;pdb|6I66|A Crystal structure of human ERRg LBD in complex with 4-sec-butylphenol [Homo sapiens] &gt;pdb|6I67|A Crystal structure of human ERRg LBD in complex with tetrahydro-2-naphtol [Homo sapiens]</Hit_def>
  <Hit_accession>6I61_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>6.82435e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>152</Hsp_query-to>
      <Hsp_hit-from>20</Hsp_hit-from>
      <Hsp_hit-to>160</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>87</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>143</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNT</Hsp_qseq>
      <Hsp_hseq>IVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDE--LVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANS</Hsp_hseq>
      <Hsp_midline>+++ L+  EP+ IYA  D T PD+    LT+L  L +R+L+ ++ W+K +PGF  L + DQ++L+Q +WM +++ G+ +RS        L +A D I++E + K +    L   + Q+ +++  +++ +EEF+ +K + L N+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>170</Hit_num>
  <Hit_id>pdb|6KNR|A</Hit_id>
  <Hit_def>Crystal structure of Estrogen-related receptor gamma ligand-binding domain with DN200699 [Homo sapiens] &gt;pdb|6KNR|B Crystal structure of Estrogen-related receptor gamma ligand-binding domain with DN200699 [Homo sapiens]</Hit_def>
  <Hit_accession>6KNR_A</Hit_accession>
  <Hit_len>243</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>7.10044e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>152</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>162</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>87</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>143</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNT</Hsp_qseq>
      <Hsp_hseq>IVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDE--LVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANS</Hsp_hseq>
      <Hsp_midline>+++ L+  EP+ IYA  D T PD+    LT+L  L +R+L+ ++ W+K +PGF  L + DQ++L+Q +WM +++ G+ +RS        L +A D I++E + K +    L   + Q+ +++  +++ +EEF+ +K + L N+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>171</Hit_num>
  <Hit_id>pdb|2E2R|A</Hit_id>
  <Hit_def>Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with bisphenol A [Homo sapiens] &gt;pdb|2ZAS|A Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with 4-alpha-cumylphenol, a bisphenol A derivative [Homo sapiens] &gt;pdb|2ZBS|A Crystal structure of human estrogen-related receptor gamma ligand binding domain apo form [Homo sapiens] &gt;pdb|2ZKC|A Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with bisphenol Z [Homo sapiens]</Hit_def>
  <Hit_accession>2E2R_A</Hit_accession>
  <Hit_len>244</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>7.39372e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>152</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>162</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>87</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>143</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNT</Hsp_qseq>
      <Hsp_hseq>IVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDE--LVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANS</Hsp_hseq>
      <Hsp_midline>+++ L+  EP+ IYA  D T PD+    LT+L  L +R+L+ ++ W+K +PGF  L + DQ++L+Q +WM +++ G+ +RS        L +A D I++E + K +    L   + Q+ +++  +++ +EEF+ +K + L N+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>172</Hit_num>
  <Hit_id>pdb|1TFC|A</Hit_id>
  <Hit_def>Crystal Structure Of The Ligand-Binding Domain Of The Estrogen-Related Receptor Gamma In Complex With A Steroid Receptor Coactivator-1 Peptide [Homo sapiens] &gt;pdb|1TFC|B Crystal Structure Of The Ligand-Binding Domain Of The Estrogen-Related Receptor Gamma In Complex With A Steroid Receptor Coactivator-1 Peptide [Homo sapiens] &gt;pdb|1VJB|A crystal structure of the ligand-binding domain of the estrogen-related receptor gamma in complex with 4-hydroxytamoxifen [Mus musculus] &gt;pdb|1VJB|B crystal structure of the ligand-binding domain of the estrogen-related receptor gamma in complex with 4-hydroxytamoxifen [Mus musculus] &gt;pdb|2P7A|A Crystal Structure of Estrogen Related Receptor g in complex with 3-methyl phenol [Homo sapiens] &gt;pdb|2P7G|A X-ray Structure of Estrogen Related Receptor g in complex with Bisphenol A. [Homo sapiens] &gt;pdb|2P7Z|A Estrogen Related Receptor Gamma in complex with 4-hydroxy-tamoxifen [Homo sapiens]</Hit_def>
  <Hit_accession>1TFC_A</Hit_accession>
  <Hit_len>251</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>8.46909e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>152</Hsp_query-to>
      <Hsp_hit-from>30</Hsp_hit-from>
      <Hsp_hit-to>170</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>87</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>143</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNT</Hsp_qseq>
      <Hsp_hseq>IVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDE--LVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANS</Hsp_hseq>
      <Hsp_midline>+++ L+  EP+ IYA  D T PD+    LT+L  L +R+L+ ++ W+K +PGF  L + DQ++L+Q +WM +++ G+ +RS        L +A D I++E + K +    L   + Q+ +++  +++ +EEF+ +K + L N+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>173</Hit_num>
  <Hit_id>pdb|1S9Q|A</Hit_id>
  <Hit_def>crystal structure of the ligand-binding domain of the estrogen-related receptor gamma in complex with 4-hydroxytamoxifen [Mus musculus] &gt;pdb|1S9Q|B crystal structure of the ligand-binding domain of the estrogen-related receptor gamma in complex with 4-hydroxytamoxifen [Mus musculus]</Hit_def>
  <Hit_accession>1S9Q_A</Hit_accession>
  <Hit_len>251</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>8.46909e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>152</Hsp_query-to>
      <Hsp_hit-from>30</Hsp_hit-from>
      <Hsp_hit-to>170</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>87</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>143</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNT</Hsp_qseq>
      <Hsp_hseq>IVSHLLVAEPEKIYAMPDPTVPDSDIKALTTLCDLADRELVVIIGWAKHIPGFSTLSLADQMSLLQSAWMEILILGVVYRSLSFEDE--LVYADDYIMDEDQSKLAGLLDLNNAILQLVKKYKSMKLEKEEFVTLKAIALANS</Hsp_hseq>
      <Hsp_midline>+++ L+  EP+ IYA  D T PD+    LT+L  L +R+L+ ++ W+K +PGF  L + DQ++L+Q +WM +++ G+ +RS        L +A D I++E + K +    L   + Q+ +++  +++ +EEF+ +K + L N+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>174</Hit_num>
  <Hit_id>pdb|5TN9|A</Hit_id>
  <Hit_def>Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-5-(4-hydroxyphenyl)-6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate [Homo sapiens] &gt;pdb|5TN9|B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-5-(4-hydroxyphenyl)-6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate [Homo sapiens] &gt;pdb|5TN9|C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-5-(4-hydroxyphenyl)-6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate [Homo sapiens] &gt;pdb|5TN9|D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-5-(4-hydroxyphenyl)-6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate [Homo sapiens] &gt;pdb|5TNB|A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-6-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate [Homo sapiens] &gt;pdb|5TNB|B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-6-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate [Homo sapiens] &gt;pdb|5TNB|C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-6-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate [Homo sapiens] &gt;pdb|5TNB|D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-6-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate [Homo sapiens]</Hit_def>
  <Hit_accession>5TN9_A</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>8.73225e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>18</Hsp_hit-from>
      <Hsp_hit-to>211</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>110</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTSHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L   DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>175</Hit_num>
  <Hit_id>pdb|3OS8|C</Hit_id>
  <Hit_def>Estrogen Receptor [Homo sapiens] &gt;pdb|3OS8|D Estrogen Receptor [Homo sapiens] &gt;pdb|3OS9|A Estrogen Receptor [Homo sapiens] &gt;pdb|3OS9|B Estrogen Receptor [Homo sapiens] &gt;pdb|3OS9|C Estrogen Receptor [Homo sapiens] &gt;pdb|3OS9|D Estrogen Receptor [Homo sapiens] &gt;pdb|3OSA|A Estrogen Receptor [Homo sapiens] &gt;pdb|3OSA|B Estrogen Receptor [Homo sapiens] &gt;pdb|3OSA|C Estrogen Receptor [Homo sapiens] &gt;pdb|3OSA|D Estrogen Receptor [Homo sapiens]</Hit_def>
  <Hit_accession>3OS8_C</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.7449</Hsp_bit-score>
      <Hsp_score>234</Hsp_score>
      <Hsp_evalue>9.866e-23</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>20</Hsp_hit-from>
      <Hsp_hit-to>213</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>110</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTRHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L   DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>176</Hit_num>
  <Hit_id>pdb|6LN4|A</Hit_id>
  <Hit_def>Estrogen-related receptor beta(ERR2) in complex with PGC1a-2a [Homo sapiens]</Hit_def>
  <Hit_accession>6LN4_A</Hit_accession>
  <Hit_len>229</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.9745</Hsp_bit-score>
      <Hsp_score>232</Hsp_score>
      <Hsp_evalue>1.14289e-22</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>152</Hsp_query-to>
      <Hsp_hit-from>9</Hsp_hit-from>
      <Hsp_hit-to>149</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>86</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>143</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNT</Hsp_qseq>
      <Hsp_hseq>IVSHLLVAEPDKLYAMPPPGMPEGDIKALTTLCDLADRELVVIIGWAKHIPGFSSLSLGDQMSLLQSAWMEILILGIVYRSLPY--DDKLVYAEDYIMDEEHSRLAGLLELYRAILQLVRRYKKLKVEKEEFVTLKALALANS</Hsp_hseq>
      <Hsp_midline>+++ L+  EPD +YA      P+     LT+L  L +R+L+ ++ W+K +PGF +L + DQ++L+Q +WM +++ G+ +RS  +     L +A D I++E+  + +    L   + Q+ + + KL+V +EEF+ +K L L N+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>177</Hit_num>
  <Hit_id>pdb|6LIT|A</Hit_id>
  <Hit_def>Estrogen-related receptor beta(ERR2) in complex with BPA [Homo sapiens] &gt;pdb|6LIT|B Estrogen-related receptor beta(ERR2) in complex with BPA [Homo sapiens]</Hit_def>
  <Hit_accession>6LIT_A</Hit_accession>
  <Hit_len>230</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>93.5893</Hsp_bit-score>
      <Hsp_score>231</Hsp_score>
      <Hsp_evalue>1.30814e-22</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>152</Hsp_query-to>
      <Hsp_hit-from>9</Hsp_hit-from>
      <Hsp_hit-to>149</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>86</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>143</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNT</Hsp_qseq>
      <Hsp_hseq>IVSHLLVAEPDKLYAMPPPGMPEGDIKALTTLCDLADRELVVIIGWAKHIPGFSSLSLGDQMSLLQSAWMEILILGIVYRSLPY--DDKLVYAEDYIMDEEHSRLAGLLELYRAILQLVRRYKKLKVEKEEFVTLKALALANS</Hsp_hseq>
      <Hsp_midline>+++ L+  EPD +YA      P+     LT+L  L +R+L+ ++ W+K +PGF +L + DQ++L+Q +WM +++ G+ +RS  +     L +A D I++E+  + +    L   + Q+ + + KL+V +EEF+ +K L L N+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>178</Hit_num>
  <Hit_id>pdb|6DF6|A</Hit_id>
  <Hit_def>Crystal structure of estrogen receptor alpha in complex with receptor degrader 16ab [Homo sapiens] &gt;pdb|6DF6|B Crystal structure of estrogen receptor alpha in complex with receptor degrader 16ab [Homo sapiens] &gt;pdb|6DF6|C Crystal structure of estrogen receptor alpha in complex with receptor degrader 16ab [Homo sapiens] &gt;pdb|6DF6|D Crystal structure of estrogen receptor alpha in complex with receptor degrader 16ab [Homo sapiens] &gt;pdb|6DFN|A Crystal structure of estrogen receptor alpha in complex with receptor degrader 16aa [Homo sapiens] &gt;pdb|6DFN|B Crystal structure of estrogen receptor alpha in complex with receptor degrader 16aa [Homo sapiens] &gt;pdb|6DFN|C Crystal structure of estrogen receptor alpha in complex with receptor degrader 16aa [Homo sapiens] &gt;pdb|6DFN|D Crystal structure of estrogen receptor alpha in complex with receptor degrader 16aa [Homo sapiens] &gt;pdb|6PET|A Crystal structure of 8-hydroxychromene compound 30 bound to estrogen receptor alpha [Homo sapiens] &gt;pdb|6PET|B Crystal structure of 8-hydroxychromene compound 30 bound to estrogen receptor alpha [Homo sapiens] &gt;pdb|6PET|C Crystal structure of 8-hydroxychromene compound 30 bound to estrogen receptor alpha [Homo sapiens] &gt;pdb|6PET|D Crystal structure of 8-hydroxychromene compound 30 bound to estrogen receptor alpha [Homo sapiens] &gt;pdb|6PFM|A Crystal structure of GDC-0927 bound to estrogen receptor alpha [Homo sapiens] &gt;pdb|6PFM|D Crystal structure of GDC-0927 bound to estrogen receptor alpha [Homo sapiens] &gt;pdb|6WOK|A Crystal structure of estrogen receptor alpha in complex with receptor degrader 6 [Homo sapiens] &gt;pdb|6WOK|B Crystal structure of estrogen receptor alpha in complex with receptor degrader 6 [Homo sapiens] &gt;pdb|6WOK|C Crystal structure of estrogen receptor alpha in complex with receptor degrader 6 [Homo sapiens] &gt;pdb|6WOK|D Crystal structure of estrogen receptor alpha in complex with receptor degrader 6 [Homo sapiens] &gt;pdb|7MSA|A Chain A, Estrogen receptor [Homo sapiens] &gt;pdb|7MSA|B Chain B, Estrogen receptor [Homo sapiens] &gt;pdb|7MSA|C Chain C, Estrogen receptor [Homo sapiens] &gt;pdb|7MSA|D Chain D, Estrogen receptor [Homo sapiens]</Hit_def>
  <Hit_accession>6DF6_A</Hit_accession>
  <Hit_len>280</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>94.3597</Hsp_bit-score>
      <Hsp_score>233</Hsp_score>
      <Hsp_evalue>1.61472e-22</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>42</Hsp_hit-from>
      <Hsp_hit-to>235</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>58</Hsp_identity>
      <Hsp_positive>110</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>196</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKA----IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTSHDQVHLLECAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLL</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P + +S++  L  L +R+L+ ++ W+K +PGF +L   DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+     L S  +  E +    R L K     I L  K  ++  Q+  +L +LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>179</Hit_num>
  <Hit_id>pdb|6IAR|A</Hit_id>
  <Hit_def>Tricyclic indazoles a novel class of selective estrogen receptor degrader antagonists [Homo sapiens]</Hit_def>
  <Hit_accession>6IAR_A</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.6633</Hsp_bit-score>
      <Hsp_score>226</Hsp_score>
      <Hsp_evalue>9.16294e-22</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>152</Hsp_query-to>
      <Hsp_hit-from>9</Hsp_hit-from>
      <Hsp_hit-to>147</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>46</Hsp_identity>
      <Hsp_positive>90</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>144</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNT</Hsp_qseq>
      <Hsp_hseq>MVSALLDAEPPILYSEYDPTRPFSMMGLLTNL---ADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEH-PGKLL-FAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNS</Hsp_hseq>
      <Hsp_midline>+++ L+  EP ++Y+ +D T+P +   LLT+L    +R+L+ ++ W+K +PGF +L + DQ+ L++ +W+ +++ GL WRS +H  G++L FAP+L+L+  + K       +   +      F  + +  EEF+C+K ++LLN+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>180</Hit_num>
  <Hit_id>pdb|7E2E|A</Hit_id>
  <Hit_def>Chain A, Steroid hormone receptor ERR1 [Homo sapiens] &gt;pdb|7E2E|B Chain B, Steroid hormone receptor ERR1 [Homo sapiens]</Hit_def>
  <Hit_accession>7E2E_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>91.6633</Hsp_bit-score>
      <Hsp_score>226</Hsp_score>
      <Hsp_evalue>9.63728e-22</Hsp_evalue>
      <Hsp_query-from>7</Hsp_query-from>
      <Hsp_query-to>152</Hsp_query-to>
      <Hsp_hit-from>12</Hsp_hit-from>
      <Hsp_hit-to>159</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>47</Hsp_identity>
      <Hsp_positive>85</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>150</Hsp_align-len>
      <Hsp_qseq>IPPLINLLMS----IEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNT</Hsp_qseq>
      <Hsp_hseq>IPEFVNALVSHLLVVEPEKLYAMPDPAGPDGHLPAVATLCDLFDREIVVTISWAKSIPGFSSLSLSDQMSVLQSVWMEVLVLGVAQRSLP--LQDELAFAEDLVLDEEGARAAGLGELGAALLQLVRRLQALRLEREEYVLLKALALANS</Hsp_hseq>
      <Hsp_midline>IP  +N L+S    +EP+ +YA  D   PD     + +L  L +R+++  + W+KS+PGF +L + DQ++++Q  WM ++V G+  RS        L FA DL+L+E+  + +    L   + Q+ +    L++ +EE++ +K L L N+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>181</Hit_num>
  <Hit_id>pdb|2PJL|A</Hit_id>
  <Hit_def>Crystal Structure of Human Estrogen-Related Receptor alpha in Complex with a Synthetic Inverse Agonist reveals its Novel Molecular Mechanism [Homo sapiens] &gt;pdb|2PJL|B Crystal Structure of Human Estrogen-Related Receptor alpha in Complex with a Synthetic Inverse Agonist reveals its Novel Molecular Mechanism [Homo sapiens]</Hit_def>
  <Hit_accession>2PJL_A</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>90.8929</Hsp_bit-score>
      <Hsp_score>224</Hsp_score>
      <Hsp_evalue>1.89847e-21</Hsp_evalue>
      <Hsp_query-from>7</Hsp_query-from>
      <Hsp_query-to>152</Hsp_query-to>
      <Hsp_hit-from>18</Hsp_hit-from>
      <Hsp_hit-to>161</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>85</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>146</Hsp_align-len>
      <Hsp_qseq>IPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNT</Hsp_qseq>
      <Hsp_hseq>VNALVSHLLVVEPEKLYAMPDPAGPDGHLPAVATLSDLFDREIVVTISWAKSIPGFSSLSLSDQMSVLQSVWMEVLVLGVAQRSLP--LQDELAFAEDLVLDEEGARAAGLGELGAALLQLVRRLQALRLEREEYVLLKALALANS</Hsp_hseq>
      <Hsp_midline>+  L++ L+ +EP+ +YA  D   PD     + +L+ L +R+++  + W+KS+PGF +L + DQ++++Q  WM ++V G+  RS        L FA DL+L+E+  + +    L   + Q+ +    L++ +EE++ +K L L N+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>182</Hit_num>
  <Hit_id>pdb|3D24|A</Hit_id>
  <Hit_def>Crystal structure of ligand-binding domain of estrogen-related receptor alpha (ERRalpha) in complex with the peroxisome proliferators-activated receptor coactivator-1alpha box3 peptide (PGC-1alpha) [Homo sapiens] &gt;pdb|3D24|C Crystal structure of ligand-binding domain of estrogen-related receptor alpha (ERRalpha) in complex with the peroxisome proliferators-activated receptor coactivator-1alpha box3 peptide (PGC-1alpha) [Homo sapiens]</Hit_def>
  <Hit_accession>3D24_A</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>89.7373</Hsp_bit-score>
      <Hsp_score>221</Hsp_score>
      <Hsp_evalue>5.46606e-21</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>152</Hsp_query-to>
      <Hsp_hit-from>27</Hsp_hit-from>
      <Hsp_hit-to>167</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>83</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>143</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNT</Hsp_qseq>
      <Hsp_hseq>LVSHLLVVEPEKLYAMPDPAGPDGHLPAVATLCDLFDREIVVTISWAKSIPGFSSLSLSDQMSVLQSVWMEVLVLGVAQRSLP--LQDELAFAEDLVLDEEGARAAGLGELGAALLQLVRRLQALRLEREEYVLLKALALANS</Hsp_hseq>
      <Hsp_midline>L++ L+ +EP+ +YA  D   PD     + +L  L +R+++  + W+KS+PGF +L + DQ++++Q  WM ++V G+  RS        L FA DL+L+E+  + +    L   + Q+ +    L++ +EE++ +K L L N+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>183</Hit_num>
  <Hit_id>pdb|1XB7|A</Hit_id>
  <Hit_def>X-ray structure of ERRalpha LBD in complex with a PGC-1alpha peptide at 2.5A resolution [Homo sapiens]</Hit_def>
  <Hit_accession>1XB7_A</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>89.7373</Hsp_bit-score>
      <Hsp_score>221</Hsp_score>
      <Hsp_evalue>5.7823e-21</Hsp_evalue>
      <Hsp_query-from>7</Hsp_query-from>
      <Hsp_query-to>152</Hsp_query-to>
      <Hsp_hit-from>18</Hsp_hit-from>
      <Hsp_hit-to>161</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>84</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>146</Hsp_align-len>
      <Hsp_qseq>IPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNT</Hsp_qseq>
      <Hsp_hseq>VNALVSHLLVVEPEKLYAMPDPAGPDGHLPAVATLCDLFDREIVVTISWAKSIPGFSSLSLSDQMSVLQSVWMEVLVLGVAQRSLP--LQDELAFAEDLVLDEEGARAAGLGELGAALLQLVRRLQALRLEREEYVLLKALALANS</Hsp_hseq>
      <Hsp_midline>+  L++ L+ +EP+ +YA  D   PD     + +L  L +R+++  + W+KS+PGF +L + DQ++++Q  WM ++V G+  RS        L FA DL+L+E+  + +    L   + Q+ +    L++ +EE++ +K L L N+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>184</Hit_num>
  <Hit_id>pdb|3K6P|A</Hit_id>
  <Hit_def>Estrogen Related Receptor alpha in Complex with an Ether Based Ligand [Homo sapiens]</Hit_def>
  <Hit_accession>3K6P_A</Hit_accession>
  <Hit_len>248</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>89.7373</Hsp_bit-score>
      <Hsp_score>221</Hsp_score>
      <Hsp_evalue>6.26427e-21</Hsp_evalue>
      <Hsp_query-from>7</Hsp_query-from>
      <Hsp_query-to>152</Hsp_query-to>
      <Hsp_hit-from>19</Hsp_hit-from>
      <Hsp_hit-to>162</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>84</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>146</Hsp_align-len>
      <Hsp_qseq>IPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNT</Hsp_qseq>
      <Hsp_hseq>VNALVSHLLVVEPEKLYAMPDPAGPDGHLPAVATLCDLFDREIVVTISWAKSIPGFSSLSLSDQMSVLQSVWMEVLVLGVAQRSLP--LQDELAFAEDLVLDEEGARAAGLGELGAALLQLVRRLQALRLEREEYVLLKALALANS</Hsp_hseq>
      <Hsp_midline>+  L++ L+ +EP+ +YA  D   PD     + +L  L +R+++  + W+KS+PGF +L + DQ++++Q  WM ++V G+  RS        L FA DL+L+E+  + +    L   + Q+ +    L++ +EE++ +K L L N+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>185</Hit_num>
  <Hit_id>pdb|2FSZ|A</Hit_id>
  <Hit_def>A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor beta [Homo sapiens] &gt;pdb|2FSZ|B A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor beta [Homo sapiens]</Hit_def>
  <Hit_accession>2FSZ_A</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>88.5817</Hsp_bit-score>
      <Hsp_score>218</Hsp_score>
      <Hsp_evalue>1.2808e-20</Hsp_evalue>
      <Hsp_query-from>29</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>30</Hsp_hit-from>
      <Hsp_hit-to>203</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>56</Hsp_identity>
      <Hsp_positive>100</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>178</Hsp_align-len>
      <Hsp_qseq>TKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIG-----LRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>SAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESSWMEVLMMGLMWRSIDH-PGK-LIFAPDLVLDRDEGKSVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNS-SMYPLVTATQDAD-SSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLL</Hsp_hseq>
      <Hsp_midline>+ P T +S++ SL +L +++L+ ++ W+K +PGF  L + DQ+ L++ SWM +++ GL WRS  H  G+ L FAPDL+L+    K       +   +      F +L++  +E+LC+K ++LLN+  +  L + TQ  +  S  +  L+ A+      +  K  +SS Q+  +L  LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>186</Hit_num>
  <Hit_id>pdb|2YLY|A</Hit_id>
  <Hit_def>Sulfonamides as selective Estrogen Receptor beta Agonists. [Homo sapiens] &gt;pdb|2YLY|B Sulfonamides as selective Estrogen Receptor beta Agonists. [Homo sapiens]</Hit_def>
  <Hit_accession>2YLY_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>87.0409</Hsp_bit-score>
      <Hsp_score>214</Hsp_score>
      <Hsp_evalue>4.89809e-20</Hsp_evalue>
      <Hsp_query-from>29</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>27</Hsp_hit-from>
      <Hsp_hit-to>199</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>99</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>178</Hsp_align-len>
      <Hsp_qseq>TKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIG-----LRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>SAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDH-PGK-LIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNS-SMYPLVTATQDDSSRK--LAHLLNAVTDALVWVIAKSGISSQQQSMRLANLL</Hsp_hseq>
      <Hsp_midline>+ P T +S++ SL +L +++L+ ++ W+K +PGF  L + DQ+ L++  WM +++ GL WRS  H  G+ L FAPDL+L+    K       +   +      F +L++  +E+LC+K ++LLN+  +  L + TQ +  R   +  L+ A+      +  K  +SS Q+  +L  LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>187</Hit_num>
  <Hit_id>pdb|4N1Y|A</Hit_id>
  <Hit_def>Crystal Structure of the Pacific Oyster Estrogen Receptor Ligand Binding Domain [Crassostrea gigas] &gt;pdb|4N1Y|B Crystal Structure of the Pacific Oyster Estrogen Receptor Ligand Binding Domain [Crassostrea gigas] &gt;pdb|4N1Y|C Crystal Structure of the Pacific Oyster Estrogen Receptor Ligand Binding Domain [Crassostrea gigas] &gt;pdb|4N1Y|D Crystal Structure of the Pacific Oyster Estrogen Receptor Ligand Binding Domain [Crassostrea gigas]</Hit_def>
  <Hit_accession>4N1Y_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>86.6557</Hsp_bit-score>
      <Hsp_score>213</Hsp_score>
      <Hsp_evalue>6.59944e-20</Hsp_evalue>
      <Hsp_query-from>21</Hsp_query-from>
      <Hsp_query-to>194</Hsp_query-to>
      <Hsp_hit-from>21</Hsp_hit-from>
      <Hsp_hit-to>181</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>46</Hsp_identity>
      <Hsp_positive>95</Hsp_positive>
      <Hsp_gaps>13</Hsp_gaps>
      <Hsp_align-len>174</Hsp_align-len>
      <Hsp_qseq>VIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFY</Hsp_qseq>
      <Hsp_hseq>VLESHHNHGQPPTKVHLLNSLVKLAERELVHLINWAKNVPGYTDLSLSDQVHLIECCWMELLLLNCAFRSIEH-GGKSLAFAPDLVLDRSSWSTVEMTEIFEQVAAVSEQMMQNHLHKDELLLLQAMVLVNA-EVRRLASYNQIFNMQQSLL-----------DAIVDTAQKYH</Hsp_hseq>
      <Hsp_midline>V+ + H++ +P T   LL SL +L ER+L+ ++ W+K++PG+ +L + DQ+ LI+  WM L++    +RS +H  G+ L FAPDL+L+           +   +  + ++ ++  + ++E L ++ ++L+N   +  L S  Q   M+ S +             +V ++Q+++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>188</Hit_num>
  <Hit_id>pdb|3OLL|A</Hit_id>
  <Hit_def>Crystal structure of phosphorylated estrogen receptor beta ligand binding domain [Homo sapiens] &gt;pdb|3OLL|B Crystal structure of phosphorylated estrogen receptor beta ligand binding domain [Homo sapiens]</Hit_def>
  <Hit_accession>3OLL_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>86.6557</Hsp_bit-score>
      <Hsp_score>213</Hsp_score>
      <Hsp_evalue>7.0917e-20</Hsp_evalue>
      <Hsp_query-from>29</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>26</Hsp_hit-from>
      <Hsp_hit-to>199</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>99</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>178</Hsp_align-len>
      <Hsp_qseq>TKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIG-----LRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>SAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDH-PGK-LIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNS-SMYPLVTATQDAD-SSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLL</Hsp_hseq>
      <Hsp_midline>+ P T +S++ SL +L +++L+ ++ W+K +PGF  L + DQ+ L++  WM +++ GL WRS  H  G+ L FAPDL+L+    K       +   +      F +L++  +E+LC+K ++LLN+  +  L + TQ  +  S  +  L+ A+      +  K  +SS Q+  +L  LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>189</Hit_num>
  <Hit_id>pdb|1ZAF|A</Hit_id>
  <Hit_def>Crystal structure of estrogen receptor beta complexed with 3-Bromo-6-hydroxy-2-(4-hydroxy-phenyl)-inden-1-one [Homo sapiens] &gt;pdb|1ZAF|B Crystal structure of estrogen receptor beta complexed with 3-Bromo-6-hydroxy-2-(4-hydroxy-phenyl)-inden-1-one [Homo sapiens]</Hit_def>
  <Hit_accession>1ZAF_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>86.6557</Hsp_bit-score>
      <Hsp_score>213</Hsp_score>
      <Hsp_evalue>7.34819e-20</Hsp_evalue>
      <Hsp_query-from>29</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>24</Hsp_hit-from>
      <Hsp_hit-to>197</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>99</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>178</Hsp_align-len>
      <Hsp_qseq>TKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIG-----LRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>SAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDH-PGK-LIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNS-AMYPLVTATQDAD-SSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLL</Hsp_hseq>
      <Hsp_midline>+ P T +S++ SL +L +++L+ ++ W+K +PGF  L + DQ+ L++  WM +++ GL WRS  H  G+ L FAPDL+L+    K       +   +      F +L++  +E+LC+K ++LLN+  +  L + TQ  +  S  +  L+ A+      +  K  +SS Q+  +L  LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>190</Hit_num>
  <Hit_id>pdb|1U3Q|A</Hit_id>
  <Hit_def>Crystal Structure of Estrogen Receptor beta complexed with CL-272 [Homo sapiens] &gt;pdb|1U3Q|B Crystal Structure of Estrogen Receptor beta complexed with CL-272 [Homo sapiens] &gt;pdb|1U3Q|C Crystal Structure of Estrogen Receptor beta complexed with CL-272 [Homo sapiens] &gt;pdb|1U3Q|D Crystal Structure of Estrogen Receptor beta complexed with CL-272 [Homo sapiens] &gt;pdb|1U3S|A Crystal Structure of Estrogen Receptor beta complexed with WAY-797 [Homo sapiens] &gt;pdb|1U3S|B Crystal Structure of Estrogen Receptor beta complexed with WAY-797 [Homo sapiens] &gt;pdb|1X76|A Crystal Structure Of Estrogen Receptor Beta Complexed With Way-697 [Homo sapiens] &gt;pdb|1X76|B Crystal Structure Of Estrogen Receptor Beta Complexed With Way-697 [Homo sapiens] &gt;pdb|1X78|A Crystal Structure Of Estrogen Receptor Beta Complexed With Way-244 [Homo sapiens] &gt;pdb|1X78|B Crystal Structure Of Estrogen Receptor Beta Complexed With Way-244 [Homo sapiens] &gt;pdb|1X7B|A Crystal Structure Of Estrogen Receptor Beta Complexed With Erb-041 [Homo sapiens] &gt;pdb|1X7B|B Crystal Structure Of Estrogen Receptor Beta Complexed With Erb-041 [Homo sapiens] &gt;pdb|1X7J|A Crystal Structure Of Estrogen Receptor Beta Complexed With Genistein [Homo sapiens] &gt;pdb|1X7J|B Crystal Structure Of Estrogen Receptor Beta Complexed With Genistein [Homo sapiens] &gt;pdb|2YJD|A Stapled peptide bound to Estrogen Receptor Beta [Homo sapiens] &gt;pdb|2YJD|B Stapled peptide bound to Estrogen Receptor Beta [Homo sapiens] &gt;pdb|3OLS|A Crystal structure of estrogen receptor beta ligand binding domain [Homo sapiens] &gt;pdb|3OLS|B Crystal structure of estrogen receptor beta ligand binding domain [Homo sapiens] &gt;pdb|3OMO|A Fragment-Based Design of novel Estrogen Receptor Ligands [Homo sapiens] &gt;pdb|3OMO|B Fragment-Based Design of novel Estrogen Receptor Ligands [Homo sapiens] &gt;pdb|3OMP|A Fragment-Based Design of novel Estrogen Receptor Ligands [Homo sapiens] &gt;pdb|3OMP|B Fragment-Based Design of novel Estrogen Receptor Ligands [Homo sapiens] &gt;pdb|3OMQ|A Fragment-Based Design of novel Estrogen Receptor Ligands [Homo sapiens] &gt;pdb|3OMQ|B Fragment-Based Design of novel Estrogen Receptor Ligands [Homo sapiens] &gt;pdb|4J24|A Estrogen Receptor in complex with proline-flanked LXXLL peptides [Homo sapiens] &gt;pdb|4J24|B Estrogen Receptor in complex with proline-flanked LXXLL peptides [Homo sapiens] &gt;pdb|4J24|C Estrogen Receptor in complex with proline-flanked LXXLL peptides [Homo sapiens] &gt;pdb|4J24|D Estrogen Receptor in complex with proline-flanked LXXLL peptides [Homo sapiens] &gt;pdb|4J26|A Estrogen Receptor in complex with proline-flanked LXXLL peptides [Homo sapiens] &gt;pdb|4J26|B Estrogen Receptor in complex with proline-flanked LXXLL peptides [Homo sapiens]</Hit_def>
  <Hit_accession>1U3Q_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>86.6557</Hsp_bit-score>
      <Hsp_score>213</Hsp_score>
      <Hsp_evalue>7.62062e-20</Hsp_evalue>
      <Hsp_query-from>29</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>26</Hsp_hit-from>
      <Hsp_hit-to>199</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>99</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>178</Hsp_align-len>
      <Hsp_qseq>TKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIG-----LRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>SAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDH-PGK-LIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNS-SMYPLVTATQDAD-SSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLL</Hsp_hseq>
      <Hsp_midline>+ P T +S++ SL +L +++L+ ++ W+K +PGF  L + DQ+ L++  WM +++ GL WRS  H  G+ L FAPDL+L+    K       +   +      F +L++  +E+LC+K ++LLN+  +  L + TQ  +  S  +  L+ A+      +  K  +SS Q+  +L  LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>191</Hit_num>
  <Hit_id>pdb|1U3R|A</Hit_id>
  <Hit_def>Crystal Structure of Estrogen Receptor beta complexed with WAY-338 [Homo sapiens] &gt;pdb|1U3R|B Crystal Structure of Estrogen Receptor beta complexed with WAY-338 [Homo sapiens] &gt;pdb|1U9E|A Crystal Structure Of Estrogen Receptor Beta Complexed With Way-397 [Homo sapiens] &gt;pdb|1U9E|B Crystal Structure Of Estrogen Receptor Beta Complexed With Way-397 [Homo sapiens]</Hit_def>
  <Hit_accession>1U3R_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>86.2705</Hsp_bit-score>
      <Hsp_score>212</Hsp_score>
      <Hsp_evalue>8.51115e-20</Hsp_evalue>
      <Hsp_query-from>29</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>26</Hsp_hit-from>
      <Hsp_hit-to>199</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>99</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>178</Hsp_align-len>
      <Hsp_qseq>TKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIG-----LRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>SAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDH-PGK-LIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNS-SMYPLVTATQDAD-SSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLL</Hsp_hseq>
      <Hsp_midline>+ P T +S++ SL +L +++L+ ++ W+K +PGF  L + DQ+ L++  WM +++ GL WRS  H  G+ L FAPDL+L+    K       +   +      F +L++  +E+LC+K ++LLN+  +  L + TQ  +  S  +  L+ A+      +  K  +SS Q+  +L  LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>192</Hit_num>
  <Hit_id>pdb|2GIU|A</Hit_id>
  <Hit_def>Human estrogen receptor beta ligand-binding domain in complex with compound 45 [Homo sapiens]</Hit_def>
  <Hit_accession>2GIU_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>86.2705</Hsp_bit-score>
      <Hsp_score>212</Hsp_score>
      <Hsp_evalue>8.77747e-20</Hsp_evalue>
      <Hsp_query-from>29</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>27</Hsp_hit-from>
      <Hsp_hit-to>200</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>99</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>178</Hsp_align-len>
      <Hsp_qseq>TKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIG-----LRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>SAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDH-PGK-LIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNS-SMYPLVTATQDAD-SSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLL</Hsp_hseq>
      <Hsp_midline>+ P T +S++ SL +L +++L+ ++ W+K +PGF  L + DQ+ L++  WM +++ GL WRS  H  G+ L FAPDL+L+    K       +   +      F +L++  +E+LC+K ++LLN+  +  L + TQ  +  S  +  L+ A+      +  K  +SS Q+  +L  LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>193</Hit_num>
  <Hit_id>pdb|1HJ1|A</Hit_id>
  <Hit_def>RAT OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH PURE ANTIOESTROGEN ICI164,384 [Rattus norvegicus] &gt;pdb|1QKN|A RAT OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH ANTAGONIST RALOXIFENE [Rattus norvegicus]</Hit_def>
  <Hit_accession>1HJ1_A</Hit_accession>
  <Hit_len>255</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>86.6557</Hsp_bit-score>
      <Hsp_score>213</Hsp_score>
      <Hsp_evalue>9.60721e-20</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>15</Hsp_hit-from>
      <Hsp_hit-to>205</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>56</Hsp_identity>
      <Hsp_positive>106</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>195</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNT--IPLEGLRSQTQFEEMRSSYIRELIKA-IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>VLTLLEAEPPNVLVS--RPSMPFTEASMMMSLTKLADKELVHMIGWAKKIPGFVELSLLDQVRLLESCWMEVLMVGLMWRSIDH-PGK-LIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLASANQEAESSRKLTHLLNAVTDALVWVIAKSGISSQQQSVRLANLL</Hsp_hseq>
      <Hsp_midline>++ LL +  P+V+ +    + P T +S++ SL +L +++L+ ++ W+K +PGF  L + DQ+ L++  WM +++ GL WRS  H  G+ L FAPDL+L+    K       +   +      F +L++  +E+LC+K ++LLN+   PL     + +     +  +  +  A + +  K  +SS Q+  +L  LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>194</Hit_num>
  <Hit_id>pdb|2J7X|A</Hit_id>
  <Hit_def>Structure Of Estradiol-bound Estrogen Receptor Beta Lbd In Complex With Lxxll Motif From Ncoa5 [Rattus norvegicus] &gt;pdb|2J7Y|A Structure Of 17-Epiestriol-Bound Estrogen Receptor Beta Lbd In Complex With Lxxll Motif From Ncoa5 [Rattus norvegicus]</Hit_def>
  <Hit_accession>2J7X_A</Hit_accession>
  <Hit_len>255</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>86.6557</Hsp_bit-score>
      <Hsp_score>213</Hsp_score>
      <Hsp_evalue>9.60721e-20</Hsp_evalue>
      <Hsp_query-from>10</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>15</Hsp_hit-from>
      <Hsp_hit-to>205</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>56</Hsp_identity>
      <Hsp_positive>106</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>195</Hsp_align-len>
      <Hsp_qseq>LINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNT--IPLEGLRSQTQFEEMRSSYIRELIKA-IGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>VLTLLEAEPPNVLVS--RPSMPFTEASMMMSLTKLADKELVHMIGWAKKIPGFVELSLLDQVRLLESCWMEVLMVGLMWRSIDH-PGK-LIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLASANQEAESSRKLTHLLNAVTDALVWVIAKSGISSQQQSVRLANLL</Hsp_hseq>
      <Hsp_midline>++ LL +  P+V+ +    + P T +S++ SL +L +++L+ ++ W+K +PGF  L + DQ+ L++  WM +++ GL WRS  H  G+ L FAPDL+L+    K       +   +      F +L++  +E+LC+K ++LLN+   PL     + +     +  +  +  A + +  K  +SS Q+  +L  LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>195</Hit_num>
  <Hit_id>pdb|2NV7|A</Hit_id>
  <Hit_def>Crystal Structure of Estrogen Receptor Beta Complexed with WAY-555 [Homo sapiens] &gt;pdb|2NV7|B Crystal Structure of Estrogen Receptor Beta Complexed with WAY-555 [Homo sapiens]</Hit_def>
  <Hit_accession>2NV7_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>86.2705</Hsp_bit-score>
      <Hsp_score>212</Hsp_score>
      <Hsp_evalue>1.04219e-19</Hsp_evalue>
      <Hsp_query-from>29</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>24</Hsp_hit-from>
      <Hsp_hit-to>197</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>99</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>178</Hsp_align-len>
      <Hsp_qseq>TKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIG-----LRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>SAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDH-PGK-LIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNS-SMYPLVTATQDAD-SSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLL</Hsp_hseq>
      <Hsp_midline>+ P T +S++ SL +L +++L+ ++ W+K +PGF  L + DQ+ L++  WM +++ GL WRS  H  G+ L FAPDL+L+    K       +   +      F +L++  +E+LC+K ++LLN+  +  L + TQ  +  S  +  L+ A+      +  K  +SS Q+  +L  LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>196</Hit_num>
  <Hit_id>pdb|4ZI1|A</Hit_id>
  <Hit_def>Human Estrogen Receptor Beta Ligand-binding Domain In Complex With Kb095285 And Cia12 Coactivator Peptide [Homo sapiens] &gt;pdb|5TOA|A Crystal Structure of ER beta bound to Estradiol [Homo sapiens] &gt;pdb|5TOA|B Crystal Structure of ER beta bound to Estradiol [Homo sapiens]</Hit_def>
  <Hit_accession>4ZI1_A</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>86.2705</Hsp_bit-score>
      <Hsp_score>212</Hsp_score>
      <Hsp_evalue>1.06411e-19</Hsp_evalue>
      <Hsp_query-from>29</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>26</Hsp_hit-from>
      <Hsp_hit-to>199</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>99</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>178</Hsp_align-len>
      <Hsp_qseq>TKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIG-----LRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>SAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDH-PGK-LIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNS-SMYPLVTATQDAD-SSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLL</Hsp_hseq>
      <Hsp_midline>+ P T +S++ SL +L +++L+ ++ W+K +PGF  L + DQ+ L++  WM +++ GL WRS  H  G+ L FAPDL+L+    K       +   +      F +L++  +E+LC+K ++LLN+  +  L + TQ  +  S  +  L+ A+      +  K  +SS Q+  +L  LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>197</Hit_num>
  <Hit_id>pdb|1NDE|A</Hit_id>
  <Hit_def>Estrogen Receptor beta with Selective Triazine Modulator [Homo sapiens]</Hit_def>
  <Hit_accession>1NDE_A</Hit_accession>
  <Hit_len>255</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>86.2705</Hsp_bit-score>
      <Hsp_score>212</Hsp_score>
      <Hsp_evalue>1.26628e-19</Hsp_evalue>
      <Hsp_query-from>29</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>40</Hsp_hit-from>
      <Hsp_hit-to>213</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>99</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>178</Hsp_align-len>
      <Hsp_qseq>TKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIG-----LRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>SAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDH-PGK-LIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNS-SMYPLVTATQDAD-SSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLL</Hsp_hseq>
      <Hsp_midline>+ P T +S++ SL +L +++L+ ++ W+K +PGF  L + DQ+ L++  WM +++ GL WRS  H  G+ L FAPDL+L+    K       +   +      F +L++  +E+LC+K ++LLN+  +  L + TQ  +  S  +  L+ A+      +  K  +SS Q+  +L  LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>198</Hit_num>
  <Hit_id>pdb|1QKM|A</Hit_id>
  <Hit_def>Human Oestrogen Receptor Beta Ligand-Binding Domain In Complex With Partial Agonist Genistein [Homo sapiens]</Hit_def>
  <Hit_accession>1QKM_A</Hit_accession>
  <Hit_len>255</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>86.2705</Hsp_bit-score>
      <Hsp_score>212</Hsp_score>
      <Hsp_evalue>1.41701e-19</Hsp_evalue>
      <Hsp_query-from>29</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>32</Hsp_hit-from>
      <Hsp_hit-to>205</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>99</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>178</Hsp_align-len>
      <Hsp_qseq>TKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIG-----LRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>SAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDH-PGK-LIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNS-SMYPLVTATQDAD-SSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLL</Hsp_hseq>
      <Hsp_midline>+ P T +S++ SL +L +++L+ ++ W+K +PGF  L + DQ+ L++  WM +++ GL WRS  H  G+ L FAPDL+L+    K       +   +      F +L++  +E+LC+K ++LLN+  +  L + TQ  +  S  +  L+ A+      +  K  +SS Q+  +L  LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>199</Hit_num>
  <Hit_id>pdb|2I0G|A</Hit_id>
  <Hit_def>Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of Benign Prostatic Hyperplasia [Homo sapiens] &gt;pdb|2I0G|B Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of Benign Prostatic Hyperplasia [Homo sapiens] &gt;pdb|2JJ3|A Estrogen receptor beta ligand binding domain in complex with a Benzopyran agonist [Homo sapiens] &gt;pdb|2JJ3|B Estrogen receptor beta ligand binding domain in complex with a Benzopyran agonist [Homo sapiens] &gt;pdb|2QTU|A Estrogen receptor beta ligand-binding domain complexed to a benzopyran ligand [Homo sapiens] &gt;pdb|2QTU|B Estrogen receptor beta ligand-binding domain complexed to a benzopyran ligand [Homo sapiens] &gt;pdb|2Z4B|A Estrogen receptor beta ligand-binding domain complexed to a benzopyran ligand [Homo sapiens] &gt;pdb|2Z4B|B Estrogen receptor beta ligand-binding domain complexed to a benzopyran ligand [Homo sapiens]</Hit_def>
  <Hit_accession>2I0G_A</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>86.2705</Hsp_bit-score>
      <Hsp_score>212</Hsp_score>
      <Hsp_evalue>1.46505e-19</Hsp_evalue>
      <Hsp_query-from>29</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>38</Hsp_hit-from>
      <Hsp_hit-to>211</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>99</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>178</Hsp_align-len>
      <Hsp_qseq>TKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIG-----LRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>SAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDH-PGK-LIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNS-SMYPLVTATQDAD-SSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLL</Hsp_hseq>
      <Hsp_midline>+ P T +S++ SL +L +++L+ ++ W+K +PGF  L + DQ+ L++  WM +++ GL WRS  H  G+ L FAPDL+L+    K       +   +      F +L++  +E+LC+K ++LLN+  +  L + TQ  +  S  +  L+ A+      +  K  +SS Q+  +L  LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>200</Hit_num>
  <Hit_id>pdb|1L2J|A</Hit_id>
  <Hit_def>Human Estrogen Receptor beta Ligand-binding Domain in Complex with (R,R)-5,11-cis-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol [Homo sapiens] &gt;pdb|1L2J|B Human Estrogen Receptor beta Ligand-binding Domain in Complex with (R,R)-5,11-cis-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol [Homo sapiens]</Hit_def>
  <Hit_accession>1L2J_A</Hit_accession>
  <Hit_len>271</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>85.8853</Hsp_bit-score>
      <Hsp_score>211</Hsp_score>
      <Hsp_evalue>2.13499e-19</Hsp_evalue>
      <Hsp_query-from>29</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>52</Hsp_hit-from>
      <Hsp_hit-to>225</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>55</Hsp_identity>
      <Hsp_positive>99</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>178</Hsp_align-len>
      <Hsp_qseq>TKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIG-----LRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>SAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDH-PGK-LIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNS-SMYPLVTATQDAD-SSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLL</Hsp_hseq>
      <Hsp_midline>+ P T +S++ SL +L +++L+ ++ W+K +PGF  L + DQ+ L++  WM +++ GL WRS  H  G+ L FAPDL+L+    K       +   +      F +L++  +E+LC+K ++LLN+  +  L + TQ  +  S  +  L+ A+      +  K  +SS Q+  +L  LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>201</Hit_num>
  <Hit_id>pdb|1YY4|A</Hit_id>
  <Hit_def>Crystal structure of estrogen receptor beta complexed with 1-chloro-6-(4-hydroxy-phenyl)-naphthalen-2-ol [Homo sapiens] &gt;pdb|1YY4|B Crystal structure of estrogen receptor beta complexed with 1-chloro-6-(4-hydroxy-phenyl)-naphthalen-2-ol [Homo sapiens] &gt;pdb|1YYE|A Crystal structure of estrogen receptor beta complexed with way-202196 [Homo sapiens] &gt;pdb|1YYE|B Crystal structure of estrogen receptor beta complexed with way-202196 [Homo sapiens]</Hit_def>
  <Hit_accession>1YY4_A</Hit_accession>
  <Hit_len>268</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>85.1149</Hsp_bit-score>
      <Hsp_score>209</Hsp_score>
      <Hsp_evalue>3.71422e-19</Hsp_evalue>
      <Hsp_query-from>29</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>24</Hsp_hit-from>
      <Hsp_hit-to>197</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>54</Hsp_identity>
      <Hsp_positive>97</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>178</Hsp_align-len>
      <Hsp_qseq>TKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMK-ESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIG-----LRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>SAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGK--LIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNS-SMYPLVTATQDAD-SSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLL</Hsp_hseq>
      <Hsp_midline>+ P T +S++ SL +L +++L+ ++ W+K +PGF  L + DQ+ L++  WM +++ GL WRS  H     L FAPDL+L+    K       +   +      F +L++  +E+LC+K ++LLN+  +  L + TQ  +  S  +  L+ A+      +  K  +SS Q+  +L  LL</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>202</Hit_num>
  <Hit_id>pdb|1G2N|A</Hit_id>
  <Hit_def>Crystal Structure Of The Ligand Binding Domain Of The Ultraspiracle Protein Usp, The Ortholog Of Rxrs In Insects [Heliothis virescens] &gt;pdb|4UMM|F The Cryo-EM structure of the palindromic DNA-bound USP-EcR nuclear receptor reveals an asymmetric organization with allosteric domain positioning [Heliothis virescens]</Hit_def>
  <Hit_accession>1G2N_A</Hit_accession>
  <Hit_len>264</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>67.781</Hsp_bit-score>
      <Hsp_score>164</Hsp_score>
      <Hsp_evalue>5.74463e-13</Hsp_evalue>
      <Hsp_query-from>25</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>31</Hsp_hit-from>
      <Hsp_hit-to>190</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>85</Hsp_positive>
      <Hsp_gaps>18</Hsp_gaps>
      <Hsp_align-len>161</Hsp_align-len>
      <Hsp_qseq>GHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYK-------HVSG---------QMLYFAPDLILNEQRMKESSFYSLC-LTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>GPDSNVPPKFRAPVSSLCQIGNKQIAALVVWARDIPHFSQLEMEDQILLIKGSWNELLLFAIAWRSMEFLTEERDGVDGTGNRTTSPPQLMCLMPGMTLHRNSALQAGVGQIFDRVLSELSLKMRTLRVDQAEYVALKAIILLNP-DVKGLKNRQEVEVLR</Hsp_hseq>
      <Hsp_midline>G D+  P    + ++SL Q+G +Q+ ++V W++ +P F  L ++DQI LI+ SW  L++F + WRS +        V G         Q++   P + L+     ++    +    + ++  +   L+V Q E++ +K ++LLN   ++GL+++ + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>203</Hit_num>
  <Hit_id>pdb|1R1K|A</Hit_id>
  <Hit_def>Crystal structure of the ligand-binding domains of the heterodimer EcR/USP bound to ponasterone A [Heliothis virescens] &gt;pdb|1R20|A Crystal structure of the ligand-binding domains of the heterodimer EcR/USP bound to the synthetic agonist BYI06830 [Heliothis virescens] &gt;pdb|2R40|A Crystal structure of 20E bound EcR/USP [Heliothis virescens] &gt;pdb|3IXP|A Crystal structure of the ecdysone receptor bound to BYI08346 [Heliothis virescens] &gt;pdb|7BJU|A Chain A, Ultraspiracle Protein [Heliothis virescens] &gt;pdb|7BJV|A Chain A, Ultraspiracle protein [Heliothis virescens] &gt;pdb|7BJV|B Chain B, Ultraspiracle protein [Heliothis virescens] &gt;pdb|7BJV|C Chain C, Ultraspiracle protein [Heliothis virescens]</Hit_def>
  <Hit_accession>1R1K_A</Hit_accession>
  <Hit_len>263</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>67.781</Hsp_bit-score>
      <Hsp_score>164</Hsp_score>
      <Hsp_evalue>6.14763e-13</Hsp_evalue>
      <Hsp_query-from>22</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>27</Hsp_hit-from>
      <Hsp_hit-to>189</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>86</Hsp_positive>
      <Hsp_gaps>18</Hsp_gaps>
      <Hsp_align-len>164</Hsp_align-len>
      <Hsp_qseq>IYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH-------VSG---------QMLYFAPDLILNEQRMKESSFYSLC-LTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>LRVGPDSNVPPKFRAPVSSLCQIGNKQIAALVVWARDIPHFSQLEMEDQILLIKGSWNELLLFAIAWRSMEFLTEERDGVDGTGNRTTSPPQLMCLMPGMTLHRNSALQAGVGQIFDRVLSELSLKMRTLRVDQAEYVALKAIILLNP-DVKGLKNRQEVEVLR</Hsp_hseq>
      <Hsp_midline>+  G D+  P    + ++SL Q+G +Q+ ++V W++ +P F  L ++DQI LI+ SW  L++F + WRS +        V G         Q++   P + L+     ++    +    + ++  +   L+V Q E++ +K ++LLN   ++GL+++ + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>204</Hit_num>
  <Hit_id>pdb|1Z5X|U</Hit_id>
  <Hit_def>hemipteran ecdysone receptor ligand-binding domain complexed with ponasterone A [Bemisia tabaci]</Hit_def>
  <Hit_accession>1Z5X_U</Hit_accession>
  <Hit_len>262</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.9954</Hsp_bit-score>
      <Hsp_score>136</Hsp_score>
      <Hsp_evalue>3.28892e-09</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>62</Hsp_hit-from>
      <Hsp_hit-to>194</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>138</Hsp_align-len>
      <Hsp_qseq>SSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKES---SFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>SRDPVSDICQAADRQLYQLIEWAKHIPHFTELPVEDQVILLKSGWNELLIAGFSHRSMSVKDGIML--ATGLVVHRNCAHQAGVGAIFDRVLT--ELVAKMREMKMDKTELGCLRSIVLFNP-EAKGLKSTQQVENLR</Hsp_hseq>
      <Hsp_midline>S   ++ + Q  +RQL  +++W+K +P F  L ++DQ+ L++  W  L++ G   RS     G ML  A  L+++     ++   + +   LT  ++  +  ++++ + E  C++ ++L N    +GL+S  Q E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>205</Hit_num>
  <Hit_id>pdb|5MJ5|A</Hit_id>
  <Hit_def>Crystal structure of the Retinoid X Receptor alpha in complex with synthetichonokiol derivative 3 and a fragment of the TIF2 co-activator. [Homo sapiens] &gt;pdb|5MK4|A Crystal structure of the Retinoid X Receptor alpha in complex with synthetic honokiol derivative 7 and a fragment of the TIF2 co-activator. [Homo sapiens] &gt;pdb|5MK4|C Crystal structure of the Retinoid X Receptor alpha in complex with synthetic honokiol derivative 7 and a fragment of the TIF2 co-activator. [Homo sapiens] &gt;pdb|5MMW|A Crystal structure of the Retinoid X Receptor alpha in complex with synthetic honokiol derivative 6 and a fragment of the TIF2 co-activator. [Homo sapiens]</Hit_def>
  <Hit_accession>5MJ5_A</Hit_accession>
  <Hit_len>229</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.6102</Hsp_bit-score>
      <Hsp_score>135</Hsp_score>
      <Hsp_evalue>4.19664e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>29</Hsp_hit-from>
      <Hsp_hit-to>165</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>206</Hit_num>
  <Hit_id>pdb|1XLS|A</Hit_id>
  <Hit_def>Crystal structure of the mouse CAR/RXR LBD heterodimer bound to TCPOBOP and 9cRA and a TIF2 peptide containg the third LXXLL motifs [Homo sapiens] &gt;pdb|1XLS|B Crystal structure of the mouse CAR/RXR LBD heterodimer bound to TCPOBOP and 9cRA and a TIF2 peptide containg the third LXXLL motifs [Homo sapiens] &gt;pdb|1XLS|C Crystal structure of the mouse CAR/RXR LBD heterodimer bound to TCPOBOP and 9cRA and a TIF2 peptide containg the third LXXLL motifs [Homo sapiens] &gt;pdb|1XLS|D Crystal structure of the mouse CAR/RXR LBD heterodimer bound to TCPOBOP and 9cRA and a TIF2 peptide containg the third LXXLL motifs [Homo sapiens]</Hit_def>
  <Hit_accession>1XLS_A</Hit_accession>
  <Hit_len>232</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.6102</Hsp_bit-score>
      <Hsp_score>135</Hsp_score>
      <Hsp_evalue>4.19899e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>31</Hsp_hit-from>
      <Hsp_hit-to>167</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>207</Hit_num>
  <Hit_id>pdb|1XDK|A</Hit_id>
  <Hit_def>Crystal Structure of the RARbeta/RXRalpha Ligand Binding Domain Heterodimer in Complex with 9-cis Retinoic Acid and a Fragment of the TRAP220 Coactivator [Mus musculus] &gt;pdb|1XDK|E Crystal Structure of the RARbeta/RXRalpha Ligand Binding Domain Heterodimer in Complex with 9-cis Retinoic Acid and a Fragment of the TRAP220 Coactivator [Mus musculus] &gt;pdb|7AOS|A Chain A, Retinoic acid receptor RXR-alpha [Mus musculus]</Hit_def>
  <Hit_accession>1XDK_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.6102</Hsp_bit-score>
      <Hsp_score>135</Hsp_score>
      <Hsp_evalue>4.27506e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>33</Hsp_hit-from>
      <Hsp_hit-to>169</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>208</Hit_num>
  <Hit_id>pdb|3H0A|A</Hit_id>
  <Hit_def>Crystal Structure of Peroxisome Proliferator-Activated Receptor Gamma (PPARg) and Retinoic Acid Receptor Alpha (RXRa) in Complex with 9-cis Retinoic Acid, Co-activator Peptide, and a Partial Agonist [Homo sapiens]</Hit_def>
  <Hit_accession>3H0A_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.6102</Hsp_bit-score>
      <Hsp_score>135</Hsp_score>
      <Hsp_evalue>4.27663e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>30</Hsp_hit-from>
      <Hsp_hit-to>166</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>209</Hit_num>
  <Hit_id>pdb|5MKU|A</Hit_id>
  <Hit_def>Crystal structure of the Retinoid X Receptor alpha in complex with synthetic honokiol derivative 4 and a fragment of the TIF2 co-activator. [Homo sapiens]</Hit_def>
  <Hit_accession>5MKU_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.6102</Hsp_bit-score>
      <Hsp_score>135</Hsp_score>
      <Hsp_evalue>4.27663e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>29</Hsp_hit-from>
      <Hsp_hit-to>165</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>210</Hit_num>
  <Hit_id>pdb|3OAP|A</Hit_id>
  <Hit_def>Crystal structure of human Retinoid X Receptor alpha-ligand binding domain complex with 9-cis retinoic acid and the coactivator peptide GRIP-1 [Homo sapiens] &gt;pdb|4K4J|A Crystal structure of human Retinoid X Receptor alpha-ligand binding domain complex with 9cUAB30 and the coactivator peptide GRIP-1 [Homo sapiens] &gt;pdb|4K6I|A Crystal structure of human retinoid X receptor alpha-ligand binding domain complex with Targretin and the coactivator peptide GRIP-1 [Homo sapiens] &gt;pdb|4M8E|A CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH (S) 4-Methyl 9cUAB30 COACTIVATOR PEPTIDE GRIP-1 [Homo sapiens] &gt;pdb|4M8H|A CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH (R)4-METHYL 9cUAB30 AND COACTIVATOR PEPTIDE GRIP-1 [Homo sapiens] &gt;pdb|4POH|A Crystal structure of human Retinoid X Receptor alpha-ligand binding domain complex with 8-methyl UAB30 and the coactivator peptide GRIP-1 [Homo sapiens] &gt;pdb|4POJ|A Crystal structure of human Retinoid X Receptor alpha-ligand binding domain complex with 7-methyl UAB30 and the coactivator peptide GRIP-1 [Homo sapiens] &gt;pdb|4PP3|A Crystal structure of human Retinoid X Receptor alpha-ligand binding domain complex with 6-methyl UAB30 and the coactivator peptide GRIP-1 [Homo sapiens] &gt;pdb|4PP5|A Crystal structure of human Retinoid X Receptor alpha-ligand binding domain complex with 5-methyl UAB30 and the coactivator peptide GRIP-1 [Homo sapiens] &gt;pdb|4RFW|A Crystal structure of human retinoid X Receptor alpha-ligand binding domain complex with 9cUAB70 and the coactivator peptide GRIP-1 [Homo sapiens] &gt;pdb|4RMC|A Crystal Structure of human retinoid X receptor alpha-ligand binding domain complex with 9cUAB76 and the coactivator peptide GRIP-1 [Homo sapiens] &gt;pdb|5Z12|B A structure of FXR/RXR [Homo sapiens] &gt;pdb|5Z12|C A structure of FXR/RXR [Homo sapiens]</Hit_def>
  <Hit_accession>3OAP_A</Hit_accession>
  <Hit_len>231</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.6102</Hsp_bit-score>
      <Hsp_score>135</Hsp_score>
      <Hsp_evalue>4.28006e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>30</Hsp_hit-from>
      <Hsp_hit-to>166</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>211</Hit_num>
  <Hit_id>pdb|1RDT|A</Hit_id>
  <Hit_def>Crystal Structure of a new rexinoid bound to the RXRalpha ligand binding doamin in the RXRalpha/PPARgamma heterodimer [Homo sapiens] &gt;pdb|3FAL|A humanRXR alpha &amp; mouse LXR alpha complexed with Retenoic acid and GSK2186 [Homo sapiens] &gt;pdb|3FAL|C humanRXR alpha &amp; mouse LXR alpha complexed with Retenoic acid and GSK2186 [Homo sapiens] &gt;pdb|3FC6|A hRXRalpha &amp; mLXRalpha with an indole Pharmacophore, SB786875 [Homo sapiens] &gt;pdb|3FC6|C hRXRalpha &amp; mLXRalpha with an indole Pharmacophore, SB786875 [Homo sapiens]</Hit_def>
  <Hit_accession>1RDT_A</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.6102</Hsp_bit-score>
      <Hsp_score>135</Hsp_score>
      <Hsp_evalue>4.30526e-09</Hsp_evalue>
      <Hsp_query-from>31</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>38</Hsp_hit-from>
      <Hsp_hit-to>173</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>139</Hsp_align-len>
      <Hsp_qseq>PDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>PSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline>P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>212</Hit_num>
  <Hit_id>pdb|4ZO1|B</Hit_id>
  <Hit_def>Crystal Structure of the T3-bound TR-beta Ligand-binding Domain in complex with RXR-alpha [Homo sapiens]</Hit_def>
  <Hit_accession>4ZO1_B</Hit_accession>
  <Hit_len>225</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.225</Hsp_bit-score>
      <Hsp_score>134</Hsp_score>
      <Hsp_evalue>4.31111e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>27</Hsp_hit-from>
      <Hsp_hit-to>163</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>213</Hit_num>
  <Hit_id>pdb|3PCU|A</Hit_id>
  <Hit_def>Crystal structure of human retinoic X receptor alpha ligand-binding domain complexed with LX0278 and SRC1 peptide [Homo sapiens] &gt;pdb|5MKJ|A Crystal structure of the Retinoid X Receptor alpha in complex with synthetic honokiol derivative 9 and a fragment of the TIF2 co-activator. [Homo sapiens]</Hit_def>
  <Hit_accession>3PCU_A</Hit_accession>
  <Hit_len>230</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.6102</Hsp_bit-score>
      <Hsp_score>135</Hsp_score>
      <Hsp_evalue>4.40451e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>29</Hsp_hit-from>
      <Hsp_hit-to>165</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>214</Hit_num>
  <Hit_id>pdb|4RMD|A</Hit_id>
  <Hit_def>Crystal structure of human Retinoid X receptor alpha ligand binding domain complex with 9cUAB110 and coactivator peptide GRIP-1 [Homo sapiens] &gt;pdb|4RME|A Crystal structure of human Retinoid X receptor alpha ligand binding domain complex with 9cUAB111 and coactivator peptide GRIP-1 [Homo sapiens]</Hit_def>
  <Hit_accession>4RMD_A</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.6102</Hsp_bit-score>
      <Hsp_score>135</Hsp_score>
      <Hsp_evalue>4.62077e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>30</Hsp_hit-from>
      <Hsp_hit-to>166</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>215</Hit_num>
  <Hit_id>pdb|3A9E|A</Hit_id>
  <Hit_def>Crystal structure of a mixed agonist-bound RAR-alpha and antagonist-bound RXR-alpha heterodimer ligand binding domains [Mus musculus]</Hit_def>
  <Hit_accession>3A9E_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.6102</Hsp_bit-score>
      <Hsp_score>135</Hsp_score>
      <Hsp_evalue>4.65468e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>35</Hsp_hit-from>
      <Hsp_hit-to>171</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>216</Hit_num>
  <Hit_id>pdb|1MV9|A</Hit_id>
  <Hit_def>Crystal Structure of the human RXR alpha ligand binding domain bound to the eicosanoid DHA (Docosa Hexaenoic Acid) and a coactivator peptide [Homo sapiens] &gt;pdb|1MVC|A Crystal structure of the human RXR alpha ligand binding domain bound to the synthetic agonist compound BMS 649 and a coactivator peptide [Homo sapiens] &gt;pdb|1MZN|A Chain A, RXR retinoid X receptor [Homo sapiens] &gt;pdb|1MZN|C Chain C, RXR retinoid X receptor [Homo sapiens] &gt;pdb|1MZN|E Chain E, RXR retinoid X receptor [Homo sapiens] &gt;pdb|1MZN|G Chain G, RXR retinoid X receptor [Homo sapiens] &gt;pdb|2P1T|A Crystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with 3-(2&apos;-methoxy)-tetrahydronaphtyl cinnamic acid and a fragment of the coactivator TIF-2 [Homo sapiens] &gt;pdb|2P1U|A Crystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with 3-(2&apos;-ethoxy)-tetrahydronaphtyl cinnamic acid and a fragment of the coactivator TIF-2 [Homo sapiens] &gt;pdb|2P1V|A Crystal structure of the ligand binding domain of the retinoid X receptor alpha in complex with 3-(2&apos;-propoxy)-tetrahydronaphtyl cinnamic acid and a fragment of the coactivator TIF-2 [Homo sapiens] &gt;pdb|2ZXZ|A Crystal structure of the human RXR alpha ligand binding domain bound to a synthetic agonist compound and a coactivator peptide [Homo sapiens] &gt;pdb|2ZY0|A Crystal structure of the human RXR alpha ligand binding domain bound to a synthetic agonist compound and a coactivator peptide [Homo sapiens] &gt;pdb|2ZY0|C Crystal structure of the human RXR alpha ligand binding domain bound to a synthetic agonist compound and a coactivator peptide [Homo sapiens] &gt;pdb|3FUG|A Crystal Structure of the Retinoid X Receptor Ligand Binding Domain Bound to the Synthetic Agonist 3-[4-Hydroxy-3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-phenyl]acrylic Acid [Homo sapiens] &gt;pdb|3NSP|A Crystal structure of tetrameric RXRalpha-LBD [Homo sapiens] &gt;pdb|3NSP|B Crystal structure of tetrameric RXRalpha-LBD [Homo sapiens] &gt;pdb|3NSQ|A Crystal structure of tetrameric RXRalpha-LBD complexed with antagonist danthron [Homo sapiens] &gt;pdb|3NSQ|B Crystal structure of tetrameric RXRalpha-LBD complexed with antagonist danthron [Homo sapiens] &gt;pdb|3R29|A Crystal structure of RXRalpha ligand-binding domain complexed with corepressor SMRT2 [Homo sapiens] &gt;pdb|3R29|B Crystal structure of RXRalpha ligand-binding domain complexed with corepressor SMRT2 [Homo sapiens] &gt;pdb|3R2A|A Crystal structure of RXRalpha ligand-binding domain complexed with corepressor SMRT2 and antagonist rhein [Homo sapiens] &gt;pdb|3R2A|B Crystal structure of RXRalpha ligand-binding domain complexed with corepressor SMRT2 and antagonist rhein [Homo sapiens] &gt;pdb|3R2A|C Crystal structure of RXRalpha ligand-binding domain complexed with corepressor SMRT2 and antagonist rhein [Homo sapiens] &gt;pdb|3R2A|D Crystal structure of RXRalpha ligand-binding domain complexed with corepressor SMRT2 and antagonist rhein [Homo sapiens] &gt;pdb|3R5M|A Crystal structure of RXRalphaLBD complexed with the agonist magnolol [Homo sapiens] &gt;pdb|3R5M|C Crystal structure of RXRalphaLBD complexed with the agonist magnolol [Homo sapiens] &gt;pdb|4ZSH|A RXR LBD in complex with 9-cis-13,14-dihydroretinoic acid [Homo sapiens] &gt;pdb|5LYQ|A Crystal structure of the Retinoic Acid Receptor alpha in complex with a synthetic spiroketal agonist and a fragment of the TIF2 co-activator. [Homo sapiens]</Hit_def>
  <Hit_accession>1MV9_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.6102</Hsp_bit-score>
      <Hsp_score>135</Hsp_score>
      <Hsp_evalue>4.74466e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>35</Hsp_hit-from>
      <Hsp_hit-to>171</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>217</Hit_num>
  <Hit_id>pdb|1XV9|A</Hit_id>
  <Hit_def>crystal structure of CAR/RXR heterodimer bound with SRC1 peptide, fatty acid, and 5b-pregnane-3,20-dione. [Homo sapiens] &gt;pdb|1XV9|C crystal structure of CAR/RXR heterodimer bound with SRC1 peptide, fatty acid, and 5b-pregnane-3,20-dione. [Homo sapiens] &gt;pdb|1XVP|A crystal structure of CAR/RXR heterodimer bound with SRC1 peptide, fatty acid and CITCO [Homo sapiens] &gt;pdb|1XVP|C crystal structure of CAR/RXR heterodimer bound with SRC1 peptide, fatty acid and CITCO [Homo sapiens]</Hit_def>
  <Hit_accession>1XV9_A</Hit_accession>
  <Hit_len>236</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.6102</Hsp_bit-score>
      <Hsp_score>135</Hsp_score>
      <Hsp_evalue>4.75427e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>31</Hsp_hit-from>
      <Hsp_hit-to>167</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>218</Hit_num>
  <Hit_id>pdb|1FBY|A</Hit_id>
  <Hit_def>Crystal Structure Of The Human Rxr Alpha Ligand Binding Domain Bound To 9-cis Retinoic Acid [Homo sapiens] &gt;pdb|1FBY|B Crystal Structure Of The Human Rxr Alpha Ligand Binding Domain Bound To 9-cis Retinoic Acid [Homo sapiens]</Hit_def>
  <Hit_accession>1FBY_A</Hit_accession>
  <Hit_len>239</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.6102</Hsp_bit-score>
      <Hsp_score>135</Hsp_score>
      <Hsp_evalue>4.83946e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>34</Hsp_hit-from>
      <Hsp_hit-to>170</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>219</Hit_num>
  <Hit_id>pdb|6SJM|A</Hit_id>
  <Hit_def>Crystal structure of the Retinoic Acid Receptor alpha in complex with compound 24 (JP175) [Homo sapiens] &gt;pdb|7B88|A Chain A, Retinoic acid receptor RXR-alpha [Homo sapiens] &gt;pdb|7B9O|A Chain A, Retinoic acid receptor RXR-alpha [Homo sapiens]</Hit_def>
  <Hit_accession>6SJM_A</Hit_accession>
  <Hit_len>230</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.225</Hsp_bit-score>
      <Hsp_score>134</Hsp_score>
      <Hsp_evalue>4.89567e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>31</Hsp_hit-from>
      <Hsp_hit-to>167</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>220</Hit_num>
  <Hit_id>pdb|3E94|A</Hit_id>
  <Hit_def>Crystal structure of RXRalpha ligand binding domain in complex with tributyltin and a coactivator fragment [Homo sapiens] &gt;pdb|3KWY|A Crystal structure of RXRalpha ligand binding domain in complex with triphenyltin and a coactivator fragment [Homo sapiens] &gt;pdb|4N5G|A Crystal Structure of RXRa LBD complexed with a synthetic modulator K8012 [Homo sapiens] &gt;pdb|4N5G|B Crystal Structure of RXRa LBD complexed with a synthetic modulator K8012 [Homo sapiens] &gt;pdb|4N5G|C Crystal Structure of RXRa LBD complexed with a synthetic modulator K8012 [Homo sapiens] &gt;pdb|4N5G|D Crystal Structure of RXRa LBD complexed with a synthetic modulator K8012 [Homo sapiens] &gt;pdb|4N8R|A Crystal structure of RXRa LBD complexed with a synthetic modulator K-8008 [Homo sapiens] &gt;pdb|4N8R|B Crystal structure of RXRa LBD complexed with a synthetic modulator K-8008 [Homo sapiens] &gt;pdb|4N8R|C Crystal structure of RXRa LBD complexed with a synthetic modulator K-8008 [Homo sapiens] &gt;pdb|4N8R|D Crystal structure of RXRa LBD complexed with a synthetic modulator K-8008 [Homo sapiens] &gt;pdb|5TBP|A Crystal Structure of RXR-alpha ligand binding domain complexed with synthetic modulator K8003 [Homo sapiens] &gt;pdb|5TBP|B Crystal Structure of RXR-alpha ligand binding domain complexed with synthetic modulator K8003 [Homo sapiens] &gt;pdb|5TBP|C Crystal Structure of RXR-alpha ligand binding domain complexed with synthetic modulator K8003 [Homo sapiens] &gt;pdb|5TBP|D Crystal Structure of RXR-alpha ligand binding domain complexed with synthetic modulator K8003 [Homo sapiens] &gt;pdb|6STI|A Crystal structure of RXRalpha LBD in complex with LG 100754 and a coactivator peptide [Homo sapiens] &gt;pdb|7BK4|A Chain A, Retinoic acid receptor RXR-alpha [Homo sapiens] &gt;pdb|7BK4|C Chain C, Retinoic acid receptor RXR-alpha [Homo sapiens]</Hit_def>
  <Hit_accession>3E94_A</Hit_accession>
  <Hit_len>244</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.6102</Hsp_bit-score>
      <Hsp_score>135</Hsp_score>
      <Hsp_evalue>4.96024e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>39</Hsp_hit-from>
      <Hsp_hit-to>175</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>221</Hit_num>
  <Hit_id>pdb|5GYM|A</Hit_id>
  <Hit_def>Chain A, Retinoic acid receptor RXR-alpha [Homo sapiens] &gt;pdb|5GYM|B Chain B, Retinoic acid receptor RXR-alpha [Homo sapiens] &gt;pdb|5GYM|C Chain C, Retinoic acid receptor RXR-alpha [Homo sapiens] &gt;pdb|5GYM|D Chain D, Retinoic acid receptor RXR-alpha [Homo sapiens] &gt;pdb|5GYM|E Chain E, Retinoic acid receptor RXR-alpha [Homo sapiens] &gt;pdb|5GYM|F Chain F, Retinoic acid receptor RXR-alpha [Homo sapiens] &gt;pdb|5GYM|G Chain G, Retinoic acid receptor RXR-alpha [Homo sapiens] &gt;pdb|5GYM|H Chain H, Retinoic acid receptor RXR-alpha [Homo sapiens]</Hit_def>
  <Hit_accession>5GYM_A</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.6102</Hsp_bit-score>
      <Hsp_score>135</Hsp_score>
      <Hsp_evalue>5.05119e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>52</Hsp_hit-from>
      <Hsp_hit-to>188</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>222</Hit_num>
  <Hit_id>pdb|1FM6|A</Hit_id>
  <Hit_def>THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES. [Homo sapiens] &gt;pdb|1FM6|U THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES. [Homo sapiens] &gt;pdb|1FM9|A THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND GI262570 AND CO-ACTIVATOR PEPTIDES. [Homo sapiens] &gt;pdb|1G1U|A The 2.5 Angstrom Resolution Crystal Structure Of The Rxralpha Ligand Binding Domain In Tetramer In The Absence Of Ligand [Homo sapiens] &gt;pdb|1G1U|B The 2.5 Angstrom Resolution Crystal Structure Of The Rxralpha Ligand Binding Domain In Tetramer In The Absence Of Ligand [Homo sapiens] &gt;pdb|1G1U|C The 2.5 Angstrom Resolution Crystal Structure Of The Rxralpha Ligand Binding Domain In Tetramer In The Absence Of Ligand [Homo sapiens] &gt;pdb|1G1U|D The 2.5 Angstrom Resolution Crystal Structure Of The Rxralpha Ligand Binding Domain In Tetramer In The Absence Of Ligand [Homo sapiens] &gt;pdb|1G5Y|A THE 2.0 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE RXRALPHA LIGAND BINDING DOMAIN TETRAMER IN THE PRESENCE OF A NON-ACTIVATING RETINOIC ACID ISOMER. [Homo sapiens] &gt;pdb|1G5Y|B THE 2.0 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE RXRALPHA LIGAND BINDING DOMAIN TETRAMER IN THE PRESENCE OF A NON-ACTIVATING RETINOIC ACID ISOMER. [Homo sapiens] &gt;pdb|1G5Y|C THE 2.0 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE RXRALPHA LIGAND BINDING DOMAIN TETRAMER IN THE PRESENCE OF A NON-ACTIVATING RETINOIC ACID ISOMER. [Homo sapiens] &gt;pdb|1G5Y|D THE 2.0 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE RXRALPHA LIGAND BINDING DOMAIN TETRAMER IN THE PRESENCE OF A NON-ACTIVATING RETINOIC ACID ISOMER. [Homo sapiens] &gt;pdb|1K74|A The 2.3 Angstrom resolution crystal structure of the heterodimer of the human PPARgamma and RXRalpha ligand binding domains respectively bound with GW409544 and 9-cis retinoic acid and co-activator peptides. [Homo sapiens] &gt;pdb|2ACL|A Liver X-Receptor alpha Ligand Binding Domain with SB313987 [Homo sapiens] &gt;pdb|2ACL|C Liver X-Receptor alpha Ligand Binding Domain with SB313987 [Homo sapiens] &gt;pdb|2ACL|E Liver X-Receptor alpha Ligand Binding Domain with SB313987 [Homo sapiens] &gt;pdb|2ACL|G Liver X-Receptor alpha Ligand Binding Domain with SB313987 [Homo sapiens] &gt;pdb|3OZJ|A Crystal structure of human retinoic X receptor alpha complexed with bigelovin and coactivator SRC-1 [Homo sapiens] &gt;pdb|3OZJ|C Crystal structure of human retinoic X receptor alpha complexed with bigelovin and coactivator SRC-1 [Homo sapiens] &gt;pdb|6A5Y|D Crystal structure of human FXR/RXR-LBD heterodimer bound to HNC143 and 9cRA and SRC1 [Homo sapiens] &gt;pdb|6A5Z|D Crystal structure of human FXR/RXR-LBD heterodimer bound to HNC180 and 9cRA and SRC1 [Homo sapiens] &gt;pdb|6A5Z|L Crystal structure of human FXR/RXR-LBD heterodimer bound to HNC180 and 9cRA and SRC1 [Homo sapiens] &gt;pdb|6A60|D Crystal structure of human FXR/RXR-LBD heterodimer bound to GW4064 and 9cRA and SRC1 [Homo sapiens]</Hit_def>
  <Hit_accession>1FM6_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.225</Hsp_bit-score>
      <Hsp_score>134</Hsp_score>
      <Hsp_evalue>5.12858e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>33</Hsp_hit-from>
      <Hsp_hit-to>169</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>223</Hit_num>
  <Hit_id>pdb|7A77|A</Hit_id>
  <Hit_def>Crystal structure of RXR alpha LBD in complexes with palmitic acid and GRIP-1 peptide [Homo sapiens]</Hit_def>
  <Hit_accession>7A77_A</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.225</Hsp_bit-score>
      <Hsp_score>134</Hsp_score>
      <Hsp_evalue>5.16332e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>37</Hsp_hit-from>
      <Hsp_hit-to>173</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>224</Hit_num>
  <Hit_id>pdb|5ZQU|A</Hit_id>
  <Hit_def>Crystal structure of tetrameric RXRalpha-LBD complexed with partial agonist CBt-PMN [Homo sapiens] &gt;pdb|5ZQU|B Crystal structure of tetrameric RXRalpha-LBD complexed with partial agonist CBt-PMN [Homo sapiens] &gt;pdb|5ZQU|C Crystal structure of tetrameric RXRalpha-LBD complexed with partial agonist CBt-PMN [Homo sapiens] &gt;pdb|5ZQU|D Crystal structure of tetrameric RXRalpha-LBD complexed with partial agonist CBt-PMN [Homo sapiens] &gt;pdb|6JNO|A RXRa structure complexed with CU-6PMN [Homo sapiens] &gt;pdb|6JNO|B RXRa structure complexed with CU-6PMN [Homo sapiens] &gt;pdb|6JNO|C RXRa structure complexed with CU-6PMN [Homo sapiens] &gt;pdb|6JNO|D RXRa structure complexed with CU-6PMN [Homo sapiens] &gt;pdb|6JNR|A RXRa structure complexed with CU-6PMN and SRC1 peptide. [Homo sapiens] &gt;pdb|6JNR|B RXRa structure complexed with CU-6PMN and SRC1 peptide. [Homo sapiens] &gt;pdb|6L6K|A Crystal structure of dimeric RXRalpha-LBD complexed with partial agonist CBt-PMN and SRC1 [Homo sapiens] &gt;pdb|6LB4|A Crystal structure of dimeric RXR-LBD complexed with NEt-3ME and TIF2 co-activator [Homo sapiens] &gt;pdb|6LB5|A Crystal structure of dimeric RXR-LBD complexed with full agonist NEt-3IB and TIF2 co-activator [Homo sapiens] &gt;pdb|6LB5|C Crystal structure of dimeric RXR-LBD complexed with full agonist NEt-3IB and TIF2 co-activator [Homo sapiens] &gt;pdb|6LB6|A Crystal structure of dimeric RXR-LBD complexed with partial agonist NEt-4IB and TIF2 co-activator [Homo sapiens] &gt;pdb|7CFO|A Chain A, Retinoic acid receptor RXR-alpha [Homo sapiens] &gt;pdb|7CFO|B Chain B, Retinoic acid receptor RXR-alpha [Homo sapiens] &gt;pdb|7CFO|C Chain C, Retinoic acid receptor RXR-alpha [Homo sapiens] &gt;pdb|7CFO|D Chain D, Retinoic acid receptor RXR-alpha [Homo sapiens]</Hit_def>
  <Hit_accession>5ZQU_A</Hit_accession>
  <Hit_len>243</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.225</Hsp_bit-score>
      <Hsp_score>134</Hsp_score>
      <Hsp_evalue>5.20816e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>38</Hsp_hit-from>
      <Hsp_hit-to>174</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>225</Hit_num>
  <Hit_id>pdb|3UVV|B</Hit_id>
  <Hit_def>Crystal Structure of the ligand binding domains of the thyroid receptor:retinoid X receptor complexed with 3,3&apos;,5 triiodo-L-thyronine and 9-cis retinoic acid [Homo sapiens]</Hit_def>
  <Hit_accession>3UVV_B</Hit_accession>
  <Hit_len>244</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.225</Hsp_bit-score>
      <Hsp_score>134</Hsp_score>
      <Hsp_evalue>5.25292e-09</Hsp_evalue>
      <Hsp_query-from>31</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>38</Hsp_hit-from>
      <Hsp_hit-to>173</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>139</Hsp_align-len>
      <Hsp_qseq>PDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>PSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline>P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>226</Hit_num>
  <Hit_id>pdb|5JI0|A</Hit_id>
  <Hit_def>PPARgamma-RXRalpha(S427F) heterodimer in complex with SRC-1, rosiglitazone, and 9-cis-retanoic acid [Homo sapiens]</Hit_def>
  <Hit_accession>5JI0_A</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.225</Hsp_bit-score>
      <Hsp_score>134</Hsp_score>
      <Hsp_evalue>5.36462e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>37</Hsp_hit-from>
      <Hsp_hit-to>173</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>227</Hit_num>
  <Hit_id>pdb|1ZH7|A</Hit_id>
  <Hit_def>Structural and Biochemical Basis for Selective Repression of the Orphan Nuclear Receptor LRH-1 by SHP [Mus musculus] &gt;pdb|1ZH7|B Structural and Biochemical Basis for Selective Repression of the Orphan Nuclear Receptor LRH-1 by SHP [Mus musculus]</Hit_def>
  <Hit_accession>1ZH7_A</Hit_accession>
  <Hit_len>243</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.225</Hsp_bit-score>
      <Hsp_score>134</Hsp_score>
      <Hsp_evalue>5.46308e-09</Hsp_evalue>
      <Hsp_query-from>7</Hsp_query-from>
      <Hsp_query-to>152</Hsp_query-to>
      <Hsp_hit-from>3</Hsp_hit-from>
      <Hsp_hit-to>161</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>23</Hsp_gaps>
      <Hsp_align-len>164</Hsp_align-len>
      <Hsp_qseq>IPPLINLLMSIEPD----------VIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH--------VSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNT</Hsp_qseq>
      <Hsp_hseq>IPHLILELLKCEPDEPQVQAKIMAYLQQEQSNRNRQEKLSAFGLLCKMADQTLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVAHGKEGTIFLVTGEHVDYSTII-----SHTEVAFNNLLSLAQELVVRLRSLQFDQREFVCLKFLVLFSS</Hsp_hseq>
      <Hsp_midline>IP LI  L+  EPD           +     N       S    L ++ ++ L S+V+W++S   FR L +DDQ+ L+Q  W  L++    +R   H        V+G+ + ++  +        E +F +L     ++      LQ  Q EF+C+K L+L ++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>228</Hit_num>
  <Hit_id>pdb|4OC7|A</Hit_id>
  <Hit_def>Retinoic acid receptor alpha in complex with (E)-3-(3&apos;-allyl-6-hydroxy-[1,1&apos;-biphenyl]-3-yl)acrylic acid and a fragment of the coactivator TIF2 [Homo sapiens]</Hit_def>
  <Hit_accession>4OC7_A</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.225</Hsp_bit-score>
      <Hsp_score>134</Hsp_score>
      <Hsp_evalue>5.58774e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>49</Hsp_hit-from>
      <Hsp_hit-to>185</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>229</Hit_num>
  <Hit_id>pdb|4IS8|A</Hit_id>
  <Hit_def>Divergent sequence tunes ligand sensitivity in phospholipid-regulated hormone receptors [Homo sapiens] &gt;pdb|4IS8|B Divergent sequence tunes ligand sensitivity in phospholipid-regulated hormone receptors [Homo sapiens]</Hit_def>
  <Hit_accession>4IS8_A</Hit_accession>
  <Hit_len>239</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.225</Hsp_bit-score>
      <Hsp_score>134</Hsp_score>
      <Hsp_evalue>5.80475e-09</Hsp_evalue>
      <Hsp_query-from>7</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>2</Hsp_hit-from>
      <Hsp_hit-to>159</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>44</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>23</Hsp_gaps>
      <Hsp_align-len>163</Hsp_align-len>
      <Hsp_qseq>IPPLINLLMSIEPD--------VIYAGHDNTKPDTSSSLLTS--LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH--------VSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>IPHLILELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMCKMADQTLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVVHGKEGSIFLVTGQQVDYS--IIASH---TEVAFNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFS</Hsp_hseq>
      <Hsp_midline>IP LI  L+  EPD        + Y   +         L T   + ++ ++ L S+V+W++S   FR L +DDQ+ L+Q  W  L++    +R   H        V+GQ + ++  +I +     E +F +L     ++  +   LQ  Q EF+C+K L+L +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>230</Hit_num>
  <Hit_id>pdb|4J5W|C</Hit_id>
  <Hit_def>Crystal Structure of the apo-PXR/RXRalpha LBD Heterotetramer Complex [Homo sapiens] &gt;pdb|4J5W|D Crystal Structure of the apo-PXR/RXRalpha LBD Heterotetramer Complex [Homo sapiens] &gt;pdb|4J5X|C Crystal Structure of the SR12813-bound PXR/RXRalpha LBD Heterotetramer Complex [Homo sapiens] &gt;pdb|4J5X|D Crystal Structure of the SR12813-bound PXR/RXRalpha LBD Heterotetramer Complex [Homo sapiens]</Hit_def>
  <Hit_accession>4J5W_C</Hit_accession>
  <Hit_len>264</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.225</Hsp_bit-score>
      <Hsp_score>134</Hsp_score>
      <Hsp_evalue>6.12387e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>31</Hsp_hit-from>
      <Hsp_hit-to>167</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>231</Hit_num>
  <Hit_id>pdb|1DKF|A</Hit_id>
  <Hit_def>CRYSTAL STRUCTURE OF A HETERODIMERIC COMPLEX OF RAR AND RXR LIGAND-BINDING DOMAINS [Mus musculus]</Hit_def>
  <Hit_accession>1DKF_A</Hit_accession>
  <Hit_len>233</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.225</Hsp_bit-score>
      <Hsp_score>134</Hsp_score>
      <Hsp_evalue>6.16391e-09</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>33</Hsp_hit-from>
      <Hsp_hit-to>169</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASASHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>232</Hit_num>
  <Hit_id>pdb|3EYB|A</Hit_id>
  <Hit_def>Structural and functional insights into the ligand binding domain of a non-duplicated RXR from the invertebrate chordate amphioxus [Branchiostoma floridae] &gt;pdb|3EYB|B Structural and functional insights into the ligand binding domain of a non-duplicated RXR from the invertebrate chordate amphioxus [Branchiostoma floridae] &gt;pdb|3EYB|C Structural and functional insights into the ligand binding domain of a non-duplicated RXR from the invertebrate chordate amphioxus [Branchiostoma floridae] &gt;pdb|3EYB|D Structural and functional insights into the ligand binding domain of a non-duplicated RXR from the invertebrate chordate amphioxus [Branchiostoma floridae]</Hit_def>
  <Hit_accession>3EYB_A</Hit_accession>
  <Hit_len>219</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>55.8398</Hsp_bit-score>
      <Hsp_score>133</Hsp_score>
      <Hsp_evalue>7.35789e-09</Hsp_evalue>
      <Hsp_query-from>15</Hsp_query-from>
      <Hsp_query-to>194</Hsp_query-to>
      <Hsp_hit-from>12</Hsp_hit-from>
      <Hsp_hit-to>202</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>45</Hsp_identity>
      <Hsp_positive>93</Hsp_positive>
      <Hsp_gaps>31</Hsp_gaps>
      <Hsp_align-len>201</Hsp_align-len>
      <Hsp_qseq>MSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKES---SFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLN------TIP--LEGLRSQT----------QFEEMRSSYIRELIKAIGLRQKGVVSSSQRFY</Hsp_qseq>
      <Hsp_hseq>MAVEP------KDGNMVEQPNDPVTNICQAADKQLVTLVEWAKRIPHFSDLPIDDQVILLRAGWNELLIAAFSHRSIDVKDGILL--ASGLHVHRSSAHQAGVGTIFDRVLT--ELVAKMRDMKMDKTELGCLRAIVLFNPDAKGLTDPSLVESLREKVYASLEEYCKQQYPEQPGRFAKLLLRLPALRSIGLKCLEHLFF</Hsp_hseq>
      <Hsp_midline>M++EP       D    +  +  +T++ Q  ++QL+++V+W+K +P F +L IDDQ+ L++  W  L++     RS     G +L  A  L ++     ++   + +   LT  ++  +   +++ + E  C++ ++L N      T P  +E LR +           Q+ E    + + L++   LR  G+      F+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>233</Hit_num>
  <Hit_id>pdb|1PK5|A</Hit_id>
  <Hit_def>Crystal structure of the orphan nuclear receptor LRH-1 [Mus musculus] &gt;pdb|1PK5|B Crystal structure of the orphan nuclear receptor LRH-1 [Mus musculus] &gt;pdb|3F5C|A Structure of Dax-1:LRH-1 complex [Mus musculus]</Hit_def>
  <Hit_accession>1PK5_A</Hit_accession>
  <Hit_len>248</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>55.8398</Hsp_bit-score>
      <Hsp_score>133</Hsp_score>
      <Hsp_evalue>7.65448e-09</Hsp_evalue>
      <Hsp_query-from>7</Hsp_query-from>
      <Hsp_query-to>152</Hsp_query-to>
      <Hsp_hit-from>8</Hsp_hit-from>
      <Hsp_hit-to>166</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>42</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>23</Hsp_gaps>
      <Hsp_align-len>164</Hsp_align-len>
      <Hsp_qseq>IPPLINLLMSIEPD----------VIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH--------VSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNT</Hsp_qseq>
      <Hsp_hseq>IPHLILELLKCEPDEPQVQAKIMAYLQQEQSNRNRQEKLSAFGLLCKMADQTLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVAHGKEGTIFLVTGEHVDYSTII-----SHTEVAFNNLLSLAQELVVRLRSLQFDQREFVCLKFLVLFSS</Hsp_hseq>
      <Hsp_midline>IP LI  L+  EPD           +     N       S    L ++ ++ L S+V+W++S   FR L +DDQ+ L+Q  W  L++    +R   H        V+G+ + ++  +        E +F +L     ++      LQ  Q EF+C+K L+L ++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>234</Hit_num>
  <Hit_id>pdb|7A79|A</Hit_id>
  <Hit_def>Crystal structure of RXR gamma LBD in complexes with palmitic acid and GRIP-1 peptide [Homo sapiens] &gt;pdb|7A79|B Crystal structure of RXR gamma LBD in complexes with palmitic acid and GRIP-1 peptide [Homo sapiens]</Hit_def>
  <Hit_accession>7A79_A</Hit_accession>
  <Hit_len>233</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>55.8398</Hsp_bit-score>
      <Hsp_score>133</Hsp_score>
      <Hsp_evalue>8.45677e-09</Hsp_evalue>
      <Hsp_query-from>15</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>14</Hsp_hit-from>
      <Hsp_hit-to>164</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>80</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>157</Hsp_align-len>
      <Hsp_qseq>MSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKES---SFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>LAVEPKTESYGDMNMENSTNDPV-TNICHAADKQLFTLVEWAKRIPHFSDLTLEDQVILLRAGWNELLIASFSHRSVSVQDGILL--ATGLHVHRSSAHSAGVGSIFDRVLT--ELVSKMKDMQMDKSELGCLRAIVLFNP-DAKGLSNPSEVETLR</Hsp_hseq>
      <Hsp_midline>+++EP     G  N +  T+  + T++    ++QL ++V+W+K +P F +L ++DQ+ L++  W  L++     RS     G +L  A  L ++      +   S +   LT  ++  +   +Q+ + E  C++ ++L N    +GL + ++ E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>235</Hit_num>
  <Hit_id>pdb|6HN6|A</Hit_id>
  <Hit_def>A revisited version of the apo structure of the ligand-binding domain of the human nuclear receptor RXR-ALPHA [Homo sapiens]</Hit_def>
  <Hit_accession>6HN6_A</Hit_accession>
  <Hit_len>282</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>56.225</Hsp_bit-score>
      <Hsp_score>134</Hsp_score>
      <Hsp_evalue>8.83093e-09</Hsp_evalue>
      <Hsp_query-from>31</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>78</Hsp_hit-from>
      <Hsp_hit-to>213</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>139</Hsp_align-len>
      <Hsp_qseq>PDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>PSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline>P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>236</Hit_num>
  <Hit_id>pdb|2GL8|A</Hit_id>
  <Hit_def>Human Retinoic acid receptor RXR-gamma ligand-binding domain [Homo sapiens] &gt;pdb|2GL8|B Human Retinoic acid receptor RXR-gamma ligand-binding domain [Homo sapiens] &gt;pdb|2GL8|C Human Retinoic acid receptor RXR-gamma ligand-binding domain [Homo sapiens] &gt;pdb|2GL8|D Human Retinoic acid receptor RXR-gamma ligand-binding domain [Homo sapiens]</Hit_def>
  <Hit_accession>2GL8_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>55.4546</Hsp_bit-score>
      <Hsp_score>132</Hsp_score>
      <Hsp_evalue>9.70836e-09</Hsp_evalue>
      <Hsp_query-from>15</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>22</Hsp_hit-from>
      <Hsp_hit-to>172</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>82</Hsp_positive>
      <Hsp_gaps>9</Hsp_gaps>
      <Hsp_align-len>157</Hsp_align-len>
      <Hsp_qseq>MSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKES---SFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>LAVEPKTESYGDMNME-NSTNDPVTNICHAADKQLFTLVEWAKRIPHFSDLTLEDQVILLRAGWNELLIASFSHRSVSVQDGILL--ATGLHVHRSSAHSAGVGSIFDRVLT--ELVSKMKDMQMDKSELGCLRAIVLFNP-DAKGLSNPSEVETLR</Hsp_hseq>
      <Hsp_midline>+++EP     G  N + ++++  +T++    ++QL ++V+W+K +P F +L ++DQ+ L++  W  L++     RS     G +L  A  L ++      +   S +   LT  ++  +   +Q+ + E  C++ ++L N    +GL + ++ E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>237</Hit_num>
  <Hit_id>pdb|1XIU|A</Hit_id>
  <Hit_def>Crystal structure of the agonist-bound ligand-binding domain of Biomphalaria glabrata RXR [Biomphalaria glabrata] &gt;pdb|1XIU|B Crystal structure of the agonist-bound ligand-binding domain of Biomphalaria glabrata RXR [Biomphalaria glabrata]</Hit_def>
  <Hit_accession>1XIU_A</Hit_accession>
  <Hit_len>230</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>55.0694</Hsp_bit-score>
      <Hsp_score>131</Hsp_score>
      <Hsp_evalue>1.2062e-08</Hsp_evalue>
      <Hsp_query-from>15</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>16</Hsp_hit-from>
      <Hsp_hit-to>161</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>157</Hsp_align-len>
      <Hsp_qseq>MSIEPDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKES---SFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>LAVDPKI------DTYIDAQKDPVTNICQAADKQLFTLVEWAKRIPHFTELPLEDQVILLRAGWNELLIAGFSHRSIMAKDGILL--ATGLHVHRSSAHQAGVGTIFDRVLT--ELVAKMRDMKMDKTELGCLRAVVLFNP-DAKGLTAVQEVEQLR</Hsp_hseq>
      <Hsp_midline>++++P +      +T  D     +T++ Q  ++QL ++V+W+K +P F  L ++DQ+ L++  W  L++ G   RS     G +L  A  L ++     ++   + +   LT  ++  +   +++ + E  C++ ++L N    +GL +  + E++R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>238</Hit_num>
  <Hit_id>pdb|4NQA|A</Hit_id>
  <Hit_def>Crystal structure of liganded hRXR-alpha/hLXR-beta heterodimer on DNA [Homo sapiens] &gt;pdb|4NQA|H Crystal structure of liganded hRXR-alpha/hLXR-beta heterodimer on DNA [Homo sapiens] &gt;pdb|5UAN|A Crystal structure of multi-domain RAR-beta-RXR-alpha heterodimer on DNA [Homo sapiens]</Hit_def>
  <Hit_accession>4NQA_A</Hit_accession>
  <Hit_len>365</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>55.8398</Hsp_bit-score>
      <Hsp_score>133</Hsp_score>
      <Hsp_evalue>1.60931e-08</Hsp_evalue>
      <Hsp_query-from>31</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>161</Hsp_hit-from>
      <Hsp_hit-to>296</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>139</Hsp_align-len>
      <Hsp_qseq>PDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>PSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline>P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>239</Hit_num>
  <Hit_id>pdb|3DZU|A</Hit_id>
  <Hit_def>Intact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with BVT.13, 9-cis Retinoic Acid and NCOA2 Peptide [Homo sapiens] &gt;pdb|3DZY|A Intact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with Rosiglitazone, 9-cis Retinoic Acid and NCOA2 Peptide [Homo sapiens] &gt;pdb|3E00|A Intact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with GW9662, 9-cis Retinoic Acid and NCOA2 Peptide [Homo sapiens]</Hit_def>
  <Hit_accession>3DZU_A</Hit_accession>
  <Hit_len>467</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>55.4546</Hsp_bit-score>
      <Hsp_score>132</Hsp_score>
      <Hsp_evalue>2.27228e-08</Hsp_evalue>
      <Hsp_query-from>30</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>262</Hsp_hit-from>
      <Hsp_hit-to>398</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>KPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>NPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPD-SKGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline> P + +  +T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>240</Hit_num>
  <Hit_id>pdb|5EC9|A</Hit_id>
  <Hit_def>Retinoic acid receptor alpha in complex with chiral dihydrobenzofuran benzoic acid 9a and a fragment of the coactivator TIF2 [Homo sapiens]</Hit_def>
  <Hit_accession>5EC9_A</Hit_accession>
  <Hit_len>210</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>54.299</Hsp_bit-score>
      <Hsp_score>129</Hsp_score>
      <Hsp_evalue>2.31299e-08</Hsp_evalue>
      <Hsp_query-from>38</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>19</Hsp_hit-from>
      <Hsp_hit-to>147</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>LTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>VTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMQMDKTELGCLRAIVLFNPDS-KGLSNPAEVEALR</Hsp_hseq>
      <Hsp_midline>+T++ Q  ++QL ++V+W+K +P F  L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +Q+ + E  C++ ++L N    +GL +  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>241</Hit_num>
  <Hit_id>pdb|4PLD|A</Hit_id>
  <Hit_def>Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, in its apo State Bound to a Fragment of Human TIF-2 [Homo sapiens] &gt;pdb|4PLE|A Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, Bound to an E. Coli Phospholipid and a Fragment of TIF-2 [Homo sapiens] &gt;pdb|4PLE|C Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, Bound to an E. Coli Phospholipid and a Fragment of TIF-2 [Homo sapiens] &gt;pdb|4PLE|E Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, Bound to an E. Coli Phospholipid and a Fragment of TIF-2 [Homo sapiens] &gt;pdb|4PLE|G Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, Bound to an E. Coli Phospholipid and a Fragment of TIF-2 [Homo sapiens]</Hit_def>
  <Hit_accession>4PLD_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.9138</Hsp_bit-score>
      <Hsp_score>128</Hsp_score>
      <Hsp_evalue>3.94331e-08</Hsp_evalue>
      <Hsp_query-from>7</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>5</Hsp_hit-from>
      <Hsp_hit-to>162</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>23</Hsp_gaps>
      <Hsp_align-len>163</Hsp_align-len>
      <Hsp_qseq>IPPLINLLMSIEPD--------VIYAGHDNTKPDTSSSLLTS--LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH--------VSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>IPHLILELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMCKMADQTLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVVHGKEGSIFLVTGQQVDYS---IIASQ--AGATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFS</Hsp_hseq>
      <Hsp_midline>IP LI  L+  EPD        + Y   +         L T   + ++ ++ L S+V+W++S   FR L +DDQ+ L+Q  W  L++    +R   H        V+GQ + ++   I+  Q    ++  +L     ++  +   LQ  Q EF+C+K L+L +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>242</Hit_num>
  <Hit_id>pdb|5L11|A</Hit_id>
  <Hit_def>Human Liver Receptor Homologue-1 (LRH-1) Bound to RJW100 and a Fragment of TIF-2 [Homo sapiens] &gt;pdb|5UNJ|A Structure of Human Liver Receptor Homolog 1 in complex with PGC1a and RJW100 [Homo sapiens] &gt;pdb|6OQX|A Human Liver Receptor Homolog-1 bound to the agonist 5N and a fragment of the Tif2 coregulator [Homo sapiens] &gt;pdb|6OQY|A Human LRH-1 bound to the agonist 6N and a fragment of the Tif2 coregulator [Homo sapiens] &gt;pdb|6OR1|A Human LRH-1 bound to the agonist 2N and a fragment of the Tif2 coregulator [Homo sapiens] &gt;pdb|6VC2|A LRH-1 bound to SS-RJW100 and a fragment of the Tif2 Coactivator [Homo sapiens] &gt;pdb|6VIF|A Human LRH-1 ligand-binding domain bound to agonist cpd 15 and fragment of coregulator TIF-2 [Homo sapiens]</Hit_def>
  <Hit_accession>5L11_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.9138</Hsp_bit-score>
      <Hsp_score>128</Hsp_score>
      <Hsp_evalue>4.09566e-08</Hsp_evalue>
      <Hsp_query-from>7</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>5</Hsp_hit-from>
      <Hsp_hit-to>162</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>23</Hsp_gaps>
      <Hsp_align-len>163</Hsp_align-len>
      <Hsp_qseq>IPPLINLLMSIEPD--------VIYAGHDNTKPDTSSSLLTS--LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH--------VSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>IPHLILELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMCKMADQTLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVVHGKEGSIFLVTGQQVDYS---IIASQ--AGATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFS</Hsp_hseq>
      <Hsp_midline>IP LI  L+  EPD        + Y   +         L T   + ++ ++ L S+V+W++S   FR L +DDQ+ L+Q  W  L++    +R   H        V+GQ + ++   I+  Q    ++  +L     ++  +   LQ  Q EF+C+K L+L +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>243</Hit_num>
  <Hit_id>pdb|1YOK|A</Hit_id>
  <Hit_def>crystal structure of human LRH-1 bound with TIF-2 peptide and phosphatidylglycerol [Homo sapiens]</Hit_def>
  <Hit_accession>1YOK_A</Hit_accession>
  <Hit_len>256</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.9138</Hsp_bit-score>
      <Hsp_score>128</Hsp_score>
      <Hsp_evalue>4.3475e-08</Hsp_evalue>
      <Hsp_query-from>7</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>16</Hsp_hit-from>
      <Hsp_hit-to>173</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>23</Hsp_gaps>
      <Hsp_align-len>163</Hsp_align-len>
      <Hsp_qseq>IPPLINLLMSIEPD--------VIYAGHDNTKPDTSSSLLTS--LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH--------VSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>IPHLILELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMCKMADQTLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVVHGKEGSIFLVTGQQVDYS---IIASQ--AGATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFS</Hsp_hseq>
      <Hsp_midline>IP LI  L+  EPD        + Y   +         L T   + ++ ++ L S+V+W++S   FR L +DDQ+ L+Q  W  L++    +R   H        V+GQ + ++   I+  Q    ++  +L     ++  +   LQ  Q EF+C+K L+L +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>244</Hit_num>
  <Hit_id>pdb|4DOS|A</Hit_id>
  <Hit_def>Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, Bound to DLPC and a Fragment of TIF-2 [Homo sapiens]</Hit_def>
  <Hit_accession>4DOS_A</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.5286</Hsp_bit-score>
      <Hsp_score>127</Hsp_score>
      <Hsp_evalue>4.40019e-08</Hsp_evalue>
      <Hsp_query-from>7</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>5</Hsp_hit-from>
      <Hsp_hit-to>162</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>23</Hsp_gaps>
      <Hsp_align-len>163</Hsp_align-len>
      <Hsp_qseq>IPPLINLLMSIEPD--------VIYAGHDNTKPDTSSSLLTS--LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH--------VSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>IPHLILELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMCKMADQTLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVVHGKEGSIFLVTGQQVDYS---IIASQ--AGATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFS</Hsp_hseq>
      <Hsp_midline>IP LI  L+  EPD        + Y   +         L T   + ++ ++ L S+V+W++S   FR L +DDQ+ L+Q  W  L++    +R   H        V+GQ + ++   I+  Q    ++  +L     ++  +   LQ  Q EF+C+K L+L +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>245</Hit_num>
  <Hit_id>pdb|1ZDU|A</Hit_id>
  <Hit_def>The Crystal Structure of Human Liver Receptor Homologue-1 [Homo sapiens]</Hit_def>
  <Hit_accession>1ZDU_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.5286</Hsp_bit-score>
      <Hsp_score>127</Hsp_score>
      <Hsp_evalue>4.63245e-08</Hsp_evalue>
      <Hsp_query-from>7</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>5</Hsp_hit-from>
      <Hsp_hit-to>162</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>23</Hsp_gaps>
      <Hsp_align-len>163</Hsp_align-len>
      <Hsp_qseq>IPPLINLLMSIEPD--------VIYAGHDNTKPDTSSSLLTS--LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH--------VSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>IPHLILELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMCKMADQTLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVVHGKEGSIFLVTGQQVDYS---IIASQ--AGATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFS</Hsp_hseq>
      <Hsp_midline>IP LI  L+  EPD        + Y   +         L T   + ++ ++ L S+V+W++S   FR L +DDQ+ L+Q  W  L++    +R   H        V+GQ + ++   I+  Q    ++  +L     ++  +   LQ  Q EF+C+K L+L +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>246</Hit_num>
  <Hit_id>pdb|5SYZ|A</Hit_id>
  <Hit_def>Human Liver Receptor Homologue-1 (LRH-1) Bound to a RJW100 stereoisomer and a Fragment of TIF-2 [Homo sapiens]</Hit_def>
  <Hit_accession>5SYZ_A</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.5286</Hsp_bit-score>
      <Hsp_score>127</Hsp_score>
      <Hsp_evalue>4.70219e-08</Hsp_evalue>
      <Hsp_query-from>7</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>5</Hsp_hit-from>
      <Hsp_hit-to>162</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>23</Hsp_gaps>
      <Hsp_align-len>163</Hsp_align-len>
      <Hsp_qseq>IPPLINLLMSIEPD--------VIYAGHDNTKPDTSSSLLTS--LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH--------VSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>IPHLILELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMCKMADQTLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVVHGKEGSIFLVTGQQVDYS---IIASQ--AGATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFS</Hsp_hseq>
      <Hsp_midline>IP LI  L+  EPD        + Y   +         L T   + ++ ++ L S+V+W++S   FR L +DDQ+ L+Q  W  L++    +R   H        V+GQ + ++   I+  Q    ++  +L     ++  +   LQ  Q EF+C+K L+L +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>247</Hit_num>
  <Hit_id>pdb|3PLZ|A</Hit_id>
  <Hit_def>Human LRH1 LBD bound to GR470 [Homo sapiens] &gt;pdb|3PLZ|B Human LRH1 LBD bound to GR470 [Homo sapiens]</Hit_def>
  <Hit_accession>3PLZ_A</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.5286</Hsp_bit-score>
      <Hsp_score>127</Hsp_score>
      <Hsp_evalue>4.90103e-08</Hsp_evalue>
      <Hsp_query-from>7</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>17</Hsp_hit-from>
      <Hsp_hit-to>174</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>23</Hsp_gaps>
      <Hsp_align-len>163</Hsp_align-len>
      <Hsp_qseq>IPPLINLLMSIEPD--------VIYAGHDNTKPDTSSSLLTS--LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH--------VSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>IPHLILELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMCKMADQTLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVVHGKEGSIFLVTGQQVDYS---IIASQ--AGATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFS</Hsp_hseq>
      <Hsp_midline>IP LI  L+  EPD        + Y   +         L T   + ++ ++ L S+V+W++S   FR L +DDQ+ L+Q  W  L++    +R   H        V+GQ + ++   I+  Q    ++  +L     ++  +   LQ  Q EF+C+K L+L +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>248</Hit_num>
  <Hit_id>pdb|4ONI|A</Hit_id>
  <Hit_def>Structure of Human Orphan Receptor LRH1 bound to two bacterial phospholipids [Homo sapiens] &gt;pdb|4ONI|B Structure of Human Orphan Receptor LRH1 bound to two bacterial phospholipids [Homo sapiens]</Hit_def>
  <Hit_accession>4ONI_A</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.5286</Hsp_bit-score>
      <Hsp_score>127</Hsp_score>
      <Hsp_evalue>5.24281e-08</Hsp_evalue>
      <Hsp_query-from>7</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>13</Hsp_hit-from>
      <Hsp_hit-to>170</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>23</Hsp_gaps>
      <Hsp_align-len>163</Hsp_align-len>
      <Hsp_qseq>IPPLINLLMSIEPD--------VIYAGHDNTKPDTSSSLLTS--LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH--------VSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>IPHLILELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMCKMADQTLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVVHGKEGSIFLVTGQQVDYS---IIASQ--AGATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFS</Hsp_hseq>
      <Hsp_midline>IP LI  L+  EPD        + Y   +         L T   + ++ ++ L S+V+W++S   FR L +DDQ+ L+Q  W  L++    +R   H        V+GQ + ++   I+  Q    ++  +L     ++  +   LQ  Q EF+C+K L+L +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>249</Hit_num>
  <Hit_id>pdb|1YUC|A</Hit_id>
  <Hit_def>Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, Bound to Phospholipid and a Fragment of Human SHP [Homo sapiens] &gt;pdb|1YUC|B Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, Bound to Phospholipid and a Fragment of Human SHP [Homo sapiens] &gt;pdb|4DOR|A Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, in its apo State Bound to a Fragment of Human SHP Box1 [Homo sapiens] &gt;pdb|4DOR|B Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, in its apo State Bound to a Fragment of Human SHP Box1 [Homo sapiens]</Hit_def>
  <Hit_accession>1YUC_A</Hit_accession>
  <Hit_len>255</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.5286</Hsp_bit-score>
      <Hsp_score>127</Hsp_score>
      <Hsp_evalue>5.2646e-08</Hsp_evalue>
      <Hsp_query-from>7</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>15</Hsp_hit-from>
      <Hsp_hit-to>172</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>23</Hsp_gaps>
      <Hsp_align-len>163</Hsp_align-len>
      <Hsp_qseq>IPPLINLLMSIEPD--------VIYAGHDNTKPDTSSSLLTS--LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH--------VSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>IPHLILELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMCKMADQTLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVVHGKEGSIFLVTGQQVDYS---IIASQ--AGATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFS</Hsp_hseq>
      <Hsp_midline>IP LI  L+  EPD        + Y   +         L T   + ++ ++ L S+V+W++S   FR L +DDQ+ L+Q  W  L++    +R   H        V+GQ + ++   I+  Q    ++  +L     ++  +   LQ  Q EF+C+K L+L +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>250</Hit_num>
  <Hit_id>pdb|1H9U|A</Hit_id>
  <Hit_def>The structure of the human retinoid-X-receptor beta ligand binding domain in complex with the specific synthetic agonist LG100268 [Homo sapiens] &gt;pdb|1H9U|B The structure of the human retinoid-X-receptor beta ligand binding domain in complex with the specific synthetic agonist LG100268 [Homo sapiens] &gt;pdb|1H9U|C The structure of the human retinoid-X-receptor beta ligand binding domain in complex with the specific synthetic agonist LG100268 [Homo sapiens] &gt;pdb|1H9U|D The structure of the human retinoid-X-receptor beta ligand binding domain in complex with the specific synthetic agonist LG100268 [Homo sapiens]</Hit_def>
  <Hit_accession>1H9U_A</Hit_accession>
  <Hit_len>224</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.1434</Hsp_bit-score>
      <Hsp_score>126</Hsp_score>
      <Hsp_evalue>5.36651e-08</Hsp_evalue>
      <Hsp_query-from>38</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>38</Hsp_hit-from>
      <Hsp_hit-to>166</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>31</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>LTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>VTNICQAADKQLFTLVEWAKRIPHFSSLPLDDQVILLRAGWNELLIASFSHRSIDVRDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMRMDKTELGCLRAIILFNP-DAKGLSNPSEVEVLR</Hsp_hseq>
      <Hsp_midline>+T++ Q  ++QL ++V+W+K +P F +L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +++ + E  C++ ++L N    +GL + ++ E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>251</Hit_num>
  <Hit_id>pdb|4RWV|A</Hit_id>
  <Hit_def>Crystal structure of PIP3 bound human nuclear receptor LRH-1 (Liver Receptor Homolog 1, NR5A2) in complex with a co-regulator DAX-1 (NR0B1) peptide at 1.86 A resolution [Homo sapiens]</Hit_def>
  <Hit_accession>4RWV_A</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.5286</Hsp_bit-score>
      <Hsp_score>127</Hsp_score>
      <Hsp_evalue>5.81875e-08</Hsp_evalue>
      <Hsp_query-from>7</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>9</Hsp_hit-from>
      <Hsp_hit-to>166</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>23</Hsp_gaps>
      <Hsp_align-len>163</Hsp_align-len>
      <Hsp_qseq>IPPLINLLMSIEPD--------VIYAGHDNTKPDTSSSLLTS--LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH--------VSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>IPHLILELLKXEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMCKMADQTLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVVHGKEGSIFLVTGQQVDYS---IIASQ--AGATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFS</Hsp_hseq>
      <Hsp_midline>IP LI  L+  EPD        + Y   +         L T   + ++ ++ L S+V+W++S   FR L +DDQ+ L+Q  W  L++    +R   H        V+GQ + ++   I+  Q    ++  +L     ++  +   LQ  Q EF+C+K L+L +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>252</Hit_num>
  <Hit_id>pdb|5HJP|A</Hit_id>
  <Hit_def>Identification of LXRbeta selective agonists for the treatment of Alzheimer&apos;s Disease [Homo sapiens] &gt;pdb|5HJP|C Identification of LXRbeta selective agonists for the treatment of Alzheimer&apos;s Disease [Homo sapiens]</Hit_def>
  <Hit_accession>5HJP_A</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.1434</Hsp_bit-score>
      <Hsp_score>126</Hsp_score>
      <Hsp_evalue>6.61971e-08</Hsp_evalue>
      <Hsp_query-from>38</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>38</Hsp_hit-from>
      <Hsp_hit-to>166</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>31</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>LTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>VTNICQAADKQLFTLVEWAKRIPHFSSLPLDDQVILLRAGWNELLIASFSHRSIDVRDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMRMDKTELGCLRAIILFNP-DAKGLSNPSEVEVLR</Hsp_hseq>
      <Hsp_midline>+T++ Q  ++QL ++V+W+K +P F +L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +++ + E  C++ ++L N    +GL + ++ E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>253</Hit_num>
  <Hit_id>pdb|1UHL|A</Hit_id>
  <Hit_def>Crystal structure of the LXRalfa-RXRbeta LBD heterodimer [Homo sapiens]</Hit_def>
  <Hit_accession>1UHL_A</Hit_accession>
  <Hit_len>236</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.1434</Hsp_bit-score>
      <Hsp_score>126</Hsp_score>
      <Hsp_evalue>7.00204e-08</Hsp_evalue>
      <Hsp_query-from>38</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>39</Hsp_hit-from>
      <Hsp_hit-to>167</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>31</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>LTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>VTNICQAADKQLFTLVEWAKRIPHFSSLPLDDQVILLRAGWNELLIASFSHRSIDVRDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMRMDKTELGCLRAIILFNP-DAKGLSNPSEVEVLR</Hsp_hseq>
      <Hsp_midline>+T++ Q  ++QL ++V+W+K +P F +L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +++ + E  C++ ++L N    +GL + ++ E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>254</Hit_num>
  <Hit_id>pdb|7A78|A</Hit_id>
  <Hit_def>Crystal structure of RXR beta LBD in complexes with palmitic acid and GRIP-1 peptide [Homo sapiens]</Hit_def>
  <Hit_accession>7A78_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.1434</Hsp_bit-score>
      <Hsp_score>126</Hsp_score>
      <Hsp_evalue>7.32055e-08</Hsp_evalue>
      <Hsp_query-from>38</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>41</Hsp_hit-from>
      <Hsp_hit-to>169</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>31</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>LTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>VTNICQAADKQLFTLVEWAKRIPHFSSLPLDDQVILLRAGWNELLIASFSHRSIDVRDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMRMDKTELGCLRAIILFNP-DAKGLSNPSEVEVLR</Hsp_hseq>
      <Hsp_midline>+T++ Q  ++QL ++V+W+K +P F +L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +++ + E  C++ ++L N    +GL + ++ E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>255</Hit_num>
  <Hit_id>pdb|5KYA|B</Hit_id>
  <Hit_def>Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core [Homo sapiens] &gt;pdb|5KYA|F Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core [Homo sapiens] &gt;pdb|5KYJ|B Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core [Homo sapiens] &gt;pdb|5KYJ|F Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core [Homo sapiens]</Hit_def>
  <Hit_accession>5KYA_B</Hit_accession>
  <Hit_len>256</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.1434</Hsp_bit-score>
      <Hsp_score>126</Hsp_score>
      <Hsp_evalue>7.37062e-08</Hsp_evalue>
      <Hsp_query-from>38</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>45</Hsp_hit-from>
      <Hsp_hit-to>173</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>31</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>LTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>VTNICQAADKQLFTLVEWAKRIPHFSSLPLDDQVILLRAGWNELLIASFSHRSIDVRDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMRMDKTELGCLRAIILFNP-DAKGLSNPSEVEVLR</Hsp_hseq>
      <Hsp_midline>+T++ Q  ++QL ++V+W+K +P F +L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +++ + E  C++ ++L N    +GL + ++ E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>256</Hit_num>
  <Hit_id>pdb|5I4V|B</Hit_id>
  <Hit_def>Discovery of novel, orally efficacious Liver X Receptor (LXR) beta agonists [Homo sapiens] &gt;pdb|5I4V|F Discovery of novel, orally efficacious Liver X Receptor (LXR) beta agonists [Homo sapiens]</Hit_def>
  <Hit_accession>5I4V_B</Hit_accession>
  <Hit_len>255</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>53.1434</Hsp_bit-score>
      <Hsp_score>126</Hsp_score>
      <Hsp_evalue>7.67561e-08</Hsp_evalue>
      <Hsp_query-from>38</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>44</Hsp_hit-from>
      <Hsp_hit-to>172</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>31</Hsp_identity>
      <Hsp_positive>68</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>LTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE-SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>VTNICQAADKQLFTLVEWAKRIPHFSSLPLDDQVILLRAGWNELLIASFSHRSIDVRDGILLATGLHVHRNSAHSAGVGAIFDRVLT--ELVSKMRDMRMDKTELGCLRAIILFNP-DAKGLSNPSEVEVLR</Hsp_hseq>
      <Hsp_midline>+T++ Q  ++QL ++V+W+K +P F +L +DDQ+ L++  W  L++     RS     G +L     +  N        + +   LT  ++  +   +++ + E  C++ ++L N    +GL + ++ E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>257</Hit_num>
  <Hit_id>pdb|3F7D|A</Hit_id>
  <Hit_def>SF-1 LBD bound by phosphatidylcholine [Mus musculus]</Hit_def>
  <Hit_accession>3F7D_A</Hit_accession>
  <Hit_len>244</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>51.6026</Hsp_bit-score>
      <Hsp_score>122</Hsp_score>
      <Hsp_evalue>2.12446e-07</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>48</Hsp_hit-from>
      <Hsp_hit-to>161</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>17</Hsp_gaps>
      <Hsp_align-len>121</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPD--LILNEQRMKESS--------FYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LXRMADQTFISIVDWARRCMVFKELEVADQMTLLQNSWSELLVLD-------HIYRQVQYGKEDSILLVTGQEVELSTVAVQAGSLLHSLVLRAQELVLQLHALQLDRQEFVCLKFLILFS</Hsp_hseq>
      <Hsp_midline>L ++ ++  +S+V W++    F+ L + DQ+TL+Q SW  L+V         H+  Q+ Y   D  L++  Q ++ S+         +SL L   ++  +   LQ+ ++EF+C+K L+L +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>258</Hit_num>
  <Hit_id>pdb|3TX7|B</Hit_id>
  <Hit_def>Crystal structure of LRH-1/beta-catenin complex [Homo sapiens]</Hit_def>
  <Hit_accession>3TX7_B</Hit_accession>
  <Hit_len>352</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>51.9878</Hsp_bit-score>
      <Hsp_score>123</Hsp_score>
      <Hsp_evalue>2.62824e-07</Hsp_evalue>
      <Hsp_query-from>7</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>112</Hsp_hit-from>
      <Hsp_hit-to>269</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>76</Hsp_positive>
      <Hsp_gaps>23</Hsp_gaps>
      <Hsp_align-len>163</Hsp_align-len>
      <Hsp_qseq>IPPLINLLMSIEPD--------VIYAGHDNTKPDTSSSLLTS--LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH--------VSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>IPHLILELLKCEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMCKMADQTLFSIVEWARSSIFFRELKVDDQMKLLQNCWSELLILDHIYRQVVHGKEGSIFLVTGQQVDYS---IIASQ--AGATLNNLMSHAQELVAKLRSLQFDQREFVCLKFLVLFS</Hsp_hseq>
      <Hsp_midline>IP LI  L+  EPD        + Y   +         L T   + ++ ++ L S+V+W++S   FR L +DDQ+ L+Q  W  L++    +R   H        V+GQ + ++   I+  Q    ++  +L     ++  +   LQ  Q EF+C+K L+L +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>259</Hit_num>
  <Hit_id>pdb|1YMT|A</Hit_id>
  <Hit_def>Mouse SF-1 LBD [Mus musculus]</Hit_def>
  <Hit_accession>1YMT_A</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>51.2174</Hsp_bit-score>
      <Hsp_score>121</Hsp_score>
      <Hsp_evalue>2.85666e-07</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>50</Hsp_hit-from>
      <Hsp_hit-to>163</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>17</Hsp_gaps>
      <Hsp_align-len>121</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPD--LILNEQRMKESS--------FYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LCRMADQTFISIVDWARRCMVFKELEVADQMTLLQNSWSELLVL-------DHIYRQVQYGKEDSILLVTGQEVELSTVAVQAGSLLHSLVLRAQELVLQLHALQLDRQEFVCLKFLILFS</Hsp_hseq>
      <Hsp_midline>L ++ ++  +S+V W++    F+ L + DQ+TL+Q SW  L+V         H+  Q+ Y   D  L++  Q ++ S+         +SL L   ++  +   LQ+ ++EF+C+K L+L +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>260</Hit_num>
  <Hit_id>pdb|1YP0|A</Hit_id>
  <Hit_def>Structure of the steroidogenic factor-1 ligand binding domain bound to phospholipid and a SHP peptide motif [Mus musculus]</Hit_def>
  <Hit_accession>1YP0_A</Hit_accession>
  <Hit_len>239</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>49.6766</Hsp_bit-score>
      <Hsp_score>117</Hsp_score>
      <Hsp_evalue>1.05388e-06</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>44</Hsp_hit-from>
      <Hsp_hit-to>157</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>32</Hsp_identity>
      <Hsp_positive>63</Hsp_positive>
      <Hsp_gaps>17</Hsp_gaps>
      <Hsp_align-len>121</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPD--LILNEQRMKESS--------FYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LCRMADQTFISIVDWARRCMVFKELEVADQMTLLQNCWSELLVLD-------HIYRQVQYGKEDSILLVTGQEVELSTVAVQAGSLLHSLVLRAQELVLQLHALQLDRQEFVCLKFLILFS</Hsp_hseq>
      <Hsp_midline>L ++ ++  +S+V W++    F+ L + DQ+TL+Q  W  L+V         H+  Q+ Y   D  L++  Q ++ S+         +SL L   ++  +   LQ+ ++EF+C+K L+L +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>261</Hit_num>
  <Hit_id>pdb|6EU9|A</Hit_id>
  <Hit_def>Crystal structure of Platynereis dumerilii RAR ligand-binding domain in complex with all-trans retinoic acid [Platynereis dumerilii] &gt;pdb|6EU9|B Crystal structure of Platynereis dumerilii RAR ligand-binding domain in complex with all-trans retinoic acid [Platynereis dumerilii] &gt;pdb|6EU9|C Crystal structure of Platynereis dumerilii RAR ligand-binding domain in complex with all-trans retinoic acid [Platynereis dumerilii] &gt;pdb|6EU9|D Crystal structure of Platynereis dumerilii RAR ligand-binding domain in complex with all-trans retinoic acid [Platynereis dumerilii]</Hit_def>
  <Hit_accession>6EU9_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>49.2914</Hsp_bit-score>
      <Hsp_score>116</Hsp_score>
      <Hsp_evalue>1.17306e-06</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>50</Hsp_hit-from>
      <Hsp_hit-to>158</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>111</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>VSELSTKAIANVVDFGKQVPVFTQLSTNDQITLLKAACLEIIILRLASR-YDDKEDTM-SFSNGLTLTQQQLEVGGFGTLTPTIFKFARSLVELSVDTAEYAMLSLICLIS</Hsp_hseq>
      <Hsp_midline>+++L  + + +VV + K +P F  L  +DQITL++ + + +++  L  R Y      M  F+  L L +Q+++   F +L  T+++  +  V+L V   E+  + ++ L++</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>262</Hit_num>
  <Hit_id>pdb|4XAJ|A</Hit_id>
  <Hit_def>Crystal structure of human NR2E1/TLX [Escherichia coli O157:H7] &gt;pdb|4XAJ|B Crystal structure of human NR2E1/TLX [Escherichia coli O157:H7] &gt;pdb|4XAJ|C Crystal structure of human NR2E1/TLX [Escherichia coli O157:H7] &gt;pdb|4XAJ|D Crystal structure of human NR2E1/TLX [Escherichia coli O157:H7]</Hit_def>
  <Hit_accession>4XAJ_A</Hit_accession>
  <Hit_len>576</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>49.6766</Hsp_bit-score>
      <Hsp_score>117</Hsp_score>
      <Hsp_evalue>1.83979e-06</Hsp_evalue>
      <Hsp_query-from>28</Hsp_query-from>
      <Hsp_query-to>154</Hsp_query-to>
      <Hsp_hit-from>365</Hsp_hit-from>
      <Hsp_hit-to>491</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>27</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>127</Hsp_align-len>
      <Hsp_qseq>NTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIP</Hsp_qseq>
      <Hsp_hseq>DAQTNAAAEFTESVCESAARLLFMSIKWAKSVPAFSTLSLQDQLMLLEDAWRELFVLGIAQWAIPVDANTLLAVSGMNGDNTDSQRLTLIISEIQALQEVVARFRQLRLDATEFACLKCIVTFKAVP</Hsp_hseq>
      <Hsp_midline>+ + + ++    S+ +   R L   +KW+KS+P F  L + DQ+ L++ +W  L V G+   +    +  +L  +     N    + +   S    + ++   F +L++   EF C+K ++    +P</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>263</Hit_num>
  <Hit_id>pdb|1XAP|A</Hit_id>
  <Hit_def>Structure of the ligand binding domain of the Retinoic Acid Receptor beta [Homo sapiens] &gt;pdb|4DM6|A Crystal structure of RARb LBD homodimer in complex with TTNPB [Homo sapiens] &gt;pdb|4DM6|B Crystal structure of RARb LBD homodimer in complex with TTNPB [Homo sapiens] &gt;pdb|4DM8|A Crystal structure of RARb LBD in complex with 9cis retinoic acid [Homo sapiens] &gt;pdb|4DM8|B Crystal structure of RARb LBD in complex with 9cis retinoic acid [Homo sapiens]</Hit_def>
  <Hit_accession>1XAP_A</Hit_accession>
  <Hit_len>267</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.2098</Hsp_bit-score>
      <Hsp_score>108</Hsp_score>
      <Hsp_evalue>1.81425e-05</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>150</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>181</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>27</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>110</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLL</Hsp_qseq>
      <Hsp_hseq>FSELATKCIIKIVEFAKRLPGFTGLTIADQITLLKAACLDILILRICTR-YTPEQDTM-TFSDGLTLNRTQMHNAGFGPLTDLVFTFANQLLPLEMDDTETGLLSAICLI</Hsp_hseq>
      <Hsp_midline> ++L  + ++ +V+++K LPGF  L I DQITL++ + + +++  +  R Y      M  F+  L LN  +M  + F  L   ++    + + L++   E   +  + L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>264</Hit_num>
  <Hit_id>pdb|2NXX|A</Hit_id>
  <Hit_def>Crystal Structure of the Ligand-Binding Domains of the T.castaneum (Coleoptera) Heterodimer EcrUSP Bound to Ponasterone A [Tribolium castaneum] &gt;pdb|2NXX|B Crystal Structure of the Ligand-Binding Domains of the T.castaneum (Coleoptera) Heterodimer EcrUSP Bound to Ponasterone A [Tribolium castaneum] &gt;pdb|2NXX|C Crystal Structure of the Ligand-Binding Domains of the T.castaneum (Coleoptera) Heterodimer EcrUSP Bound to Ponasterone A [Tribolium castaneum] &gt;pdb|2NXX|D Crystal Structure of the Ligand-Binding Domains of the T.castaneum (Coleoptera) Heterodimer EcrUSP Bound to Ponasterone A [Tribolium castaneum]</Hit_def>
  <Hit_accession>2NXX_A</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.8246</Hsp_bit-score>
      <Hsp_score>107</Hsp_score>
      <Hsp_evalue>1.82641e-05</Hsp_evalue>
      <Hsp_query-from>43</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>44</Hsp_hit-from>
      <Hsp_hit-to>167</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>65</Hsp_positive>
      <Hsp_gaps>8</Hsp_gaps>
      <Hsp_align-len>129</Hsp_align-len>
      <Hsp_qseq>QLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKE---SSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>QATHKQLFQLVQWAKLVPHFTSLPLTDQVQLLRAGWNELLIAAFSHRSMQ--AQDAIVLATGLTVNKSTAHAVGVGNIYDRVLS--ELVNKMKEMKMDKTELGCLRAIILYNP-DVRGIKSVQEVEMLR</Hsp_hseq>
      <Hsp_midline>Q   +QL  +V+W+K +P F +L + DQ+ L++  W  L++     RS +  +   +  A  L +N+         + Y   L+  ++  +  ++++ + E  C++ ++L N   + G++S  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>265</Hit_num>
  <Hit_id>pdb|4JYG|A</Hit_id>
  <Hit_def>Crystal structure of RARbeta LBD in complex with agonist BMS411 [4-{[(5,5-dimethyl-8-phenyl-5,6-dihydronaphthalen-2-yl)carbonyl]amino}benzoic acid] [Homo sapiens] &gt;pdb|4JYG|B Crystal structure of RARbeta LBD in complex with agonist BMS411 [4-{[(5,5-dimethyl-8-phenyl-5,6-dihydronaphthalen-2-yl)carbonyl]amino}benzoic acid] [Homo sapiens] &gt;pdb|4JYH|A Crystal structure of RARbeta LBD in complex with selective agonist BMS948 [4-{[(8-phenylnaphthalen-2-yl)carbonyl]amino}benzoic acid] [Homo sapiens] &gt;pdb|4JYH|B Crystal structure of RARbeta LBD in complex with selective agonist BMS948 [4-{[(8-phenylnaphthalen-2-yl)carbonyl]amino}benzoic acid] [Homo sapiens] &gt;pdb|4JYI|A Crystal structure of RARbeta LBD in complex with selective partial agonist BMS641 [3-chloro-4-[(E)-2-(5,5-dimethyl-8-phenyl-5,6-dihydronaphthalen-2-yl)ethenyl]benzoic acid] [Homo sapiens] &gt;pdb|4JYI|B Crystal structure of RARbeta LBD in complex with selective partial agonist BMS641 [3-chloro-4-[(E)-2-(5,5-dimethyl-8-phenyl-5,6-dihydronaphthalen-2-yl)ethenyl]benzoic acid] [Homo sapiens] &gt;pdb|6SSQ|A Crystal structure of RARbeta LBD in complex with LG 100754 [Homo sapiens] &gt;pdb|6SSQ|B Crystal structure of RARbeta LBD in complex with LG 100754 [Homo sapiens]</Hit_def>
  <Hit_accession>4JYG_A</Hit_accession>
  <Hit_len>267</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>46.2098</Hsp_bit-score>
      <Hsp_score>108</Hsp_score>
      <Hsp_evalue>1.91743e-05</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>150</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>181</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>27</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>110</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLL</Hsp_qseq>
      <Hsp_hseq>FSELATKCIIKIVEFAKRLPGFTGLTIADQITLLKAACLDILILRICTR-YTPEQDTM-TFSDGLTLNRTQMHNAGFGPLTDLVFTFANQLLPLEMDDTETGLLSAICLI</Hsp_hseq>
      <Hsp_midline> ++L  + ++ +V+++K LPGF  L I DQITL++ + + +++  +  R Y      M  F+  L LN  +M  + F  L   ++    + + L++   E   +  + L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>266</Hit_num>
  <Hit_id>pdb|1XDK|B</Hit_id>
  <Hit_def>Crystal Structure of the RARbeta/RXRalpha Ligand Binding Domain Heterodimer in Complex with 9-cis Retinoic Acid and a Fragment of the TRAP220 Coactivator [Mus musculus] &gt;pdb|1XDK|F Crystal Structure of the RARbeta/RXRalpha Ligand Binding Domain Heterodimer in Complex with 9-cis Retinoic Acid and a Fragment of the TRAP220 Coactivator [Mus musculus]</Hit_def>
  <Hit_accession>1XDK_B</Hit_accession>
  <Hit_len>303</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.8246</Hsp_bit-score>
      <Hsp_score>107</Hsp_score>
      <Hsp_evalue>2.46208e-05</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>150</Hsp_query-to>
      <Hsp_hit-from>76</Hsp_hit-from>
      <Hsp_hit-to>183</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>27</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>110</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLL</Hsp_qseq>
      <Hsp_hseq>FSELATKCIIKIVEFAKRLPGFTGLTIADQITLLKAACLDILILRICTR-YTPEQDTM-TFSDGLTLNRTQMHNAGFGPLTDLVFTFANQLLPLEMDDTETGLLSAICLI</Hsp_hseq>
      <Hsp_midline> ++L  + ++ +V+++K LPGF  L I DQITL++ + + +++  +  R Y      M  F+  L LN  +M  + F  L   ++    + + L++   E   +  + L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>267</Hit_num>
  <Hit_id>pdb|1M7W|A</Hit_id>
  <Hit_def>HNF4a ligand binding domain with bound fatty acid [Rattus rattus] &gt;pdb|1M7W|B HNF4a ligand binding domain with bound fatty acid [Rattus rattus] &gt;pdb|1M7W|C HNF4a ligand binding domain with bound fatty acid [Rattus rattus] &gt;pdb|1M7W|D HNF4a ligand binding domain with bound fatty acid [Rattus rattus]</Hit_def>
  <Hit_accession>1M7W_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.4394</Hsp_bit-score>
      <Hsp_score>106</Hsp_score>
      <Hsp_evalue>2.61765e-05</Hsp_evalue>
      <Hsp_query-from>38</Hsp_query-from>
      <Hsp_query-to>183</Hsp_query-to>
      <Hsp_hit-from>43</Hsp_hit-from>
      <Hsp_hit-to>186</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>71</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>148</Hsp_align-len>
      <Hsp_qseq>LTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQ--RMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQ</Hsp_qseq>
      <Hsp_hseq>ITDVCESMKEQLLVLVEWAKYIPAFCELLLDDQVALLRAHAGEHLLLGATKRSM--VFKDVLLLGNDYIVPRHCPELAEMSRVSIRI-LDELVLPFQELQIDDNEYACLKAIIFFDP-DAKGLSDPGKIKRLRSQVQVSLEDYINDRQ</Hsp_hseq>
      <Hsp_midline>+T + +  + QLL +V+W+K +P F  L +DDQ+ L++      ++ G   RS   V   +L    D I+      + E S  S+ + + ++   F +LQ+   E+ C+K ++  +    +GL    + + +RS     L   I  RQ</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>268</Hit_num>
  <Hit_id>pdb|1FCX|A</Hit_id>
  <Hit_def>ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE RARGAMMA-SELECTIVE RETINOID BMS184394 [Homo sapiens] &gt;pdb|1FCZ|A ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE PANAGONIST RETINOID BMS181156 [Homo sapiens] &gt;pdb|1FD0|A ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE RARGAMMA-SELECTIVE RETINOID SR11254 [Homo sapiens]</Hit_def>
  <Hit_accession>1FCX_A</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>3.10296e-05</Hsp_evalue>
      <Hsp_query-from>42</Hsp_query-from>
      <Hsp_query-to>140</Hsp_query-to>
      <Hsp_hit-from>49</Hsp_hit-from>
      <Hsp_hit-to>145</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>52</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>NQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEE</Hsp_qseq>
      <Hsp_hseq>SELATKCIIKIVEFAKRLPGFTGLSIADQITLLKAACLDILMLRICTR-YTPEQDTM-TFSDGLTLNRTQMHNAGFGPLTDLVFAFAGQLLPLEMDDTE</Hsp_hseq>
      <Hsp_midline>++L  + ++ +V+++K LPGF  L I DQITL++ + + +++  +  R Y      M  F+  L LN  +M  + F  L   ++    + + L++   E</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>269</Hit_num>
  <Hit_id>pdb|1FCY|A</Hit_id>
  <Hit_def>ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE RARBETA/GAMMA-SELECTIVE RETINOID CD564 [Homo sapiens]</Hit_def>
  <Hit_accession>1FCY_A</Hit_accession>
  <Hit_len>236</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>3.15003e-05</Hsp_evalue>
      <Hsp_query-from>42</Hsp_query-from>
      <Hsp_query-to>140</Hsp_query-to>
      <Hsp_hit-from>50</Hsp_hit-from>
      <Hsp_hit-to>146</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>52</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>NQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEE</Hsp_qseq>
      <Hsp_hseq>SELATKCIIKIVEFAKRLPGFTGLSIADQITLLKAACLDILMLRICTR-YTPEQDTM-TFSDGLTLNRTQMHNAGFGPLTDLVFAFAGQLLPLEMDDTE</Hsp_hseq>
      <Hsp_midline>++L  + ++ +V+++K LPGF  L I DQITL++ + + +++  +  R Y      M  F+  L LN  +M  + F  L   ++    + + L++   E</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>270</Hit_num>
  <Hit_id>pdb|1DKF|B</Hit_id>
  <Hit_def>CRYSTAL STRUCTURE OF A HETERODIMERIC COMPLEX OF RAR AND RXR LIGAND-BINDING DOMAINS [Homo sapiens]</Hit_def>
  <Hit_accession>1DKF_B</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>3.22043e-05</Hsp_evalue>
      <Hsp_query-from>42</Hsp_query-from>
      <Hsp_query-to>140</Hsp_query-to>
      <Hsp_hit-from>48</Hsp_hit-from>
      <Hsp_hit-to>144</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>NQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEE</Hsp_qseq>
      <Hsp_hseq>SELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTR-YTPEQDTM-TFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAE</Hsp_hseq>
      <Hsp_midline>++L  + ++  V+++K LPGF  L I DQITL++ + + +++  +  R Y      M  F+  L LN  +M  + F  L   ++    + + L++   E</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>271</Hit_num>
  <Hit_id>pdb|1ZDT|A</Hit_id>
  <Hit_def>The Crystal Structure of Human Steroidogenic Factor-1 [Homo sapiens] &gt;pdb|1ZDT|B The Crystal Structure of Human Steroidogenic Factor-1 [Homo sapiens]</Hit_def>
  <Hit_accession>1ZDT_A</Hit_accession>
  <Hit_len>241</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>3.23886e-05</Hsp_evalue>
      <Hsp_query-from>29</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>34</Hsp_hit-from>
      <Hsp_hit-to>158</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>67</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>TKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH--------VSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>SRPDQPAAF-GLLCRMADQTFISIVDWARRCMVFKELEVADQMTLLQNCWSELLVFDHIYRQVQHGKEGSILLVTGQEVELT-----TVATQAGSLLHSLVLRAQELVLQLLALQLDRQEFVCLKFIILFS</Hsp_hseq>
      <Hsp_midline>++PD  ++    L ++ ++  +S+V W++    F+ L + DQ+TL+Q  W  L+VF   +R  +H        V+GQ +               S  +SL L   ++  + + LQ+ ++EF+C+K ++L +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>272</Hit_num>
  <Hit_id>pdb|4DQM|A</Hit_id>
  <Hit_def>Revealing a marine natural product as a novel agonist for retinoic acid receptors with a unique binding mode and antitumor activity [Homo sapiens] &gt;pdb|4DQM|C Revealing a marine natural product as a novel agonist for retinoic acid receptors with a unique binding mode and antitumor activity [Homo sapiens]</Hit_def>
  <Hit_accession>4DQM_A</Hit_accession>
  <Hit_len>234</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>3.44879e-05</Hsp_evalue>
      <Hsp_query-from>42</Hsp_query-from>
      <Hsp_query-to>140</Hsp_query-to>
      <Hsp_hit-from>48</Hsp_hit-from>
      <Hsp_hit-to>144</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>NQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEE</Hsp_qseq>
      <Hsp_hseq>SELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTR-YTPEQDTM-TFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAE</Hsp_hseq>
      <Hsp_midline>++L  + ++  V+++K LPGF  L I DQITL++ + + +++  +  R Y      M  F+  L LN  +M  + F  L   ++    + + L++   E</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>273</Hit_num>
  <Hit_id>pdb|1YOW|A</Hit_id>
  <Hit_def>human Steroidogenic Factor 1 LBD with bound Co-factor Peptide [Homo sapiens]</Hit_def>
  <Hit_accession>1YOW_A</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>3.57244e-05</Hsp_evalue>
      <Hsp_query-from>29</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>35</Hsp_hit-from>
      <Hsp_hit-to>98</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>19</Hsp_identity>
      <Hsp_positive>38</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>65</Hsp_align-len>
      <Hsp_qseq>TKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH</Hsp_qseq>
      <Hsp_hseq>SRPDQPAAF-GLLCRMADQTFISIVDWARRCMVFKELEVADQMTLLQNCWSELLVFDHIYRQVQH</Hsp_hseq>
      <Hsp_midline>++PD  ++    L ++ ++  +S+V W++    F+ L + DQ+TL+Q  W  L+VF   +R  +H</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>274</Hit_num>
  <Hit_id>pdb|5K13|A</Hit_id>
  <Hit_def>Crystal structure of the RAR alpha ligand-binding domain in complex with an antagonist [Homo sapiens]</Hit_def>
  <Hit_accession>5K13_A</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>3.64713e-05</Hsp_evalue>
      <Hsp_query-from>42</Hsp_query-from>
      <Hsp_query-to>140</Hsp_query-to>
      <Hsp_hit-from>49</Hsp_hit-from>
      <Hsp_hit-to>145</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>99</Hsp_align-len>
      <Hsp_qseq>NQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEE</Hsp_qseq>
      <Hsp_hseq>SELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTR-YTPEQDTM-TFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAE</Hsp_hseq>
      <Hsp_midline>++L  + ++  V+++K LPGF  L I DQITL++ + + +++  +  R Y      M  F+  L LN  +M  + F  L   ++    + + L++   E</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>275</Hit_num>
  <Hit_id>pdb|1HG4|A</Hit_id>
  <Hit_def>Ultraspiracle ligand binding domain from Drosophila melanogaster [Drosophila melanogaster] &gt;pdb|1HG4|B Ultraspiracle ligand binding domain from Drosophila melanogaster [Drosophila melanogaster] &gt;pdb|1HG4|C Ultraspiracle ligand binding domain from Drosophila melanogaster [Drosophila melanogaster] &gt;pdb|1HG4|D Ultraspiracle ligand binding domain from Drosophila melanogaster [Drosophila melanogaster] &gt;pdb|1HG4|E Ultraspiracle ligand binding domain from Drosophila melanogaster [Drosophila melanogaster] &gt;pdb|1HG4|F Ultraspiracle ligand binding domain from Drosophila melanogaster [Drosophila melanogaster]</Hit_def>
  <Hit_accession>1HG4_A</Hit_accession>
  <Hit_len>279</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>3.92597e-05</Hsp_evalue>
      <Hsp_query-from>26</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>38</Hsp_hit-from>
      <Hsp_hit-to>101</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>17</Hsp_identity>
      <Hsp_positive>41</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>65</Hsp_align-len>
      <Hsp_qseq>HDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRS</Hsp_qseq>
      <Hsp_hseq>YSTVQPDYKGAV-SALCQVVNKQLFQMVEYARMMPHFAQVPLDDQVILLKAAWIELLIANVAWCS</Hsp_hseq>
      <Hsp_midline>+   +PD   ++ ++L Q+  +QL  +V++++ +P F  + +DDQ+ L++ +W+ L++  + W S</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>276</Hit_num>
  <Hit_id>pdb|2Q60|A</Hit_id>
  <Hit_def>Crystal structure of the ligand binding domain of polyandrocarpa misakiensis rxr in tetramer in absence of ligand [Polyandrocarpa misakiensis] &gt;pdb|2Q60|B Crystal structure of the ligand binding domain of polyandrocarpa misakiensis rxr in tetramer in absence of ligand [Polyandrocarpa misakiensis] &gt;pdb|2Q60|C Crystal structure of the ligand binding domain of polyandrocarpa misakiensis rxr in tetramer in absence of ligand [Polyandrocarpa misakiensis] &gt;pdb|2Q60|D Crystal structure of the ligand binding domain of polyandrocarpa misakiensis rxr in tetramer in absence of ligand [Polyandrocarpa misakiensis]</Hit_def>
  <Hit_accession>2Q60_A</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>4.0038e-05</Hsp_evalue>
      <Hsp_query-from>38</Hsp_query-from>
      <Hsp_query-to>90</Hsp_query-to>
      <Hsp_hit-from>60</Hsp_hit-from>
      <Hsp_hit-to>112</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>16</Hsp_identity>
      <Hsp_positive>36</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>53</Hsp_align-len>
      <Hsp_qseq>LTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRS</Hsp_qseq>
      <Hsp_hseq>VSNICKAADRQLVTLVEWAKRIPHFSSLPLEDQVILLRAGWNELLIASFSHRS</Hsp_hseq>
      <Hsp_midline>++++ +  +RQL+++V+W+K +P F +L ++DQ+ L++  W  L++     RS</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>277</Hit_num>
  <Hit_id>pdb|4QJR|A</Hit_id>
  <Hit_def>Crystal structure of human nuclear receptor sf-1 (nr5a1) bound to its hormone pip3 at 2.4 a resolution [Homo sapiens] &gt;pdb|4QK4|A Crystal structure of human nuclear receptor sf-1 (nr5a1) bound to pip2 at 2.8 a resolution [Homo sapiens] &gt;pdb|7KHT|A Chain A, Steroidogenic factor 1 [Homo sapiens]</Hit_def>
  <Hit_accession>4QJR_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>4.16901e-05</Hsp_evalue>
      <Hsp_query-from>29</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>38</Hsp_hit-from>
      <Hsp_hit-to>162</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>33</Hsp_identity>
      <Hsp_positive>67</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>131</Hsp_align-len>
      <Hsp_qseq>TKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH--------VSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>SRPDQPAAF-GLLCRMADQTFISIVDWARRCMVFKELEVADQMTLLQNCWSELLVFDHIYRQVQHGKEGSILLVTGQEVELT-----TVATQAGSLLHSLVLRAQELVLQLLALQLDRQEFVCLKFIILFS</Hsp_hseq>
      <Hsp_midline>++PD  ++    L ++ ++  +S+V W++    F+ L + DQ+TL+Q  W  L+VF   +R  +H        V+GQ +               S  +SL L   ++  + + LQ+ ++EF+C+K ++L +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>278</Hit_num>
  <Hit_id>pdb|7APO|A</Hit_id>
  <Hit_def>Chain A, Retinoic acid receptor alpha [Homo sapiens] &gt;pdb|7APO|B Chain B, Retinoic acid receptor alpha [Homo sapiens]</Hit_def>
  <Hit_accession>7APO_A</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>4.17443e-05</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>140</Hsp_query-to>
      <Hsp_hit-from>56</Hsp_hit-from>
      <Hsp_hit-to>153</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEE</Hsp_qseq>
      <Hsp_hseq>FSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTR-YTPEQDTM-TFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAE</Hsp_hseq>
      <Hsp_midline> ++L  + ++  V+++K LPGF  L I DQITL++ + + +++  +  R Y      M  F+  L LN  +M  + F  L   ++    + + L++   E</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>279</Hit_num>
  <Hit_id>pdb|5UAN|B</Hit_id>
  <Hit_def>Crystal structure of multi-domain RAR-beta-RXR-alpha heterodimer on DNA [Homo sapiens]</Hit_def>
  <Hit_accession>5UAN_B</Hit_accession>
  <Hit_len>397</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.4394</Hsp_bit-score>
      <Hsp_score>106</Hsp_score>
      <Hsp_evalue>4.22708e-05</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>150</Hsp_query-to>
      <Hsp_hit-from>170</Hsp_hit-from>
      <Hsp_hit-to>277</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>25</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>110</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLL</Hsp_qseq>
      <Hsp_hseq>FSELATKCIIKIVEFAKRLPGFTGLTIADQITLLKAACLDILILRICTRYTPEQ--DTMTFSDGLTLNRTQMHNAGFGPLTDLVFTFANQLLPLEMDDTETGLLSAICLI</Hsp_hseq>
      <Hsp_midline> ++L  + ++ +V+++K LPGF  L I DQITL++ + + +++  +  R         + F+  L LN  +M  + F  L   ++    + + L++   E   +  + L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>280</Hit_num>
  <Hit_id>pdb|1EXA|A</Hit_id>
  <Hit_def>Enantiomer Discrimination Illustrated By Crystal Structures Of The Human Retinoic Acid Receptor Hrargamma Ligand Binding Domain: The Complex With The Active R-Enantiomer Bms270394. [Homo sapiens] &gt;pdb|1EXX|A ENANTIOMER DISCRIMINATION ILLUSTRATED BY CRYSTAL STRUCTURES OF THE HUMAN RETINOIC ACID RECEPTOR HRARGAMMA LIGAND BINDING DOMAIN: THE COMPLEX WITH THE INACTIVE S-ENANTIOMER BMS270395. [Homo sapiens]</Hit_def>
  <Hit_accession>1EXA_A</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>4.22899e-05</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>140</Hsp_query-to>
      <Hsp_hit-from>53</Hsp_hit-from>
      <Hsp_hit-to>150</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>52</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEE</Hsp_qseq>
      <Hsp_hseq>FSELATKCIIKIVEFAKRLPGFTGLSIADQITLLKAACLDILMLRICTR-YTPEQDTM-TFSDGLTLNRTQMHNAGFGPLTDLVFAFAGQLLPLEMDDTE</Hsp_hseq>
      <Hsp_midline> ++L  + ++ +V+++K LPGF  L I DQITL++ + + +++  +  R Y      M  F+  L LN  +M  + F  L   ++    + + L++   E</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>281</Hit_num>
  <Hit_id>pdb|5M24|A</Hit_id>
  <Hit_def>RARg mutant-S371E [Homo sapiens]</Hit_def>
  <Hit_accession>5M24_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>4.31241e-05</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>140</Hsp_query-to>
      <Hsp_hit-from>57</Hsp_hit-from>
      <Hsp_hit-to>154</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>52</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEE</Hsp_qseq>
      <Hsp_hseq>FSELATKCIIKIVEFAKRLPGFTGLSIADQITLLKAACLDILMLRICTR-YTPEQDTM-TFSDGLTLNRTQMHNAGFGPLTDLVFAFAGQLLPLEMDDTE</Hsp_hseq>
      <Hsp_midline> ++L  + ++ +V+++K LPGF  L I DQITL++ + + +++  +  R Y      M  F+  L LN  +M  + F  L   ++    + + L++   E</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>282</Hit_num>
  <Hit_id>pdb|3KMR|A</Hit_id>
  <Hit_def>Crystal structure of RARalpha ligand binding domain in complex with an agonist ligand (Am580) and a coactivator fragment [Homo sapiens] &gt;pdb|3KMZ|A Crystal structure of RARalpha ligand binding domain in complex with the inverse agonist BMS493 and a corepressor fragment [Homo sapiens] &gt;pdb|3KMZ|B Crystal structure of RARalpha ligand binding domain in complex with the inverse agonist BMS493 and a corepressor fragment [Homo sapiens] &gt;pdb|7AOS|B Chain B, Retinoic acid receptor alpha [Homo sapiens]</Hit_def>
  <Hit_accession>3KMR_A</Hit_accession>
  <Hit_len>266</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>4.53832e-05</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>140</Hsp_query-to>
      <Hsp_hit-from>73</Hsp_hit-from>
      <Hsp_hit-to>170</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEE</Hsp_qseq>
      <Hsp_hseq>FSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTR-YTPEQDTM-TFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAE</Hsp_hseq>
      <Hsp_midline> ++L  + ++  V+++K LPGF  L I DQITL++ + + +++  +  R Y      M  F+  L LN  +M  + F  L   ++    + + L++   E</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>283</Hit_num>
  <Hit_id>pdb|2LBD|A</Hit_id>
  <Hit_def>LIGAND-BINDING DOMAIN OF THE HUMAN RETINOIC ACID RECEPTOR GAMMA BOUND TO ALL-TRANS RETINOIC ACID [Homo sapiens] &gt;pdb|3LBD|A Ligand-binding Domain Of The Human Retinoic Acid Receptor Gamma Bound To 9-cis Retinoic Acid [Homo sapiens] &gt;pdb|4LBD|A Ligand-binding Domain Of The Human Retinoic Acid Receptor Gamma Bound To The Synthetic Agonist Bms961 [Homo sapiens]</Hit_def>
  <Hit_accession>2LBD_A</Hit_accession>
  <Hit_len>267</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.0542</Hsp_bit-score>
      <Hsp_score>105</Hsp_score>
      <Hsp_evalue>4.59827e-05</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>140</Hsp_query-to>
      <Hsp_hit-from>74</Hsp_hit-from>
      <Hsp_hit-to>171</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>24</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEE</Hsp_qseq>
      <Hsp_hseq>FSELATKCIIKIVEFAKRLPGFTGLSIADQITLLKAACLDILMLRICTRYTPEQD--TMTFSDGLTLNRTQMHNAGFGPLTDLVFAFAGQLLPLEMDDTE</Hsp_hseq>
      <Hsp_midline> ++L  + ++ +V+++K LPGF  L I DQITL++ + + +++  +  R         + F+  L LN  +M  + F  L   ++    + + L++   E</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>284</Hit_num>
  <Hit_id>pdb|3A9E|B</Hit_id>
  <Hit_def>Crystal structure of a mixed agonist-bound RAR-alpha and antagonist-bound RXR-alpha heterodimer ligand binding domains [Homo sapiens]</Hit_def>
  <Hit_accession>3A9E_B</Hit_accession>
  <Hit_len>269</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>44.669</Hsp_bit-score>
      <Hsp_score>104</Hsp_score>
      <Hsp_evalue>4.80744e-05</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>140</Hsp_query-to>
      <Hsp_hit-from>76</Hsp_hit-from>
      <Hsp_hit-to>173</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>51</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>100</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEE</Hsp_qseq>
      <Hsp_hseq>FSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTR-YTPEQDTM-TFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAE</Hsp_hseq>
      <Hsp_midline> ++L  + ++  V+++K LPGF  L I DQITL++ + + +++  +  R Y      M  F+  L LN  +M  + F  L   ++    + + L++   E</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>285</Hit_num>
  <Hit_id>pdb|4LOG|A</Hit_id>
  <Hit_def>The crystal structure of the orphan nuclear receptor PNR ligand binding domain fused with MBP [Homo sapiens] &gt;pdb|4LOG|B The crystal structure of the orphan nuclear receptor PNR ligand binding domain fused with MBP [Homo sapiens]</Hit_def>
  <Hit_accession>4LOG_A</Hit_accession>
  <Hit_len>574</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>45.4394</Hsp_bit-score>
      <Hsp_score>106</Hsp_score>
      <Hsp_evalue>4.84999e-05</Hsp_evalue>
      <Hsp_query-from>28</Hsp_query-from>
      <Hsp_query-to>169</Hsp_query-to>
      <Hsp_hit-from>365</Hsp_hit-from>
      <Hsp_hit-to>505</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>38</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>5</Hsp_gaps>
      <Hsp_align-len>144</Hsp_align-len>
      <Hsp_qseq>NTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLY--FAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRS</Hsp_qseq>
      <Hsp_hseq>DAQTNAAAEFLDSIHETSARLLFMAVKWAKNLPVFSSLPFRDQVILLEEAWSELFLLGAIQWSLPLDSCPLLAPPEASAAGGAQGRLTLASMETRVLQ--ETISRFRALAVDPTEFACMKALVLFKP-ETRGLKDPEHVEALQD</Hsp_hseq>
      <Hsp_midline>+ + + ++  L S+++   R L   VKW+K+LP F +L   DQ+ L++ +W  L + G    S    S  +L    A      + R+  +S  +  L   +    F  L V   EF CMK L+L       GL+     E ++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>286</Hit_num>
  <Hit_id>pdb|3CJW|A</Hit_id>
  <Hit_def>Crystal structure of the human COUP-TFII ligand binding domain [Homo sapiens]</Hit_def>
  <Hit_accession>3CJW_A</Hit_accession>
  <Hit_len>244</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>44.669</Hsp_bit-score>
      <Hsp_score>104</Hsp_score>
      <Hsp_evalue>5.17915e-05</Hsp_evalue>
      <Hsp_query-from>11</Hsp_query-from>
      <Hsp_query-to>152</Hsp_query-to>
      <Hsp_hit-from>12</Hsp_hit-from>
      <Hsp_hit-to>153</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>150</Hsp_align-len>
      <Hsp_qseq>INLLMSIEP-DVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLI---LNEQRMKESSFYSLCLTMWQIPQEFVK----LQVSQEEFLCMKVLLLLNT</Hsp_qseq>
      <Hsp_hseq>ISLLLRAEPYPTSRFGSQCMQPNNIMGI-ENICELAARMLFSAVEWARNIPFFPDLQITDQVALLRLTWSELFVLNAAQCSMP------LHVAPLLAAAGLHASPMSADRVVAF-MDHIRIFQEQVEKLKALHVDSAEYSCLKAIVLFTS</Hsp_hseq>
      <Hsp_midline>I+LL+  EP      G    +P+    +  ++ +L  R L S V+W++++P F +L I DQ+ L++ +W  L V      S        L+ AP L    L+   M      +  +   +I QE V+    L V   E+ C+K ++L  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>287</Hit_num>
  <Hit_id>pdb|4OZR|U</Hit_id>
  <Hit_def>Crystal structure of the ligand binding domains of the Bovicola ovis ecdysone receptor EcR/USP heterodimer (methylene lactam crystal) [Pediculus humanus corporis]</Hit_def>
  <Hit_accession>4OZR_U</Hit_accession>
  <Hit_len>196</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>43.5134</Hsp_bit-score>
      <Hsp_score>101</Hsp_score>
      <Hsp_evalue>8.06751e-05</Hsp_evalue>
      <Hsp_query-from>34</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>1</Hsp_hit-from>
      <Hsp_hit-to>133</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>67</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>136</Hsp_align-len>
      <Hsp_qseq>SSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNE-QRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>AANAVANICQATNTQLYQLVEWAKHIPHFSSLPIEDQVLLLRAGWNELLIAAFSHRSVEVRDGIVLGAGITVHRNSAHQAGVGTIFDRVLT--ELVAKMRDMNMDRTELGSLRSIILFNP-EVRGLKSGQEVELLR</Hsp_hseq>
      <Hsp_midline>+++ + ++ Q    QL  +V+W+K +P F +L I+DQ+ L++  W  L++     RS +   G +L     +  N   +    + +   LT  ++  +   + + + E   ++ ++L N   + GL+S  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>288</Hit_num>
  <Hit_id>pdb|1LV2|A</Hit_id>
  <Hit_def>Hepatocyte Nuclear Factor 4 is a Transcription Factor that Constitutively Binds Fatty Acids [Homo sapiens]</Hit_def>
  <Hit_accession>1LV2_A</Hit_accession>
  <Hit_len>229</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>43.5134</Hsp_bit-score>
      <Hsp_score>101</Hsp_score>
      <Hsp_evalue>0.000103966</Hsp_evalue>
      <Hsp_query-from>46</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>45</Hsp_hit-from>
      <Hsp_hit-to>164</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>125</Hsp_align-len>
      <Hsp_qseq>ERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRS--YKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>KQQLLVLVEWAKYIPAFCELPLDDQVALLRAHAGEHLLLGATKRSMMYKDI----LLLGNNYVIHRNSCEVEISRVANRVLDELVRPFQEIQIDDNEYACLKAIVFFDP-DAKGLSDPVKIKNMR</Hsp_hseq>
      <Hsp_midline>++QLL +V+W+K +P F  L +DDQ+ L++      ++ G   RS  YK +    L    + +++    +          + ++ + F ++Q+   E+ C+K ++  +    +GL    + + MR</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>289</Hit_num>
  <Hit_id>pdb|6FX0|A</Hit_id>
  <Hit_def>Structure-based design of Trifarotene (CD5789), a potent and selective RAR gamma agonist for the treatment of acne [Homo sapiens]</Hit_def>
  <Hit_accession>6FX0_A</Hit_accession>
  <Hit_len>454</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>44.2838</Hsp_bit-score>
      <Hsp_score>103</Hsp_score>
      <Hsp_evalue>0.000107227</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>150</Hsp_query-to>
      <Hsp_hit-from>230</Hsp_hit-from>
      <Hsp_hit-to>337</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>25</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>110</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLL</Hsp_qseq>
      <Hsp_hseq>FSELATKCIIKIVEFAKRLPGFTGLSIADQITLLKAACLDILMLRICTRYTPEQ--DTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFAGQLLPLEMDDTETGLLSAICLI</Hsp_hseq>
      <Hsp_midline> ++L  + ++ +V+++K LPGF  L I DQITL++ + + +++  +  R         + F+  L LN  +M  + F  L   ++    + + L++   E   +  + L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>290</Hit_num>
  <Hit_id>pdb|4RZF|A</Hit_id>
  <Hit_def>Crystal Structure Analysis of the NUR77 Ligand Binding Domain, S441W mutant [Homo sapiens] &gt;pdb|4RZF|B Crystal Structure Analysis of the NUR77 Ligand Binding Domain, S441W mutant [Homo sapiens]</Hit_def>
  <Hit_accession>4RZF_A</Hit_accession>
  <Hit_len>256</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>43.1282</Hsp_bit-score>
      <Hsp_score>100</Hsp_score>
      <Hsp_evalue>0.000177966</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>206</Hsp_query-to>
      <Hsp_hit-from>67</Hsp_hit-from>
      <Hsp_hit-to>212</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>158</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR---SSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDL</Hsp_qseq>
      <Hsp_hseq>IRKWAEKIPGFAELSPADQDLLLEWAFLELFILRLAYRS-KPGEGKLI-FCSGLVLHRLQCAR-GFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITD--RHGLQEPRRVEELQNRIASCLKEHVAA-------VAGEPQPASCLSRLLGKLPEL</Hsp_hseq>
      <Hsp_midline>+ KW++ +PGF  L   DQ  L++++++ L +  L +RS K   G+++ F   L+L+  +     F     ++    +    L V    F C+  L+L+      GL+   + EE++   +S ++E + A       V    Q    L++LL  L +L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>291</Hit_num>
  <Hit_id>pdb|4OZT|U</Hit_id>
  <Hit_def>crystal structure of the ligand binding domains of the Bovicola ovis ecdysone receptor EcR/USP heterodimer (PonA crystal) [Pediculus humanus corporis]</Hit_def>
  <Hit_accession>4OZT_U</Hit_accession>
  <Hit_len>195</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>42.3578</Hsp_bit-score>
      <Hsp_score>98</Hsp_score>
      <Hsp_evalue>0.000202736</Hsp_evalue>
      <Hsp_query-from>38</Hsp_query-from>
      <Hsp_query-to>168</Hsp_query-to>
      <Hsp_hit-from>3</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>64</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>132</Hsp_align-len>
      <Hsp_qseq>LTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNE-QRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR</Hsp_qseq>
      <Hsp_hseq>VANICQATNSQLYQLVEWAKHIPHFSSLPIEDQVLLLRAGWNELLIAAFSHRSVEVRDGIVLGAGITVHRNSAHQAGVGTIFDRVLT--ELVAKMRDMNMDRTELGSLRSIILFNP-EVRGLKSGQEVELLR</Hsp_hseq>
      <Hsp_midline>+ ++ Q    QL  +V+W+K +P F +L I+DQ+ L++  W  L++     RS +   G +L     +  N   +    + +   LT  ++  +   + + + E   ++ ++L N   + GL+S  + E +R</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>292</Hit_num>
  <Hit_id>pdb|2XHS|A</Hit_id>
  <Hit_def>Crystal structure of the ligand binding domain of Fushi tarazu factor 1 of Drosophila melanogaster. [Drosophila melanogaster]</Hit_def>
  <Hit_accession>2XHS_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>42.3578</Hsp_bit-score>
      <Hsp_score>98</Hsp_score>
      <Hsp_evalue>0.00025211</Hsp_evalue>
      <Hsp_query-from>46</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>56</Hsp_hit-from>
      <Hsp_hit-to>161</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>29</Hsp_identity>
      <Hsp_positive>55</Hsp_positive>
      <Hsp_gaps>22</Hsp_gaps>
      <Hsp_align-len>117</Hsp_align-len>
      <Hsp_qseq>ERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSL-CLTMWQIPQ----------EFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>DQNLFSQVDWARNTVFFKDLKVDDQXKLLQHSWSDXLVL-------DHLHHRIHNGLPD----ETQLNNGQVFNLXSLGLLGVPQLGDYFNELQNKLQDLKFDXGDYVCXKFLILLN</Hsp_hseq>
      <Hsp_midline>++ L S V W+++   F++L +DDQ  L+Q+SW   +V         H+  ++    PD    E ++     ++L  L +  +PQ          +   L+    +++C K L+LLN</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>293</Hit_num>
  <Hit_id>pdb|2QW4|A</Hit_id>
  <Hit_def>Human NR4A1 ligand-binding domain [Homo sapiens] &gt;pdb|2QW4|B Human NR4A1 ligand-binding domain [Homo sapiens] &gt;pdb|2QW4|C Human NR4A1 ligand-binding domain [Homo sapiens] &gt;pdb|2QW4|D Human NR4A1 ligand-binding domain [Homo sapiens]</Hit_def>
  <Hit_accession>2QW4_A</Hit_accession>
  <Hit_len>273</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>42.3578</Hsp_bit-score>
      <Hsp_score>98</Hsp_score>
      <Hsp_evalue>0.00034027</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>206</Hsp_query-to>
      <Hsp_hit-from>92</Hsp_hit-from>
      <Hsp_hit-to>237</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>158</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR---SSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDL</Hsp_qseq>
      <Hsp_hseq>IRKWAEKIPGFAELSPADQDLLLESAFLELFILRLAYRS-KPGEGKLI-FCSGLVLHRLQCAR-GFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITD--RHGLQEPRRVEELQNRIASCLKEHVAA-------VAGEPQPASCLSRLLGKLPEL</Hsp_hseq>
      <Hsp_midline>+ KW++ +PGF  L   DQ  L++ +++ L +  L +RS K   G+++ F   L+L+  +     F     ++    +    L V    F C+  L+L+      GL+   + EE++   +S ++E + A       V    Q    L++LL  L +L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>294</Hit_num>
  <Hit_id>pdb|4RE8|A</Hit_id>
  <Hit_def>Crystal Structure of TR3 LBD in complex with Molecule 5 [Homo sapiens] &gt;pdb|4RE8|B Crystal Structure of TR3 LBD in complex with Molecule 5 [Homo sapiens] &gt;pdb|4REE|A Crystal Structure of TR3 LBD in complex with Molecule 6 [Homo sapiens] &gt;pdb|4REE|B Crystal Structure of TR3 LBD in complex with Molecule 6 [Homo sapiens] &gt;pdb|4RZG|A Crystal Structure Analysis of the DNPA-bounded NUR77 Ligand binding Domain [Homo sapiens] &gt;pdb|4RZG|B Crystal Structure Analysis of the DNPA-bounded NUR77 Ligand binding Domain [Homo sapiens]</Hit_def>
  <Hit_accession>4RE8_A</Hit_accession>
  <Hit_len>256</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.9726</Hsp_bit-score>
      <Hsp_score>97</Hsp_score>
      <Hsp_evalue>0.000377759</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>206</Hsp_query-to>
      <Hsp_hit-from>67</Hsp_hit-from>
      <Hsp_hit-to>212</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>158</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR---SSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDL</Hsp_qseq>
      <Hsp_hseq>IRKWAEKIPGFAELSPADQDLLLESAFLELFILRLAYRS-KPGEGKLI-FCSGLVLHRLQCAR-GFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITD--RHGLQEPRRVEELQNRIASCLKEHVAA-------VAGEPQPASCLSRLLGKLPEL</Hsp_hseq>
      <Hsp_midline>+ KW++ +PGF  L   DQ  L++ +++ L +  L +RS K   G+++ F   L+L+  +     F     ++    +    L V    F C+  L+L+      GL+   + EE++   +S ++E + A       V    Q    L++LL  L +L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>295</Hit_num>
  <Hit_id>pdb|3V3E|A</Hit_id>
  <Hit_def>Crystal Structure of the Human Nur77 Ligand-binding Domain [Homo sapiens] &gt;pdb|3V3E|B Crystal Structure of the Human Nur77 Ligand-binding Domain [Homo sapiens] &gt;pdb|3V3Q|A Crystal Structure of Human Nur77 Ligand-binding Domain in Complex with Ethyl 2-[2,3,4 trimethoxy-6(1-octanoyl)phenyl]acetate [Homo sapiens] &gt;pdb|3V3Q|B Crystal Structure of Human Nur77 Ligand-binding Domain in Complex with Ethyl 2-[2,3,4 trimethoxy-6(1-octanoyl)phenyl]acetate [Homo sapiens] &gt;pdb|4KZI|A Crystal Structure of TR3 LBD in complex with DPDO [Homo sapiens] &gt;pdb|4KZI|B Crystal Structure of TR3 LBD in complex with DPDO [Homo sapiens] &gt;pdb|4WHF|A Crystal Structure of TR3 LBD in complex with 1-(3,4,5-trihydroxyphenyl)decan-1-one [Homo sapiens] &gt;pdb|4WHF|B Crystal Structure of TR3 LBD in complex with 1-(3,4,5-trihydroxyphenyl)decan-1-one [Homo sapiens] &gt;pdb|4WHG|A Crystal Structure of TR3 LBD in complex with Molecule 3 [Homo sapiens] &gt;pdb|4WHG|B Crystal Structure of TR3 LBD in complex with Molecule 3 [Homo sapiens] &gt;pdb|6KZ5|A Crystal Structure Analysis of the Csn-B-bounded NUR77 Ligand binding Domain [Homo sapiens] &gt;pdb|6KZ5|B Crystal Structure Analysis of the Csn-B-bounded NUR77 Ligand binding Domain [Homo sapiens]</Hit_def>
  <Hit_accession>3V3E_A</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.9726</Hsp_bit-score>
      <Hsp_score>97</Hsp_score>
      <Hsp_evalue>0.000411832</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>206</Hsp_query-to>
      <Hsp_hit-from>68</Hsp_hit-from>
      <Hsp_hit-to>213</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>158</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR---SSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDL</Hsp_qseq>
      <Hsp_hseq>IRKWAEKIPGFAELSPADQDLLLESAFLELFILRLAYRS-KPGEGKLI-FCSGLVLHRLQCAR-GFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITD--RHGLQEPRRVEELQNRIASCLKEHVAA-------VAGEPQPASCLSRLLGKLPEL</Hsp_hseq>
      <Hsp_midline>+ KW++ +PGF  L   DQ  L++ +++ L +  L +RS K   G+++ F   L+L+  +     F     ++    +    L V    F C+  L+L+      GL+   + EE++   +S ++E + A       V    Q    L++LL  L +L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>296</Hit_num>
  <Hit_id>pdb|4JGV|A</Hit_id>
  <Hit_def>Crystal Structure of Human Nur77 Ligand-binding Domain in Complex with THPN [Homo sapiens] &gt;pdb|4JGV|B Crystal Structure of Human Nur77 Ligand-binding Domain in Complex with THPN [Homo sapiens]</Hit_def>
  <Hit_accession>4JGV_A</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.9726</Hsp_bit-score>
      <Hsp_score>97</Hsp_score>
      <Hsp_evalue>0.000425357</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>206</Hsp_query-to>
      <Hsp_hit-from>68</Hsp_hit-from>
      <Hsp_hit-to>213</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>158</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR---SSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDL</Hsp_qseq>
      <Hsp_hseq>IRKWAEKIPGFAELSPADQDLLLESAFLELFILRLAYRS-KPGEGKLI-FCSGLVLHRLQCAR-GFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITD--RHGLQEPRRVEELQNRIASCLKEHVAA-------VAGEPQPASCLSRLLGKLPEL</Hsp_hseq>
      <Hsp_midline>+ KW++ +PGF  L   DQ  L++ +++ L +  L +RS K   G+++ F   L+L+  +     F     ++    +    L V    F C+  L+L+      GL+   + EE++   +S ++E + A       V    Q    L++LL  L +L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>297</Hit_num>
  <Hit_id>pdb|4KZJ|A</Hit_id>
  <Hit_def>Crystal Structure of TR3 LBD L449W Mutant [Homo sapiens] &gt;pdb|4KZJ|B Crystal Structure of TR3 LBD L449W Mutant [Homo sapiens]</Hit_def>
  <Hit_accession>4KZJ_A</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.9726</Hsp_bit-score>
      <Hsp_score>97</Hsp_score>
      <Hsp_evalue>0.00045136</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>206</Hsp_query-to>
      <Hsp_hit-from>68</Hsp_hit-from>
      <Hsp_hit-to>213</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>158</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR---SSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDL</Hsp_qseq>
      <Hsp_hseq>IRKWAEKIPGFAELSPADQDLLLESAFLELFIWRLAYRS-KPGEGKLI-FCSGLVLHRLQCAR-GFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITD--RHGLQEPRRVEELQNRIASCLKEHVAA-------VAGEPQPASCLSRLLGKLPEL</Hsp_hseq>
      <Hsp_midline>+ KW++ +PGF  L   DQ  L++ +++ L ++ L +RS K   G+++ F   L+L+  +     F     ++    +    L V    F C+  L+L+      GL+   + EE++   +S ++E + A       V    Q    L++LL  L +L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>298</Hit_num>
  <Hit_id>pdb|4REF|A</Hit_id>
  <Hit_def>Crystal Structure of TR3 LBD_L449W in complex with Molecule 2 [Homo sapiens] &gt;pdb|4REF|B Crystal Structure of TR3 LBD_L449W in complex with Molecule 2 [Homo sapiens]</Hit_def>
  <Hit_accession>4REF_A</Hit_accession>
  <Hit_len>256</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.9726</Hsp_bit-score>
      <Hsp_score>97</Hsp_score>
      <Hsp_evalue>0.000457961</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>206</Hsp_query-to>
      <Hsp_hit-from>67</Hsp_hit-from>
      <Hsp_hit-to>212</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>74</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>158</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR---SSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDL</Hsp_qseq>
      <Hsp_hseq>IRKWAEKIPGFAELSPADQDLLLESAFLELFIWRLAYRS-KPGEGKLI-FCSGLVLHRLQCAR-GFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITD--RHGLQEPRRVEELQNRIASCLKEHVAA-------VAGEPQPASCLSRLLGKLPEL</Hsp_hseq>
      <Hsp_midline>+ KW++ +PGF  L   DQ  L++ +++ L ++ L +RS K   G+++ F   L+L+  +     F     ++    +    L V    F C+  L+L+      GL+   + EE++   +S ++E + A       V    Q    L++LL  L +L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>299</Hit_num>
  <Hit_id>pdb|4KZM|A</Hit_id>
  <Hit_def>Crystal Structure of TR3 LBD S553A Mutant [Homo sapiens] &gt;pdb|4KZM|B Crystal Structure of TR3 LBD S553A Mutant [Homo sapiens]</Hit_def>
  <Hit_accession>4KZM_A</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.5874</Hsp_bit-score>
      <Hsp_score>96</Hsp_score>
      <Hsp_evalue>0.000513135</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>206</Hsp_query-to>
      <Hsp_hit-from>68</Hsp_hit-from>
      <Hsp_hit-to>213</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>158</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR---SSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDL</Hsp_qseq>
      <Hsp_hseq>IRKWAEKIPGFAELSPADQDLLLESAFLELFILRLAYRS-KPGEGKLI-FCSGLVLHRLQCAR-GFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITD--RHGLQEPRRVEELQNRIASCLKEHVAA-------VAGEPQPASCLARLLGKLPEL</Hsp_hseq>
      <Hsp_midline>+ KW++ +PGF  L   DQ  L++ +++ L +  L +RS K   G+++ F   L+L+  +     F     ++    +    L V    F C+  L+L+      GL+   + EE++   +S ++E + A       V    Q    L +LL  L +L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>300</Hit_num>
  <Hit_id>pdb|1YJE|A</Hit_id>
  <Hit_def>Crystal structure of the rNGFI-B ligand-binding domain [Rattus norvegicus]</Hit_def>
  <Hit_accession>1YJE_A</Hit_accession>
  <Hit_len>264</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.2022</Hsp_bit-score>
      <Hsp_score>95</Hsp_score>
      <Hsp_evalue>0.000724762</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>206</Hsp_query-to>
      <Hsp_hit-from>83</Hsp_hit-from>
      <Hsp_hit-to>228</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>158</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR---SSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDL</Hsp_qseq>
      <Hsp_hseq>IRKWAEKIPGFIELSPGDQDLLLESAFLELFILRLAYRS-KPGEGKLI-FCSGLVLHRLQCAR-GFGDWIDNILAFSRSLHSLGVDVPAFACLSALVLITD--RHGLQDPRRVEELQNRIASCLKEHMAA-------VAGDPQPASCLSRLLGKLPEL</Hsp_hseq>
      <Hsp_midline>+ KW++ +PGF  L   DQ  L++ +++ L +  L +RS K   G+++ F   L+L+  +     F      +    +    L V    F C+  L+L+      GL+   + EE++   +S ++E + A       V    Q    L++LL  L +L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>301</Hit_num>
  <Hit_id>pdb|4RZE|A</Hit_id>
  <Hit_def>Crystal Structure Analysis of the NUR77 Ligand Binding Domain, L437W,D594E mutant [Homo sapiens] &gt;pdb|4RZE|B Crystal Structure Analysis of the NUR77 Ligand Binding Domain, L437W,D594E mutant [Homo sapiens]</Hit_def>
  <Hit_accession>4RZE_A</Hit_accession>
  <Hit_len>256</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>41.2022</Hsp_bit-score>
      <Hsp_score>95</Hsp_score>
      <Hsp_evalue>0.000830576</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>206</Hsp_query-to>
      <Hsp_hit-from>67</Hsp_hit-from>
      <Hsp_hit-to>212</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>39</Hsp_identity>
      <Hsp_positive>73</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>158</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMR---SSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDL</Hsp_qseq>
      <Hsp_hseq>IRKWAEKIPGFAELSPADQDWLLESAFLELFILRLAYRS-KPGEGKLI-FCSGLVLHRLQCAR-GFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITD--RHGLQEPRRVEELQNRIASCLKEHVAA-------VAGEPQPASCLSRLLGKLPEL</Hsp_hseq>
      <Hsp_midline>+ KW++ +PGF  L   DQ  L++ +++ L +  L +RS K   G+++ F   L+L+  +     F     ++    +    L V    F C+  L+L+      GL+   + EE++   +S ++E + A       V    Q    L++LL  L +L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>302</Hit_num>
  <Hit_id>pdb|6CHT|A</Hit_id>
  <Hit_def>HNF4alpha in complex with the corepressor EBP1 fragment [Homo sapiens] &gt;pdb|6CHT|B HNF4alpha in complex with the corepressor EBP1 fragment [Homo sapiens] &gt;pdb|6CHT|D HNF4alpha in complex with the corepressor EBP1 fragment [Homo sapiens] &gt;pdb|6CHT|E HNF4alpha in complex with the corepressor EBP1 fragment [Homo sapiens] &gt;pdb|6CHT|G HNF4alpha in complex with the corepressor EBP1 fragment [Homo sapiens] &gt;pdb|6CHT|H HNF4alpha in complex with the corepressor EBP1 fragment [Homo sapiens] &gt;pdb|6CHT|J HNF4alpha in complex with the corepressor EBP1 fragment [Homo sapiens] &gt;pdb|6CHT|K HNF4alpha in complex with the corepressor EBP1 fragment [Homo sapiens] &gt;pdb|6CHT|M HNF4alpha in complex with the corepressor EBP1 fragment [Homo sapiens] &gt;pdb|6CHT|N HNF4alpha in complex with the corepressor EBP1 fragment [Homo sapiens] &gt;pdb|6CHT|P HNF4alpha in complex with the corepressor EBP1 fragment [Homo sapiens] &gt;pdb|6CHT|Q HNF4alpha in complex with the corepressor EBP1 fragment [Homo sapiens] &gt;pdb|6CHT|S HNF4alpha in complex with the corepressor EBP1 fragment [Homo sapiens] &gt;pdb|6CHT|T HNF4alpha in complex with the corepressor EBP1 fragment [Homo sapiens] &gt;pdb|6CHT|V HNF4alpha in complex with the corepressor EBP1 fragment [Homo sapiens] &gt;pdb|6CHT|W HNF4alpha in complex with the corepressor EBP1 fragment [Homo sapiens]</Hit_def>
  <Hit_accession>6CHT_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>40.817</Hsp_bit-score>
      <Hsp_score>94</Hsp_score>
      <Hsp_evalue>0.00108658</Hsp_evalue>
      <Hsp_query-from>46</Hsp_query-from>
      <Hsp_query-to>183</Hsp_query-to>
      <Hsp_hit-from>46</Hsp_hit-from>
      <Hsp_hit-to>181</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>ERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQ--RMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQ</Hsp_qseq>
      <Hsp_hseq>KEQLLVLVEWAKYIPAFCELPLDDQVALLRAHAGEHLLLGATKRSM--VFKDVLLLGNDYIVPRHCPELAEMSRVSIRI-LDELVLPFQELQIDDNEYAYLKAIIFFDP-DAKGLSDPGKIKRLRSQVQVSLEDYINDRQ</Hsp_hseq>
      <Hsp_midline>+ QLL +V+W+K +P F  L +DDQ+ L++      ++ G   RS   V   +L    D I+      + E S  S+ + + ++   F +LQ+   E+  +K ++  +    +GL    + + +RS     L   I  RQ</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>303</Hit_num>
  <Hit_id>pdb|3FS1|A</Hit_id>
  <Hit_def>Crystal structure of HNF4a LBD in complex with the ligand and the coactivator PGC-1a fragment [Homo sapiens]</Hit_def>
  <Hit_accession>3FS1_A</Hit_accession>
  <Hit_len>230</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>39.6614</Hsp_bit-score>
      <Hsp_score>91</Hsp_score>
      <Hsp_evalue>0.0022411</Hsp_evalue>
      <Hsp_query-from>46</Hsp_query-from>
      <Hsp_query-to>183</Hsp_query-to>
      <Hsp_hit-from>45</Hsp_hit-from>
      <Hsp_hit-to>180</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>ERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQ--RMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQ</Hsp_qseq>
      <Hsp_hseq>KEQLLVLVEWAKYIPAFCELPLDDQVALLRAHAGEHLLLGATKRSM--VFKDVLLLGNDYIVPRHCPELAEMSRVSIRI-LDELVLPFQELQIDDNEYAYLKAIIFFDP-DAKGLSDPGKIKRLRSQVQVSLEDYINDRQ</Hsp_hseq>
      <Hsp_midline>+ QLL +V+W+K +P F  L +DDQ+ L++      ++ G   RS   V   +L    D I+      + E S  S+ + + ++   F +LQ+   E+  +K ++  +    +GL    + + +RS     L   I  RQ</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>304</Hit_num>
  <Hit_id>pdb|4B7W|A</Hit_id>
  <Hit_def>Ligand binding domain human hepatocyte nuclear factor 4alpha: Apo form [Homo sapiens] &gt;pdb|4B7W|B Ligand binding domain human hepatocyte nuclear factor 4alpha: Apo form [Homo sapiens] &gt;pdb|4B7W|C Ligand binding domain human hepatocyte nuclear factor 4alpha: Apo form [Homo sapiens] &gt;pdb|4B7W|D Ligand binding domain human hepatocyte nuclear factor 4alpha: Apo form [Homo sapiens]</Hit_def>
  <Hit_accession>4B7W_A</Hit_accession>
  <Hit_len>239</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>39.6614</Hsp_bit-score>
      <Hsp_score>91</Hsp_score>
      <Hsp_evalue>0.00237524</Hsp_evalue>
      <Hsp_query-from>46</Hsp_query-from>
      <Hsp_query-to>183</Hsp_query-to>
      <Hsp_hit-from>54</Hsp_hit-from>
      <Hsp_hit-to>189</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>ERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQ--RMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQ</Hsp_qseq>
      <Hsp_hseq>KEQLLVLVEWAKYIPAFCELPLDDQVALLRAHAGEHLLLGATKRSM--VFKDVLLLGNDYIVPRHCPELAEMSRVSIRI-LDELVLPFQELQIDDNEYAYLKAIIFFDP-DAKGLSDPGKIKRLRSQVQVSLEDYINDRQ</Hsp_hseq>
      <Hsp_midline>+ QLL +V+W+K +P F  L +DDQ+ L++      ++ G   RS   V   +L    D I+      + E S  S+ + + ++   F +LQ+   E+  +K ++  +    +GL    + + +RS     L   I  RQ</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>305</Hit_num>
  <Hit_id>pdb|1PZL|A</Hit_id>
  <Hit_def>Crystal structure of HNF4a LBD in complex with the ligand and the coactivator SRC-1 peptide [Homo sapiens]</Hit_def>
  <Hit_accession>1PZL_A</Hit_accession>
  <Hit_len>237</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>39.2762</Hsp_bit-score>
      <Hsp_score>90</Hsp_score>
      <Hsp_evalue>0.00262927</Hsp_evalue>
      <Hsp_query-from>46</Hsp_query-from>
      <Hsp_query-to>183</Hsp_query-to>
      <Hsp_hit-from>51</Hsp_hit-from>
      <Hsp_hit-to>186</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>66</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>140</Hsp_align-len>
      <Hsp_qseq>ERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQ--RMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQ</Hsp_qseq>
      <Hsp_hseq>KEQLLVLVEWAKYIPAFCELPLDDQVALLRAHAGEHLLLGATKRSM--VFKDVLLLGNDYIVPRHCPELAEMSRVSIRI-LDELVLPFQELQIDDNEYAYLKAIIFFDP-DAKGLSDPGKIKRLRSQVQVSLEDYINDRQ</Hsp_hseq>
      <Hsp_midline>+ QLL +V+W+K +P F  L +DDQ+ L++      ++ G   RS   V   +L    D I+      + E S  S+ + + ++   F +LQ+   E+  +K ++  +    +GL    + + +RS     L   I  RQ</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>306</Hit_num>
  <Hit_id>pdb|4WVD|A</Hit_id>
  <Hit_def>Identification of a novel FXR ligand that regulates metabolism [Homo sapiens] &gt;pdb|4WVD|B Identification of a novel FXR ligand that regulates metabolism [Homo sapiens]</Hit_def>
  <Hit_accession>4WVD_A</Hit_accession>
  <Hit_len>211</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.891</Hsp_bit-score>
      <Hsp_score>89</Hsp_score>
      <Hsp_evalue>0.0033413</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>44</Hsp_hit-from>
      <Hsp_hit-to>149</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>307</Hit_num>
  <Hit_id>pdb|3HC6|A</Hit_id>
  <Hit_def>FXR with SRC1 and GSK088 [Homo sapiens]</Hit_def>
  <Hit_accession>3HC6_A</Hit_accession>
  <Hit_len>232</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.891</Hsp_bit-score>
      <Hsp_score>89</Hsp_score>
      <Hsp_evalue>0.00396007</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>47</Hsp_hit-from>
      <Hsp_hit-to>152</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>308</Hit_num>
  <Hit_id>pdb|3GD2|A</Hit_id>
  <Hit_def>isoxazole ligand bound to farnesoid X receptor (FXR) [Homo sapiens]</Hit_def>
  <Hit_accession>3GD2_A</Hit_accession>
  <Hit_len>229</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.891</Hsp_bit-score>
      <Hsp_score>89</Hsp_score>
      <Hsp_evalue>0.00409099</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>44</Hsp_hit-from>
      <Hsp_hit-to>149</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>309</Hit_num>
  <Hit_id>pdb|5Y44|A</Hit_id>
  <Hit_def>A novel moderator XD4 for bile acid receptor [Homo sapiens]</Hit_def>
  <Hit_accession>5Y44_A</Hit_accession>
  <Hit_len>227</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.891</Hsp_bit-score>
      <Hsp_score>89</Hsp_score>
      <Hsp_evalue>0.00428336</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>44</Hsp_hit-from>
      <Hsp_hit-to>149</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>310</Hit_num>
  <Hit_id>pdb|6A5W|A</Hit_id>
  <Hit_def>FXR-LBD with HNC143 and SRC1 [Homo sapiens] &gt;pdb|6A5W|C FXR-LBD with HNC143 and SRC1 [Homo sapiens] &gt;pdb|6A5Y|A Crystal structure of human FXR/RXR-LBD heterodimer bound to HNC143 and 9cRA and SRC1 [Homo sapiens]</Hit_def>
  <Hit_accession>6A5W_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.891</Hsp_bit-score>
      <Hsp_score>89</Hsp_score>
      <Hsp_evalue>0.00438287</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>44</Hsp_hit-from>
      <Hsp_hit-to>149</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>311</Hit_num>
  <Hit_id>pdb|3P89|A</Hit_id>
  <Hit_def>FXR bound to a quinolinecarboxylic acid [Homo sapiens] &gt;pdb|6A5X|A FXR-LBD with HNC180 and SRC1 [Homo sapiens] &gt;pdb|6A5Z|A Crystal structure of human FXR/RXR-LBD heterodimer bound to HNC180 and 9cRA and SRC1 [Homo sapiens] &gt;pdb|6A5Z|H Crystal structure of human FXR/RXR-LBD heterodimer bound to HNC180 and 9cRA and SRC1 [Homo sapiens] &gt;pdb|6A60|A Crystal structure of human FXR/RXR-LBD heterodimer bound to GW4064 and 9cRA and SRC1 [Homo sapiens]</Hit_def>
  <Hit_accession>3P89_A</Hit_accession>
  <Hit_len>229</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.5058</Hsp_bit-score>
      <Hsp_score>88</Hsp_score>
      <Hsp_evalue>0.00460961</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>44</Hsp_hit-from>
      <Hsp_hit-to>149</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>312</Hit_num>
  <Hit_id>pdb|7D42|A</Hit_id>
  <Hit_def>Chain A, Bile acid receptor [Homo sapiens]</Hit_def>
  <Hit_accession>7D42_A</Hit_accession>
  <Hit_len>248</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.891</Hsp_bit-score>
      <Hsp_score>89</Hsp_score>
      <Hsp_evalue>0.00462456</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>65</Hsp_hit-from>
      <Hsp_hit-to>170</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>313</Hit_num>
  <Hit_id>pdb|4OIV|A</Hit_id>
  <Hit_def>Structural basis for small molecule NDB as a selective antagonist of FXR [Homo sapiens] &gt;pdb|4OIV|B Structural basis for small molecule NDB as a selective antagonist of FXR [Homo sapiens]</Hit_def>
  <Hit_accession>4OIV_A</Hit_accession>
  <Hit_len>226</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.5058</Hsp_bit-score>
      <Hsp_score>88</Hsp_score>
      <Hsp_evalue>0.00463105</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>44</Hsp_hit-from>
      <Hsp_hit-to>149</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>314</Hit_num>
  <Hit_id>pdb|3P88|A</Hit_id>
  <Hit_def>FXR bound to isoquinolinecarboxylic acid [Homo sapiens]</Hit_def>
  <Hit_accession>3P88_A</Hit_accession>
  <Hit_len>229</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.5058</Hsp_bit-score>
      <Hsp_score>88</Hsp_score>
      <Hsp_evalue>0.00465212</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>44</Hsp_hit-from>
      <Hsp_hit-to>149</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>315</Hit_num>
  <Hit_id>pdb|3L1B|A</Hit_id>
  <Hit_def>Complex Structure of FXR Ligand-binding domain with a tetrahydroazepinoindole compound [Homo sapiens]</Hit_def>
  <Hit_accession>3L1B_A</Hit_accession>
  <Hit_len>233</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.5058</Hsp_bit-score>
      <Hsp_score>88</Hsp_score>
      <Hsp_evalue>0.00482201</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>48</Hsp_hit-from>
      <Hsp_hit-to>153</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>316</Hit_num>
  <Hit_id>pdb|3FLI|A</Hit_id>
  <Hit_def>Discovery of XL335, a Highly Potent, Selective and Orally-Active Agonist of the Farnesoid X Receptor (FXR) [Homo sapiens]</Hit_def>
  <Hit_accession>3FLI_A</Hit_accession>
  <Hit_len>231</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.5058</Hsp_bit-score>
      <Hsp_score>88</Hsp_score>
      <Hsp_evalue>0.00505097</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>46</Hsp_hit-from>
      <Hsp_hit-to>151</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>317</Hit_num>
  <Hit_id>pdb|5Y41|A</Hit_id>
  <Hit_def>Crystal Structure of LIGAND-BOUND NURR1-LBD [Homo sapiens] &gt;pdb|5Y41|B Crystal Structure of LIGAND-BOUND NURR1-LBD [Homo sapiens] &gt;pdb|5YD6|A Crystal structure of PG-bound Nurr1-LBD [Homo sapiens] &gt;pdb|5YD6|B Crystal structure of PG-bound Nurr1-LBD [Homo sapiens] &gt;pdb|5YD6|C Crystal structure of PG-bound Nurr1-LBD [Homo sapiens] &gt;pdb|5YD6|D Crystal structure of PG-bound Nurr1-LBD [Homo sapiens]</Hit_def>
  <Hit_accession>5Y41_A</Hit_accession>
  <Hit_len>271</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.891</Hsp_bit-score>
      <Hsp_score>89</Hsp_score>
      <Hsp_evalue>0.00511252</Hsp_evalue>
      <Hsp_query-from>19</Hsp_query-from>
      <Hsp_query-to>206</Hsp_query-to>
      <Hsp_hit-from>64</Hsp_hit-from>
      <Hsp_hit-to>235</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>79</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>188</Hsp_align-len>
      <Hsp_qseq>PDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDL</Hsp_qseq>
      <Hsp_hseq>PDYQMSGDDTQHIQQFYDLLTGSMEI-------IRGWAEKIPGFADLPKADQDLLFESAFLELFVLRLAYRS-NPVEGKLIFCNGVVLHRLQCVR--GFGEWIDSIVEFSSNLQNMNIDISAFSCIAALAMVTE--RHGLKEPKRVEELQNKIVNCLKDHVTFNNGGL----NRPNYLSKLLGKLPEL</Hsp_hseq>
      <Hsp_midline>PD   +G D         LLT   ++       +  W++ +PGF +L   DQ  L + +++ L V  L +RS   V G++++    ++   Q ++   F     ++ +       + +    F C+  L ++      GL+   + EE+++  +  L   +     G+     R   L+KLL  L +L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>318</Hit_num>
  <Hit_id>pdb|3HC5|A</Hit_id>
  <Hit_def>FXR with SRC1 and GSK826 [Homo sapiens] &gt;pdb|3RVF|A FXR with SRC1 and GSK2034 [Homo sapiens]</Hit_def>
  <Hit_accession>3HC5_A</Hit_accession>
  <Hit_len>232</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.5058</Hsp_bit-score>
      <Hsp_score>88</Hsp_score>
      <Hsp_evalue>0.00516679</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>47</Hsp_hit-from>
      <Hsp_hit-to>152</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>319</Hit_num>
  <Hit_id>pdb|5WZX|A</Hit_id>
  <Hit_def>Structural basis for a pentacyclic oleanane-type triterpenoid as a ligand of FXR [Homo sapiens] &gt;pdb|5WZX|B Structural basis for a pentacyclic oleanane-type triterpenoid as a ligand of FXR [Homo sapiens]</Hit_def>
  <Hit_accession>5WZX_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.5058</Hsp_bit-score>
      <Hsp_score>88</Hsp_score>
      <Hsp_evalue>0.00526637</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>44</Hsp_hit-from>
      <Hsp_hit-to>149</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>320</Hit_num>
  <Hit_id>pdb|1OSH|A</Hit_id>
  <Hit_def>A Chemical, Genetic, and Structural Analysis of the nuclear bile acid receptor FXR [Homo sapiens]</Hit_def>
  <Hit_accession>1OSH_A</Hit_accession>
  <Hit_len>232</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.5058</Hsp_bit-score>
      <Hsp_score>88</Hsp_score>
      <Hsp_evalue>0.0053598</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>47</Hsp_hit-from>
      <Hsp_hit-to>152</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>321</Hit_num>
  <Hit_id>pdb|4QE6|A</Hit_id>
  <Hit_def>FXR with CDCA and NCoA-2 peptide [Homo sapiens] &gt;pdb|4QE8|A FXR with DM175 and NCoA-2 peptide [Homo sapiens] &gt;pdb|4QE8|B FXR with DM175 and NCoA-2 peptide [Homo sapiens]</Hit_def>
  <Hit_accession>4QE6_A</Hit_accession>
  <Hit_len>233</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.5058</Hsp_bit-score>
      <Hsp_score>88</Hsp_score>
      <Hsp_evalue>0.00543227</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>48</Hsp_hit-from>
      <Hsp_hit-to>153</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>322</Hit_num>
  <Hit_id>pdb|3RUT|A</Hit_id>
  <Hit_def>FXR with SRC1 and GSK359 [Homo sapiens] &gt;pdb|3RUU|A FXR with SRC1 and GSK237 [Homo sapiens] &gt;pdb|5ICK|A A unique binding model of FXR LBD with feroline [Homo sapiens] &gt;pdb|5ICK|B A unique binding model of FXR LBD with feroline [Homo sapiens] &gt;pdb|5YXB|A A ligand binding to FXR [Homo sapiens] &gt;pdb|5YXD|A A ligand F binding to FXR [Homo sapiens] &gt;pdb|5YXJ|A FXR ligand binding domain [Homo sapiens] &gt;pdb|5YXJ|B FXR ligand binding domain [Homo sapiens] &gt;pdb|5YXL|A A ligand M binding to FXR [Homo sapiens] &gt;pdb|5YXL|C A ligand M binding to FXR [Homo sapiens]</Hit_def>
  <Hit_accession>3RUT_A</Hit_accession>
  <Hit_len>229</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.5058</Hsp_bit-score>
      <Hsp_score>88</Hsp_score>
      <Hsp_evalue>0.00548778</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>44</Hsp_hit-from>
      <Hsp_hit-to>149</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>323</Hit_num>
  <Hit_id>pdb|5Y49|A</Hit_id>
  <Hit_def>A moderator XD22 binding to bile acid receptor [Homo sapiens] &gt;pdb|5Y49|B A moderator XD22 binding to bile acid receptor [Homo sapiens]</Hit_def>
  <Hit_accession>5Y49_A</Hit_accession>
  <Hit_len>227</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.5058</Hsp_bit-score>
      <Hsp_score>88</Hsp_score>
      <Hsp_evalue>0.00564213</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>43</Hsp_hit-from>
      <Hsp_hit-to>148</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>324</Hit_num>
  <Hit_id>pdb|5IAW|A</Hit_id>
  <Hit_def>Novel natural FXR modulator with a unique binding mode [Homo sapiens] &gt;pdb|5IAW|B Novel natural FXR modulator with a unique binding mode [Homo sapiens] &gt;pdb|5Z12|A A structure of FXR/RXR [Homo sapiens] &gt;pdb|5Z12|D A structure of FXR/RXR [Homo sapiens]</Hit_def>
  <Hit_accession>5IAW_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.5058</Hsp_bit-score>
      <Hsp_score>88</Hsp_score>
      <Hsp_evalue>0.00566763</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>43</Hsp_hit-from>
      <Hsp_hit-to>148</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>325</Hit_num>
  <Hit_id>pdb|6DDA|A</Hit_id>
  <Hit_def>Nurr1 Covalently Modified by a Dopamine Metabolite [Homo sapiens]</Hit_def>
  <Hit_accession>6DDA_A</Hit_accession>
  <Hit_len>272</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.5058</Hsp_bit-score>
      <Hsp_score>88</Hsp_score>
      <Hsp_evalue>0.00571729</Hsp_evalue>
      <Hsp_query-from>19</Hsp_query-from>
      <Hsp_query-to>206</Hsp_query-to>
      <Hsp_hit-from>65</Hsp_hit-from>
      <Hsp_hit-to>236</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>79</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>188</Hsp_align-len>
      <Hsp_qseq>PDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDL</Hsp_qseq>
      <Hsp_hseq>PDYQMSGDDTQHIQQFYDLLTGSMEI-------IRGWAEKIPGFADLPKADQDLLFESAFLELFVLRLAYRS-NPVEGKLIFXNGVVLHRLQCVR--GFGEWIDSIVEFSSNLQNMNIDISAFSCIAALAMVTE--RHGLKEPKRVEELQNKIVNCLKDHVTFNNGGL----NRPNYLSKLLGKLPEL</Hsp_hseq>
      <Hsp_midline>PD   +G D         LLT   ++       +  W++ +PGF +L   DQ  L + +++ L V  L +RS   V G++++    ++   Q ++   F     ++ +       + +    F C+  L ++      GL+   + EE+++  +  L   +     G+     R   L+KLL  L +L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>326</Hit_num>
  <Hit_id>pdb|6DDA|B</Hit_id>
  <Hit_def>Nurr1 Covalently Modified by a Dopamine Metabolite [Homo sapiens] &gt;pdb|6DDA|C Nurr1 Covalently Modified by a Dopamine Metabolite [Homo sapiens]</Hit_def>
  <Hit_accession>6DDA_B</Hit_accession>
  <Hit_len>272</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.5058</Hsp_bit-score>
      <Hsp_score>88</Hsp_score>
      <Hsp_evalue>0.00582211</Hsp_evalue>
      <Hsp_query-from>19</Hsp_query-from>
      <Hsp_query-to>206</Hsp_query-to>
      <Hsp_hit-from>65</Hsp_hit-from>
      <Hsp_hit-to>236</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>79</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>188</Hsp_align-len>
      <Hsp_qseq>PDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDL</Hsp_qseq>
      <Hsp_hseq>PDYQMSGDDTQHIQQFYDLLTGSMEI-------IRGWAEKIPGFADLPKADQDLLFESAFLELFVLRLAYRS-NPVEGKLIFCNGVVLHRLQCVR--GFGEWIDSIVEFSSNLQNMNIDISAFSCIAALAMVTE--RHGLKEPKRVEELQNKIVNCLKDHVTFNNGGL----NRPNYLSKLLGKLPEL</Hsp_hseq>
      <Hsp_midline>PD   +G D         LLT   ++       +  W++ +PGF +L   DQ  L + +++ L V  L +RS   V G++++    ++   Q ++   F     ++ +       + +    F C+  L ++      GL+   + EE+++  +  L   +     G+     R   L+KLL  L +L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>327</Hit_num>
  <Hit_id>pdb|6HL0|A</Hit_id>
  <Hit_def>Crystal Structure of Farnesoid X receptor (FXR) with bound NCoA-2 peptide [Homo sapiens] &gt;pdb|6HL1|A Crystal Structure of Farnesoid X receptor (FXR) with bound NCoA-2 peptide and CDCA [Homo sapiens]</Hit_def>
  <Hit_accession>6HL0_A</Hit_accession>
  <Hit_len>232</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.5058</Hsp_bit-score>
      <Hsp_score>88</Hsp_score>
      <Hsp_evalue>0.00592847</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>47</Hsp_hit-from>
      <Hsp_hit-to>152</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>328</Hit_num>
  <Hit_id>pdb|3BEJ|A</Hit_id>
  <Hit_def>Structure of human FXR in complex with MFA-1 and co-activator peptide [Homo sapiens] &gt;pdb|3BEJ|B Structure of human FXR in complex with MFA-1 and co-activator peptide [Homo sapiens]</Hit_def>
  <Hit_accession>3BEJ_A</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.1206</Hsp_bit-score>
      <Hsp_score>87</Hsp_score>
      <Hsp_evalue>0.0062455</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>53</Hsp_hit-from>
      <Hsp_hit-to>158</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>329</Hit_num>
  <Hit_id>pdb|4IQR|A</Hit_id>
  <Hit_def>Multi-Domain Organization of the HNF4alpha Nuclear Receptor Complex on DNA [Homo sapiens] &gt;pdb|4IQR|B Multi-Domain Organization of the HNF4alpha Nuclear Receptor Complex on DNA [Homo sapiens] &gt;pdb|4IQR|E Multi-Domain Organization of the HNF4alpha Nuclear Receptor Complex on DNA [Homo sapiens] &gt;pdb|4IQR|F Multi-Domain Organization of the HNF4alpha Nuclear Receptor Complex on DNA [Homo sapiens]</Hit_def>
  <Hit_accession>4IQR_A</Hit_accession>
  <Hit_len>338</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.5058</Hsp_bit-score>
      <Hsp_score>88</Hsp_score>
      <Hsp_evalue>0.00660838</Hsp_evalue>
      <Hsp_query-from>9</Hsp_query-from>
      <Hsp_query-to>169</Hsp_query-to>
      <Hsp_hit-from>111</Hsp_hit-from>
      <Hsp_hit-to>274</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>41</Hsp_identity>
      <Hsp_positive>75</Hsp_positive>
      <Hsp_gaps>11</Hsp_gaps>
      <Hsp_align-len>168</Hsp_align-len>
      <Hsp_qseq>PLINLLMSIE--PDVIYAGHDNTKPDTSSSLLTSLNQLGE---RQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQ--RMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRS</Hsp_qseq>
      <Hsp_hseq>PSINALLQAEVLSRQITSPVSGINGDIRAKKIASIADVCESMKEQLLVLVEWAKYIPAFCELPLDDQVALLRAHAGEHLLLGATKRSM--VFKDVLLLGNDYIVPRHCPELAEMSRVSI-RILDELVLPFQELQIDDNEYAYLKAIIFFDP-DAKGLSDPGKIKRLRS</Hsp_hseq>
      <Hsp_midline>P IN L+  E     I +       D  +  + S+  + E    QLL +V+W+K +P F  L +DDQ+ L++      ++ G   RS   V   +L    D I+      + E S  S+   + ++   F +LQ+   E+  +K ++  +    +GL    + + +RS</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>330</Hit_num>
  <Hit_id>pdb|3DCT|A</Hit_id>
  <Hit_def>FXR with SRC1 and GW4064 [Homo sapiens] &gt;pdb|3DCU|A FXR with SRC1 and GSK8062 [Homo sapiens]</Hit_def>
  <Hit_accession>3DCT_A</Hit_accession>
  <Hit_len>235</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.1206</Hsp_bit-score>
      <Hsp_score>87</Hsp_score>
      <Hsp_evalue>0.00701441</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>50</Hsp_hit-from>
      <Hsp_hit-to>155</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>331</Hit_num>
  <Hit_id>pdb|1OT7|A</Hit_id>
  <Hit_def>Structural Basis for 3-deoxy-CDCA Binding and Activation of FXR [Rattus norvegicus] &gt;pdb|1OT7|B Structural Basis for 3-deoxy-CDCA Binding and Activation of FXR [Rattus norvegicus]</Hit_def>
  <Hit_accession>1OT7_A</Hit_accession>
  <Hit_len>229</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.1206</Hsp_bit-score>
      <Hsp_score>87</Hsp_score>
      <Hsp_evalue>0.00749614</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>45</Hsp_hit-from>
      <Hsp_hit-to>150</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>62</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATSHVQILVEFTKRLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPAGHADLL--EERIRKSGISDEYITPMFSFYKSVGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R+++S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>332</Hit_num>
  <Hit_id>pdb|1OSV|A</Hit_id>
  <Hit_def>Structural Basis For Bile Acid Binding And Activation Of The Nuclear Receptor Fxr [Rattus norvegicus] &gt;pdb|1OSV|B Structural Basis For Bile Acid Binding And Activation Of The Nuclear Receptor Fxr [Rattus norvegicus]</Hit_def>
  <Hit_accession>1OSV_A</Hit_accession>
  <Hit_len>230</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>38.1206</Hsp_bit-score>
      <Hsp_score>87</Hsp_score>
      <Hsp_evalue>0.00766783</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>45</Hsp_hit-from>
      <Hsp_hit-to>150</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>62</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATSHVQILVEFTKRLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPAGHADLL--EERIRKSGISDEYITPMFSFYKSVGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E+R+++S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>333</Hit_num>
  <Hit_id>pdb|5Y1J|A</Hit_id>
  <Hit_def>Crystal structure of human FXR in complex with a functional drug ligand [Homo sapiens]</Hit_def>
  <Hit_accession>5Y1J_A</Hit_accession>
  <Hit_len>228</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>37.7354</Hsp_bit-score>
      <Hsp_score>86</Hsp_score>
      <Hsp_evalue>0.00921579</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>44</Hsp_hit-from>
      <Hsp_hit-to>149</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>60</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EARIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>334</Hit_num>
  <Hit_id>pdb|6ITM|A</Hit_id>
  <Hit_def>Crystal structure of FXR in complex with agonist XJ034 [Homo sapiens] &gt;pdb|6ITM|C Crystal structure of FXR in complex with agonist XJ034 [Homo sapiens]</Hit_def>
  <Hit_accession>6ITM_A</Hit_accession>
  <Hit_len>240</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>37.7354</Hsp_bit-score>
      <Hsp_score>86</Hsp_score>
      <Hsp_evalue>0.00958414</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>55</Hsp_hit-from>
      <Hsp_hit-to>160</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>60</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EARIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>335</Hit_num>
  <Hit_id>pdb|4N73|A</Hit_id>
  <Hit_def>Crystal structure of the ligand binding domain (LBD) of REV-ERB beta bound to Cobalt Protoporphyrin IX [Homo sapiens]</Hit_def>
  <Hit_accession>4N73_A</Hit_accession>
  <Hit_len>199</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>37.3502</Hsp_bit-score>
      <Hsp_score>85</Hsp_score>
      <Hsp_evalue>0.00979997</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>175</Hsp_query-to>
      <Hsp_hit-from>37</Hsp_hit-from>
      <Hsp_hit-to>157</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>63</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQY-SWMSLMV-----FGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIREL</Hsp_qseq>
      <Hsp_hseq>VVEFAKRIPGFRDLSQHDQVNLLKAGTFEVLMVRFASLFDAKERTVTFLSGKK-YSVDDL----HSMGAG---DLLNSMFEFSEKLNALQLSDEEMSLFTAVVLV-SADRSGIENVNSVEALQETLIRAL</Hsp_hseq>
      <Hsp_midline>VV+++K +PGFR+L   DQ+ L++  ++  LMV     F    R+   +SG+  Y   DL      M       L  +M++  ++   LQ+S EE      ++L+ +    G+ +    E ++ + IR L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>336</Hit_num>
  <Hit_id>pdb|6WMQ|A</Hit_id>
  <Hit_def>Chain A, Nuclear receptor Rev-ErbA beta variant 1 [Homo sapiens] &gt;pdb|6WMQ|B Chain B, Nuclear receptor Rev-ErbA beta variant 1 [Homo sapiens] &gt;pdb|6WMS|A Chain A, Nuclear receptor Rev-ErbA beta variant 1 [Homo sapiens] &gt;pdb|6WMS|B Chain B, Nuclear receptor Rev-ErbA beta variant 1 [Homo sapiens]</Hit_def>
  <Hit_accession>6WMQ_A</Hit_accession>
  <Hit_len>199</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>37.3502</Hsp_bit-score>
      <Hsp_score>85</Hsp_score>
      <Hsp_evalue>0.0101699</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>175</Hsp_query-to>
      <Hsp_hit-from>36</Hsp_hit-from>
      <Hsp_hit-to>156</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>35</Hsp_identity>
      <Hsp_positive>63</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQY-SWMSLMV-----FGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIREL</Hsp_qseq>
      <Hsp_hseq>VVEFAKRIPGFRDLSQHDQVNLLKAGTFEVLMVRFASLFDAKERTVTFLSGKK-YSVDDL----HSMGAG---DLLNSMFEFSEKLNALQLSDEEMSLFTAVVLV-SADRSGIENVNSVEALQETLIRAL</Hsp_hseq>
      <Hsp_midline>VV+++K +PGFR+L   DQ+ L++  ++  LMV     F    R+   +SG+  Y   DL      M       L  +M++  ++   LQ+S EE      ++L+ +    G+ +    E ++ + IR L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>337</Hit_num>
  <Hit_id>pdb|1Z5X|E</Hit_id>
  <Hit_def>hemipteran ecdysone receptor ligand-binding domain complexed with ponasterone A [Bemisia tabaci]</Hit_def>
  <Hit_accession>1Z5X_E</Hit_accession>
  <Hit_len>310</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>37.7354</Hsp_bit-score>
      <Hsp_score>86</Hsp_score>
      <Hsp_evalue>0.0102544</Hsp_evalue>
      <Hsp_query-from>28</Hsp_query-from>
      <Hsp_query-to>235</Hsp_query-to>
      <Hsp_hit-from>105</Hsp_hit-from>
      <Hsp_hit-to>305</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>89</Hsp_positive>
      <Hsp_gaps>13</Hsp_gaps>
      <Hsp_align-len>211</Hsp_align-len>
      <Hsp_qseq>NTKPDTSSSLLTSLNQLGERQLLSV---VKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEV</Hsp_qseq>
      <Hsp_hseq>NAAPEEENVAEERFRHITEITILTVQLIVEFSKRLPGFDKLIREDQIALLKACSSEVMMFRMA-RRYDAETDSIL-FATNQPYTRESYTVAGMGDTVEDLLRFCRHMCAMKVDNAEYALLTAIVIFSERP--SLSEGWKVEKIQEIYIEALKAYVENRRKPYATTI--FAKLLSVLTELRTLGNMNSETCFSLKLKNRKV----PSFLEEI</Hsp_hseq>
      <Hsp_midline>N  P+  +        + E  +L+V   V++SK LPGF  L  +DQI L++     +M+F +  R Y   +  +L FA +     +    +        + +  +    ++V   E+  +  +++ +  P   L    + E+++  YI  L   +  R+K   ++   F +L  +L  L  L       C +  +++R +    P  + E+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>338</Hit_num>
  <Hit_id>pdb|3FXV|A</Hit_id>
  <Hit_def>Identification of an N-oxide pyridine GW4064 analogue as a potent FXR agonist [Homo sapiens] &gt;pdb|3OKH|A Crystal structure of human FXR in complex with 2-(4-chlorophenyl)-1-[(1S)-1-cyclohexyl-2-(cyclohexylamino)-2-oxoethyl]-1H-benzimidazole-6-carboxylic acid [Homo sapiens] &gt;pdb|3OKI|A Crystal structure of human FXR in complex with (2S)-2-[2-(4-chlorophenyl)-1H-benzimidazol-1-yl]-N,2-dicyclohexylethanamide [Homo sapiens] &gt;pdb|3OKI|C Crystal structure of human FXR in complex with (2S)-2-[2-(4-chlorophenyl)-1H-benzimidazol-1-yl]-N,2-dicyclohexylethanamide [Homo sapiens] &gt;pdb|3OLF|A Crystal structure of human FXR in complex with 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)-3-methylbenzoic acid [Homo sapiens] &gt;pdb|3OLF|C Crystal structure of human FXR in complex with 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)-3-methylbenzoic acid [Homo sapiens] &gt;pdb|3OMK|A Crystal structure of human FXR in complex with (2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexyl-N-(2-methylphenyl)ethanamide [Homo sapiens] &gt;pdb|3OMK|C Crystal structure of human FXR in complex with (2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexyl-N-(2-methylphenyl)ethanamide [Homo sapiens] &gt;pdb|3OMM|A Crystal structure of human FXR in complex with 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)-3-fluorobenzoic acid [Homo sapiens] &gt;pdb|3OMM|C Crystal structure of human FXR in complex with 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)-3-fluorobenzoic acid [Homo sapiens] &gt;pdb|3OOF|A Crystal structure of human FXR in complex with 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)benzoic acid [Homo sapiens] &gt;pdb|3OOF|C Crystal structure of human FXR in complex with 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)benzoic acid [Homo sapiens] &gt;pdb|3OOK|A Crystal structure of human FXR in complex with 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)-3,5-difluorobenzoic acid [Homo sapiens] &gt;pdb|3OOK|C Crystal structure of human FXR in complex with 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)-3,5-difluorobenzoic acid [Homo sapiens] &gt;pdb|5Q0I|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0J|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0J|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0K|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0M|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0N|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0N|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0O|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0O|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0P|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0P|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0Q|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0Q|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0R|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0S|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0S|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0T|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0U|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0U|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0V|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0V|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0W|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0X|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0Y|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0Y|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0Z|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0Z|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q10|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q11|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q12|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q13|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q13|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q14|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q14|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q15|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q15|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q16|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q16|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q17|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q18|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q18|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q19|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q19|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q1A|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q1A|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q1B|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q1B|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q1C|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q1C|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q1D|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q1D|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q1E|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q1F|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q1F|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q1G|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q1H|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q1H|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q1H|E Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q1H|G Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q1I|A Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens]</Hit_def>
  <Hit_accession>3FXV_A</Hit_accession>
  <Hit_len>233</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>37.7354</Hsp_bit-score>
      <Hsp_score>86</Hsp_score>
      <Hsp_evalue>0.0106003</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>48</Hsp_hit-from>
      <Hsp_hit-to>153</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>28</Hsp_identity>
      <Hsp_positive>60</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFL----RSAEIFNKKLPSGHSDLL--EARIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L ++    +  +V+++K LPGF+ L  +DQI L++ S +  M      RS +  + ++     DL+  E R++ S      +T M+   +   +L+++QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>339</Hit_num>
  <Hit_id>pdb|3N00|A</Hit_id>
  <Hit_def>Crystal Structure of a deletion mutant of human Reverba ligand binding domain bound with an NCoR ID1 peptide determined to 2.60A [Homo sapiens]</Hit_def>
  <Hit_accession>3N00_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>37.3502</Hsp_bit-score>
      <Hsp_score>85</Hsp_score>
      <Hsp_evalue>0.0148469</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>170</Hsp_query-to>
      <Hsp_hit-from>81</Hsp_hit-from>
      <Hsp_hit-to>196</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>119</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSS</Hsp_qseq>
      <Hsp_hseq>VVEFAKHIPGFRDLSQHDQVTLLKAGTFEVLM--VRFASLFNVKDQTVMFLSRTTYSLQELGAMGMGDLLSAMFDFSEKLNSLALTEEE-LGLFTAVVLVSADRSGMENSASVEQLQET</Hsp_hseq>
      <Hsp_midline>VV+++K +PGFR+L   DQ+TL++     +++  + + S  +V  Q + F      + Q +       L   M+   ++   L +++EE L +   ++L +    G+ +    E+++ +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>340</Hit_num>
  <Hit_id>pdb|1OVL|B</Hit_id>
  <Hit_def>Crystal Structure of Nurr1 LBD [Homo sapiens] &gt;pdb|1OVL|C Crystal Structure of Nurr1 LBD [Homo sapiens] &gt;pdb|1OVL|E Crystal Structure of Nurr1 LBD [Homo sapiens] &gt;pdb|1OVL|F Crystal Structure of Nurr1 LBD [Homo sapiens]</Hit_def>
  <Hit_accession>1OVL_B</Hit_accession>
  <Hit_len>271</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>37.3502</Hsp_bit-score>
      <Hsp_score>85</Hsp_score>
      <Hsp_evalue>0.0151951</Hsp_evalue>
      <Hsp_query-from>19</Hsp_query-from>
      <Hsp_query-to>206</Hsp_query-to>
      <Hsp_hit-from>64</Hsp_hit-from>
      <Hsp_hit-to>235</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>188</Hsp_align-len>
      <Hsp_qseq>PDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDL</Hsp_qseq>
      <Hsp_hseq>PDYQMSGDDTQHIQQFYDLLTGSXEI-------IRGWAEKIPGFADLPKADQDLLFESAFLELFVLRLAYRS-NPVEGKLIFCNGVVLHRLQCVR--GFGEWIDSIVEFSSNLQNXNIDISAFSCIAALAXVTE--RHGLKEPKRVEELQNKIVNCLKDHVTFNNGGL----NRPNYLSKLLGKLPEL</Hsp_hseq>
      <Hsp_midline>PD   +G D         LLT   ++       +  W++ +PGF +L   DQ  L + +++ L V  L +RS   V G++++    ++   Q ++   F     ++ +         +    F C+  L  +      GL+   + EE+++  +  L   +     G+     R   L+KLL  L +L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>341</Hit_num>
  <Hit_id>pdb|1PRG|A</Hit_id>
  <Hit_def>Ligand Binding Domain Of The Human Peroxisome Proliferator Activated Receptor Gamma [Homo sapiens] &gt;pdb|1PRG|B Ligand Binding Domain Of The Human Peroxisome Proliferator Activated Receptor Gamma [Homo sapiens] &gt;pdb|2QMV|A High Resolution Structure of Peroxisone Proliferation-Activated Receptor gamma and Characterisation of its Interaction with the Co-activator Transcriptional Intermediary Factor 2 [Homo sapiens] &gt;pdb|4FGY|A Identification of a unique PPAR ligand with an unexpected binding mode and antibetic activity [Homo sapiens] &gt;pdb|4PRG|A 0072 PARTIAL AGONIST PPAR GAMMA COCRYSTAL [Homo sapiens] &gt;pdb|4PRG|B 0072 PARTIAL AGONIST PPAR GAMMA COCRYSTAL [Homo sapiens] &gt;pdb|4PRG|C 0072 PARTIAL AGONIST PPAR GAMMA COCRYSTAL [Homo sapiens] &gt;pdb|4PRG|D 0072 PARTIAL AGONIST PPAR GAMMA COCRYSTAL [Homo sapiens]</Hit_def>
  <Hit_accession>1PRG_A</Hit_accession>
  <Hit_len>270</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0219777</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>90</Hsp_hit-from>
      <Hsp_hit-to>115</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>342</Hit_num>
  <Hit_id>pdb|7AHJ|A</Hit_id>
  <Hit_def>Crystal structure of PPARgamma V290M mutant ligand binding domain in complex with farglitazar [Homo sapiens] &gt;pdb|7AHJ|B Crystal structure of PPARgamma V290M mutant ligand binding domain in complex with farglitazar [Homo sapiens]</Hit_def>
  <Hit_accession>7AHJ_A</Hit_accession>
  <Hit_len>275</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.965</Hsp_bit-score>
      <Hsp_score>84</Hsp_score>
      <Hsp_evalue>0.0220538</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>94</Hsp_hit-from>
      <Hsp_hit-to>119</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>343</Hit_num>
  <Hit_id>pdb|2ATH|A</Hit_id>
  <Hit_def>Crystal structure of the ligand binding domain of human PPAR-gamma im complex with an agonist [Homo sapiens] &gt;pdb|2ATH|B Crystal structure of the ligand binding domain of human PPAR-gamma im complex with an agonist [Homo sapiens] &gt;pdb|2F4B|A Crystal structure of the ligand binding domain of human PPAR-gamma in complex with an agonist [Homo sapiens] &gt;pdb|2F4B|B Crystal structure of the ligand binding domain of human PPAR-gamma in complex with an agonist [Homo sapiens] &gt;pdb|2FVJ|A A novel anti-adipogenic partial agonist of peroxisome proliferator-activated receptor-gamma (PPARG) recruits pparg-coactivator-1 alpha (PGC1A) but potentiates insulin signaling in vitro [Homo sapiens] &gt;pdb|2G0G|A Structure-based drug design of a novel family of PPAR partial agonists: virtual screening, x-ray crystallography and in vitro/in vivo biological activities [Homo sapiens] &gt;pdb|2G0G|B Structure-based drug design of a novel family of PPAR partial agonists: virtual screening, x-ray crystallography and in vitro/in vivo biological activities [Homo sapiens] &gt;pdb|2G0H|A Structure-based drug design of a novel family of PPAR partial agonists: virtual screening, x-ray crystallography and in vitro/in vivo biological activities [Homo sapiens] &gt;pdb|2G0H|B Structure-based drug design of a novel family of PPAR partial agonists: virtual screening, x-ray crystallography and in vitro/in vivo biological activities [Homo sapiens] &gt;pdb|2GTK|A Structure-based Design of Indole Propionic Acids as Novel PPARag CO-Agonists [Homo sapiens] &gt;pdb|2HWQ|A Structural basis for the structure-activity relationships of Peroxisome Proliferator-Activated Receptor agonists [Homo sapiens] &gt;pdb|2HWQ|B Structural basis for the structure-activity relationships of Peroxisome Proliferator-Activated Receptor agonists [Homo sapiens] &gt;pdb|2HWR|A Structural basis for the structure-activity relationships of Peroxisome Proliferator-Activated Receptor agonists [Homo sapiens] &gt;pdb|2HWR|B Structural basis for the structure-activity relationships of Peroxisome Proliferator-Activated Receptor agonists [Homo sapiens] &gt;pdb|2PRG|A LIGAND-BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA [Homo sapiens] &gt;pdb|2PRG|B LIGAND-BINDING DOMAIN OF THE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA [Homo sapiens] &gt;pdb|2Q8S|A X-ray Crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a PPAR gamma/alpha dual agonist [Homo sapiens] &gt;pdb|2Q8S|B X-ray Crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a PPAR gamma/alpha dual agonist [Homo sapiens] &gt;pdb|3FEJ|A Design and biological evaluation of novel, balanced dual PPARa/g agonists [Homo sapiens] &gt;pdb|3G9E|A Aleglitaar. a new. potent, and balanced dual ppara/g agonist for the treatment of type II diabetes [Homo sapiens] &gt;pdb|3GBK|A Crystal Structure of Human PPAR-gamma Ligand Binding Domain Complexed with a Potent and Selective Agonist [Homo sapiens] &gt;pdb|3GBK|B Crystal Structure of Human PPAR-gamma Ligand Binding Domain Complexed with a Potent and Selective Agonist [Homo sapiens] &gt;pdb|3IA6|A X-ray Crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a PPAR gamma/alpha dual agonist [Homo sapiens] &gt;pdb|3IA6|B X-ray Crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a PPAR gamma/alpha dual agonist [Homo sapiens] &gt;pdb|3NOA|A Crystal structure of human PPAR-gamma ligand binding domain complex with a potency improved agonist [Homo sapiens] &gt;pdb|3NOA|B Crystal structure of human PPAR-gamma ligand binding domain complex with a potency improved agonist [Homo sapiens] &gt;pdb|3QT0|A Revealing a steroid receptor ligand as a unique PPARgamma agonist [Homo sapiens] &gt;pdb|5UGM|A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Edaglitazone [Homo sapiens] &gt;pdb|5UGM|B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Edaglitazone [Homo sapiens] &gt;pdb|6DH9|A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with MSDC-0602 [Homo sapiens] &gt;pdb|6DH9|B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with MSDC-0602 [Homo sapiens] &gt;pdb|6DHA|A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Hydroxy Pioglitazone (M-IV) [Homo sapiens] &gt;pdb|6DHA|B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Hydroxy Pioglitazone (M-IV) [Homo sapiens]</Hit_def>
  <Hit_accession>2ATH_A</Hit_accession>
  <Hit_len>271</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0222343</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>90</Hsp_hit-from>
      <Hsp_hit-to>115</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>344</Hit_num>
  <Hit_id>pdb|6FZG|A</Hit_id>
  <Hit_def>PPAR gamma mutant complex [Homo sapiens]</Hit_def>
  <Hit_accession>6FZG_A</Hit_accession>
  <Hit_len>276</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0223085</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>95</Hsp_hit-from>
      <Hsp_hit-to>120</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>345</Hit_num>
  <Hit_id>pdb|2VSR|A</Hit_id>
  <Hit_def>hPPARgamma Ligand binding domain in complex with 9-(S)-HODE [Homo sapiens] &gt;pdb|2VSR|B hPPARgamma Ligand binding domain in complex with 9-(S)-HODE [Homo sapiens] &gt;pdb|2VST|A hPPARgamma Ligand binding domain in complex with 13-(S)-HODE [Homo sapiens] &gt;pdb|2VST|B hPPARgamma Ligand binding domain in complex with 13-(S)-HODE [Homo sapiens] &gt;pdb|2VV0|A hPPARgamma Ligand binding domain in complex with DHA [Homo sapiens] &gt;pdb|2VV0|B hPPARgamma Ligand binding domain in complex with DHA [Homo sapiens] &gt;pdb|2VV1|A hPPARgamma Ligand binding domain in complex with 4-HDHA [Homo sapiens] &gt;pdb|2VV2|A hPPARgamma Ligand binding domain in complex with 5-HEPA [Homo sapiens] &gt;pdb|2VV2|B hPPARgamma Ligand binding domain in complex with 5-HEPA [Homo sapiens] &gt;pdb|2VV3|A hPPARgamma Ligand binding domain in complex with 4-oxoDHA [Homo sapiens] &gt;pdb|2VV3|B hPPARgamma Ligand binding domain in complex with 4-oxoDHA [Homo sapiens] &gt;pdb|2VV4|A hPPARgamma Ligand binding domain in complex with 6-oxoOTE [Homo sapiens] &gt;pdb|3X1H|A hPPARgamma Ligand binding domain in complex with 5-oxo-tricosahexaenoic acid [Homo sapiens] &gt;pdb|3X1H|B hPPARgamma Ligand binding domain in complex with 5-oxo-tricosahexaenoic acid [Homo sapiens] &gt;pdb|3X1I|A hPPARgamma Ligand binding domain in complex with 6-oxo-tetracosahexaenoic acid [Homo sapiens] &gt;pdb|3X1I|B hPPARgamma Ligand binding domain in complex with 6-oxo-tetracosahexaenoic acid [Homo sapiens] &gt;pdb|5AZV|A Crystal structure of hPPARgamma ligand binding domain complexed with 17-oxoDHA [Homo sapiens] &gt;pdb|5AZV|B Crystal structure of hPPARgamma ligand binding domain complexed with 17-oxoDHA [Homo sapiens] &gt;pdb|5WQX|A Covalent bond formation of synthetic ligand with hPPARg-LBD [Homo sapiens] &gt;pdb|5WQX|B Covalent bond formation of synthetic ligand with hPPARg-LBD [Homo sapiens] &gt;pdb|5WR0|A Huisgen cycloaddition for PPARg-LBD labeling by soaking method [Homo sapiens] &gt;pdb|5WR0|B Huisgen cycloaddition for PPARg-LBD labeling by soaking method [Homo sapiens] &gt;pdb|5WR1|A Covalent bond formation of bifunctional ligand with hPPARg-LBD [Homo sapiens] &gt;pdb|5WR1|B Covalent bond formation of bifunctional ligand with hPPARg-LBD [Homo sapiens] &gt;pdb|6JEY|A Covalent bond formation between ynone moiety of synthetic fatty acid and hPPARg-LBD [Homo sapiens] &gt;pdb|6JEY|B Covalent bond formation between ynone moiety of synthetic fatty acid and hPPARg-LBD [Homo sapiens] &gt;pdb|6JF0|A Covalent labeling of hPPARg-LBD by turn-on fluorescent probe mediated by conjugate addition and cyclization [Homo sapiens] &gt;pdb|6JF0|B Covalent labeling of hPPARg-LBD by turn-on fluorescent probe mediated by conjugate addition and cyclization [Homo sapiens] &gt;pdb|7EFQ|A Chain A, Peroxisome proliferator-activated receptor gamma [Homo sapiens] &gt;pdb|7EFQ|B Chain B, Peroxisome proliferator-activated receptor gamma [Homo sapiens]</Hit_def>
  <Hit_accession>2VSR_A</Hit_accession>
  <Hit_len>276</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0223085</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>95</Hsp_hit-from>
      <Hsp_hit-to>120</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>346</Hit_num>
  <Hit_id>pdb|6VZM|A</Hit_id>
  <Hit_def>Chain A, Peroxisome proliferator-activated receptor gamma [Homo sapiens] &gt;pdb|6VZM|B Chain B, Peroxisome proliferator-activated receptor gamma [Homo sapiens] &gt;pdb|6VZN|A Chain A, Peroxisome proliferator-activated receptor gamma [Homo sapiens] &gt;pdb|6VZN|B Chain B, Peroxisome proliferator-activated receptor gamma [Homo sapiens]</Hit_def>
  <Hit_accession>6VZM_A</Hit_accession>
  <Hit_len>275</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0224567</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>94</Hsp_hit-from>
      <Hsp_hit-to>119</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>347</Hit_num>
  <Hit_id>pdb|1RDT|D</Hit_id>
  <Hit_def>Crystal Structure of a new rexinoid bound to the RXRalpha ligand binding doamin in the RXRalpha/PPARgamma heterodimer [Homo sapiens]</Hit_def>
  <Hit_accession>1RDT_D</Hit_accession>
  <Hit_len>284</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.965</Hsp_bit-score>
      <Hsp_score>84</Hsp_score>
      <Hsp_evalue>0.022523</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>103</Hsp_hit-from>
      <Hsp_hit-to>128</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>348</Hit_num>
  <Hit_id>pdb|5Y2O|A</Hit_id>
  <Hit_def>Structure of PPARgamma ligand binding domain-pioglitazone complex [Homo sapiens] &gt;pdb|5Y2O|B Structure of PPARgamma ligand binding domain-pioglitazone complex [Homo sapiens] &gt;pdb|5Y2T|A Structure of PPARgamma ligand binding domain - lobeglitazone complex [Homo sapiens] &gt;pdb|5Y2T|B Structure of PPARgamma ligand binding domain - lobeglitazone complex [Homo sapiens]</Hit_def>
  <Hit_accession>5Y2O_A</Hit_accession>
  <Hit_len>294</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.965</Hsp_bit-score>
      <Hsp_score>84</Hsp_score>
      <Hsp_evalue>0.0225987</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>113</Hsp_hit-from>
      <Hsp_hit-to>138</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>349</Hit_num>
  <Hit_id>pdb|2Q59|A</Hit_id>
  <Hit_def>Crystal Structure of PPARgamma LBD bound to full agonist MRL20 [Homo sapiens]</Hit_def>
  <Hit_accession>2Q59_A</Hit_accession>
  <Hit_len>274</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0226055</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>93</Hsp_hit-from>
      <Hsp_hit-to>118</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>350</Hit_num>
  <Hit_id>pdb|2VV1|B</Hit_id>
  <Hit_def>hPPARgamma Ligand binding domain in complex with 4-HDHA [Homo sapiens]</Hit_def>
  <Hit_accession>2VV1_B</Hit_accession>
  <Hit_len>276</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.022716</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>95</Hsp_hit-from>
      <Hsp_hit-to>120</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>351</Hit_num>
  <Hit_id>pdb|7JQG|A</Hit_id>
  <Hit_def>Chain A, Peroxisome proliferator-activated receptor gamma [Homo sapiens] &gt;pdb|7JQG|B Chain B, Peroxisome proliferator-activated receptor gamma [Homo sapiens]</Hit_def>
  <Hit_accession>7JQG_A</Hit_accession>
  <Hit_len>276</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.022716</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>95</Hsp_hit-from>
      <Hsp_hit-to>120</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>352</Hit_num>
  <Hit_id>pdb|3WJ4|A</Hit_id>
  <Hit_def>Crystal structure of PPARgamma ligand binding domain in complex with tributyltin [Homo sapiens] &gt;pdb|3WJ4|B Crystal structure of PPARgamma ligand binding domain in complex with tributyltin [Homo sapiens] &gt;pdb|3WJ5|A Crystal structure of PPARgamma ligand binding domain in complex with triphenyltin [Homo sapiens] &gt;pdb|3WJ5|B Crystal structure of PPARgamma ligand binding domain in complex with triphenyltin [Homo sapiens]</Hit_def>
  <Hit_accession>3WJ4_A</Hit_accession>
  <Hit_len>276</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.022716</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>95</Hsp_hit-from>
      <Hsp_hit-to>120</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>353</Hit_num>
  <Hit_id>pdb|5JI0|D</Hit_id>
  <Hit_def>PPARgamma-RXRalpha(S427F) heterodimer in complex with SRC-1, rosiglitazone, and 9-cis-retanoic acid [Homo sapiens]</Hit_def>
  <Hit_accession>5JI0_D</Hit_accession>
  <Hit_len>273</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0227548</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>92</Hsp_hit-from>
      <Hsp_hit-to>117</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>354</Hit_num>
  <Hit_id>pdb|3CWD|A</Hit_id>
  <Hit_def>Molecular recognition of nitro-fatty acids by PPAR gamma [Homo sapiens] &gt;pdb|3CWD|B Molecular recognition of nitro-fatty acids by PPAR gamma [Homo sapiens]</Hit_def>
  <Hit_accession>3CWD_A</Hit_accession>
  <Hit_len>270</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0227888</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>89</Hsp_hit-from>
      <Hsp_hit-to>114</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>355</Hit_num>
  <Hit_id>pdb|3B0Q|A</Hit_id>
  <Hit_def>Human PPAR gamma ligand binding domain in complex with MCC555 [Homo sapiens] &gt;pdb|3B0Q|B Human PPAR gamma ligand binding domain in complex with MCC555 [Homo sapiens] &gt;pdb|3B0R|A Human PPAR gamma ligand binding dmain complexed with GW9662 in a covalent bonded form [Homo sapiens] &gt;pdb|3B0R|B Human PPAR gamma ligand binding dmain complexed with GW9662 in a covalent bonded form [Homo sapiens]</Hit_def>
  <Hit_accession>3B0Q_A</Hit_accession>
  <Hit_len>274</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0228112</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>94</Hsp_hit-from>
      <Hsp_hit-to>119</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>356</Hit_num>
  <Hit_id>pdb|4OJ4|A</Hit_id>
  <Hit_def>Crystal structure of V290M PPARgamma mutant in complex with diclofenac [Homo sapiens]</Hit_def>
  <Hit_accession>4OJ4_A</Hit_accession>
  <Hit_len>278</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0228249</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>97</Hsp_hit-from>
      <Hsp_hit-to>122</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>357</Hit_num>
  <Hit_id>pdb|6KTM|A</Hit_id>
  <Hit_def>The ligand-free structure of human PPARgamma ligand-binding domain R288A mutant in the presence of the SRC-1 coactivator peptide [Homo sapiens] &gt;pdb|6KTN|A Human PPARgamma ligand-binding domain R288A mutant in complex with imatinib [Homo sapiens]</Hit_def>
  <Hit_accession>6KTM_A</Hit_accession>
  <Hit_len>283</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0228825</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>102</Hsp_hit-from>
      <Hsp_hit-to>127</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>358</Hit_num>
  <Hit_id>pdb|1FM6|D</Hit_id>
  <Hit_def>THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES. [Homo sapiens] &gt;pdb|1FM6|X THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND ROSIGLITAZONE AND CO-ACTIVATOR PEPTIDES. [Homo sapiens] &gt;pdb|1FM9|D THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND GI262570 AND CO-ACTIVATOR PEPTIDES. [Homo sapiens] &gt;pdb|1ZGY|A Structural and Biochemical Basis for Selective Repression of the Orphan Nuclear Receptor LRH-1 by SHP [Homo sapiens] &gt;pdb|2POB|A PPARgamma Ligand binding domain complexed with a farglitazar analogue gw4709 [Homo sapiens] &gt;pdb|2POB|B PPARgamma Ligand binding domain complexed with a farglitazar analogue gw4709 [Homo sapiens] &gt;pdb|3FUR|A Crystal Structure of PPARg in complex with INT131 [Homo sapiens] &gt;pdb|3H0A|D Crystal Structure of Peroxisome Proliferator-Activated Receptor Gamma (PPARg) and Retinoic Acid Receptor Alpha (RXRa) in Complex with 9-cis Retinoic Acid, Co-activator Peptide, and a Partial Agonist [Homo sapiens] &gt;pdb|3K8S|A Crystal Structure of PPARg in complex with T2384 [Homo sapiens] &gt;pdb|3K8S|B Crystal Structure of PPARg in complex with T2384 [Homo sapiens] &gt;pdb|3KMG|A The X-ray Crystal Structure of PPAR-gamma in Complex with an Indole Derivative Modulator, GSK538, and an SRC-1 Peptide [Homo sapiens] &gt;pdb|3KMG|D The X-ray Crystal Structure of PPAR-gamma in Complex with an Indole Derivative Modulator, GSK538, and an SRC-1 Peptide [Homo sapiens] &gt;pdb|4CI5|A Structural basis for GL479 a dual Peroxisome Proliferator-Activated Receptor gamma agonist [Homo sapiens] &gt;pdb|4CI5|B Structural basis for GL479 a dual Peroxisome Proliferator-Activated Receptor gamma agonist [Homo sapiens] &gt;pdb|5TWO|A Peroxisome proliferator-activated receptor gamma ligand binding domain in complex with a novel selectively PPAR gamma-modulating ligand VSP-51 [Homo sapiens] &gt;pdb|6ICJ|A Crystal structure of PPARgamma with compound BR102375K [Homo sapiens] &gt;pdb|6ILQ|A Crystal structure of PPARgamma with compound BR101549 [Homo sapiens]</Hit_def>
  <Hit_accession>1FM6_D</Hit_accession>
  <Hit_len>272</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0229046</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>91</Hsp_hit-from>
      <Hsp_hit-to>116</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>359</Hit_num>
  <Hit_id>pdb|2VV4|B</Hit_id>
  <Hit_def>hPPARgamma Ligand binding domain in complex with 6-oxoOTE [Homo sapiens]</Hit_def>
  <Hit_accession>2VV4_B</Hit_accession>
  <Hit_len>276</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0229226</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>95</Hsp_hit-from>
      <Hsp_hit-to>120</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>360</Hit_num>
  <Hit_id>pdb|3T03|A</Hit_id>
  <Hit_def>Crystal structure of PPAR gamma ligand binding domain in complex with a novel partial agonist GQ-16 [Homo sapiens] &gt;pdb|3T03|B Crystal structure of PPAR gamma ligand binding domain in complex with a novel partial agonist GQ-16 [Homo sapiens]</Hit_def>
  <Hit_accession>3T03_A</Hit_accession>
  <Hit_len>284</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.022934</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>103</Hsp_hit-from>
      <Hsp_hit-to>128</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>361</Hit_num>
  <Hit_id>pdb|3U9Q|A</Hit_id>
  <Hit_def>Ligand binding domain of PPARgamma complexed with Decanoic Acid and PGC-1a peptide [Homo sapiens] &gt;pdb|4Y29|A Identification of a novel PPARg ligand that regulates metabolism [Homo sapiens]</Hit_def>
  <Hit_accession>3U9Q_A</Hit_accession>
  <Hit_len>269</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0229372</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>89</Hsp_hit-from>
      <Hsp_hit-to>114</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>362</Hit_num>
  <Hit_id>pdb|6D8X|A</Hit_id>
  <Hit_def>PPAR gamma LBD complexed with the agonist GW1929 [Homo sapiens] &gt;pdb|6D94|A Crystal structure of PPAR gamma in complex with Mediator of RNA polymerase II transcription subunit 1 [Homo sapiens] &gt;pdb|6DBH|A Crystal structure of PPAR gamma in complex with NMP422 [Homo sapiens] &gt;pdb|6DBH|B Crystal structure of PPAR gamma in complex with NMP422 [Homo sapiens] &gt;pdb|6DGP|A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with TRAP220 Coactivator Peptide [Homo sapiens] &gt;pdb|6DGP|B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with TRAP220 Coactivator Peptide [Homo sapiens] &gt;pdb|6DGR|A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with CAY10638 [Homo sapiens] &gt;pdb|6DGR|B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with CAY10638 [Homo sapiens]</Hit_def>
  <Hit_accession>6D8X_A</Hit_accession>
  <Hit_len>297</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.965</Hsp_bit-score>
      <Hsp_score>84</Hsp_score>
      <Hsp_evalue>0.0229422</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>116</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>363</Hit_num>
  <Hit_id>pdb|6E5A|A</Hit_id>
  <Hit_def>PPARg in complex with compound 4b [Homo sapiens] &gt;pdb|6E5A|B PPARg in complex with compound 4b [Homo sapiens]</Hit_def>
  <Hit_accession>6E5A_A</Hit_accession>
  <Hit_len>273</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0229618</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>92</Hsp_hit-from>
      <Hsp_hit-to>117</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>364</Hit_num>
  <Hit_id>pdb|1KNU|A</Hit_id>
  <Hit_def>Ligand Binding Domain Of The Human Peroxisome Proliferator Activated Receptor Gamma In Complex With A Synthetic Agonist [Homo sapiens] &gt;pdb|1KNU|B Ligand Binding Domain Of The Human Peroxisome Proliferator Activated Receptor Gamma In Complex With A Synthetic Agonist [Homo sapiens] &gt;pdb|2XKW|A LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH THE AGONIST PIOGLITAZONE [Homo sapiens] &gt;pdb|2XKW|B LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH THE AGONIST PIOGLITAZONE [Homo sapiens] &gt;pdb|3R5N|A Crystal structure of PPARgammaLBD complexed with the agonist magnolol [Homo sapiens] &gt;pdb|6IJS|A Human PPARgamma ligand binding domain complexed with SB1494 [Homo sapiens]</Hit_def>
  <Hit_accession>1KNU_A</Hit_accession>
  <Hit_len>274</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0230186</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>93</Hsp_hit-from>
      <Hsp_hit-to>118</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>365</Hit_num>
  <Hit_id>pdb|6C1I|A</Hit_id>
  <Hit_def>Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with T0070907 [Homo sapiens] &gt;pdb|6C1I|B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with T0070907 [Homo sapiens]</Hit_def>
  <Hit_accession>6C1I_A</Hit_accession>
  <Hit_len>275</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.023075</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>95</Hsp_hit-from>
      <Hsp_hit-to>120</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>366</Hit_num>
  <Hit_id>pdb|6FZF|A</Hit_id>
  <Hit_def>PPAR mutant complex [Homo sapiens] &gt;pdb|6FZF|B PPAR mutant complex [Homo sapiens] &gt;pdb|6FZY|A PPAR mutant [Homo sapiens] &gt;pdb|6FZY|B PPAR mutant [Homo sapiens]</Hit_def>
  <Hit_accession>6FZF_A</Hit_accession>
  <Hit_len>279</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0230867</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>98</Hsp_hit-from>
      <Hsp_hit-to>123</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>367</Hit_num>
  <Hit_id>pdb|4R06|A</Hit_id>
  <Hit_def>Crystal Structure of SR2067 bound to PPARgamma [Homo sapiens] &gt;pdb|4R06|B Crystal Structure of SR2067 bound to PPARgamma [Homo sapiens] &gt;pdb|5TTO|A X-ray crystal structure of PPARgamma in complex with SR1643 [Homo sapiens] &gt;pdb|5TTO|B X-ray crystal structure of PPARgamma in complex with SR1643 [Homo sapiens] &gt;pdb|5U5L|A X-ray Crystal Structure of the PPARgamma Ligand Binding Domain in Complex with Rivoglitazone [Homo sapiens] &gt;pdb|5U5L|B X-ray Crystal Structure of the PPARgamma Ligand Binding Domain in Complex with Rivoglitazone [Homo sapiens]</Hit_def>
  <Hit_accession>4R06_A</Hit_accession>
  <Hit_len>273</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0231707</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>92</Hsp_hit-from>
      <Hsp_hit-to>117</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>368</Hit_num>
  <Hit_id>pdb|1ZEO|A</Hit_id>
  <Hit_def>Crystal Structure of Human PPAR-gamma Ligand Binding Domain Complexed with an Alpha-Aryloxyphenylacetic Acid Agonist [Homo sapiens] &gt;pdb|1ZEO|B Crystal Structure of Human PPAR-gamma Ligand Binding Domain Complexed with an Alpha-Aryloxyphenylacetic Acid Agonist [Homo sapiens] &gt;pdb|2P4Y|A Crystal structure of human PPAR-gamma-ligand binding domain complexed with an indole-based modulator [Homo sapiens] &gt;pdb|2P4Y|B Crystal structure of human PPAR-gamma-ligand binding domain complexed with an indole-based modulator [Homo sapiens] &gt;pdb|3TY0|A Structure of PPARgamma ligand binding domain in complex with (R)-5-(3-((3-(6-methoxybenzo[d]isoxazol-3-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)methyl)phenyl)-5-methyloxazolidine-2,4-dione [Homo sapiens] &gt;pdb|3TY0|B Structure of PPARgamma ligand binding domain in complex with (R)-5-(3-((3-(6-methoxybenzo[d]isoxazol-3-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)methyl)phenyl)-5-methyloxazolidine-2,4-dione [Homo sapiens]</Hit_def>
  <Hit_accession>1ZEO_A</Hit_accession>
  <Hit_len>277</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0231866</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>96</Hsp_hit-from>
      <Hsp_hit-to>121</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>369</Hit_num>
  <Hit_id>pdb|6T6B|A</Hit_id>
  <Hit_def>Crystal structure of PPARgamma in complex with compound 16 (MF27) [Homo sapiens] &gt;pdb|6TSG|A Crystal structure of Peroxisome proliferator-activated receptor gamma (PPARG) in complex with TETRAC [Homo sapiens] &gt;pdb|6Y3U|A Crystal structure of PPARgamma in complex with compound (R)-16 [Homo sapiens] &gt;pdb|7A7H|A Chain A, Peroxisome proliferator-activated receptor gamma [Homo sapiens] &gt;pdb|7AWC|A Crystal structure of Peroxisome proliferator-activated receptor gamma (PPARG)in complex with rosiglitazone [Homo sapiens] &gt;pdb|7AWD|A Crystal structure of Peroxisome proliferator-activated receptor gamma (PPARG)in complex with garcinoic acid [Homo sapiens]</Hit_def>
  <Hit_accession>6T6B_A</Hit_accession>
  <Hit_len>277</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0231866</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>96</Hsp_hit-from>
      <Hsp_hit-to>121</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>370</Hit_num>
  <Hit_id>pdb|3R8A|A</Hit_id>
  <Hit_def>X-ray crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a compound with dual PPAR gamma agonism and Angiotensin II Type I receptor antagonism activity [Homo sapiens] &gt;pdb|3R8A|B X-ray crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a compound with dual PPAR gamma agonism and Angiotensin II Type I receptor antagonism activity [Homo sapiens] &gt;pdb|4HEE|X Crystal structure of PPARgamma in complex with compound 13 [Homo sapiens]</Hit_def>
  <Hit_accession>3R8A_A</Hit_accession>
  <Hit_len>282</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0232473</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>101</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>371</Hit_num>
  <Hit_id>pdb|4L96|A</Hit_id>
  <Hit_def>Structure of the complex between the F360L PPARgamma mutant and the ligand LT175 (space group I222) [Homo sapiens] &gt;pdb|4L98|A Crystal structure of the complex of F360L PPARgamma mutant with the ligand LT175 [Homo sapiens] &gt;pdb|4L98|B Crystal structure of the complex of F360L PPARgamma mutant with the ligand LT175 [Homo sapiens]</Hit_def>
  <Hit_accession>4L96_A</Hit_accession>
  <Hit_len>275</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0232849</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>94</Hsp_hit-from>
      <Hsp_hit-to>119</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>372</Hit_num>
  <Hit_id>pdb|3CS8|A</Hit_id>
  <Hit_def>Structural and Biochemical Basis for the Binding Selectivity of PPARg to PGC-1a [Homo sapiens]</Hit_def>
  <Hit_accession>3CS8_A</Hit_accession>
  <Hit_len>275</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0232849</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>95</Hsp_hit-from>
      <Hsp_hit-to>120</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>373</Hit_num>
  <Hit_id>pdb|6T1V|A</Hit_id>
  <Hit_def>Chain A, Peroxisome proliferator-activated receptor gamma [Homo sapiens]</Hit_def>
  <Hit_accession>6T1V_A</Hit_accession>
  <Hit_len>279</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0232965</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>98</Hsp_hit-from>
      <Hsp_hit-to>123</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>374</Hit_num>
  <Hit_id>pdb|3B1M|A</Hit_id>
  <Hit_def>Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator Cerco-A [Homo sapiens] &gt;pdb|3LMP|A Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator [Homo sapiens] &gt;pdb|3V9T|A Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator [Homo sapiens] &gt;pdb|3V9V|A Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator [Homo sapiens] &gt;pdb|3V9Y|A Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator [Homo sapiens] &gt;pdb|4F9M|A Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator [Homo sapiens] &gt;pdb|5Z5S|A Crystal structure of the PPARgamma-LBD complexed with compound 13ab [Homo sapiens] &gt;pdb|5Z6S|A Crystal structure of the PPARgamma-LBD complexed with compound DS-6930 [Homo sapiens] &gt;pdb|6IZM|A Crystal structure of the PPARgamma-LBD complexed with compound 1l [Homo sapiens] &gt;pdb|6IZN|A Crystal structure of the PPARgamma-LBD complexed with compound 3g [Homo sapiens]</Hit_def>
  <Hit_accession>3B1M_A</Hit_accession>
  <Hit_len>283</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0233001</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>102</Hsp_hit-from>
      <Hsp_hit-to>127</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>375</Hit_num>
  <Hit_id>pdb|1K74|D</Hit_id>
  <Hit_def>The 2.3 Angstrom resolution crystal structure of the heterodimer of the human PPARgamma and RXRalpha ligand binding domains respectively bound with GW409544 and 9-cis retinoic acid and co-activator peptides. [Homo sapiens]</Hit_def>
  <Hit_accession>1K74_D</Hit_accession>
  <Hit_len>283</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0233001</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>102</Hsp_hit-from>
      <Hsp_hit-to>127</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>376</Hit_num>
  <Hit_id>pdb|6DCU|A</Hit_id>
  <Hit_def>Crystal structure of PPAR gamma co-crystallized with nTZDpa [Homo sapiens] &gt;pdb|6DCU|B Crystal structure of PPAR gamma co-crystallized with nTZDpa [Homo sapiens]</Hit_def>
  <Hit_accession>6DCU_A</Hit_accession>
  <Hit_len>301</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.965</Hsp_bit-score>
      <Hsp_score>84</Hsp_score>
      <Hsp_evalue>0.0233323</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>116</Hsp_hit-from>
      <Hsp_hit-to>141</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>377</Hit_num>
  <Hit_id>pdb|6AUG|A</Hit_id>
  <Hit_def>Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with SR16832 [Homo sapiens] &gt;pdb|6AUG|B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with SR16832 [Homo sapiens] &gt;pdb|6AVI|A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with GW9662 and Nonanoic acid [Homo sapiens] &gt;pdb|6AVI|B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with GW9662 and Nonanoic acid [Homo sapiens] &gt;pdb|6DGL|A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Darglitazone [Homo sapiens] &gt;pdb|6DGL|B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Darglitazone [Homo sapiens] &gt;pdb|6DGQ|A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with CAY10506 [Homo sapiens] &gt;pdb|6DGQ|B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with CAY10506 [Homo sapiens]</Hit_def>
  <Hit_accession>6AUG_A</Hit_accession>
  <Hit_len>276</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0233413</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>95</Hsp_hit-from>
      <Hsp_hit-to>120</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>378</Hit_num>
  <Hit_id>pdb|6D3E|A</Hit_id>
  <Hit_def>PPARg LBD in Complex with SR1988 [Homo sapiens] &gt;pdb|6D3E|B PPARg LBD in Complex with SR1988 [Homo sapiens]</Hit_def>
  <Hit_accession>6D3E_A</Hit_accession>
  <Hit_len>280</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0233509</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>100</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>379</Hit_num>
  <Hit_id>pdb|6C5Q|A</Hit_id>
  <Hit_def>PPARg LBD bound to SR10171 [Homo sapiens]</Hit_def>
  <Hit_accession>6C5Q_A</Hit_accession>
  <Hit_len>281</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0234049</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>100</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>380</Hit_num>
  <Hit_id>pdb|2Q59|B</Hit_id>
  <Hit_def>Crystal Structure of PPARgamma LBD bound to full agonist MRL20 [Homo sapiens] &gt;pdb|2Q5P|A Crystal Structure of PPARgamma bound to partial agonist MRL24 [Homo sapiens] &gt;pdb|2Q5P|B Crystal Structure of PPARgamma bound to partial agonist MRL24 [Homo sapiens] &gt;pdb|2Q5S|A Crystal Structure of PPARgamma bound to partial agonist nTZDpa [Homo sapiens] &gt;pdb|2Q5S|B Crystal Structure of PPARgamma bound to partial agonist nTZDpa [Homo sapiens] &gt;pdb|2Q61|A Crystal Structure of PPARgamma ligand binding domain bound to partial agonist SR145 [Homo sapiens] &gt;pdb|2Q61|B Crystal Structure of PPARgamma ligand binding domain bound to partial agonist SR145 [Homo sapiens] &gt;pdb|2Q6R|A Crystal structure of PPAR gamma complexed with partial agonist SF147 [Homo sapiens] &gt;pdb|2Q6R|B Crystal structure of PPAR gamma complexed with partial agonist SF147 [Homo sapiens] &gt;pdb|2Q6S|A 2.4 angstrom crystal structure of PPAR gamma complexed to BVT.13 without co-activator peptides [Homo sapiens] &gt;pdb|2Q6S|B 2.4 angstrom crystal structure of PPAR gamma complexed to BVT.13 without co-activator peptides [Homo sapiens]</Hit_def>
  <Hit_accession>2Q59_B</Hit_accession>
  <Hit_len>274</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0234393</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>93</Hsp_hit-from>
      <Hsp_hit-to>118</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>381</Hit_num>
  <Hit_id>pdb|6MS7|A</Hit_id>
  <Hit_def>Peroxisome proliferator-activated receptor gamma ligand binding domain in complex with a novel selective PPAR-gamma modulator VSP-77 [Homo sapiens]</Hit_def>
  <Hit_accession>6MS7_A</Hit_accession>
  <Hit_len>274</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0234393</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>93</Hsp_hit-from>
      <Hsp_hit-to>118</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>382</Hit_num>
  <Hit_id>pdb|2OM9|A</Hit_id>
  <Hit_def>Ajulemic acid, a synthetic cannabinoid bound to PPAR gamma [Homo sapiens] &gt;pdb|2OM9|B Ajulemic acid, a synthetic cannabinoid bound to PPAR gamma [Homo sapiens] &gt;pdb|2OM9|C Ajulemic acid, a synthetic cannabinoid bound to PPAR gamma [Homo sapiens] &gt;pdb|2OM9|D Ajulemic acid, a synthetic cannabinoid bound to PPAR gamma [Homo sapiens] &gt;pdb|3SZ1|A Human PPAR gamma ligand binding domain in complex with luteolin and myristic acid [Homo sapiens] &gt;pdb|3SZ1|B Human PPAR gamma ligand binding domain in complex with luteolin and myristic acid [Homo sapiens] &gt;pdb|4XTA|A MECHANISMS OF PPARgamma ACTIVATION BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS [Homo sapiens] &gt;pdb|4XTA|B MECHANISMS OF PPARgamma ACTIVATION BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS [Homo sapiens] &gt;pdb|4XUH|A PPARgamma ligand binding domain in complex with sulindac sulfide [Homo sapiens] &gt;pdb|4XUH|B PPARgamma ligand binding domain in complex with sulindac sulfide [Homo sapiens] &gt;pdb|4XUM|A PPARgamma ligand binding domain in complex with indomethacin [Homo sapiens] &gt;pdb|4XUM|B PPARgamma ligand binding domain in complex with indomethacin [Homo sapiens] &gt;pdb|7LOT|A Chain A, Peroxisome proliferator-activated receptor gamma [Homo sapiens] &gt;pdb|7LOT|B Chain B, Peroxisome proliferator-activated receptor gamma [Homo sapiens]</Hit_def>
  <Hit_accession>2OM9_A</Hit_accession>
  <Hit_len>278</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.023453</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>97</Hsp_hit-from>
      <Hsp_hit-to>122</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>383</Hit_num>
  <Hit_id>pdb|4O8F|A</Hit_id>
  <Hit_def>Crystal Structure of the complex between PPARgamma mutant R357A and rosiglitazone [Homo sapiens] &gt;pdb|4O8F|B Crystal Structure of the complex between PPARgamma mutant R357A and rosiglitazone [Homo sapiens]</Hit_def>
  <Hit_accession>4O8F_A</Hit_accession>
  <Hit_len>287</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0235075</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>106</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>384</Hit_num>
  <Hit_id>pdb|5GTN|A</Hit_id>
  <Hit_def>Human PPARgamma ligand binding dmain complexed with R35 [Homo sapiens] &gt;pdb|5GTO|A Human PPARgamma ligand binding dmain complexed with S35 [Homo sapiens] &gt;pdb|5GTP|A The agonist-free structure of human PPARgamma ligand binding domain in the presence of the SRC-1 coactivator peptide [Homo sapiens] &gt;pdb|5YCN|A Human PPARgamma ligand binding domain complexed with Lobeglitazone [Homo sapiens] &gt;pdb|5YCP|A Human PPARgamma ligand binding domain complexed with Rosiglitazone [Homo sapiens] &gt;pdb|6IJR|A Human PPARgamma ligand binding domain complexed with SB1495 [Homo sapiens] &gt;pdb|6IJR|C Human PPARgamma ligand binding domain complexed with SB1495 [Homo sapiens] &gt;pdb|6JQ7|A The ligand-free structure of human PPARgamma LBD in the presence of the SRC-1 coactivator peptide [Homo sapiens] &gt;pdb|6L8B|A The ligand-free structure of human PPARgamma LBD [Homo sapiens] &gt;pdb|6L8B|B The ligand-free structure of human PPARgamma LBD [Homo sapiens]</Hit_def>
  <Hit_accession>5GTN_A</Hit_accession>
  <Hit_len>283</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0235117</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>102</Hsp_hit-from>
      <Hsp_hit-to>127</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>385</Hit_num>
  <Hit_id>pdb|3ET0|A</Hit_id>
  <Hit_def>Structure of PPARgamma with 3-(5-Methoxy-1H-indol-3-yl)-propionic acid [Homo sapiens] &gt;pdb|3ET0|B Structure of PPARgamma with 3-(5-Methoxy-1H-indol-3-yl)-propionic acid [Homo sapiens]</Hit_def>
  <Hit_accession>3ET0_A</Hit_accession>
  <Hit_len>292</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.023545</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>111</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>386</Hit_num>
  <Hit_id>pdb|6C5T|A</Hit_id>
  <Hit_def>PPARg LBD bound to SR11023 [Homo sapiens]</Hit_def>
  <Hit_accession>6C5T_A</Hit_accession>
  <Hit_len>276</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0235536</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>95</Hsp_hit-from>
      <Hsp_hit-to>120</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>387</Hit_num>
  <Hit_id>pdb|1NYX|A</Hit_id>
  <Hit_def>Ligand binding domain of the human peroxisome proliferator activated receptor gamma in complex with an agonist [Homo sapiens] &gt;pdb|1NYX|B Ligand binding domain of the human peroxisome proliferator activated receptor gamma in complex with an agonist [Homo sapiens]</Hit_def>
  <Hit_accession>1NYX_A</Hit_accession>
  <Hit_len>276</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0235536</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>95</Hsp_hit-from>
      <Hsp_hit-to>120</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>388</Hit_num>
  <Hit_id>pdb|3S9S|A</Hit_id>
  <Hit_def>Ligand binding domain of PPARgamma complexed with a benzimidazole partial agonist [Homo sapiens]</Hit_def>
  <Hit_accession>3S9S_A</Hit_accession>
  <Hit_len>284</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0235646</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>103</Hsp_hit-from>
      <Hsp_hit-to>128</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>389</Hit_num>
  <Hit_id>pdb|4EM9|A</Hit_id>
  <Hit_def>Human PPAR gamma in complex with nonanoic acids [Homo sapiens] &gt;pdb|4EM9|B Human PPAR gamma in complex with nonanoic acids [Homo sapiens] &gt;pdb|4EMA|A Human peroxisome proliferator-activated receptor gamma in complex with rosiglitazone [Homo sapiens] &gt;pdb|4EMA|B Human peroxisome proliferator-activated receptor gamma in complex with rosiglitazone [Homo sapiens]</Hit_def>
  <Hit_accession>4EM9_A</Hit_accession>
  <Hit_len>275</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0237103</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>94</Hsp_hit-from>
      <Hsp_hit-to>119</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>390</Hit_num>
  <Hit_id>pdb|6FZJ|A</Hit_id>
  <Hit_def>PPAR gamma mutant complex [Homo sapiens] &gt;pdb|6FZJ|B PPAR gamma mutant complex [Homo sapiens]</Hit_def>
  <Hit_accession>6FZJ_A</Hit_accession>
  <Hit_len>275</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0237103</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>94</Hsp_hit-from>
      <Hsp_hit-to>119</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>391</Hit_num>
  <Hit_id>pdb|4R2U|A</Hit_id>
  <Hit_def>Crystal Structure of PPARgamma in complex with SR1664 [Homo sapiens] &gt;pdb|4R2U|D Crystal Structure of PPARgamma in complex with SR1664 [Homo sapiens] &gt;pdb|6DGO|A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Troglitazone [Homo sapiens] &gt;pdb|6DGO|B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Troglitazone [Homo sapiens] &gt;pdb|6FZP|A PPAR gamma complex [Homo sapiens] &gt;pdb|6MCZ|A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Arachidonic Acid [Homo sapiens] &gt;pdb|6MCZ|B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Arachidonic Acid [Homo sapiens] &gt;pdb|6MD0|A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Oleic Acid [Homo sapiens] &gt;pdb|6MD0|B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Oleic Acid [Homo sapiens] &gt;pdb|6MD1|A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with GW9662 and Oleic acid [Homo sapiens] &gt;pdb|6MD1|B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with GW9662 and Oleic acid [Homo sapiens] &gt;pdb|6MD2|A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with GW9662 and Arachidonic acid [Homo sapiens] &gt;pdb|6MD2|B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with GW9662 and Arachidonic acid [Homo sapiens] &gt;pdb|6MD4|A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Rosiglitazone and Oleic acid [Homo sapiens] &gt;pdb|6MD4|B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Rosiglitazone and Oleic acid [Homo sapiens] &gt;pdb|6O67|A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Mitoglitazone [Homo sapiens] &gt;pdb|6O67|B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Mitoglitazone [Homo sapiens] &gt;pdb|6O68|A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Ciglitazone [Homo sapiens] &gt;pdb|6O68|B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Ciglitazone [Homo sapiens] &gt;pdb|6ONI|B Crystal structure of PPARgamma ligand binding domain in complex with N-CoR peptide and inverse agonist T0070907 [Homo sapiens] &gt;pdb|6ONJ|A Crystal structure of PPARgamma ligand binding domain in complex with TRAP220 peptide and agonist rosiglitazone [Homo sapiens] &gt;pdb|6PDZ|A Crystal structure of PPARgamma ligand binding domain in complex with SMRT peptide and inverse agonist T0070907 [Homo sapiens] &gt;pdb|6PDZ|B Crystal structure of PPARgamma ligand binding domain in complex with SMRT peptide and inverse agonist T0070907 [Homo sapiens] &gt;pdb|6VZL|A Chain A, Peroxisome proliferator-activated receptor gamma [Homo sapiens] &gt;pdb|6VZL|B Chain B, Peroxisome proliferator-activated receptor gamma [Homo sapiens] &gt;pdb|6VZO|A Chain A, Peroxisome proliferator-activated receptor gamma [Homo sapiens] &gt;pdb|6VZO|B Chain B, Peroxisome proliferator-activated receptor gamma [Homo sapiens]</Hit_def>
  <Hit_accession>4R2U_A</Hit_accession>
  <Hit_len>275</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0237103</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>94</Hsp_hit-from>
      <Hsp_hit-to>119</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>392</Hit_num>
  <Hit_id>pdb|2I4J|A</Hit_id>
  <Hit_def>Crystal structure of the complex between PPARgamma and the agonist LT160 (ureidofibrate derivative) [Homo sapiens] &gt;pdb|2I4J|B Crystal structure of the complex between PPARgamma and the agonist LT160 (ureidofibrate derivative) [Homo sapiens] &gt;pdb|2I4P|A Crystal structure of the complex between PPARgamma and the partial agonist LT127 (ureidofibrate derivative). Structure obtained from crystals of the apo-form soaked for 30 days. [Homo sapiens] &gt;pdb|2I4P|B Crystal structure of the complex between PPARgamma and the partial agonist LT127 (ureidofibrate derivative). Structure obtained from crystals of the apo-form soaked for 30 days. [Homo sapiens] &gt;pdb|2I4Z|A Crystal structure of the complex between PPARgamma and the partial agonist LT127 (ureidofibrate derivative). This structure has been obtained from crystals soaked for 6 hours. [Homo sapiens] &gt;pdb|2I4Z|B Crystal structure of the complex between PPARgamma and the partial agonist LT127 (ureidofibrate derivative). This structure has been obtained from crystals soaked for 6 hours. [Homo sapiens] &gt;pdb|2ZK0|A Human peroxisome proliferator-activated receptor gamma ligand binding domain [Homo sapiens] &gt;pdb|2ZK0|B Human peroxisome proliferator-activated receptor gamma ligand binding domain [Homo sapiens] &gt;pdb|2ZK1|A Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 15-deoxy-delta12,14-prostaglandin J2 [Homo sapiens] &gt;pdb|2ZK1|B Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 15-deoxy-delta12,14-prostaglandin J2 [Homo sapiens] &gt;pdb|2ZK2|A Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with glutathion conjugated 15-deoxy-delta12,14-prostaglandin J2 [Homo sapiens] &gt;pdb|2ZK2|B Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with glutathion conjugated 15-deoxy-delta12,14-prostaglandin J2 [Homo sapiens] &gt;pdb|2ZK3|A Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 8-oxo-eicosatetraenoic acid [Homo sapiens] &gt;pdb|2ZK3|B Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 8-oxo-eicosatetraenoic acid [Homo sapiens] &gt;pdb|2ZK4|A Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 15-oxo-eicosatetraenoic acid [Homo sapiens] &gt;pdb|2ZK4|B Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 15-oxo-eicosatetraenoic acid [Homo sapiens] &gt;pdb|2ZK5|A Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with nitro-233 [Homo sapiens] &gt;pdb|2ZK5|B Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with nitro-233 [Homo sapiens] &gt;pdb|2ZK6|A Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with C8-BODIPY [Homo sapiens] &gt;pdb|2ZK6|B Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with C8-BODIPY [Homo sapiens] &gt;pdb|2ZNO|A Human PPAR gamma ligand binding domain in complex with a synthetic agonist TIPP703 [Homo sapiens] &gt;pdb|2ZNO|B Human PPAR gamma ligand binding domain in complex with a synthetic agonist TIPP703 [Homo sapiens] &gt;pdb|3AN3|A Human PPAR gamma ligand binding domain in complex with a gamma selective agonist MO3S [Homo sapiens] &gt;pdb|3AN3|B Human PPAR gamma ligand binding domain in complex with a gamma selective agonist MO3S [Homo sapiens] &gt;pdb|3AN4|A Human PPAR gamma ligand binding domain in complex with a gamma selective agonist MO4R [Homo sapiens] &gt;pdb|3AN4|B Human PPAR gamma ligand binding domain in complex with a gamma selective agonist MO4R [Homo sapiens] &gt;pdb|3B3K|A Crystal structure of the complex between PPARgamma and the full agonist LT175 [Homo sapiens] &gt;pdb|3B3K|B Crystal structure of the complex between PPARgamma and the full agonist LT175 [Homo sapiens] &gt;pdb|3CDP|A Crystal structure of PPAR-gamma LBD complexed with a partial agonist, analogue of clofibric acid [Homo sapiens] &gt;pdb|3CDP|B Crystal structure of PPAR-gamma LBD complexed with a partial agonist, analogue of clofibric acid [Homo sapiens] &gt;pdb|3CDS|A Crystal structure of the complex between PPAR-gamma and the agonist LT248 (clofibric acid analogue) [Homo sapiens] &gt;pdb|3CDS|B Crystal structure of the complex between PPAR-gamma and the agonist LT248 (clofibric acid analogue) [Homo sapiens] &gt;pdb|3D6D|A Crystal Structure of the complex between PPARgamma LBD and the LT175(R-enantiomer) [Homo sapiens] &gt;pdb|3D6D|B Crystal Structure of the complex between PPARgamma LBD and the LT175(R-enantiomer) [Homo sapiens] &gt;pdb|3HO0|A Crystal structure of the PPARgamma-LBD complexed with a new aryloxy-3phenylpropanoic acid [Homo sapiens] &gt;pdb|3HO0|B Crystal structure of the PPARgamma-LBD complexed with a new aryloxy-3phenylpropanoic acid [Homo sapiens] &gt;pdb|3HOD|A Crystal structure of the PPARgamma-LBD complexed with a new aryloxy-3phenylpropanoic acid [Homo sapiens] &gt;pdb|3HOD|B Crystal structure of the PPARgamma-LBD complexed with a new aryloxy-3phenylpropanoic acid [Homo sapiens] &gt;pdb|3VJH|A Human PPAR GAMMA ligand binding domain in complex with JKPL35 [Homo sapiens] &gt;pdb|3VJH|B Human PPAR GAMMA ligand binding domain in complex with JKPL35 [Homo sapiens] &gt;pdb|3VJI|A Human PPAR gamma ligand binding domain in complex with JKPL53 [Homo sapiens] &gt;pdb|3VJI|B Human PPAR gamma ligand binding domain in complex with JKPL53 [Homo sapiens] &gt;pdb|3VSO|A Human PPAR gamma ligand binding domain in complex with a gamma selective agonist mekt21 [Homo sapiens] &gt;pdb|3VSO|B Human PPAR gamma ligand binding domain in complex with a gamma selective agonist mekt21 [Homo sapiens] &gt;pdb|3VSP|A Human PPAR gamma ligand binding domain in complex with a gamma selective agonist mekt28 [Homo sapiens] &gt;pdb|3VSP|B Human PPAR gamma ligand binding domain in complex with a gamma selective agonist mekt28 [Homo sapiens] &gt;pdb|3WMH|A Human PPAR gamma ligand binding domain in complex with a gammma selective synthetic partial agonist MEKT75 [Homo sapiens] &gt;pdb|3WMH|B Human PPAR gamma ligand binding domain in complex with a gammma selective synthetic partial agonist MEKT75 [Homo sapiens] &gt;pdb|4YT1|A Human PPAR Gamma Ligand Binding Domain in complex with a Gammma Selective Synthetic Partial Agonist MEKT76 [Homo sapiens] &gt;pdb|4YT1|B Human PPAR Gamma Ligand Binding Domain in complex with a Gammma Selective Synthetic Partial Agonist MEKT76 [Homo sapiens]</Hit_def>
  <Hit_accession>2I4J_A</Hit_accession>
  <Hit_len>286</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.023884</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>106</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>393</Hit_num>
  <Hit_id>pdb|2ZVT|A</Hit_id>
  <Hit_def>Cys285Ser mutant PPARgamma ligand-binding domain complexed with 15-deoxy-delta12,14-prostaglandin J2 [Homo sapiens] &gt;pdb|2ZVT|B Cys285Ser mutant PPARgamma ligand-binding domain complexed with 15-deoxy-delta12,14-prostaglandin J2 [Homo sapiens]</Hit_def>
  <Hit_accession>2ZVT_A</Hit_accession>
  <Hit_len>286</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.023884</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>106</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>394</Hit_num>
  <Hit_id>pdb|4R6S|A</Hit_id>
  <Hit_def>Crystal structure of PPARgammma in complex with SR1663 [Homo sapiens] &gt;pdb|4R6S|B Crystal structure of PPARgammma in complex with SR1663 [Homo sapiens]</Hit_def>
  <Hit_accession>4R6S_A</Hit_accession>
  <Hit_len>275</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0239259</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>94</Hsp_hit-from>
      <Hsp_hit-to>119</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>395</Hit_num>
  <Hit_id>pdb|6T1S|A</Hit_id>
  <Hit_def>Chain A, Peroxisome proliferator-activated receptor gamma [Homo sapiens]</Hit_def>
  <Hit_accession>6T1S_A</Hit_accession>
  <Hit_len>279</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0239375</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>98</Hsp_hit-from>
      <Hsp_hit-to>123</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>396</Hit_num>
  <Hit_id>pdb|3ET3|A</Hit_id>
  <Hit_def>Structure of PPARgamma with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid [Homo sapiens] &gt;pdb|6TDC|A PPAR gamma ligand binding domain in complex with MRL-871 [Homo sapiens]</Hit_def>
  <Hit_accession>3ET3_A</Hit_accession>
  <Hit_len>292</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0239741</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>111</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>397</Hit_num>
  <Hit_id>pdb|1I7I|A</Hit_id>
  <Hit_def>Crystal Structure Of The Ligand Binding Domain Of Human Ppar-Gamma In Complex With The Agonist Az 242 [Homo sapiens] &gt;pdb|1I7I|B Crystal Structure Of The Ligand Binding Domain Of Human Ppar-Gamma In Complex With The Agonist Az 242 [Homo sapiens]</Hit_def>
  <Hit_accession>1I7I_A</Hit_accession>
  <Hit_len>292</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0239741</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>111</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>398</Hit_num>
  <Hit_id>pdb|3PRG|A</Hit_id>
  <Hit_def>Ligand Binding Domain Of Human Peroxisome Proliferator Activated Receptor [Homo sapiens]</Hit_def>
  <Hit_accession>3PRG_A</Hit_accession>
  <Hit_len>278</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0240984</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>97</Hsp_hit-from>
      <Hsp_hit-to>122</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>399</Hit_num>
  <Hit_id>pdb|6ENQ|A</Hit_id>
  <Hit_def>Structure of human PPAR gamma LBD in complex with Lanifibranor (IVA337) [Homo sapiens] &gt;pdb|6ENQ|B Structure of human PPAR gamma LBD in complex with Lanifibranor (IVA337) [Homo sapiens]</Hit_def>
  <Hit_accession>6ENQ_A</Hit_accession>
  <Hit_len>282</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0241036</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>101</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>400</Hit_num>
  <Hit_id>pdb|2HFP|A</Hit_id>
  <Hit_def>Crystal Structure of PPAR Gamma with N-sulfonyl-2-indole carboxamide ligands [Homo sapiens]</Hit_def>
  <Hit_accession>2HFP_A</Hit_accession>
  <Hit_len>282</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0241036</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>101</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>401</Hit_num>
  <Hit_id>pdb|5LSG|A</Hit_id>
  <Hit_def>PPARgamma complex with the betulinic acid [Homo sapiens] &gt;pdb|5LSG|B PPARgamma complex with the betulinic acid [Homo sapiens] &gt;pdb|6F2L|A Crystal structure of the complex between PPARgamma LBD and the ligand LJ570: structure obtained from crystals of the apo-form soaked for 15 days. [Homo sapiens] &gt;pdb|6F2L|B Crystal structure of the complex between PPARgamma LBD and the ligand LJ570: structure obtained from crystals of the apo-form soaked for 15 days. [Homo sapiens] &gt;pdb|6QJ5|A X-ray structure of PPARgamma LBD with the ligand NV1380 [Homo sapiens] &gt;pdb|6QJ5|B X-ray structure of PPARgamma LBD with the ligand NV1380 [Homo sapiens] &gt;pdb|6T9C|A Crystal structure of the complex between PPARgamma LBD and the ligand NV1346 (3a) [Homo sapiens] &gt;pdb|6T9C|B Crystal structure of the complex between PPARgamma LBD and the ligand NV1346 (3a) [Homo sapiens]</Hit_def>
  <Hit_accession>5LSG_A</Hit_accession>
  <Hit_len>304</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0241091</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>123</Hsp_hit-from>
      <Hsp_hit-to>148</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>402</Hit_num>
  <Hit_id>pdb|4FHH|A</Hit_id>
  <Hit_def>Development of synthetically accessible non-secosteroidal hybrid molecules combining vitamin D receptor agonism and histone deacetylase inhibition [Danio rerio] &gt;pdb|4FHI|A Development of synthetically accessible non-secosteroidal hybrid molecules combining vitamin D receptor agonism and histone deacetylase inhibition [Danio rerio] &gt;pdb|4G1D|A Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor [Danio rerio] &gt;pdb|4G1Y|A Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor [Danio rerio] &gt;pdb|4G1Z|A Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor [Danio rerio] &gt;pdb|4G20|A Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor [Danio rerio] &gt;pdb|4G21|A Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor [Danio rerio] &gt;pdb|4G2H|A Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor [Danio rerio] &gt;pdb|4IA1|A Diastereotopic and Deuterium Effects in Gemini [Danio rerio] &gt;pdb|4IA2|A Diastereotopic and Deuterium Effects in Gemini [Danio rerio] &gt;pdb|4IA3|A Diastereotopic and Deuterium Effects in Gemini [Danio rerio] &gt;pdb|4IA7|A Diastereotopic and Deuterium Effects in Gemini [Danio rerio] &gt;pdb|5E7V|A Potent Vitamin D Receptor Agonist [Danio rerio] &gt;pdb|5LGA|A Structural analysis and biological activities of BXL0124, a Gemini analog of Vitamin D [Danio rerio] &gt;pdb|5MX7|A1 Chain A1, Vitamin D3 receptor A [Danio rerio] &gt;pdb|6FO7|A Vitamin D nuclear receptor complex 3 [Danio rerio] &gt;pdb|6FO8|1 Vitamin D nuclear receptor complex 4 [Danio rerio] &gt;pdb|6FO9|A Vitamin D nuclear receptor complex 2 [Danio rerio] &gt;pdb|6FOB|A Vitamin D receptor complex 5 [Danio rerio] &gt;pdb|6FOD|A Vitamin D nuclear receptor complex 1 [Danio rerio]</Hit_def>
  <Hit_accession>4FHH_A</Hit_accession>
  <Hit_len>300</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0241429</Hsp_evalue>
      <Hsp_query-from>27</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>84</Hsp_hit-from>
      <Hsp_hit-to>148</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>20</Hsp_identity>
      <Hsp_positive>36</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>65</Hsp_align-len>
      <Hsp_qseq>DNTKPDTSS-------SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>DSGSPDSSEEDQQSRLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTAEDQIALLKSSAIEIIML</Hsp_hseq>
      <Hsp_midline>D+  PD+S        S+L  L  L    +  V+ ++K +PGFR+L  +DQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>403</Hit_num>
  <Hit_id>pdb|2YFE|A</Hit_id>
  <Hit_def>Ligand binding domain of human PPAR gamma in complex with amorfrutin 1 [Homo sapiens] &gt;pdb|2YFE|B Ligand binding domain of human PPAR gamma in complex with amorfrutin 1 [Homo sapiens] &gt;pdb|3ADS|A Human PPARgamma ligand-binding domain in complex with indomethacin [Homo sapiens] &gt;pdb|3ADS|B Human PPARgamma ligand-binding domain in complex with indomethacin [Homo sapiens] &gt;pdb|3ADT|A Human PPARgamma ligand-binding domain in complex with 5-hydroxy-indole acetate [Homo sapiens] &gt;pdb|3ADT|B Human PPARgamma ligand-binding domain in complex with 5-hydroxy-indole acetate [Homo sapiens] &gt;pdb|3ADU|A Human PPARgamma ligand-binding domain in complex with 5-methoxy-indole acetate [Homo sapiens] &gt;pdb|3ADU|B Human PPARgamma ligand-binding domain in complex with 5-methoxy-indole acetate [Homo sapiens] &gt;pdb|3ADV|A Human PPARgamma ligand-binding domain in complex with serotonin [Homo sapiens] &gt;pdb|3ADV|B Human PPARgamma ligand-binding domain in complex with serotonin [Homo sapiens] &gt;pdb|3ADW|A Human PPARgamma ligand-binding domain in complex with 5-methoxy-indole acetate and 15-oxo-eicosatetraenoic acid [Homo sapiens] &gt;pdb|3ADW|B Human PPARgamma ligand-binding domain in complex with 5-methoxy-indole acetate and 15-oxo-eicosatetraenoic acid [Homo sapiens] &gt;pdb|3ADX|A Human PPARgamma ligand-binding domain in complex with indomethacin and nitro-233 [Homo sapiens] &gt;pdb|3ADX|B Human PPARgamma ligand-binding domain in complex with indomethacin and nitro-233 [Homo sapiens] &gt;pdb|3R8I|A Crystal Structure of PPARgamma with an achiral ureidofibrate derivative (RT86) [Homo sapiens] &gt;pdb|3R8I|B Crystal Structure of PPARgamma with an achiral ureidofibrate derivative (RT86) [Homo sapiens] &gt;pdb|4A4V|A Ligand binding domain of human PPAR gamma in complex with amorfrutin 2 [Homo sapiens] &gt;pdb|4A4V|B Ligand binding domain of human PPAR gamma in complex with amorfrutin 2 [Homo sapiens] &gt;pdb|4A4W|A Ligand binding domain of human PPAR gamma in complex with amorfrutin B [Homo sapiens] &gt;pdb|4A4W|B Ligand binding domain of human PPAR gamma in complex with amorfrutin B [Homo sapiens] &gt;pdb|4E4K|A Crystal Structure of PPARgamma with the ligand JO21 [Homo sapiens] &gt;pdb|4E4K|B Crystal Structure of PPARgamma with the ligand JO21 [Homo sapiens] &gt;pdb|4E4Q|A Crystal structure of PPARgamma with the ligand FS214 [Homo sapiens] &gt;pdb|4E4Q|B Crystal structure of PPARgamma with the ligand FS214 [Homo sapiens] &gt;pdb|4JAZ|A Crystal structure of the complex between PPARgamma LBD and trans-resveratrol [Homo sapiens] &gt;pdb|4JAZ|B Crystal structure of the complex between PPARgamma LBD and trans-resveratrol [Homo sapiens] &gt;pdb|4JL4|A Crystal structure of the complex between PPARgamma LBD and the ligand LJ570 [(2S)-3-(biphenyl-4-yl)-2-(biphenyl-4-yloxy)propanoic acid] [Homo sapiens] &gt;pdb|4JL4|B Crystal structure of the complex between PPARgamma LBD and the ligand LJ570 [(2S)-3-(biphenyl-4-yl)-2-(biphenyl-4-yloxy)propanoic acid] [Homo sapiens] &gt;pdb|4PVU|A Crystal structure of the complex between PPARgamma-LBD and the R enantiomer of Mbx-102 (Metaglidasen) [Homo sapiens] &gt;pdb|4PVU|B Crystal structure of the complex between PPARgamma-LBD and the R enantiomer of Mbx-102 (Metaglidasen) [Homo sapiens] &gt;pdb|4PWL|A Crystal structure of the complex between PPARgamma-LBD and the S enantiomer of Mbx-102 (Metaglidasen) [Homo sapiens] &gt;pdb|4PWL|B Crystal structure of the complex between PPARgamma-LBD and the S enantiomer of Mbx-102 (Metaglidasen) [Homo sapiens] &gt;pdb|5DSH|A Human PPARgamma ligand binding dmain complexed with SB1406 in a covalent bonded form [Homo sapiens] &gt;pdb|5DV3|A Human PPARgamma ligand binding dmain complexed with SB1405 in a covalent bonded form [Homo sapiens] &gt;pdb|5DV6|A Human PPARgamma ligand binding dmain complexed with SB1404 in a covalent bonded form [Homo sapiens] &gt;pdb|5DV8|A Human PPARgamma ligand binding dmain complexed with SB1451 in a covalent bonded form [Homo sapiens] &gt;pdb|5DVC|A Human PPARgamma ligand binding dmain complexed with SB1453 in a covalent bonded form [Homo sapiens] &gt;pdb|5DWL|A Human PPARgamma ligand binding dmain in complex with SR1664 [Homo sapiens] &gt;pdb|5F9B|A X-ray crystal structure of PPARgamma in the complex with caulophyllogenin [Homo sapiens] &gt;pdb|5F9B|B X-ray crystal structure of PPARgamma in the complex with caulophyllogenin [Homo sapiens] &gt;pdb|5HZC|A Crystal structure of the complex PPARgamma/AL26-29 [Homo sapiens] &gt;pdb|5HZC|B Crystal structure of the complex PPARgamma/AL26-29 [Homo sapiens] &gt;pdb|6AD9|A Crystal Structure of PPARgamma Ligand Binding Domain in complex with dibenzooxepine derivative compound-9 [Homo sapiens] &gt;pdb|6L89|A Human PPARgamma ligand binding domain complexed with Butyrolactone 1 [Homo sapiens] &gt;pdb|6L89|B Human PPARgamma ligand binding domain complexed with Butyrolactone 1 [Homo sapiens]</Hit_def>
  <Hit_accession>2YFE_A</Hit_accession>
  <Hit_len>287</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0241535</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>106</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>404</Hit_num>
  <Hit_id>pdb|3BC5|A</Hit_id>
  <Hit_def>X-ray crystal structure of human ppar gamma with 2-(5-(3-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)benzyl)-2-phenyl-2h-1,2,3-triazol-4-yl)acetic acid [Homo sapiens] &gt;pdb|4XLD|A Crystal structure of the human PPARg-LBD/rosiglitazone complex obtained by dry co-crystallization and in situ diffraction [Homo sapiens]</Hit_def>
  <Hit_accession>3BC5_A</Hit_accession>
  <Hit_len>296</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0241706</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>115</Hsp_hit-from>
      <Hsp_hit-to>140</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>405</Hit_num>
  <Hit_id>pdb|1WM0|X</Hit_id>
  <Hit_def>PPARgamma in complex with a 2-BABA compound [Homo sapiens]</Hit_def>
  <Hit_accession>1WM0_X</Hit_accession>
  <Hit_len>292</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0241916</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>111</Hsp_hit-from>
      <Hsp_hit-to>136</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>406</Hit_num>
  <Hit_id>pdb|6K0T|A</Hit_id>
  <Hit_def>Crystal Structure of PPARgamma Ligand Binding Domain in complex with dibenzooxepine derivative compound-17 [Homo sapiens] &gt;pdb|6K0T|C Crystal Structure of PPARgamma Ligand Binding Domain in complex with dibenzooxepine derivative compound-17 [Homo sapiens]</Hit_def>
  <Hit_accession>6K0T_A</Hit_accession>
  <Hit_len>287</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0243727</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>106</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>407</Hit_num>
  <Hit_id>pdb|3OSI|A</Hit_id>
  <Hit_def>Crystal structure of PPARgamma ligand binding domain in complex with tetrachloro-bisphenol A (TCBPA) [Homo sapiens] &gt;pdb|3OSI|B Crystal structure of PPARgamma ligand binding domain in complex with tetrachloro-bisphenol A (TCBPA) [Homo sapiens] &gt;pdb|3OSW|A Crystal structure of PPARgamma ligand binding domain in complex with tetrabromo-bisphenol A (TBBPA) [Homo sapiens] &gt;pdb|3OSW|B Crystal structure of PPARgamma ligand binding domain in complex with tetrabromo-bisphenol A (TBBPA) [Homo sapiens]</Hit_def>
  <Hit_accession>3OSI_A</Hit_accession>
  <Hit_len>285</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0244866</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>105</Hsp_hit-from>
      <Hsp_hit-to>130</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>408</Hit_num>
  <Hit_id>pdb|3PBA|A</Hit_id>
  <Hit_def>Crystal structure of PPARgamma ligand binding domain in complex with monosulfate tetrabromo-bisphenol A (MonoTBBPA) [Homo sapiens] &gt;pdb|3PBA|B Crystal structure of PPARgamma ligand binding domain in complex with monosulfate tetrabromo-bisphenol A (MonoTBBPA) [Homo sapiens] &gt;pdb|3PO9|A Crystal structure of PPARgamma ligand binding domain in complex with tripropyltin [Homo sapiens] &gt;pdb|3PO9|B Crystal structure of PPARgamma ligand binding domain in complex with tripropyltin [Homo sapiens] &gt;pdb|6AN1|A Crystal structure of the complex between PPARgamma LBD and the ligand AM-879 [Homo sapiens] &gt;pdb|6AN1|B Crystal structure of the complex between PPARgamma LBD and the ligand AM-879 [Homo sapiens]</Hit_def>
  <Hit_accession>3PBA_A</Hit_accession>
  <Hit_len>286</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0245404</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>105</Hsp_hit-from>
      <Hsp_hit-to>130</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>409</Hit_num>
  <Hit_id>pdb|3VN2|A</Hit_id>
  <Hit_def>Crystal Structure of PPARgamma complexed with Telmisartan [Homo sapiens]</Hit_def>
  <Hit_accession>3VN2_A</Hit_accession>
  <Hit_len>285</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0247089</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>104</Hsp_hit-from>
      <Hsp_hit-to>129</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>410</Hit_num>
  <Hit_id>pdb|6U2H|C</Hit_id>
  <Hit_def>BRAF dimer bound to 14-3-3 [Homo sapiens] &gt;pdb|6U2H|D BRAF dimer bound to 14-3-3 [Homo sapiens] &gt;pdb|6XAG|C Apo BRAF dimer bound to 14-3-3 [Homo sapiens] &gt;pdb|6XAG|D Apo BRAF dimer bound to 14-3-3 [Homo sapiens]</Hit_def>
  <Hit_accession>6U2H_C</Hit_accession>
  <Hit_len>290</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0247522</Hsp_evalue>
      <Hsp_query-from>65</Hsp_query-from>
      <Hsp_query-to>252</Hsp_query-to>
      <Hsp_hit-from>139</Hsp_hit-from>
      <Hsp_hit-to>288</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>80</Hsp_positive>
      <Hsp_gaps>42</Hsp_gaps>
      <Hsp_align-len>190</Hsp_align-len>
      <Hsp_qseq>LHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEV--IAAQLPKILAGMVKPLL</Hsp_qseq>
      <Hsp_hseq>LHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI----RMQDSNPYS--------------FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM-----------VG---RGSLSPD-----LSKVRSNCPKRMKRLMAECLK---KKRDERPSFPRILAEIEELARELPKIHRSAXEPSL</Hsp_hseq>
      <Hsp_midline>LH D+ + +  +   ++     G   ++ +SG +L+ AP++I    RM++S+ YS               Q     F  +   L+   +P   + ++ Q  EM           +G   +G +S       L+K+  N    +K+L   CL    + R     FP +++E+  +A +LPKI     +P L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>411</Hit_num>
  <Hit_id>pdb|6ZLY|A</Hit_id>
  <Hit_def>Crystal structure of the complex between PPARgamma LBD and the ligand NV1362 (7a) [Homo sapiens] &gt;pdb|6ZLY|B Crystal structure of the complex between PPARgamma LBD and the ligand NV1362 (7a) [Homo sapiens]</Hit_def>
  <Hit_accession>6ZLY_A</Hit_accession>
  <Hit_len>300</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0248053</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>119</Hsp_hit-from>
      <Hsp_hit-to>144</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>412</Hit_num>
  <Hit_id>pdb|5NMB|2</Hit_id>
  <Hit_def>Structure-activity relationship study of vitamin D analogs with oxolane group in their side chain [Danio rerio]</Hit_def>
  <Hit_accession>5NMB_2</Hit_accession>
  <Hit_len>317</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0248949</Hsp_evalue>
      <Hsp_query-from>27</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>86</Hsp_hit-from>
      <Hsp_hit-to>150</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>20</Hsp_identity>
      <Hsp_positive>36</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>65</Hsp_align-len>
      <Hsp_qseq>DNTKPDTSS-------SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>DSGSPDSSEEDQQSRLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTAEDQIALLKSSAIEIIML</Hsp_hseq>
      <Hsp_midline>D+  PD+S        S+L  L  L    +  V+ ++K +PGFR+L  +DQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>413</Hit_num>
  <Hit_id>pdb|1OVL|A</Hit_id>
  <Hit_def>Crystal Structure of Nurr1 LBD [Homo sapiens] &gt;pdb|1OVL|D Crystal Structure of Nurr1 LBD [Homo sapiens]</Hit_def>
  <Hit_accession>1OVL_A</Hit_accession>
  <Hit_len>271</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.025936</Hsp_evalue>
      <Hsp_query-from>19</Hsp_query-from>
      <Hsp_query-to>206</Hsp_query-to>
      <Hsp_hit-from>64</Hsp_hit-from>
      <Hsp_hit-to>235</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>40</Hsp_identity>
      <Hsp_positive>77</Hsp_positive>
      <Hsp_gaps>16</Hsp_gaps>
      <Hsp_align-len>188</Hsp_align-len>
      <Hsp_qseq>PDVIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDL</Hsp_qseq>
      <Hsp_hseq>PDYQMSGDDTQHIQQFYDLLTGSMEI-------IRGWAEKIPGFADLPKADQDLLFESAFLELFVLRLAYRS-NPVEGKLIFCNGVVLHRLQCVR--GFGEWIDSIVEFSSNLQNXNIDISAFSCIAALAXVTE--RHGLKEPKRVEELQNKIVNCLKDHVTFNNGGL----NRPNYLSKLLGKLPEL</Hsp_hseq>
      <Hsp_midline>PD   +G D         LLT   ++       +  W++ +PGF +L   DQ  L + +++ L V  L +RS   V G++++    ++   Q ++   F     ++ +         +    F C+  L  +      GL+   + EE+++  +  L   +     G+     R   L+KLL  L +L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>414</Hit_num>
  <Hit_id>pdb|2HBH|A</Hit_id>
  <Hit_def>Chain A, Vitamin D receptor [Danio rerio] &gt;pdb|2HC4|A Chain A, Vitamin D receptor [Danio rerio] &gt;pdb|2HCD|A Chain A, Vitamin D receptor [Danio rerio] &gt;pdb|3DR1|A Chain A, Vitamin D3 receptor A [Danio rerio] &gt;pdb|3O1D|A Structure-function study of Gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097. [Danio rerio] &gt;pdb|3O1E|A Structure-function of Gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097. [Danio rerio] &gt;pdb|4Q0A|C Vitamin D Receptor complex with lithocholic acid [Danio rerio] &gt;pdb|5NKY|A Structure-activity relationship study of vitamin D analogs with oxolane group in their side chain [Danio rerio] &gt;pdb|5NMA|A Structure-activity relationship study of vitamin D analogs with oxolane group in their side chain [Danio rerio] &gt;pdb|5NMB|A2 Chain A2, Vitamin D3 receptor A [Danio rerio] &gt;pdb|5OW7|A VDR complex [Danio rerio] &gt;pdb|5OW9|A Vitamin D receptor complex [Danio rerio] &gt;pdb|5OWD|A Vitamin D receptor complex [Danio rerio] &gt;pdb|6T2M|A VDR-ZK168281 complex [Danio rerio] &gt;pdb|6XZH|A Chain A, Vitamin D3 receptor A [Danio rerio] &gt;pdb|6XZI|A Chain A, Vitamin D3 receptor A [Danio rerio] &gt;pdb|6XZJ|A Chain A, Vitamin D3 receptor A [Danio rerio] &gt;pdb|6XZK|A Chain A, Vitamin D3 receptor A [Danio rerio] &gt;pdb|6XZV|A Chain A, Vitamin D3 receptor A [Danio rerio]</Hit_def>
  <Hit_accession>2HBH_A</Hit_accession>
  <Hit_len>302</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0260491</Hsp_evalue>
      <Hsp_query-from>27</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>86</Hsp_hit-from>
      <Hsp_hit-to>150</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>20</Hsp_identity>
      <Hsp_positive>36</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>65</Hsp_align-len>
      <Hsp_qseq>DNTKPDTSS-------SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>DSGSPDSSEEDQQSRLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTAEDQIALLKSSAIEIIML</Hsp_hseq>
      <Hsp_midline>D+  PD+S        S+L  L  L    +  V+ ++K +PGFR+L  +DQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>415</Hit_num>
  <Hit_id>pdb|4RUJ|A</Hit_id>
  <Hit_def>Crystal structure of zVDR L337H mutant-VD complex [Danio rerio] &gt;pdb|4RUO|X Crystal structure of zVDR L337H mutant-gemini complex [Danio rerio] &gt;pdb|4RUP|A Crystal structure of zVDR L337H mutant-Gemini72 complex [Danio rerio]</Hit_def>
  <Hit_accession>4RUJ_A</Hit_accession>
  <Hit_len>302</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0267634</Hsp_evalue>
      <Hsp_query-from>27</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>86</Hsp_hit-from>
      <Hsp_hit-to>150</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>20</Hsp_identity>
      <Hsp_positive>36</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>65</Hsp_align-len>
      <Hsp_qseq>DNTKPDTSS-------SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>DSGSPDSSEEDQQSRLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTAEDQIALLKSSAIEIIML</Hsp_hseq>
      <Hsp_midline>D+  PD+S        S+L  L  L    +  V+ ++K +PGFR+L  +DQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>416</Hit_num>
  <Hit_id>pdb|3DZU|D</Hit_id>
  <Hit_def>Intact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with BVT.13, 9-cis Retinoic Acid and NCOA2 Peptide [Homo sapiens] &gt;pdb|3DZY|D Intact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with Rosiglitazone, 9-cis Retinoic Acid and NCOA2 Peptide [Homo sapiens] &gt;pdb|3E00|D Intact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with GW9662, 9-cis Retinoic Acid and NCOA2 Peptide [Homo sapiens]</Hit_def>
  <Hit_accession>3DZU_D</Hit_accession>
  <Hit_len>419</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>36.5798</Hsp_bit-score>
      <Hsp_score>83</Hsp_score>
      <Hsp_evalue>0.0304806</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>238</Hsp_hit-from>
      <Hsp_hit-to>263</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>12</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>ITEYAKSIPGFVNLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++KS+PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>417</Hit_num>
  <Hit_id>pdb|1XV9|B</Hit_id>
  <Hit_def>crystal structure of CAR/RXR heterodimer bound with SRC1 peptide, fatty acid, and 5b-pregnane-3,20-dione. [Homo sapiens] &gt;pdb|1XV9|D crystal structure of CAR/RXR heterodimer bound with SRC1 peptide, fatty acid, and 5b-pregnane-3,20-dione. [Homo sapiens] &gt;pdb|1XVP|B crystal structure of CAR/RXR heterodimer bound with SRC1 peptide, fatty acid and CITCO [Homo sapiens] &gt;pdb|1XVP|D crystal structure of CAR/RXR heterodimer bound with SRC1 peptide, fatty acid and CITCO [Homo sapiens]</Hit_def>
  <Hit_accession>1XV9_B</Hit_accession>
  <Hit_len>246</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.8094</Hsp_bit-score>
      <Hsp_score>81</Hsp_score>
      <Hsp_evalue>0.0401813</Hsp_evalue>
      <Hsp_query-from>37</Hsp_query-from>
      <Hsp_query-to>81</Hsp_query-to>
      <Hsp_hit-from>55</Hsp_hit-from>
      <Hsp_hit-to>99</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>16</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>45</Hsp_align-len>
      <Hsp_qseq>LLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSL</Hsp_qseq>
      <Hsp_hseq>LVTHFADINTFMVLQVIKFTKDLPVFRSLPIEDQISLLKGAAVEI</Hsp_hseq>
      <Hsp_midline>L+T    +    +L V+K++K LP FR+L I+DQI+L++ + + +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>418</Hit_num>
  <Hit_id>pdb|2V7C|A</Hit_id>
  <Hit_def>Crystal Structure of Rev-Erb beta [Homo sapiens] &gt;pdb|2V7C|B Crystal Structure of Rev-Erb beta [Homo sapiens]</Hit_def>
  <Hit_accession>2V7C_A</Hit_accession>
  <Hit_len>194</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.4242</Hsp_bit-score>
      <Hsp_score>80</Hsp_score>
      <Hsp_evalue>0.0475776</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>175</Hsp_query-to>
      <Hsp_hit-from>31</Hsp_hit-from>
      <Hsp_hit-to>151</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLM------VFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIREL</Hsp_qseq>
      <Hsp_hseq>VVEFAKRIPGFRDLSQHDQVNLLKAGTFEVLXVRFASLFDAKERTVTFLSGKK-YSVDDL-------HSXGAGDLLNSXFEFSEKLNALQLSDEEXSLFTAVVLV-SADRSGIENVNSVEALQETLIRAL</Hsp_hseq>
      <Hsp_midline>VV+++K +PGFR+L   DQ+ L++     ++      +F    R+   +SG+  Y   DL              L  + ++  ++   LQ+S EE      ++L+ +    G+ +    E ++ + IR L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>419</Hit_num>
  <Hit_id>pdb|3VT7|A</Hit_id>
  <Hit_def>Crystal structures of rat VDR-LBD with W282R mutation [Rattus norvegicus] &gt;pdb|3VT8|A Crystal structures of rat VDR-LBD with W282R mutation [Rattus norvegicus] &gt;pdb|3VT9|A Crystal structures of rat VDR-LBD with W282R mutation [Rattus norvegicus]</Hit_def>
  <Hit_accession>3VT7_A</Hit_accession>
  <Hit_len>271</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.4242</Hsp_bit-score>
      <Hsp_score>80</Hsp_score>
      <Hsp_evalue>0.0539845</Hsp_evalue>
      <Hsp_query-from>36</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>69</Hsp_hit-from>
      <Hsp_hit-to>117</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>17</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>49</Hsp_align-len>
      <Hsp_qseq>SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>SMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSDDQIVLLKSSAIEVIML</Hsp_hseq>
      <Hsp_midline>S+L  L  L    +  V+ ++K +PGFR+L  DDQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>420</Hit_num>
  <Hit_id>pdb|3CQV|A</Hit_id>
  <Hit_def>Crystal structure of Reverb beta in complex with heme [Homo sapiens]</Hit_def>
  <Hit_accession>3CQV_A</Hit_accession>
  <Hit_len>199</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0541698</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>175</Hsp_query-to>
      <Hsp_hit-from>36</Hsp_hit-from>
      <Hsp_hit-to>156</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>30</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLM------VFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIREL</Hsp_qseq>
      <Hsp_hseq>VVEFAKRIPGFRDLSQHDQVNLLKAGTFEVLXVRFASLFDAKERTVTFLSGKK-YSVDDL-------HSXGAGDLLNSXFEFSEKLNALQLSDEEXSLFTAVVLV-SADRSGIENVNSVEALQETLIRAL</Hsp_hseq>
      <Hsp_midline>VV+++K +PGFR+L   DQ+ L++     ++      +F    R+   +SG+  Y   DL              L  + ++  ++   LQ+S EE      ++L+ +    G+ +    E ++ + IR L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>421</Hit_num>
  <Hit_id>pdb|5GID|A</Hit_id>
  <Hit_def>Crystal structure of VDR in complex with DLAM-4 (C2 form) [Rattus norvegicus]</Hit_def>
  <Hit_accession>5GID_A</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.4242</Hsp_bit-score>
      <Hsp_score>80</Hsp_score>
      <Hsp_evalue>0.0604821</Hsp_evalue>
      <Hsp_query-from>36</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>51</Hsp_hit-from>
      <Hsp_hit-to>99</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>17</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>49</Hsp_align-len>
      <Hsp_qseq>SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>SMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSDDQIVLLKSSAIEVIML</Hsp_hseq>
      <Hsp_midline>S+L  L  L    +  V+ ++K +PGFR+L  DDQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>422</Hit_num>
  <Hit_id>pdb|5GIE|A</Hit_id>
  <Hit_def>Crystal structure of VDR in complex with DLAM-4P (P21 form) [Rattus norvegicus] &gt;pdb|5GIE|D Crystal structure of VDR in complex with DLAM-4P (P21 form) [Rattus norvegicus]</Hit_def>
  <Hit_accession>5GIE_A</Hit_accession>
  <Hit_len>256</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.4242</Hsp_bit-score>
      <Hsp_score>80</Hsp_score>
      <Hsp_evalue>0.0611451</Hsp_evalue>
      <Hsp_query-from>36</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>58</Hsp_hit-from>
      <Hsp_hit-to>106</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>17</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>49</Hsp_align-len>
      <Hsp_qseq>SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>SMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSDDQIVLLKSSAIEVIML</Hsp_hseq>
      <Hsp_midline>S+L  L  L    +  V+ ++K +PGFR+L  DDQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>423</Hit_num>
  <Hit_id>pdb|3W0G|A</Hit_id>
  <Hit_def>Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands [Rattus norvegicus] &gt;pdb|3W0I|A Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands [Rattus norvegicus] &gt;pdb|3W0J|A Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands [Rattus norvegicus]</Hit_def>
  <Hit_accession>3W0G_A</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.4242</Hsp_bit-score>
      <Hsp_score>80</Hsp_score>
      <Hsp_evalue>0.0634481</Hsp_evalue>
      <Hsp_query-from>36</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>54</Hsp_hit-from>
      <Hsp_hit-to>102</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>17</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>49</Hsp_align-len>
      <Hsp_qseq>SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>SMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSDDQIVLLKSSAIEVIML</Hsp_hseq>
      <Hsp_midline>S+L  L  L    +  V+ ++K +PGFR+L  DDQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>424</Hit_num>
  <Hit_id>pdb|5GIC|A</Hit_id>
  <Hit_def>Crystal structure of VDR in complex with DLAM-2P [Rattus norvegicus]</Hit_def>
  <Hit_accession>5GIC_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.4242</Hsp_bit-score>
      <Hsp_score>80</Hsp_score>
      <Hsp_evalue>0.0640555</Hsp_evalue>
      <Hsp_query-from>36</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>51</Hsp_hit-from>
      <Hsp_hit-to>99</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>17</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>49</Hsp_align-len>
      <Hsp_qseq>SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>SMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSDDQIVLLKSSAIEVIML</Hsp_hseq>
      <Hsp_midline>S+L  L  L    +  V+ ++K +PGFR+L  DDQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>425</Hit_num>
  <Hit_id>pdb|6S4N|A</Hit_id>
  <Hit_def>LXRbeta ligand binding domain in comlpex with small molecule inhibitors [Homo sapiens] &gt;pdb|6S4N|B LXRbeta ligand binding domain in comlpex with small molecule inhibitors [Homo sapiens] &gt;pdb|6S4N|C LXRbeta ligand binding domain in comlpex with small molecule inhibitors [Homo sapiens] &gt;pdb|6S4N|D LXRbeta ligand binding domain in comlpex with small molecule inhibitors [Homo sapiens] &gt;pdb|6S4T|A LXRbeta ligand binding domain in comlpex with small molecule inhibitors [Homo sapiens] &gt;pdb|6S4U|A LXRbeta ligand binding domain in comlpex with small molecule inhibitors [Homo sapiens] &gt;pdb|6S4U|B LXRbeta ligand binding domain in comlpex with small molecule inhibitors [Homo sapiens] &gt;pdb|6S4U|C LXRbeta ligand binding domain in comlpex with small molecule inhibitors [Homo sapiens] &gt;pdb|6S5K|A LXRbeta ligand binding domain in complex with small molecule inhibitors [Homo sapiens]</Hit_def>
  <Hit_accession>6S4N_A</Hit_accession>
  <Hit_len>245</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.4242</Hsp_bit-score>
      <Hsp_score>80</Hsp_score>
      <Hsp_evalue>0.0642591</Hsp_evalue>
      <Hsp_query-from>25</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>39</Hsp_hit-from>
      <Hsp_hit-to>106</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>19</Hsp_identity>
      <Hsp_positive>31</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>69</Hsp_align-len>
      <Hsp_qseq>GHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH</Hsp_qseq>
      <Hsp_hseq>GADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETA-RRYNH</Hsp_hseq>
      <Hsp_midline>G D    D          +L    +  +V ++K +PGF  L  +DQI L++ S + +M+     R Y H</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>426</Hit_num>
  <Hit_id>pdb|1RJK|A</Hit_id>
  <Hit_def>crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2MD and a synthetic peptide containing the NR2 box of DRIP 205 [Rattus norvegicus] &gt;pdb|1RK3|A crystal structure of the rat vitamin D receptor ligand binding domain complexed with 1,25-dihydroxyvitamin D3 and a synthetic peptide containing the NR2 box of DRIP 205 [Rattus norvegicus] &gt;pdb|1RKG|A crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2MbisP and a synthetic peptide containing the NR2 box of DRIP 205 [Rattus norvegicus] &gt;pdb|1RKH|A crystal structure of the rat vitamin D receptor ligand binding domain complexed with 2AM20R and a synthetic peptide containing the NR2 box of DRIP 205 [Rattus norvegicus] &gt;pdb|2O4J|A Crystal Structure of Rat Vitamin D Receptor Ligand Binding Domain Complexed with VitIII 17-20Z and the NR2 Box of DRIP 205 [Rattus norvegicus] &gt;pdb|2O4R|A Crystal Structure of Rat Vitamin D Receptor Ligand Binding Domain Complexed with VitIII 17-20E and the NR2 Box of DRIP 205 [Rattus norvegicus]</Hit_def>
  <Hit_accession>1RJK_A</Hit_accession>
  <Hit_len>292</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.4242</Hsp_bit-score>
      <Hsp_score>80</Hsp_score>
      <Hsp_evalue>0.0664471</Hsp_evalue>
      <Hsp_query-from>36</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>59</Hsp_hit-from>
      <Hsp_hit-to>107</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>17</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>49</Hsp_align-len>
      <Hsp_qseq>SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>SMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSDDQIVLLKSSAIEVIML</Hsp_hseq>
      <Hsp_midline>S+L  L  L    +  V+ ++K +PGFR+L  DDQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>427</Hit_num>
  <Hit_id>pdb|2ZL9|A</Hit_id>
  <Hit_def>2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure [Rattus norvegicus] &gt;pdb|2ZLA|A 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure [Rattus norvegicus] &gt;pdb|2ZLC|A 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation and crystal structure [Rattus norvegicus] &gt;pdb|2ZMH|A Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism [Rattus norvegicus] &gt;pdb|2ZMI|A Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism [Rattus norvegicus] &gt;pdb|2ZMJ|A Crystal Structure of Rat Vitamin D Receptor Bound to Adamantyl Vitamin D Analogs: Structural Basis for Vitamin D Receptor Antagonism and/or Partial Agonism [Rattus norvegicus] &gt;pdb|2ZXM|A A New Class of Vitamin D Receptor Ligands that Induce Structural Rearrangement of the Ligand-binding Pocket [Rattus norvegicus] &gt;pdb|2ZXN|A A New Class of Vitamin D Receptor Ligands that Induce Structural Rearrangement of the Ligand-binding Pocket [Rattus norvegicus] &gt;pdb|3AFR|A Crystal Structure of VDR-LBD/22S-Butyl-1a,24R-dihydroxyvitamin D3 complex [Rattus norvegicus] &gt;pdb|3VJS|A Vitamin D receptor complex with a carborane compound [Rattus norvegicus] &gt;pdb|3VJT|A Vitamin D receptor complex with a carborane compound [Rattus norvegicus] &gt;pdb|3VRT|A VDR ligand binding domain in complex with 2-Mehylidene-19,25,26,27-tetranor-1alpha,24-dihydroxyvitaminD3 [Rattus norvegicus] &gt;pdb|3VRU|A VDR ligand binding domain in complex with 2-Methylidene-19,24-dinor-1alpha,25-dihydroxy vitaminD3 [Rattus norvegicus] &gt;pdb|3VRV|A VDR ligand binding domain in complex with 2-Methylidene-26,27-dimethyl-19,24-dinor-1alpha,25-dihydroxyvitamin D3 [Rattus norvegicus] &gt;pdb|3VRW|A VDR ligand binding domain in complex with 22S-Butyl-2-methylidene-26,27-dimethyl-19,24-dinor-1alpha,25-dihydroxyvitamin D3 [Rattus norvegicus] &gt;pdb|3VT6|A Crystal structure of rat VDR-LBD with 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 [Rattus norvegicus] &gt;pdb|3VTB|A Crystal structure of rat vitamin D receptor bound to a partial agonist 25-adamantyl-23-yne-19-norvitammin D ADTK1 [Rattus norvegicus] &gt;pdb|3VTC|A Crystal structure of rat vitamin D receptor bound to a partial agonist 26-adamantyl-23-yne-19-norvitammin D ADTK3 [Rattus norvegicus] &gt;pdb|3VTD|A Crystal structure of rat vitamin D receptor bound to a partial agonist 26-adamantyl-23-yne-19-norvitammin D ADTK4 [Rattus norvegicus] &gt;pdb|3W5P|A Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid derivatives [Rattus norvegicus] &gt;pdb|3W5Q|A Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid derivatives [Rattus norvegicus] &gt;pdb|3W5R|A Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid derivatives [Rattus norvegicus] &gt;pdb|3W5T|A Crystal structure of complexes of vitamin D receptor ligand binding domain with lithocholic acid derivatives [Rattus norvegicus] &gt;pdb|3WT5|A A mixed population of antagonist and agonist binding conformers in a single crystal explains partial agonism against vitamin D receptor: Active vitamin D analogues with 22R-alkyl group [Rattus norvegicus] &gt;pdb|3WT6|A A mixed population of antagonist and agonist binding conformers in a single crystal explains partial agonism against vitamin D receptor: Active vitamin D analogues with 22R-alkyl group [Rattus norvegicus] &gt;pdb|3WT7|A Crystal structure of VDR-LBD complexed with 22R-Butyl-2-methylidene-26,27-dimethyl-19,24-dinor-1, 25-dihydroxyvitamin D3 [Rattus norvegicus] &gt;pdb|3WTQ|A Crystal structure of VDR-LBD complexed with 22S-butyl-2-methylidene-19-nor-1a,25-dihydroxyvitamin D3 [Rattus norvegicus] &gt;pdb|4YNK|A Crystal structure of vitamin D receptor ligand binding domain complexed with a 19-norvitamin D compound [Rattus norvegicus] &gt;pdb|5AWJ|A Crystal structure of VDR-LBD/partial agonist complex: 22S-hexyl analogue [Rattus norvegicus] &gt;pdb|5AWK|A Crystal structure of VDR-LBD/partial agonist complex: 22S-ethyl analogue [Rattus norvegicus] &gt;pdb|5B41|A Crystal structure of VDR-LBD complexed with 2-methylidene-19-nor-1a,25-dihydroxyvitamin D3 [Rattus norvegicus] &gt;pdb|5B5B|A Crystal structure of VDR-LBD complexed with 2-methylidene-26,27-diphenyl-19-nor-1,25-dihydroxyvitamin D3 [Rattus norvegicus] &gt;pdb|5B5B|D Crystal structure of VDR-LBD complexed with 2-methylidene-26,27-diphenyl-19-nor-1,25-dihydroxyvitamin D3 [Rattus norvegicus] &gt;pdb|5H1E|A Interaction between vitamin D receptor and coactivator peptide SRC2-3 [Rattus norvegicus] &gt;pdb|5XPL|A Crystal structure of VDR-LBD complexed with 22S-butyl-25-hydroxyphenyl-2-methylidene-19,26,27-trinor-25-oxo-1-hydroxyvitamin D3 [Rattus norvegicus] &gt;pdb|5XPM|A Crystal structure of VDR-LBD complexed with 22S-Butyl-25RS-(hydroxyphenyl)-25-methoxy-2-methylidene-19,26,27-trinor-1-hydroxyvitamin D3 [Rattus norvegicus] &gt;pdb|5XPN|A Crystal structure of VDR-LBD complexed with 25RS-(hydroxyphenyl)-25-methoxy-2-methylidene-19,26,27-trinor-1-hydroxyvitamin D3 [Rattus norvegicus] &gt;pdb|5XPO|A Crystal structure of VDR-LBD complexed with 25-(hydroxyphenyl)-2-methylidene-19,26,27-trinor-25-oxo-1-hydroxyvitamin D3 [Rattus norvegicus] &gt;pdb|5XPP|A Crystal structure of VDR-LBD complexed with 25RS-(Hydroxyphenyl)-2-methylidene-19,26,27-trinor-1,25-dihydroxyvitamin D3 [Rattus norvegicus] &gt;pdb|5XUQ|A Crystal structure of VDR-LBD complexed with an antagonist, 2-methylidene-19,26,27-trinor-22-(S)-butyl-1-hydroxy-25-oxo-25-(1H-pyrrol-2-yl)- vitamin D3 [Rattus norvegicus] &gt;pdb|5XZF|A Vitamin D receptor with a synthetic ligand ADRO1 [Rattus norvegicus] &gt;pdb|5XZH|A Vitamin D receptor with a synthetic ligand ADRO2 [Rattus norvegicus] &gt;pdb|5ZWE|A Covalent bond formation between histidine of Vitamin D receptor (VDR) and a full agonist having a vinyl ketone group via conjugate addition reaction [Rattus norvegicus] &gt;pdb|5ZWF|A Covalent bond formation between histidine of Vitamin D receptor (VDR) and a full agonist having a enone with a beta methyl group via conjugate addition reaction [Rattus norvegicus] &gt;pdb|5ZWH|A Covalent bond formation between histidine of Vitamin D receptor (VDR) and a full agonist having an ene-ynone group via conjugate addition reaction [Rattus norvegicus] &gt;pdb|5ZWI|A Interaction between Vitamin D receptor (VDR) and a ligand having a dienone group [Rattus norvegicus] &gt;pdb|6JEZ|A Covalent labeling of rVDR-LBD by turn-on fluorescent probe mediated by conjugate addition and cyclization [Rattus norvegicus] &gt;pdb|6K5O|A Development of Novel Lithocholic Acid Derivatives as Vitamin D Receptor Agonists [Rattus norvegicus] &gt;pdb|7C7V|A Chain A, Vitamin D3 receptor [Rattus norvegicus] &gt;pdb|7C7W|A Chain A, Vitamin D3 receptor [Rattus norvegicus]</Hit_def>
  <Hit_accession>2ZL9_A</Hit_accession>
  <Hit_len>271</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.4242</Hsp_bit-score>
      <Hsp_score>80</Hsp_score>
      <Hsp_evalue>0.0664635</Hsp_evalue>
      <Hsp_query-from>36</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>69</Hsp_hit-from>
      <Hsp_hit-to>117</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>17</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>49</Hsp_align-len>
      <Hsp_qseq>SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>SMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSDDQIVLLKSSAIEVIML</Hsp_hseq>
      <Hsp_midline>S+L  L  L    +  V+ ++K +PGFR+L  DDQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>428</Hit_num>
  <Hit_id>pdb|2ZFX|A</Hit_id>
  <Hit_def>Crystal structure of the rat vitamin D receptor ligand binding domain complexed with YR301 and a synthetic peptide containing the NR2 box of DRIP 205 [Rattus norvegicus] &gt;pdb|3A2H|A Crystal structure of the rat vitamin D receptor ligand binding domain complexed with TEI-9647 and a synthetic peptide containing the NR2 box of DRIP 205 [Rattus norvegicus] &gt;pdb|3AUN|A Crystal structure of the rat vitamin D receptor ligand binding domain complexed with YR335 and a synthetic peptide containing the NR2 box of DRIP 205 [Rattus norvegicus]</Hit_def>
  <Hit_accession>2ZFX_A</Hit_accession>
  <Hit_len>265</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.4242</Hsp_bit-score>
      <Hsp_score>80</Hsp_score>
      <Hsp_evalue>0.0667004</Hsp_evalue>
      <Hsp_query-from>36</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>63</Hsp_hit-from>
      <Hsp_hit-to>111</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>17</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>49</Hsp_align-len>
      <Hsp_qseq>SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>SMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSDDQIVLLKSSAIEVIML</Hsp_hseq>
      <Hsp_midline>S+L  L  L    +  V+ ++K +PGFR+L  DDQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>429</Hit_num>
  <Hit_id>pdb|3VT3|A</Hit_id>
  <Hit_def>Crystal structures of rat VDR-LBD with R270L mutation [Rattus norvegicus] &gt;pdb|3VT4|A Crystal structures of rat VDR-LBD with R270L mutation [Rattus norvegicus] &gt;pdb|3VT5|A Crystal structures of rat VDR-LBD with R270L mutation [Rattus norvegicus]</Hit_def>
  <Hit_accession>3VT3_A</Hit_accession>
  <Hit_len>271</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.4242</Hsp_bit-score>
      <Hsp_score>80</Hsp_score>
      <Hsp_evalue>0.0676761</Hsp_evalue>
      <Hsp_query-from>36</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>69</Hsp_hit-from>
      <Hsp_hit-to>117</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>17</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>49</Hsp_align-len>
      <Hsp_qseq>SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>SMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSDDQIVLLKSSAIEVIML</Hsp_hseq>
      <Hsp_midline>S+L  L  L    +  V+ ++K +PGFR+L  DDQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>430</Hit_num>
  <Hit_id>pdb|3W0H|A</Hit_id>
  <Hit_def>Crystal Structure of Rat VDR Ligand Binding Domain in Complex with Novel Nonsecosteroidal Ligands [Rattus norvegicus]</Hit_def>
  <Hit_accession>3W0H_A</Hit_accession>
  <Hit_len>258</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0697933</Hsp_evalue>
      <Hsp_query-from>36</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>59</Hsp_hit-from>
      <Hsp_hit-to>107</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>17</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>49</Hsp_align-len>
      <Hsp_qseq>SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>SMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSDDQIVLLKSSAIEVIML</Hsp_hseq>
      <Hsp_midline>S+L  L  L    +  V+ ++K +PGFR+L  DDQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>431</Hit_num>
  <Hit_id>pdb|2NPA|A</Hit_id>
  <Hit_def>the crystal structure of the human PPARaplpha ligand binding domain in complex with a a-hydroxyimino phenylpropanoic acid [Homo sapiens] &gt;pdb|2NPA|C the crystal structure of the human PPARaplpha ligand binding domain in complex with a a-hydroxyimino phenylpropanoic acid [Homo sapiens]</Hit_def>
  <Hit_accession>2NPA_A</Hit_accession>
  <Hit_len>270</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0700027</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>89</Hsp_hit-from>
      <Hsp_hit-to>114</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>11</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>LTEFAKAIPGFANLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++K++PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>432</Hit_num>
  <Hit_id>pdb|4DK8|A</Hit_id>
  <Hit_def>Crystal structure of LXR ligand binding domain in complex with partial agonist 5 [Homo sapiens] &gt;pdb|4DK8|C Crystal structure of LXR ligand binding domain in complex with partial agonist 5 [Homo sapiens]</Hit_def>
  <Hit_accession>4DK8_A</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0720946</Hsp_evalue>
      <Hsp_query-from>25</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>41</Hsp_hit-from>
      <Hsp_hit-to>108</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>19</Hsp_identity>
      <Hsp_positive>31</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>69</Hsp_align-len>
      <Hsp_qseq>GHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH</Hsp_qseq>
      <Hsp_hseq>GADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETA-RRYNH</Hsp_hseq>
      <Hsp_midline>G D    D          +L    +  +V ++K +PGF  L  +DQI L++ S + +M+     R Y H</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>433</Hit_num>
  <Hit_id>pdb|1I7G|A</Hit_id>
  <Hit_def>Crystal Structure Of The Ligand Binding Domain From Human Ppar-Alpha In Complex With The Agonist Az 242 [Homo sapiens]</Hit_def>
  <Hit_accession>1I7G_A</Hit_accession>
  <Hit_len>287</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0726512</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>106</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>11</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>LTEFAKAIPGFANLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++K++PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>434</Hit_num>
  <Hit_id>pdb|5AZT|A</Hit_id>
  <Hit_def>Ternary complex of hPPARalpha ligand binding domain, 17-oxoDHA and a SRC1 peptide [Homo sapiens] &gt;pdb|5AZT|B Ternary complex of hPPARalpha ligand binding domain, 17-oxoDHA and a SRC1 peptide [Homo sapiens]</Hit_def>
  <Hit_accession>5AZT_A</Hit_accession>
  <Hit_len>269</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0730659</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>88</Hsp_hit-from>
      <Hsp_hit-to>113</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>11</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>LTEFAKAIPGFANLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++K++PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>435</Hit_num>
  <Hit_id>pdb|3G8I|A</Hit_id>
  <Hit_def>Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes [Homo sapiens]</Hit_def>
  <Hit_accession>3G8I_A</Hit_accession>
  <Hit_len>270</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0732393</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>89</Hsp_hit-from>
      <Hsp_hit-to>114</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>11</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>LTEFAKAIPGFANLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++K++PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>436</Hit_num>
  <Hit_id>pdb|6KXX|A</Hit_id>
  <Hit_def>Human PPAR alpha ligand binding domain in complex with a synthetic agonist (compound A) [Homo sapiens] &gt;pdb|6KXY|A Human PPAR alpha ligand binding domain in complex with a synthetic agonist (compound B) [Homo sapiens]</Hit_def>
  <Hit_accession>6KXX_A</Hit_accession>
  <Hit_len>272</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0742502</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>91</Hsp_hit-from>
      <Hsp_hit-to>116</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>11</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>LTEFAKAIPGFANLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++K++PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>437</Hit_num>
  <Hit_id>pdb|1KKQ|A</Hit_id>
  <Hit_def>Crystal structure of the human PPAR-alpha ligand-binding domain in complex with an antagonist GW6471 and a SMRT corepressor motif [Homo sapiens] &gt;pdb|1KKQ|B Crystal structure of the human PPAR-alpha ligand-binding domain in complex with an antagonist GW6471 and a SMRT corepressor motif [Homo sapiens] &gt;pdb|1KKQ|C Crystal structure of the human PPAR-alpha ligand-binding domain in complex with an antagonist GW6471 and a SMRT corepressor motif [Homo sapiens] &gt;pdb|1KKQ|D Crystal structure of the human PPAR-alpha ligand-binding domain in complex with an antagonist GW6471 and a SMRT corepressor motif [Homo sapiens]</Hit_def>
  <Hit_accession>1KKQ_A</Hit_accession>
  <Hit_len>269</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0743991</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>88</Hsp_hit-from>
      <Hsp_hit-to>113</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>11</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>LTEFAKAIPGFANLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++K++PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>438</Hit_num>
  <Hit_id>pdb|2REW|A</Hit_id>
  <Hit_def>Crystal Structure of PPARalpha ligand binding domain with BMS-631707 [Homo sapiens] &gt;pdb|3KDT|A Crystal structure of peroxisome proliferator-activatedeceptor alpha (PPARalpha) complex with N-3-((2-(4-Chlorophenyl)-5-methyl-1,3-oxazol-4-yl)methoxy)benzyl)-N-(methoxycarbonyl)glycine [Homo sapiens] &gt;pdb|3KDT|B Crystal structure of peroxisome proliferator-activatedeceptor alpha (PPARalpha) complex with N-3-((2-(4-Chlorophenyl)-5-methyl-1,3-oxazol-4-yl)methoxy)benzyl)-N-(methoxycarbonyl)glycine [Homo sapiens] &gt;pdb|3KDU|A Crystal structure of peroxisome proliferator-activatedeceptor alpha (PPARalpha) complex with N-3-((2-(4-Chlorophenyl)-5-methyl-1,3-oxazol-4-yl)methoxy)benzyl)-N-((4-methylphenoxy)carbonyl)glycine [Homo sapiens] &gt;pdb|3KDU|B Crystal structure of peroxisome proliferator-activatedeceptor alpha (PPARalpha) complex with N-3-((2-(4-Chlorophenyl)-5-methyl-1,3-oxazol-4-yl)methoxy)benzyl)-N-((4-methylphenoxy)carbonyl)glycine [Homo sapiens]</Hit_def>
  <Hit_accession>2REW_A</Hit_accession>
  <Hit_len>277</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0744179</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>96</Hsp_hit-from>
      <Hsp_hit-to>121</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>11</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>LTEFAKAIPGFANLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++K++PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>439</Hit_num>
  <Hit_id>pdb|2P54|A</Hit_id>
  <Hit_def>a crystal structure of PPAR alpha bound with SRC1 peptide and GW735 [Homo sapiens] &gt;pdb|3FEI|A Design and biological evaluation of novel, balanced dual PPARa/g agonists [Homo sapiens]</Hit_def>
  <Hit_accession>2P54_A</Hit_accession>
  <Hit_len>267</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0753938</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>86</Hsp_hit-from>
      <Hsp_hit-to>111</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>11</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>LTEFAKAIPGFANLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++K++PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>440</Hit_num>
  <Hit_id>pdb|7C6Q|A</Hit_id>
  <Hit_def>Chain A, Peroxisome proliferator-activated receptor alpha [Homo sapiens]</Hit_def>
  <Hit_accession>7C6Q_A</Hit_accession>
  <Hit_len>273</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0757782</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>92</Hsp_hit-from>
      <Hsp_hit-to>117</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>11</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>LTEFAKAIPGFANLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++K++PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>441</Hit_num>
  <Hit_id>pdb|3ET1|A</Hit_id>
  <Hit_def>Structure of PPARalpha with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid [Homo sapiens] &gt;pdb|3ET1|B Structure of PPARalpha with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid [Homo sapiens]</Hit_def>
  <Hit_accession>3ET1_A</Hit_accession>
  <Hit_len>291</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.075917</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>110</Hsp_hit-from>
      <Hsp_hit-to>135</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>11</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>LTEFAKAIPGFANLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++K++PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>442</Hit_num>
  <Hit_id>pdb|3SP6|A</Hit_id>
  <Hit_def>Structural basis for iloprost as a dual PPARalpha/delta agonist [Homo sapiens]</Hit_def>
  <Hit_accession>3SP6_A</Hit_accession>
  <Hit_len>285</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0763793</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>104</Hsp_hit-from>
      <Hsp_hit-to>129</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>11</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>LTEFAKAIPGFANLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++K++PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>443</Hit_num>
  <Hit_id>pdb|2ZNN|A</Hit_id>
  <Hit_def>Human PPAR alpha ligand binding domain in complex with a synthetic agonist TIPP703 [Homo sapiens] &gt;pdb|3VI8|A Human PPAR alpha ligand binding domain in complex with a synthetic agonist APHM13 [Homo sapiens] &gt;pdb|6KAX|A X-ray structure of human PPARalpha ligand binding domain-intrinsic fatty acid (E. coli origin) co-crystals obtained by cross-seeding [Homo sapiens] &gt;pdb|6KAY|A X-ray structure of human PPARalpha ligand binding domain-GW7647 co-crystals obtained by soaking [Homo sapiens] &gt;pdb|6KAZ|A X-ray structure of human PPARalpha ligand binding domain-pemafibrate co-crystals obtained by soaking [Homo sapiens] &gt;pdb|6KB0|A X-ray structure of human PPARalpha ligand binding domain-5,8,11,14-eicosatetraynoic acid (ETYA) co-crystals obtained by soaking [Homo sapiens] &gt;pdb|6KB1|A X-ray structure of human PPARalpha ligand binding domain-tetradecylthioacetic acid (TTA) co-crystals obtained by soaking [Homo sapiens] &gt;pdb|6KB2|A X-ray structure of human PPARalpha ligand binding domain-Wy14643 co-crystals obtained by soaking [Homo sapiens] &gt;pdb|6KB3|A X-ray structure of human PPARalpha ligand binding domain-GW7647 co-crystals obtained by delipidation and cross-seeding [Homo sapiens] &gt;pdb|6KB4|A X-ray structure of human PPARalpha ligand binding domain-pemafibrate co-crystals obtained by delipidation and cross-seeding [Homo sapiens] &gt;pdb|6KB5|A X-ray structure of human PPARalpha ligand binding domain-5,8,11,14-eicosatetraynoic Acid (ETYA) co-crystals obtained by delipidation and cross-seeding [Homo sapiens] &gt;pdb|6KB6|A X-ray structure of human PPARalpha ligand binding domain-tetradecylthioacetic acid (TTA) co-crystals obtained by delipidation and cross-seeding [Homo sapiens] &gt;pdb|6KB7|A X-ray structure of human PPARalpha ligand binding domain-Wy14643 co-crystals obtained by delipidation and cross-seeding [Homo sapiens] &gt;pdb|6KB8|A X-ray structure of human PPARalpha ligand binding domain-GW7647 co-crystals obtained by cross-seeding [Homo sapiens] &gt;pdb|6KB9|A X-ray structure of human PPARalpha ligand binding domain-pemafibrate co-crystals obtained by cross-seeding [Homo sapiens] &gt;pdb|6KBA|A X-ray structure of human PPARalpha ligand binding domain-Wy14643 co-crystals obtained by co-crystallization [Homo sapiens] &gt;pdb|6KYP|A X-ray structure of human PPARalpha ligand binding domain-GW9662-clofibric acid co-crystals obtained by delipidation and co-crystallization [Homo sapiens] &gt;pdb|6KYP|B X-ray structure of human PPARalpha ligand binding domain-GW9662-clofibric acid co-crystals obtained by delipidation and co-crystallization [Homo sapiens] &gt;pdb|6L36|A X-ray structure of human PPARalpha ligand binding domain-GW9662-fenofibric acid co-crystals obtained by delipidation and co-crystallization [Homo sapiens] &gt;pdb|6L36|B X-ray structure of human PPARalpha ligand binding domain-GW9662-fenofibric acid co-crystals obtained by delipidation and co-crystallization [Homo sapiens] &gt;pdb|6L37|A X-ray structure of human PPARalpha ligand binding domain-GW9662-ciprofibrate co-crystals obtained by delipidation and co-crystallization [Homo sapiens] &gt;pdb|6L37|B X-ray structure of human PPARalpha ligand binding domain-GW9662-ciprofibrate co-crystals obtained by delipidation and co-crystallization [Homo sapiens] &gt;pdb|6L38|A X-ray structure of human PPARalpha ligand binding domain-GW9662-gemfibrozil co-crystals obtained by delipidation and co-crystallization [Homo sapiens] &gt;pdb|6L38|B X-ray structure of human PPARalpha ligand binding domain-GW9662-gemfibrozil co-crystals obtained by delipidation and co-crystallization [Homo sapiens] &gt;pdb|6LX4|A X-ray structure of human PPARalpha ligand binding domain-fenofibric acid co-crystals obtained by delipidation and co-crystallization [Homo sapiens] &gt;pdb|6LX4|B X-ray structure of human PPARalpha ligand binding domain-fenofibric acid co-crystals obtained by delipidation and co-crystallization [Homo sapiens] &gt;pdb|6LX5|A X-ray structure of human PPARalpha ligand binding domain-ciprofibrate co-crystals obtained by delipidation and co-crystallization [Homo sapiens] &gt;pdb|6LX5|B X-ray structure of human PPARalpha ligand binding domain-ciprofibrate co-crystals obtained by delipidation and co-crystallization [Homo sapiens] &gt;pdb|6LX6|A X-ray structure of human PPARalpha ligand binding domain-palmitic acid co-crystals obtained by delipidation and cross-seeding [Homo sapiens] &gt;pdb|6LX7|A X-ray structure of human PPARalpha ligand binding domain-stearic acid co-crystals obtained by delipidation and cross-seeding [Homo sapiens] &gt;pdb|6LX8|A X-ray structure of human PPARalpha ligand binding domain-oleic acid co-crystals obtained by delipidation and cross-seeding [Homo sapiens] &gt;pdb|6LX9|A X-ray structure of human PPARalpha ligand binding domain-arachidonic acid co-crystals obtained by delipidation and cross-seeding [Homo sapiens] &gt;pdb|6LXA|A X-ray structure of human PPARalpha ligand binding domain-eicosapentaenoic acid (EPA) co-crystals obtained by delipidation and cross-seeding [Homo sapiens] &gt;pdb|6LXB|A X-ray structure of human PPARalpha ligand binding domain-saroglitazar co-crystals obtained by soaking [Homo sapiens] &gt;pdb|6LXC|A X-ray structure of human PPARalpha ligand binding domain-saroglitazar co-crystals obtained by delipidation and cross-seeding [Homo sapiens] &gt;pdb|7BPY|A X-ray structure of human PPARalpha ligand binding domain-clofibric acid-SRC1 coactivator peptide co-crystals obtained by delipidation and co-crystallization [Homo sapiens] &gt;pdb|7BPY|C X-ray structure of human PPARalpha ligand binding domain-clofibric acid-SRC1 coactivator peptide co-crystals obtained by delipidation and co-crystallization [Homo sapiens] &gt;pdb|7BPZ|A X-ray structure of human PPARalpha ligand binding domain-bezafibrate-SRC1 coactivator peptide co-crystals obtained by soaking [Homo sapiens] &gt;pdb|7BPZ|C X-ray structure of human PPARalpha ligand binding domain-bezafibrate-SRC1 coactivator peptide co-crystals obtained by soaking [Homo sapiens] &gt;pdb|7BQ0|A X-ray structure of human PPARalpha ligand binding domain-fenofibric acid-SRC1 coactivator peptide co-crystals obtained by delipidation and co-crystallization [Homo sapiens] &gt;pdb|7BQ0|C X-ray structure of human PPARalpha ligand binding domain-fenofibric acid-SRC1 coactivator peptide co-crystals obtained by delipidation and co-crystallization [Homo sapiens] &gt;pdb|7BQ1|A X-ray structure of human PPARalpha ligand binding domain-intrinsic fatty acid (E. coli origin)-SRC1 coactivator peptide co-crystals obtained by co-crystallization [Homo sapiens] &gt;pdb|7BQ2|A X-ray structure of human PPARalpha ligand binding domain-pemafibrate-SRC1 coactivator peptide co-crystals obtained by soaking [Homo sapiens] &gt;pdb|7BQ3|A X-ray structure of human PPARalpha ligand binding domain-GW7647-SRC1 coactivator peptide co-crystals obtained by delipidation and co-crystallization [Homo sapiens] &gt;pdb|7BQ4|A X-ray structure of human PPARalpha ligand binding domain-eicosapentaenoic acid (EPA)-SRC1 coactivator peptide co-crystals obtained by delipidation and co-crystallization [Homo sapiens]</Hit_def>
  <Hit_accession>2ZNN_A</Hit_accession>
  <Hit_len>273</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0771598</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>92</Hsp_hit-from>
      <Hsp_hit-to>117</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>11</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>LTEFAKAIPGFANLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++K++PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>444</Hit_num>
  <Hit_id>pdb|4BCR|A</Hit_id>
  <Hit_def>Structure of PPARalpha in complex with WY14643 [Homo sapiens] &gt;pdb|4BCR|B Structure of PPARalpha in complex with WY14643 [Homo sapiens] &gt;pdb|4CI4|A Structural basis for GL479 a dual Peroxisome Proliferator-Activated Receptor alpha agonist [Homo sapiens]</Hit_def>
  <Hit_accession>4BCR_A</Hit_accession>
  <Hit_len>274</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0773353</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>93</Hsp_hit-from>
      <Hsp_hit-to>118</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>11</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>LTEFAKAIPGFANLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++K++PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>445</Hit_num>
  <Hit_id>pdb|6L96|A</Hit_id>
  <Hit_def>Structure of PPARalpha-LBD/pemafibrate/SRC1 peptide [Homo sapiens] &gt;pdb|6L96|B Structure of PPARalpha-LBD/pemafibrate/SRC1 peptide [Homo sapiens]</Hit_def>
  <Hit_accession>6L96_A</Hit_accession>
  <Hit_len>275</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0775096</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>94</Hsp_hit-from>
      <Hsp_hit-to>119</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>11</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>LTEFAKAIPGFANLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++K++PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>446</Hit_num>
  <Hit_id>pdb|5HYK|A</Hit_id>
  <Hit_def>Crystal structure of the complex PPARalpha/AL26-29 [Homo sapiens]</Hit_def>
  <Hit_accession>5HYK_A</Hit_accession>
  <Hit_len>272</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0776817</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>91</Hsp_hit-from>
      <Hsp_hit-to>116</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>11</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>LTEFAKAIPGFANLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++K++PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>447</Hit_num>
  <Hit_id>pdb|1P8D|A</Hit_id>
  <Hit_def>X-Ray Crystal Structure of LXR Ligand Binding Domain with 24(S),25-epoxycholesterol [Homo sapiens] &gt;pdb|1P8D|B X-Ray Crystal Structure of LXR Ligand Binding Domain with 24(S),25-epoxycholesterol [Homo sapiens]</Hit_def>
  <Hit_accession>1P8D_A</Hit_accession>
  <Hit_len>250</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0782081</Hsp_evalue>
      <Hsp_query-from>25</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>44</Hsp_hit-from>
      <Hsp_hit-to>111</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>19</Hsp_identity>
      <Hsp_positive>31</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>69</Hsp_align-len>
      <Hsp_qseq>GHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH</Hsp_qseq>
      <Hsp_hseq>GADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETA-RRYNH</Hsp_hseq>
      <Hsp_midline>G D    D          +L    +  +V ++K +PGF  L  +DQI L++ S + +M+     R Y H</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>448</Hit_num>
  <Hit_id>pdb|1K7L|A</Hit_id>
  <Hit_def>The 2.5 Angstrom resolution crystal structure of the human PPARalpha ligand binding domain bound with GW409544 and a co-activator peptide. [Homo sapiens] &gt;pdb|1K7L|C The 2.5 Angstrom resolution crystal structure of the human PPARalpha ligand binding domain bound with GW409544 and a co-activator peptide. [Homo sapiens] &gt;pdb|1K7L|E The 2.5 Angstrom resolution crystal structure of the human PPARalpha ligand binding domain bound with GW409544 and a co-activator peptide. [Homo sapiens] &gt;pdb|1K7L|G The 2.5 Angstrom resolution crystal structure of the human PPARalpha ligand binding domain bound with GW409544 and a co-activator peptide. [Homo sapiens]</Hit_def>
  <Hit_accession>1K7L_A</Hit_accession>
  <Hit_len>288</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0789497</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>77</Hsp_query-to>
      <Hsp_hit-from>107</Hsp_hit-from>
      <Hsp_hit-to>132</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>11</Hsp_identity>
      <Hsp_positive>22</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>26</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYS</Hsp_qseq>
      <Hsp_hseq>LTEFAKAIPGFANLDLNDQVTLLKYG</Hsp_hseq>
      <Hsp_midline>+ +++K++PGF NL ++DQ+TL++Y </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>449</Hit_num>
  <Hit_id>pdb|3FAL|B</Hit_id>
  <Hit_def>humanRXR alpha &amp; mouse LXR alpha complexed with Retenoic acid and GSK2186 [Mus musculus] &gt;pdb|3FAL|D humanRXR alpha &amp; mouse LXR alpha complexed with Retenoic acid and GSK2186 [Mus musculus] &gt;pdb|3FC6|B hRXRalpha &amp; mLXRalpha with an indole Pharmacophore, SB786875 [Mus musculus] &gt;pdb|3FC6|D hRXRalpha &amp; mLXRalpha with an indole Pharmacophore, SB786875 [Mus musculus]</Hit_def>
  <Hit_accession>3FAL_B</Hit_accession>
  <Hit_len>266</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.080126</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>175</Hsp_query-to>
      <Hsp_hit-from>87</Hsp_hit-from>
      <Hsp_hit-to>208</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>125</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSF-YSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIREL</Hsp_qseq>
      <Hsp_hseq>IVDFAKQLPGFLQLSREDQIALLKTSAIEVMLLETSRR--YNPGSESITFLKDFSYNREDFAKAGLQVEFINPIFEFSRAMNELQLNDAEFALL-IAISIFSADRPNVQDQLQVERLQHTYVEAL</Hsp_hseq>
      <Hsp_midline>+V ++K LPGF  L  +DQI L++ S + +M+     R   +   + + F  D   N +   ++         +++  +   +LQ++  EF  + + + + +     ++ Q Q E ++ +Y+  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>450</Hit_num>
  <Hit_id>pdb|4RAK|A</Hit_id>
  <Hit_def>Crystal structure of nuclear receptor subfamily 1, group h, member 2 (lxrb) complexed with partial agonist [Homo sapiens] &gt;pdb|4RAK|B Crystal structure of nuclear receptor subfamily 1, group h, member 2 (lxrb) complexed with partial agonist [Homo sapiens] &gt;pdb|5JY3|A CRYSTAL STRUCTURE OF LXRbeta (NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 2) COMPLEXED WITH BMS-852927 [Homo sapiens] &gt;pdb|5JY3|B CRYSTAL STRUCTURE OF LXRbeta (NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 2) COMPLEXED WITH BMS-852927 [Homo sapiens] &gt;pdb|5JY3|C CRYSTAL STRUCTURE OF LXRbeta (NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 2) COMPLEXED WITH BMS-852927 [Homo sapiens] &gt;pdb|5JY3|D CRYSTAL STRUCTURE OF LXRbeta (NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 2) COMPLEXED WITH BMS-852927 [Homo sapiens]</Hit_def>
  <Hit_accession>4RAK_A</Hit_accession>
  <Hit_len>264</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0811884</Hsp_evalue>
      <Hsp_query-from>25</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>58</Hsp_hit-from>
      <Hsp_hit-to>125</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>19</Hsp_identity>
      <Hsp_positive>31</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>69</Hsp_align-len>
      <Hsp_qseq>GHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH</Hsp_qseq>
      <Hsp_hseq>GADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETA-RRYNH</Hsp_hseq>
      <Hsp_midline>G D    D          +L    +  +V ++K +PGF  L  +DQI L++ S + +M+     R Y H</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>451</Hit_num>
  <Hit_id>pdb|1UHL|B</Hit_id>
  <Hit_def>Crystal structure of the LXRalfa-RXRbeta LBD heterodimer [Homo sapiens]</Hit_def>
  <Hit_accession>1UHL_B</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0851475</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>193</Hsp_query-to>
      <Hsp_hit-from>63</Hsp_hit-from>
      <Hsp_hit-to>221</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>23</Hsp_gaps>
      <Hsp_align-len>162</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSF-YSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYI-------------------RELIKAIGLRQKGVVSSSQRF</Hsp_qseq>
      <Hsp_hseq>IVDFAKQLPGFLQLSREDQIALLKTSAIEVMLLETSRR--YNPGSESITFLKDFSYNREDFAKAGLQVEFINPIFEFSRAMNELQLNDAEFALL-IAISIFSADRPNVQDQLQVERLQHTYVEALHAYVSIHHPHDRLMFPRMLMKLVSLRTLSSVHSEQVF</Hsp_hseq>
      <Hsp_midline>+V ++K LPGF  L  +DQI L++ S + +M+     R   +   + + F  D   N +   ++         +++  +   +LQ++  EF  + + + + +     ++ Q Q E ++ +Y+                   R L+K + LR    V S Q F</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>452</Hit_num>
  <Hit_id>pdb|1XNX|A</Hit_id>
  <Hit_def>Crystal structure of constitutive androstane receptor [Mus musculus] &gt;pdb|1XNX|B Crystal structure of constitutive androstane receptor [Mus musculus]</Hit_def>
  <Hit_accession>1XNX_A</Hit_accession>
  <Hit_len>256</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0870665</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>87</Hsp_query-to>
      <Hsp_hit-from>27</Hsp_hit-from>
      <Hsp_hit-to>115</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>21</Hsp_identity>
      <Hsp_positive>45</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>GQDIQLIPPLINLLMSIEPDV-IYAGHDNTKPDTSS-SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLG</Hsp_qseq>
      <Hsp_hseq>GAHTRHVGPLFDQFVQFKPPAYLFMHHRPFQPRGPVLPLLTHFADINTFMVQQIIKFTKDLPLFRSLTMEDQISLLKGAAVEILHISLN</Hsp_hseq>
      <Hsp_midline>G   + + PL +  +  +P   ++  H   +P      LLT    +    +  ++K++K LP FR+L ++DQI+L++ + + ++   L </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>453</Hit_num>
  <Hit_id>pdb|1PQ6|A</Hit_id>
  <Hit_def>Human Lxr Beta Hormone Receptor / Gw3965 Complex [Homo sapiens] &gt;pdb|1PQ6|B Human Lxr Beta Hormone Receptor / Gw3965 Complex [Homo sapiens] &gt;pdb|1PQ6|C Human Lxr Beta Hormone Receptor / Gw3965 Complex [Homo sapiens] &gt;pdb|1PQ6|D Human Lxr Beta Hormone Receptor / Gw3965 Complex [Homo sapiens] &gt;pdb|1PQ9|A Human Lxr Beta Hormone Receptor Complexed With T0901317 Complex [Homo sapiens] &gt;pdb|1PQ9|B Human Lxr Beta Hormone Receptor Complexed With T0901317 Complex [Homo sapiens] &gt;pdb|1PQ9|C Human Lxr Beta Hormone Receptor Complexed With T0901317 Complex [Homo sapiens] &gt;pdb|1PQ9|D Human Lxr Beta Hormone Receptor Complexed With T0901317 Complex [Homo sapiens] &gt;pdb|1PQC|A Human Lxr Beta Hormone Receptor Complexed With T0901317 [Homo sapiens] &gt;pdb|1PQC|B Human Lxr Beta Hormone Receptor Complexed With T0901317 [Homo sapiens] &gt;pdb|1PQC|C Human Lxr Beta Hormone Receptor Complexed With T0901317 [Homo sapiens] &gt;pdb|1PQC|D Human Lxr Beta Hormone Receptor Complexed With T0901317 [Homo sapiens] &gt;pdb|3KFC|A Complex Structure of LXR with an agonist [Homo sapiens] &gt;pdb|3KFC|B Complex Structure of LXR with an agonist [Homo sapiens] &gt;pdb|3KFC|C Complex Structure of LXR with an agonist [Homo sapiens] &gt;pdb|3KFC|D Complex Structure of LXR with an agonist [Homo sapiens]</Hit_def>
  <Hit_accession>1PQ6_A</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.0879386</Hsp_evalue>
      <Hsp_query-from>25</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>47</Hsp_hit-from>
      <Hsp_hit-to>114</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>19</Hsp_identity>
      <Hsp_positive>31</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>69</Hsp_align-len>
      <Hsp_qseq>GHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH</Hsp_qseq>
      <Hsp_hseq>GADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETA-RRYNH</Hsp_hseq>
      <Hsp_midline>G D    D          +L    +  +V ++K +PGF  L  +DQI L++ S + +M+     R Y H</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>454</Hit_num>
  <Hit_id>pdb|2ACL|B</Hit_id>
  <Hit_def>Liver X-Receptor alpha Ligand Binding Domain with SB313987 [Mus musculus] &gt;pdb|2ACL|D Liver X-Receptor alpha Ligand Binding Domain with SB313987 [Mus musculus] &gt;pdb|2ACL|F Liver X-Receptor alpha Ligand Binding Domain with SB313987 [Mus musculus] &gt;pdb|2ACL|H Liver X-Receptor alpha Ligand Binding Domain with SB313987 [Mus musculus]</Hit_def>
  <Hit_accession>2ACL_B</Hit_accession>
  <Hit_len>244</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>34.6538</Hsp_bit-score>
      <Hsp_score>78</Hsp_score>
      <Hsp_evalue>0.0880399</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>175</Hsp_query-to>
      <Hsp_hit-from>65</Hsp_hit-from>
      <Hsp_hit-to>186</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>59</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>125</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSF-YSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIREL</Hsp_qseq>
      <Hsp_hseq>IVDFAKQLPGFLQLSREDQIALLKTSAIEVMLLETSRR--YNPGSESITFLKDFSYNREDFAKAGLQVEFINPIFEFSRAMNELQLNDAEFALL-IAISIFSADRPNVQDQLQVERLQHTYVEAL</Hsp_hseq>
      <Hsp_midline>+V ++K LPGF  L  +DQI L++ S + +M+     R   +   + + F  D   N +   ++         +++  +   +LQ++  EF  + + + + +     ++ Q Q E ++ +Y+  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>455</Hit_num>
  <Hit_id>pdb|2V0V|A</Hit_id>
  <Hit_def>Crystal Structure of Rev-Erb beta [Homo sapiens] &gt;pdb|2V0V|B Crystal Structure of Rev-Erb beta [Homo sapiens] &gt;pdb|2V0V|C Crystal Structure of Rev-Erb beta [Homo sapiens] &gt;pdb|2V0V|D Crystal Structure of Rev-Erb beta [Homo sapiens]</Hit_def>
  <Hit_accession>2V0V_A</Hit_accession>
  <Hit_len>194</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>34.2686</Hsp_bit-score>
      <Hsp_score>77</Hsp_score>
      <Hsp_evalue>0.100525</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>175</Hsp_query-to>
      <Hsp_hit-from>31</Hsp_hit-from>
      <Hsp_hit-to>151</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>61</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>130</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQY-SWMSLMV-----FGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIREL</Hsp_qseq>
      <Hsp_hseq>VVEFAKRIPGFRDLSQHDQVNLLKAGTFEVLMVRFASLFDAKERTVTFL-GSKKYSVDDL----HSMGAG---DLLNSMFEFSEKLNALQLSDEEMSLFTAVVLV-SADRSGIENVNSVEALQETLIRAL</Hsp_hseq>
      <Hsp_midline>VV+++K +PGFR+L   DQ+ L++  ++  LMV     F    R+   + G   Y   DL      M       L  +M++  ++   LQ+S EE      ++L+ +    G+ +    E ++ + IR L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>456</Hit_num>
  <Hit_id>pdb|4NQA|B</Hit_id>
  <Hit_def>Crystal structure of liganded hRXR-alpha/hLXR-beta heterodimer on DNA [Homo sapiens] &gt;pdb|4NQA|I Crystal structure of liganded hRXR-alpha/hLXR-beta heterodimer on DNA [Homo sapiens]</Hit_def>
  <Hit_accession>4NQA_B</Hit_accession>
  <Hit_len>391</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>35.039</Hsp_bit-score>
      <Hsp_score>79</Hsp_score>
      <Hsp_evalue>0.102037</Hsp_evalue>
      <Hsp_query-from>25</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>185</Hsp_hit-from>
      <Hsp_hit-to>252</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>19</Hsp_identity>
      <Hsp_positive>31</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>69</Hsp_align-len>
      <Hsp_qseq>GHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH</Hsp_qseq>
      <Hsp_hseq>GADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETA-RRYNH</Hsp_hseq>
      <Hsp_midline>G D    D          +L    +  +V ++K +PGF  L  +DQI L++ S + +M+     R Y H</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>457</Hit_num>
  <Hit_id>pdb|1UPV|A</Hit_id>
  <Hit_def>Crystal structure of the human Liver X receptor beta ligand binding domain in complex with a synthetic agonist [Homo sapiens] &gt;pdb|1UPW|A Crystal structure of the human Liver X receptor beta ligand binding domain in complex with a synthetic agonist [Homo sapiens]</Hit_def>
  <Hit_accession>1UPV_A</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>34.6538</Hsp_bit-score>
      <Hsp_score>78</Hsp_score>
      <Hsp_evalue>0.103688</Hsp_evalue>
      <Hsp_query-from>25</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>51</Hsp_hit-from>
      <Hsp_hit-to>118</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>19</Hsp_identity>
      <Hsp_positive>31</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>69</Hsp_align-len>
      <Hsp_qseq>GHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH</Hsp_qseq>
      <Hsp_hseq>GADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETA-RRYNH</Hsp_hseq>
      <Hsp_midline>G D    D          +L    +  +V ++K +PGF  L  +DQI L++ S + +M+     R Y H</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>458</Hit_num>
  <Hit_id>pdb|3IPQ|A</Hit_id>
  <Hit_def>X-ray structure of GW3965 synthetic agonist bound to the LXR-alpha [Homo sapiens] &gt;pdb|3IPS|A X-ray structure of benzisoxazole synthetic agonist bound to the LXR-alpha [Homo sapiens] &gt;pdb|3IPS|B X-ray structure of benzisoxazole synthetic agonist bound to the LXR-alpha [Homo sapiens] &gt;pdb|3IPU|A X-ray structure of benzisoxazole urea synthetic agonist bound to the LXR-alpha [Homo sapiens] &gt;pdb|3IPU|B X-ray structure of benzisoxazole urea synthetic agonist bound to the LXR-alpha [Homo sapiens] &gt;pdb|5AVI|A Crystal structure of LXRalpha in complex with tert-butyl benzoate analog, compound 4 [Homo sapiens] &gt;pdb|5AVI|C Crystal structure of LXRalpha in complex with tert-butyl benzoate analog, compound 4 [Homo sapiens] &gt;pdb|5AVL|A Crystal structure of LXRalpha in complex with tert-butyl benzoate analog, compound 32b [Homo sapiens] &gt;pdb|5HJS|A Identification of LXRbeta selective agonists for the treatment of Alzheimer&apos;s Disease [Homo sapiens] &gt;pdb|5HJS|B Identification of LXRbeta selective agonists for the treatment of Alzheimer&apos;s Disease [Homo sapiens]</Hit_def>
  <Hit_accession>3IPQ_A</Hit_accession>
  <Hit_len>283</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>34.6538</Hsp_bit-score>
      <Hsp_score>78</Hsp_score>
      <Hsp_evalue>0.109103</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>193</Hsp_query-to>
      <Hsp_hit-from>104</Hsp_hit-from>
      <Hsp_hit-to>262</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>34</Hsp_identity>
      <Hsp_positive>69</Hsp_positive>
      <Hsp_gaps>23</Hsp_gaps>
      <Hsp_align-len>162</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSF-YSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYI-------------------RELIKAIGLRQKGVVSSSQRF</Hsp_qseq>
      <Hsp_hseq>IVDFAKQLPGFLQLSREDQIALLKTSAIEVMLLETSRR--YNPGSESITFLKDFSYNREDFAKAGLQVEFINPIFEFSRAMNELQLNDAEFALL-IAISIFSADRPNVQDQLQVERLQHTYVEALHAYVSIHHPHDRLMFPRMLMKLVSLRTLSSVHSEQVF</Hsp_hseq>
      <Hsp_midline>+V ++K LPGF  L  +DQI L++ S + +M+     R   +   + + F  D   N +   ++         +++  +   +LQ++  EF  + + + + +     ++ Q Q E ++ +Y+                   R L+K + LR    V S Q F</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>459</Hit_num>
  <Hit_id>pdb|1XLS|E</Hit_id>
  <Hit_def>Crystal structure of the mouse CAR/RXR LBD heterodimer bound to TCPOBOP and 9cRA and a TIF2 peptide containg the third LXXLL motifs [Mus musculus] &gt;pdb|1XLS|F Crystal structure of the mouse CAR/RXR LBD heterodimer bound to TCPOBOP and 9cRA and a TIF2 peptide containg the third LXXLL motifs [Mus musculus] &gt;pdb|1XLS|G Crystal structure of the mouse CAR/RXR LBD heterodimer bound to TCPOBOP and 9cRA and a TIF2 peptide containg the third LXXLL motifs [Mus musculus] &gt;pdb|1XLS|H Crystal structure of the mouse CAR/RXR LBD heterodimer bound to TCPOBOP and 9cRA and a TIF2 peptide containg the third LXXLL motifs [Mus musculus]</Hit_def>
  <Hit_accession>1XLS_E</Hit_accession>
  <Hit_len>242</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>34.6538</Hsp_bit-score>
      <Hsp_score>78</Hsp_score>
      <Hsp_evalue>0.11387</Hsp_evalue>
      <Hsp_query-from>1</Hsp_query-from>
      <Hsp_query-to>87</Hsp_query-to>
      <Hsp_hit-from>13</Hsp_hit-from>
      <Hsp_hit-to>101</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>21</Hsp_identity>
      <Hsp_positive>44</Hsp_positive>
      <Hsp_gaps>2</Hsp_gaps>
      <Hsp_align-len>89</Hsp_align-len>
      <Hsp_qseq>GQDIQLIPPLINLLMSIEPDV-IYAGHDNTKPDTSS-SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLG</Hsp_qseq>
      <Hsp_hseq>GAHTRHVGPLFDQFVQFRPPAYLFMHHRPFQPRGPVLPLLTHFADINTFMVQQIIKFTKDLPLFRSLTMEDQISLLKGAAVEILHISLN</Hsp_hseq>
      <Hsp_midline>G   + + PL +  +   P   ++  H   +P      LLT    +    +  ++K++K LP FR+L ++DQI+L++ + + ++   L </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>460</Hit_num>
  <Hit_id>pdb|3L0E|A</Hit_id>
  <Hit_def>X-ray crystal structure of a Potent Liver X Receptor Modulator [Homo sapiens]</Hit_def>
  <Hit_accession>3L0E_A</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>34.6538</Hsp_bit-score>
      <Hsp_score>78</Hsp_score>
      <Hsp_evalue>0.116459</Hsp_evalue>
      <Hsp_query-from>25</Hsp_query-from>
      <Hsp_query-to>100</Hsp_query-to>
      <Hsp_hit-from>47</Hsp_hit-from>
      <Hsp_hit-to>121</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>19</Hsp_identity>
      <Hsp_positive>34</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>76</Hsp_align-len>
      <Hsp_qseq>GHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLY</Hsp_qseq>
      <Hsp_hseq>GADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETA-RRYNHETESITF</Hsp_hseq>
      <Hsp_midline>G D    D          +L    +  +V ++K +PGF  L  +DQI L++ S + +M+     R Y H +  + +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>461</Hit_num>
  <Hit_id>pdb|2NXX|E</Hit_id>
  <Hit_def>Crystal Structure of the Ligand-Binding Domains of the T.castaneum (Coleoptera) Heterodimer EcrUSP Bound to Ponasterone A [Tribolium castaneum] &gt;pdb|2NXX|F Crystal Structure of the Ligand-Binding Domains of the T.castaneum (Coleoptera) Heterodimer EcrUSP Bound to Ponasterone A [Tribolium castaneum] &gt;pdb|2NXX|G Crystal Structure of the Ligand-Binding Domains of the T.castaneum (Coleoptera) Heterodimer EcrUSP Bound to Ponasterone A [Tribolium castaneum] &gt;pdb|2NXX|H Crystal Structure of the Ligand-Binding Domains of the T.castaneum (Coleoptera) Heterodimer EcrUSP Bound to Ponasterone A [Tribolium castaneum]</Hit_def>
  <Hit_accession>2NXX_E</Hit_accession>
  <Hit_len>248</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>34.2686</Hsp_bit-score>
      <Hsp_score>77</Hsp_score>
      <Hsp_evalue>0.119096</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>235</Hsp_query-to>
      <Hsp_hit-from>68</Hsp_hit-from>
      <Hsp_hit-to>241</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>43</Hsp_identity>
      <Hsp_positive>86</Hsp_positive>
      <Hsp_gaps>44</Hsp_gaps>
      <Hsp_align-len>201</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFY------------SLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIP--LEGLRSQTQFEEMRSSYIRELIKAIGLRQK---GVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEV</Hsp_qseq>
      <Hsp_hseq>IVEFAKRLPGFDKLLREDQIALLKACSSEVMMFRMA-RRYDVQTDSILF------VNNQPYSRDSYNLAGMGETIEDLLHFCRTMYS-------MRVDNAEYALLTAIVIFSERPALIEGWK----VEKIQEIYLEALRAYVDNRRKPKPGTI-----FAKLLSVLTELRTLGNQNSEMCFSLKLKNKKL----PPFLAEI</Hsp_hseq>
      <Hsp_midline>+V+++K LPGF  L  +DQI L++     +M+F +  R Y   +  +L+      +N Q     S+               C TM+        ++V   E+  +  +++ +  P  +EG +     E+++  Y+  L   +  R+K   G +     F +L  +L  L  L  Q    C +  ++++ L    P  ++E+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>462</Hit_num>
  <Hit_id>pdb|1R20|D</Hit_id>
  <Hit_def>Crystal structure of the ligand-binding domains of the heterodimer EcR/USP bound to the synthetic agonist BYI06830 [Heliothis virescens] &gt;pdb|3IXP|D Crystal structure of the ecdysone receptor bound to BYI08346 [Helicoverpa armigera]</Hit_def>
  <Hit_accession>1R20_D</Hit_accession>
  <Hit_len>265</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>34.2686</Hsp_bit-score>
      <Hsp_score>77</Hsp_score>
      <Hsp_evalue>0.13142</Hsp_evalue>
      <Hsp_query-from>43</Hsp_query-from>
      <Hsp_query-to>224</Hsp_query-to>
      <Hsp_hit-from>71</Hsp_hit-from>
      <Hsp_hit-to>251</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>185</Hsp_align-len>
      <Hsp_qseq>QLGERQLLSV---VKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRAL</Hsp_qseq>
      <Hsp_hseq>QITEMTILTVQLIVEFAKGLPGFSKISQSDQITLLKACSSEVMMLRVA-RRYDAATDSVL-FANNQAYTRDNYRKAGMAYVIEDLLHFCRCMYSMMMDNVHYALLTAIVIFSDRP--GLEQPSLVEEIQRYYLNTLRVYILNQNSASPRSAVIFGKILGILTEIRTLGMQNSNMCISLKLKNRKL</Hsp_hseq>
      <Hsp_midline>Q+ E  +L+V   V+++K LPGF  +   DQITL++     +M+  +  R Y   +  +L FA +        +++    +   +    +    + +    +  +  +++ +  P  GL   +  EE++  Y+  L   I  +      S+  F ++  +L  +  L  Q    C++  +++R L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>463</Hit_num>
  <Hit_id>pdb|7BJU|D</Hit_id>
  <Hit_def>Chain D, Ecdysone Receptor [Heliothis virescens] &gt;pdb|7BJV|D Chain D, Ecdysone Receptor [Heliothis virescens] &gt;pdb|7BJV|E Chain E, Ecdysone Receptor [Heliothis virescens] &gt;pdb|7BJV|F Chain F, Ecdysone Receptor [Heliothis virescens]</Hit_def>
  <Hit_accession>7BJU_D</Hit_accession>
  <Hit_len>266</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>34.2686</Hsp_bit-score>
      <Hsp_score>77</Hsp_score>
      <Hsp_evalue>0.139068</Hsp_evalue>
      <Hsp_query-from>43</Hsp_query-from>
      <Hsp_query-to>224</Hsp_query-to>
      <Hsp_hit-from>72</Hsp_hit-from>
      <Hsp_hit-to>252</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>37</Hsp_identity>
      <Hsp_positive>81</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>185</Hsp_align-len>
      <Hsp_qseq>QLGERQLLSV---VKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRAL</Hsp_qseq>
      <Hsp_hseq>QITEMTILTVQLIVEFAKGLPGFSKISQSDQITLLKACSSEVMMLRVA-RRYDAATDSVL-FANNQAYTRDNYRKAGMAYVIEDLLHFCRCMYSMMMDNVHYALLTAIVIFSDRP--GLEQPSLVEEIQRYYLNTLRVYILNQNSASPRSAVIFGKILGILTEIRTLGMQNSNMCISLKLKNRKL</Hsp_hseq>
      <Hsp_midline>Q+ E  +L+V   V+++K LPGF  +   DQITL++     +M+  +  R Y   +  +L FA +        +++    +   +    +    + +    +  +  +++ +  P  GL   +  EE++  Y+  L   I  +      S+  F ++  +L  +  L  Q    C++  +++R L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>464</Hit_num>
  <Hit_id>pdb|3P0U|A</Hit_id>
  <Hit_def>Crystal Structure of the ligand binding domain of human testicular receptor 4 [Homo sapiens] &gt;pdb|3P0U|B Crystal Structure of the ligand binding domain of human testicular receptor 4 [Homo sapiens]</Hit_def>
  <Hit_accession>3P0U_A</Hit_accession>
  <Hit_len>249</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>34.2686</Hsp_bit-score>
      <Hsp_score>77</Hsp_score>
      <Hsp_evalue>0.147117</Hsp_evalue>
      <Hsp_query-from>45</Hsp_query-from>
      <Hsp_query-to>200</Hsp_query-to>
      <Hsp_hit-from>43</Hsp_hit-from>
      <Hsp_hit-to>197</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>70</Hsp_positive>
      <Hsp_gaps>15</Hsp_gaps>
      <Hsp_align-len>163</Hsp_align-len>
      <Hsp_qseq>GERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILN---EQRMKESSFYSLCLTMWQIPQEF----VKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLL</Hsp_qseq>
      <Hsp_hseq>ASRLLFLSMHWARSIPAFQALGQDCNTSLVRACWNELFTLGLAQCAQVMSLSTILAAIVNHLQNSIQEDKLSGDRIKQVMEHIWKL-QEFCNSMAKLDIDGYEYAYLKAIVLFSP-DHPGLTSTSQIEKFQEAAQMELQDYVQ------ATYSEDTYRLARIL</Hsp_hseq>
      <Hsp_midline>  R L   + W++S+P F+ L  D   +L++  W  L   GL   +       +L    + + N   E ++       +   +W++ QEF     KL +   E+  +K ++L +     GL S +Q E+ + +   EL   +        + S+  Y+L ++L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>465</Hit_num>
  <Hit_id>pdb|5HJP|B</Hit_id>
  <Hit_def>Identification of LXRbeta selective agonists for the treatment of Alzheimer&apos;s Disease [Homo sapiens] &gt;pdb|5HJP|D Identification of LXRbeta selective agonists for the treatment of Alzheimer&apos;s Disease [Homo sapiens]</Hit_def>
  <Hit_accession>5HJP_B</Hit_accession>
  <Hit_len>264</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.8834</Hsp_bit-score>
      <Hsp_score>76</Hsp_score>
      <Hsp_evalue>0.167331</Hsp_evalue>
      <Hsp_query-from>25</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>39</Hsp_hit-from>
      <Hsp_hit-to>106</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>19</Hsp_identity>
      <Hsp_positive>31</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>69</Hsp_align-len>
      <Hsp_qseq>GHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH</Hsp_qseq>
      <Hsp_hseq>GADPASGSASQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETA-RRYNH</Hsp_hseq>
      <Hsp_midline>G D      S        +L    +  +V ++K +PGF  L  +DQI L++ S + +M+     R Y H</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>466</Hit_num>
  <Hit_id>pdb|6JIO|A</Hit_id>
  <Hit_def>Human LXR-beta in complex with a ligand [Homo sapiens] &gt;pdb|6JIO|B Human LXR-beta in complex with a ligand [Homo sapiens] &gt;pdb|6JIO|C Human LXR-beta in complex with a ligand [Homo sapiens] &gt;pdb|6JIO|D Human LXR-beta in complex with a ligand [Homo sapiens] &gt;pdb|6K9G|A Human LXR-beta in complex with an agonist [Homo sapiens] &gt;pdb|6K9G|B Human LXR-beta in complex with an agonist [Homo sapiens] &gt;pdb|6K9G|C Human LXR-beta in complex with an agonist [Homo sapiens] &gt;pdb|6K9G|D Human LXR-beta in complex with an agonist [Homo sapiens] &gt;pdb|6K9H|A Human LXR-beta in complex with an agonist [Homo sapiens] &gt;pdb|6K9H|B Human LXR-beta in complex with an agonist [Homo sapiens] &gt;pdb|6K9M|A Human LXR-beta in complex with an agonist [Homo sapiens] &gt;pdb|6K9M|B Human LXR-beta in complex with an agonist [Homo sapiens] &gt;pdb|6K9M|C Human LXR-beta in complex with an agonist [Homo sapiens] &gt;pdb|6K9M|D Human LXR-beta in complex with an agonist [Homo sapiens]</Hit_def>
  <Hit_accession>6JIO_A</Hit_accession>
  <Hit_len>274</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.8834</Hsp_bit-score>
      <Hsp_score>76</Hsp_score>
      <Hsp_evalue>0.17741</Hsp_evalue>
      <Hsp_query-from>25</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>49</Hsp_hit-from>
      <Hsp_hit-to>116</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>19</Hsp_identity>
      <Hsp_positive>31</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>69</Hsp_align-len>
      <Hsp_qseq>GHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH</Hsp_qseq>
      <Hsp_hseq>GADPASGSASQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETA-RRYNH</Hsp_hseq>
      <Hsp_midline>G D      S        +L    +  +V ++K +PGF  L  +DQI L++ S + +M+     R Y H</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>467</Hit_num>
  <Hit_id>pdb|5I4V|A</Hit_id>
  <Hit_def>Discovery of novel, orally efficacious Liver X Receptor (LXR) beta agonists [Homo sapiens] &gt;pdb|5I4V|E Discovery of novel, orally efficacious Liver X Receptor (LXR) beta agonists [Homo sapiens]</Hit_def>
  <Hit_accession>5I4V_A</Hit_accession>
  <Hit_len>270</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.8834</Hsp_bit-score>
      <Hsp_score>76</Hsp_score>
      <Hsp_evalue>0.199555</Hsp_evalue>
      <Hsp_query-from>25</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>45</Hsp_hit-from>
      <Hsp_hit-to>112</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>19</Hsp_identity>
      <Hsp_positive>31</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>69</Hsp_align-len>
      <Hsp_qseq>GHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH</Hsp_qseq>
      <Hsp_hseq>GADPASGSASQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETA-RRYNH</Hsp_hseq>
      <Hsp_midline>G D      S        +L    +  +V ++K +PGF  L  +DQI L++ S + +M+     R Y H</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>468</Hit_num>
  <Hit_id>pdb|5KYA|A</Hit_id>
  <Hit_def>Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core [Homo sapiens] &gt;pdb|5KYA|E Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core [Homo sapiens] &gt;pdb|5KYJ|A Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core [Homo sapiens] &gt;pdb|5KYJ|E Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core [Homo sapiens]</Hit_def>
  <Hit_accession>5KYA_A</Hit_accession>
  <Hit_len>287</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.8834</Hsp_bit-score>
      <Hsp_score>76</Hsp_score>
      <Hsp_evalue>0.212201</Hsp_evalue>
      <Hsp_query-from>25</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>62</Hsp_hit-from>
      <Hsp_hit-to>129</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>19</Hsp_identity>
      <Hsp_positive>31</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>69</Hsp_align-len>
      <Hsp_qseq>GHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH</Hsp_qseq>
      <Hsp_hseq>GADPASGSASQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETA-RRYNH</Hsp_hseq>
      <Hsp_midline>G D      S        +L    +  +V ++K +PGF  L  +DQI L++ S + +M+     R Y H</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>469</Hit_num>
  <Hit_id>pdb|3B0T|A</Hit_id>
  <Hit_def>Human VDR ligand binding domain in complex with maxacalcitol [Homo sapiens]</Hit_def>
  <Hit_accession>3B0T_A</Hit_accession>
  <Hit_len>254</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.4982</Hsp_bit-score>
      <Hsp_score>75</Hsp_score>
      <Hsp_evalue>0.230215</Hsp_evalue>
      <Hsp_query-from>36</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>56</Hsp_hit-from>
      <Hsp_hit-to>104</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>16</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>49</Hsp_align-len>
      <Hsp_qseq>SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>SMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIML</Hsp_hseq>
      <Hsp_midline>S+L  L  L    +  V+ ++K +PGFR+L  +DQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>470</Hit_num>
  <Hit_id>pdb|3M7R|A</Hit_id>
  <Hit_def>Crystal structure of VDR H305Q mutant [Homo sapiens]</Hit_def>
  <Hit_accession>3M7R_A</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.4982</Hsp_bit-score>
      <Hsp_score>75</Hsp_score>
      <Hsp_evalue>0.233821</Hsp_evalue>
      <Hsp_query-from>36</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>55</Hsp_hit-from>
      <Hsp_hit-to>103</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>16</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>49</Hsp_align-len>
      <Hsp_qseq>SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>SMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIML</Hsp_hseq>
      <Hsp_midline>S+L  L  L    +  V+ ++K +PGFR+L  +DQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>471</Hit_num>
  <Hit_id>pdb|3AZ1|A</Hit_id>
  <Hit_def>Crystal Structure Analysis of Vitamin D receptor [Homo sapiens] &gt;pdb|3AZ2|A Crystal Structure Analysis of Vitamin D receptor [Homo sapiens] &gt;pdb|3AZ3|A Crystal Structure Analysis of Vitamin D receptor [Homo sapiens] &gt;pdb|3W0A|A Crystal Structure Analysis of Vitamin D receptor [Homo sapiens] &gt;pdb|3W0C|A Crystal Structure Analysis of Vitamin D receptor [Homo sapiens] &gt;pdb|3W0Y|A Crystal Structure Analysis of Vitamin D receptor [Homo sapiens] &gt;pdb|3WGP|A Crystal Structure Analysis of Vitamin D receptor [Homo sapiens]</Hit_def>
  <Hit_accession>3AZ1_A</Hit_accession>
  <Hit_len>253</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.4982</Hsp_bit-score>
      <Hsp_score>75</Hsp_score>
      <Hsp_evalue>0.235945</Hsp_evalue>
      <Hsp_query-from>36</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>55</Hsp_hit-from>
      <Hsp_hit-to>103</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>16</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>49</Hsp_align-len>
      <Hsp_qseq>SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>SMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIML</Hsp_hseq>
      <Hsp_midline>S+L  L  L    +  V+ ++K +PGFR+L  +DQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>472</Hit_num>
  <Hit_id>pdb|5GT4|A</Hit_id>
  <Hit_def>Crystal structure of the human vitamin D receptor ligand binding domain complexed with (1R,2S,3R,5Z,7E,14beta,17alpha)-2-cyanopropoxy-9,10-secocholesta-5,7,10-triene-1,3,25-triol [Homo sapiens] &gt;pdb|5YSY|A Crystal structure of the human vitamin D receptor ligand binding domain complexed with (1R,2R,3R)-5-[(E)-2-{(1R,3aS,7aR)-1-[(R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,6,7,7a-hexahydro-1H-inden-4-yl}vinyl]-2-(3-hydroxypropyl)cyclohex-4-ene-1,3-diol [Homo sapiens] &gt;pdb|5YT2|A Crystal structure of the human vitamin D receptor ligand binding domain complexed with (1R,2S,3R)-5-[(E)-2-{(1R,3aS,7aR)-1-[(R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,6,7,7a-hexahydro-1H-inden-4-yl}vinyl]-2-(3-hydroxypropyl)cyclohex-4-ene-1,3-diol [Homo sapiens]</Hit_def>
  <Hit_accession>5GT4_A</Hit_accession>
  <Hit_len>255</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.4982</Hsp_bit-score>
      <Hsp_score>75</Hsp_score>
      <Hsp_evalue>0.24147</Hsp_evalue>
      <Hsp_query-from>36</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>57</Hsp_hit-from>
      <Hsp_hit-to>105</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>16</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>49</Hsp_align-len>
      <Hsp_qseq>SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>SMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIML</Hsp_hseq>
      <Hsp_midline>S+L  L  L    +  V+ ++K +PGFR+L  +DQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>473</Hit_num>
  <Hit_id>pdb|5V39|A</Hit_id>
  <Hit_def>Crystal structure of human vitamin D receptor ligand binding domain in complex with a VDRM [Homo sapiens]</Hit_def>
  <Hit_accession>5V39_A</Hit_accession>
  <Hit_len>257</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.4982</Hsp_bit-score>
      <Hsp_score>75</Hsp_score>
      <Hsp_evalue>0.244872</Hsp_evalue>
      <Hsp_query-from>36</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>56</Hsp_hit-from>
      <Hsp_hit-to>104</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>16</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>49</Hsp_align-len>
      <Hsp_qseq>SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>SMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIML</Hsp_hseq>
      <Hsp_midline>S+L  L  L    +  V+ ++K +PGFR+L  +DQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>474</Hit_num>
  <Hit_id>pdb|3A2I|A</Hit_id>
  <Hit_def>Crystal structure of the human vitamin D receptor (H305F) ligand binding domain complexed with TEI-9647 [Homo sapiens]</Hit_def>
  <Hit_accession>3A2I_A</Hit_accession>
  <Hit_len>263</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.4982</Hsp_bit-score>
      <Hsp_score>75</Hsp_score>
      <Hsp_evalue>0.252914</Hsp_evalue>
      <Hsp_query-from>36</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>61</Hsp_hit-from>
      <Hsp_hit-to>109</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>16</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>49</Hsp_align-len>
      <Hsp_qseq>SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>SMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIML</Hsp_hseq>
      <Hsp_midline>S+L  L  L    +  V+ ++K +PGFR+L  +DQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>475</Hit_num>
  <Hit_id>pdb|1DB1|A</Hit_id>
  <Hit_def>Crystal Structure Of The Nuclear Receptor For Vitamin D Complexed To Vitamin D [Homo sapiens] &gt;pdb|1IE8|A Crystal Structure Of The Nuclear Receptor For Vitamin D Ligand Binding Domain Bound to KH1060 [Homo sapiens] &gt;pdb|1IE9|A Crystal Structure Of The Nuclear Receptor For Vitamin D Ligand Binding Domain Bound to MC1288 [Homo sapiens] &gt;pdb|3KPZ|A Crystal structure of a novel vitamin D3 analogue, ZK203278 showing dissociated profile [Homo sapiens] &gt;pdb|3OGT|A Design, Chemical synthesis, Functional characterization and Crystal structure of the sidechain analogue of 1,25-dihydroxyvitamin D3. [Homo sapiens] &gt;pdb|3TKC|A Design, Synthesis, Evaluation and Structure of Vitamin D Analogues with Furan Side Chains [Homo sapiens] &gt;pdb|4G2I|A Structural basis for the accommodation of bis- and tris-aromatic derivatives in Vitamin D Nuclear Receptor [Homo sapiens]</Hit_def>
  <Hit_accession>1DB1_A</Hit_accession>
  <Hit_len>259</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.4982</Hsp_bit-score>
      <Hsp_score>75</Hsp_score>
      <Hsp_evalue>0.255117</Hsp_evalue>
      <Hsp_query-from>36</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>57</Hsp_hit-from>
      <Hsp_hit-to>105</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>16</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>49</Hsp_align-len>
      <Hsp_qseq>SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>SMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIML</Hsp_hseq>
      <Hsp_midline>S+L  L  L    +  V+ ++K +PGFR+L  +DQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>476</Hit_num>
  <Hit_id>pdb|1S0Z|A</Hit_id>
  <Hit_def>Crystal structure of the VDR LBD complexed to seocalcitol. [Homo sapiens] &gt;pdb|1S19|A Crystal structure of VDR ligand binding domain complexed to calcipotriol. [Homo sapiens] &gt;pdb|1TXI|A Crystal structure of the vdr ligand binding domain complexed to TX522 [Homo sapiens] &gt;pdb|2HAM|A Crystal structure of VDR LBD complexed to 2alpha-propyl-calcitriol [Homo sapiens] &gt;pdb|2HAR|A Crystal structure of VDR LBD in complex with 2 alpha-(3-hydroxy-1-propoxy) calcitriol [Homo sapiens] &gt;pdb|2HAS|A Crystal structure of VDR LBD in complex with 2alpha-(1-propoxy) calcitriol [Homo sapiens] &gt;pdb|2HB7|A Crystal structure of VDR LBD in complex with 2alpha(3-hydroxy-1-propyl) calcitriol [Homo sapiens] &gt;pdb|2HB8|A Crystal structure of VDR LBD in complex with 2alpha-methyl calcitriol [Homo sapiens] &gt;pdb|3A3Z|X Crystal structure of the human VDR ligand binding domain bound to the synthetic agonist compound 2alpha-methyl-AMCR277A(C23S) [Homo sapiens] &gt;pdb|3A40|X Crystal structure of the human VDR ligand binding domain bound to the synthetic agonist compound 2alpha-methyl-AMCR277B(C23R) [Homo sapiens] &gt;pdb|3A78|A Crystal structure of the human VDR ligand binding domain bound to the natural metabolite 1alpha,25-dihydroxy-3-epi-vitamin D3 [Homo sapiens] &gt;pdb|3AUQ|A Crystal structure of the human vitamin D receptor ligand binding domain complexed with Yne-diene type analog of active 14-epi-2alpha-methyl-19-norvitamin D3 [Homo sapiens] &gt;pdb|3AUR|A Crystal structure of the human vitamin D receptor ligand binding domain complexed with Yne-diene type analog of active 14-epi-2beta-methyl-19-norvitamin D3 [Homo sapiens] &gt;pdb|3AX8|A Crystal structure of the human vitamin D receptor ligand binding domain complexed with 15alpha-methoxy-1alpha,25-dihydroxyvitamin D3 [Homo sapiens] &gt;pdb|3CS4|A Structure-based design of a superagonist ligand for the vitamin D nuclear receptor [Homo sapiens] &gt;pdb|3CS6|A Structure-based design of a superagonist ligand for the vitamin D nuclear receptor [Homo sapiens] &gt;pdb|3VHW|A Crystal structure of the human vitamin D receptor ligand binding domain complexed with 4-MP [Homo sapiens] &gt;pdb|3WWR|A Crystal structure of the human vitamin D receptor ligand binding domain complexed with 1-((((1S,2R,6R,Z)-2,6-dihydroxy-4-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-3-methylenecyclohexyl)oxy)methyl)cyclopropanecarbonitrile [Homo sapiens] &gt;pdb|3X31|A Crystal structure of the human vitamin D receptor ligand binding domain complexed with 7,8-cis-14-epi-1a,25-Dihydroxy-19-norvitamin D3 [Homo sapiens] &gt;pdb|3X36|A Crystal structure of the human vitamin D receptor ligand binding domain complexed with 7,8-cis-1a,25-Dihydroxy-19-norvitamin D3 [Homo sapiens] &gt;pdb|4ITE|A Crystal structure of the human vitamin D receptor ligand binding domain complexed with 1alpha,25-Dihydroxy-2alpha-[2-(2H-tetrazol-2-yl)ethyl]vitamin D3 [Homo sapiens] &gt;pdb|4ITF|A Crystal structure of the human vitamin D receptor ligand binding domain complexed with 1alpha,25-Dihydroxy-2alpha-[2-(1H-tetrazole-1-yl)ethyl]vitamin D3 [Homo sapiens]</Hit_def>
  <Hit_accession>1S0Z_A</Hit_accession>
  <Hit_len>263</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.4982</Hsp_bit-score>
      <Hsp_score>75</Hsp_score>
      <Hsp_evalue>0.255207</Hsp_evalue>
      <Hsp_query-from>36</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>61</Hsp_hit-from>
      <Hsp_hit-to>109</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>16</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>49</Hsp_align-len>
      <Hsp_qseq>SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>SMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIML</Hsp_hseq>
      <Hsp_midline>S+L  L  L    +  V+ ++K +PGFR+L  +DQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>477</Hit_num>
  <Hit_id>pdb|3P8X|A</Hit_id>
  <Hit_def>Synthesis, Structure, and Biological Activity of des-Side Chain Analogues of 1alpha,25-Dihydroxyvitamin D3 with Substituents at C-18 [Homo sapiens]</Hit_def>
  <Hit_accession>3P8X_A</Hit_accession>
  <Hit_len>280</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.4982</Hsp_bit-score>
      <Hsp_score>75</Hsp_score>
      <Hsp_evalue>0.255223</Hsp_evalue>
      <Hsp_query-from>36</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>78</Hsp_hit-from>
      <Hsp_hit-to>126</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>16</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>49</Hsp_align-len>
      <Hsp_qseq>SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>SMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIML</Hsp_hseq>
      <Hsp_midline>S+L  L  L    +  V+ ++K +PGFR+L  +DQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>478</Hit_num>
  <Hit_id>pdb|3A2J|A</Hit_id>
  <Hit_def>Crystal structure of the human vitamin D receptor (H305F/H397F) ligand binding domain complexed with TEI-9647 [Homo sapiens]</Hit_def>
  <Hit_accession>3A2J_A</Hit_accession>
  <Hit_len>263</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.4982</Hsp_bit-score>
      <Hsp_score>75</Hsp_score>
      <Hsp_evalue>0.257522</Hsp_evalue>
      <Hsp_query-from>36</Hsp_query-from>
      <Hsp_query-to>84</Hsp_query-to>
      <Hsp_hit-from>61</Hsp_hit-from>
      <Hsp_hit-to>109</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>16</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>0</Hsp_gaps>
      <Hsp_align-len>49</Hsp_align-len>
      <Hsp_qseq>SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVF</Hsp_qseq>
      <Hsp_hseq>SMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIML</Hsp_hseq>
      <Hsp_midline>S+L  L  L    +  V+ ++K +PGFR+L  +DQI L++ S + +++ </Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>479</Hit_num>
  <Hit_id>pdb|4Y72|A</Hit_id>
  <Hit_def>Human CDK1/CyclinB1/CKS2 With Inhibitor [Homo sapiens] &gt;pdb|4YC3|A CDK1/CyclinB1/CKS2 Apo [Homo sapiens] &gt;pdb|5HQ0|A Ternary complex of human proteins CDK1, Cyclin B and CKS2, bound to an inhibitor [Homo sapiens] &gt;pdb|5LQF|A CDK1/CyclinB1/CKS2 in complex with NU6102 [Homo sapiens] &gt;pdb|5LQF|D CDK1/CyclinB1/CKS2 in complex with NU6102 [Homo sapiens] &gt;pdb|6GU2|A CDK1/CyclinB/Cks2 in complex with Flavopiridol [Homo sapiens] &gt;pdb|6GU3|A CDK1/CyclinB/Cks2 in complex with AZD5438 [Homo sapiens] &gt;pdb|6GU4|A CDK1/CyclinB/Cks2 in complex with CGP74514A [Homo sapiens] &gt;pdb|6GU6|A CDK1/Cks2 in complex with Dinaciclib [Homo sapiens] &gt;pdb|6GU7|A CDK1/Cks2 in complex with AZD5438 [Homo sapiens] &gt;pdb|6GU7|C CDK1/Cks2 in complex with AZD5438 [Homo sapiens] &gt;pdb|6GU7|E CDK1/Cks2 in complex with AZD5438 [Homo sapiens] &gt;pdb|6GU7|G CDK1/Cks2 in complex with AZD5438 [Homo sapiens]</Hit_def>
  <Hit_accession>4Y72_A</Hit_accession>
  <Hit_len>302</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.4982</Hsp_bit-score>
      <Hsp_score>75</Hsp_score>
      <Hsp_evalue>0.272684</Hsp_evalue>
      <Hsp_query-from>63</Hsp_query-from>
      <Hsp_query-to>141</Hsp_query-to>
      <Hsp_hit-from>137</Hsp_hit-from>
      <Hsp_hit-to>209</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>22</Hsp_identity>
      <Hsp_positive>36</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>79</Hsp_align-len>
      <Hsp_qseq>RNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEF</Hsp_qseq>
      <Hsp_hseq>QNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSAR------YSTPVDIWSIGTIFAELATKKPLF</Hsp_hseq>
      <Hsp_midline>+NL IDD+ T+    +     FG+  R Y H    + Y +P+++L   R      YS  + +W I   F +L   +  F</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>480</Hit_num>
  <Hit_id>pdb|1E6U|A</Hit_id>
  <Hit_def>GDP 4-keto-6-deoxy-D-mannose epimerase reductase [Escherichia coli]</Hit_def>
  <Hit_accession>1E6U_A</Hit_accession>
  <Hit_len>321</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.4982</Hsp_bit-score>
      <Hsp_score>75</Hsp_score>
      <Hsp_evalue>0.280574</Hsp_evalue>
      <Hsp_query-from>16</Hsp_query-from>
      <Hsp_query-to>69</Hsp_query-to>
      <Hsp_hit-from>160</Hsp_hit-from>
      <Hsp_hit-to>216</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>18</Hsp_identity>
      <Hsp_positive>26</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>57</Hsp_align-len>
      <Hsp_qseq>SIEPDVIYAGHDNTKPDTSS---SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDD</Hsp_qseq>
      <Hsp_hseq>SVMPTNLYGPHDNFHPSNSHVIPALLRRFHEATAQKAPDVVVWGSGTPMREFLHVDD</Hsp_hseq>
      <Hsp_midline>S+ P  +Y  HDN  P  S    +LL   ++   ++   VV W    P    LH+DD</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>481</Hit_num>
  <Hit_id>pdb|7NJ0|B</Hit_id>
  <Hit_def>Chain B, Cyclin-dependent kinase 1 [Homo sapiens]</Hit_def>
  <Hit_accession>7NJ0_B</Hit_accession>
  <Hit_len>318</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.4982</Hsp_bit-score>
      <Hsp_score>75</Hsp_score>
      <Hsp_evalue>0.292194</Hsp_evalue>
      <Hsp_query-from>63</Hsp_query-from>
      <Hsp_query-to>141</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>204</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>22</Hsp_identity>
      <Hsp_positive>36</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>79</Hsp_align-len>
      <Hsp_qseq>RNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEF</Hsp_qseq>
      <Hsp_hseq>QNLLIDDKGTIKLADFGLARAFGIPIRVYXHEVVTLWYRSPEVLLGSAR------YSTPVDIWSIGTIFAELATKKPLF</Hsp_hseq>
      <Hsp_midline>+NL IDD+ T+    +     FG+  R Y H    + Y +P+++L   R      YS  + +W I   F +L   +  F</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>482</Hit_num>
  <Hit_id>pdb|4YC6|A</Hit_id>
  <Hit_def>Cdk1/cks1 [Homo sapiens] &gt;pdb|4YC6|C Cdk1/cks1 [Homo sapiens] &gt;pdb|4YC6|E Cdk1/cks1 [Homo sapiens] &gt;pdb|4YC6|G Cdk1/cks1 [Homo sapiens]</Hit_def>
  <Hit_accession>4YC6_A</Hit_accession>
  <Hit_len>297</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.4982</Hsp_bit-score>
      <Hsp_score>75</Hsp_score>
      <Hsp_evalue>0.298523</Hsp_evalue>
      <Hsp_query-from>63</Hsp_query-from>
      <Hsp_query-to>141</Hsp_query-to>
      <Hsp_hit-from>132</Hsp_hit-from>
      <Hsp_hit-to>204</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>22</Hsp_identity>
      <Hsp_positive>36</Hsp_positive>
      <Hsp_gaps>6</Hsp_gaps>
      <Hsp_align-len>79</Hsp_align-len>
      <Hsp_qseq>RNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEF</Hsp_qseq>
      <Hsp_hseq>QNLLIDDKGTIKLADFGLARAFGIPIRVYTHEVVTLWYRSPEVLLGSAR------YSTPVDIWSIGTIFAELATKKPLF</Hsp_hseq>
      <Hsp_midline>+NL IDD+ T+    +     FG+  R Y H    + Y +P+++L   R      YS  + +W I   F +L   +  F</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>483</Hit_num>
  <Hit_id>pdb|1BSV|A</Hit_id>
  <Hit_def>Gdp-Fucose Synthetase From Escherichia Coli Complex With Nadph [Escherichia coli K-12] &gt;pdb|1FXS|A Gdp-fucose Synthetase From Escherichia Coli Complex With Nadp [Escherichia coli K-12] &gt;pdb|1GFS|A Gdp-Fucose Synthetase From E. Coli [Escherichia coli K-12]</Hit_def>
  <Hit_accession>1BSV_A</Hit_accession>
  <Hit_len>321</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.113</Hsp_bit-score>
      <Hsp_score>74</Hsp_score>
      <Hsp_evalue>0.383872</Hsp_evalue>
      <Hsp_query-from>16</Hsp_query-from>
      <Hsp_query-to>69</Hsp_query-to>
      <Hsp_hit-from>160</Hsp_hit-from>
      <Hsp_hit-to>216</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>18</Hsp_identity>
      <Hsp_positive>25</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>57</Hsp_align-len>
      <Hsp_qseq>SIEPDVIYAGHDNTKPDTSS---SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDD</Hsp_qseq>
      <Hsp_hseq>SVMPTNLYGPHDNFHPSNSHVIPALLRRFHEATAQNAPDVVVWGSGTPMREFLHVDD</Hsp_hseq>
      <Hsp_midline>S+ P  +Y  HDN  P  S    +LL   ++   +    VV W    P    LH+DD</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>484</Hit_num>
  <Hit_id>pdb|1BWS|A</Hit_id>
  <Hit_def>Crystal Structure Of Gdp-4-Keto-6-Deoxy-D-Mannose EpimeraseREDUCTASE From Escherichia Coli A Key Enzyme In The Biosynthesis Of Gdp-L- Fucose [Escherichia coli]</Hit_def>
  <Hit_accession>1BWS_A</Hit_accession>
  <Hit_len>321</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>33.113</Hsp_bit-score>
      <Hsp_score>74</Hsp_score>
      <Hsp_evalue>0.397869</Hsp_evalue>
      <Hsp_query-from>16</Hsp_query-from>
      <Hsp_query-to>69</Hsp_query-to>
      <Hsp_hit-from>160</Hsp_hit-from>
      <Hsp_hit-to>216</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>18</Hsp_identity>
      <Hsp_positive>25</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>57</Hsp_align-len>
      <Hsp_qseq>SIEPDVIYAGHDNTKPDTSS---SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDD</Hsp_qseq>
      <Hsp_hseq>SVMPTNLYGPHDNFHPSNSHVIPALLRRFHEATAQNAPDVVVWGSGTPMREFLHVDD</Hsp_hseq>
      <Hsp_midline>S+ P  +Y  HDN  P  S    +LL   ++   +    VV W    P    LH+DD</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>485</Hit_num>
  <Hit_id>pdb|1E7Q|A</Hit_id>
  <Hit_def>GDP 4-keto-6-deoxy-D-mannose epimerase reductase S107A [Escherichia coli]</Hit_def>
  <Hit_accession>1E7Q_A</Hit_accession>
  <Hit_len>321</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>32.7278</Hsp_bit-score>
      <Hsp_score>73</Hsp_score>
      <Hsp_evalue>0.439044</Hsp_evalue>
      <Hsp_query-from>16</Hsp_query-from>
      <Hsp_query-to>69</Hsp_query-to>
      <Hsp_hit-from>160</Hsp_hit-from>
      <Hsp_hit-to>216</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>18</Hsp_identity>
      <Hsp_positive>25</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>57</Hsp_align-len>
      <Hsp_qseq>SIEPDVIYAGHDNTKPDTSS---SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDD</Hsp_qseq>
      <Hsp_hseq>SVMPTNLYGPHDNFHPSNSHVIPALLRRFHEATAQSAPDVVVWGSGTPMREFLHVDD</Hsp_hseq>
      <Hsp_midline>S+ P  +Y  HDN  P  S    +LL   ++   +    VV W    P    LH+DD</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>486</Hit_num>
  <Hit_id>pdb|1E7S|A</Hit_id>
  <Hit_def>GDP 4-keto-6-deoxy-D-mannose epimerase reductase K140R [Escherichia coli]</Hit_def>
  <Hit_accession>1E7S_A</Hit_accession>
  <Hit_len>321</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>32.7278</Hsp_bit-score>
      <Hsp_score>73</Hsp_score>
      <Hsp_evalue>0.450994</Hsp_evalue>
      <Hsp_query-from>16</Hsp_query-from>
      <Hsp_query-to>69</Hsp_query-to>
      <Hsp_hit-from>160</Hsp_hit-from>
      <Hsp_hit-to>216</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>18</Hsp_identity>
      <Hsp_positive>25</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>57</Hsp_align-len>
      <Hsp_qseq>SIEPDVIYAGHDNTKPDTSS---SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDD</Hsp_qseq>
      <Hsp_hseq>SVMPTNLYGPHDNFHPSNSHVIPALLRRFHEATAQSAPDVVVWGSGTPMREFLHVDD</Hsp_hseq>
      <Hsp_midline>S+ P  +Y  HDN  P  S    +LL   ++   +    VV W    P    LH+DD</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>487</Hit_num>
  <Hit_id>pdb|1E7R|A</Hit_id>
  <Hit_def>GDP 4-keto-6-deoxy-D-mannose epimerase reductase Y136E [Escherichia coli]</Hit_def>
  <Hit_accession>1E7R_A</Hit_accession>
  <Hit_len>321</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>32.7278</Hsp_bit-score>
      <Hsp_score>73</Hsp_score>
      <Hsp_evalue>0.484471</Hsp_evalue>
      <Hsp_query-from>16</Hsp_query-from>
      <Hsp_query-to>69</Hsp_query-to>
      <Hsp_hit-from>160</Hsp_hit-from>
      <Hsp_hit-to>216</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>18</Hsp_identity>
      <Hsp_positive>25</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>57</Hsp_align-len>
      <Hsp_qseq>SIEPDVIYAGHDNTKPDTSS---SLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDD</Hsp_qseq>
      <Hsp_hseq>SVMPTNLYGPHDNFHPSNSHVIPALLRRFHEATAQSAPDVVVWGSGTPMREFLHVDD</Hsp_hseq>
      <Hsp_midline>S+ P  +Y  HDN  P  S    +LL   ++   +    VV W    P    LH+DD</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>488</Hit_num>
  <Hit_id>pdb|4DK7|A</Hit_id>
  <Hit_def>Crystal structure of LXR ligand binding domain in complex with full agonist 1 [Homo sapiens] &gt;pdb|4DK7|C Crystal structure of LXR ligand binding domain in complex with full agonist 1 [Homo sapiens]</Hit_def>
  <Hit_accession>4DK7_A</Hit_accession>
  <Hit_len>247</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>32.3426</Hsp_bit-score>
      <Hsp_score>72</Hsp_score>
      <Hsp_evalue>0.514962</Hsp_evalue>
      <Hsp_query-from>25</Hsp_query-from>
      <Hsp_query-to>93</Hsp_query-to>
      <Hsp_hit-from>41</Hsp_hit-from>
      <Hsp_hit-to>108</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>18</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>69</Hsp_align-len>
      <Hsp_qseq>GHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKH</Hsp_qseq>
      <Hsp_hseq>GADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIXLLETA-RRYNH</Hsp_hseq>
      <Hsp_midline>G D    D          +L    +  +V ++K +PGF  L  +DQI L++ S + + +     R Y H</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>489</Hit_num>
  <Hit_id>pdb|4OZR|E</Hit_id>
  <Hit_def>Crystal structure of the ligand binding domains of the Bovicola ovis ecdysone receptor EcR/USP heterodimer (methylene lactam crystal) [Pediculus humanus corporis]</Hit_def>
  <Hit_accession>4OZR_E</Hit_accession>
  <Hit_len>197</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>32.3426</Hsp_bit-score>
      <Hsp_score>72</Hsp_score>
      <Hsp_evalue>0.554633</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>106</Hsp_query-to>
      <Hsp_hit-from>43</Hsp_hit-from>
      <Hsp_hit-to>96</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>18</Hsp_identity>
      <Hsp_positive>30</Hsp_positive>
      <Hsp_gaps>1</Hsp_gaps>
      <Hsp_align-len>55</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLI</Hsp_qseq>
      <Hsp_hseq>IVEFAKRLPGFDKLLREDQIALLKACSSEVMMLRMA-RRYDVGSDSILATVDDLL</Hsp_hseq>
      <Hsp_midline>+V+++K LPGF  L  +DQI L++     +M+  +  R Y   S  +L    DL+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>490</Hit_num>
  <Hit_id>pdb|1NAV|A</Hit_id>
  <Hit_def>Thyroid Receptor Alpha in complex with an agonist selective for Thyroid Receptor Beta1 [Homo sapiens]</Hit_def>
  <Hit_accession>1NAV_A</Hit_accession>
  <Hit_len>263</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>32.3426</Hsp_bit-score>
      <Hsp_score>72</Hsp_score>
      <Hsp_evalue>0.628917</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>186</Hsp_query-to>
      <Hsp_hit-from>84</Hsp_hit-from>
      <Hsp_hit-to>215</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>27</Hsp_identity>
      <Hsp_positive>60</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGV</Hsp_qseq>
      <Hsp_hseq>VVDFAKKLPMFSELPCEDQIILLKGCCMEIMSLRAAVR-YDPES-DTLTLSGEMAVKREQLKNGGLGVVSDAIFELGKSLSAFNLDDTEVALLQAVLLMST-DRSGLLCVDKIEKSQEAYLLAFEHYVNHRKHNI</Hsp_hseq>
      <Hsp_midline>VV ++K LP F  L  +DQI L++   M +M      R Y   S   L  + ++ +  +++K      +   ++++ +      +   E   ++ +LL++T    GL    + E+ + +Y+      +  R+  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>491</Hit_num>
  <Hit_id>pdb|2H77|A</Hit_id>
  <Hit_def>Crystal structure of human TR alpha bound T3 in monoclinic space group [Homo sapiens]</Hit_def>
  <Hit_accession>2H77_A</Hit_accession>
  <Hit_len>269</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>31.9574</Hsp_bit-score>
      <Hsp_score>71</Hsp_score>
      <Hsp_evalue>0.722345</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>172</Hsp_query-to>
      <Hsp_hit-from>88</Hsp_hit-from>
      <Hsp_hit-to>205</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>121</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYI</Hsp_qseq>
      <Hsp_hseq>VVDFAKKLPMFSELPCEDQIILLKGCCMEIMSLRAAVR-YDPES-DTLTLSGEMAVKREQLKNGGLGVVSDAIFELGKSLSAFNLDDTEVALLQAVLLMST-DRSGLLXVDKIEKSQEAYL</Hsp_hseq>
      <Hsp_midline>VV ++K LP F  L  +DQI L++   M +M      R Y   S   L  + ++ +  +++K      +   ++++ +      +   E   ++ +LL++T    GL    + E+ + +Y+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>492</Hit_num>
  <Hit_id>pdb|1R1K|D</Hit_id>
  <Hit_def>Crystal structure of the ligand-binding domains of the heterodimer EcR/USP bound to ponasterone A [Heliothis virescens] &gt;pdb|2R40|D Crystal structure of 20E bound EcR/USP [Heliothis virescens] &gt;pdb|4UMM|G The Cryo-EM structure of the palindromic DNA-bound USP-EcR nuclear receptor reveals an asymmetric organization with allosteric domain positioning [Heliothis virescens]</Hit_def>
  <Hit_accession>1R1K_D</Hit_accession>
  <Hit_len>266</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>31.9574</Hsp_bit-score>
      <Hsp_score>71</Hsp_score>
      <Hsp_evalue>0.77158</Hsp_evalue>
      <Hsp_query-from>43</Hsp_query-from>
      <Hsp_query-to>100</Hsp_query-to>
      <Hsp_hit-from>72</Hsp_hit-from>
      <Hsp_hit-to>131</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>19</Hsp_identity>
      <Hsp_positive>34</Hsp_positive>
      <Hsp_gaps>4</Hsp_gaps>
      <Hsp_align-len>61</Hsp_align-len>
      <Hsp_qseq>QLGERQLLSV---VKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLY</Hsp_qseq>
      <Hsp_hseq>QITEMTILTVQLIVEFAKGLPGFAKISQSDQITLLKACSSEVMMLRVA-RRYDAATDSVLF</Hsp_hseq>
      <Hsp_midline>Q+ E  +L+V   V+++K LPGF  +   DQITL++     +M+  +  R Y   +  +L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>493</Hit_num>
  <Hit_id>pdb|1PDU|A</Hit_id>
  <Hit_def>Ligand-binding domain of Drosophila orphan nuclear receptor DHR38 [Drosophila melanogaster] &gt;pdb|1PDU|B Ligand-binding domain of Drosophila orphan nuclear receptor DHR38 [Drosophila melanogaster]</Hit_def>
  <Hit_accession>1PDU_A</Hit_accession>
  <Hit_len>244</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>31.9574</Hsp_bit-score>
      <Hsp_score>71</Hsp_score>
      <Hsp_evalue>0.788707</Hsp_evalue>
      <Hsp_query-from>4</Hsp_query-from>
      <Hsp_query-to>175</Hsp_query-to>
      <Hsp_hit-from>13</Hsp_hit-from>
      <Hsp_hit-to>181</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>72</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>174</Hsp_align-len>
      <Hsp_qseq>IQLIPPLINLLMSIEPD--VIYAGHDNTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIREL</Hsp_qseq>
      <Hsp_hseq>ISLITALVRSHVDTTPDPSCLDYSHYEEQSMSEADKVQQFYQLLTSSVDVIKQFAEKIPGYFDLLPEDQELLFQSASLELFVLRLAYRA--RIDDTKLIFCNGTVLHRTQCLR-SFGEWLNDIMEFSRSLHNLEIDISAFACLCALTLITE--RHGLREPKKVEQLQMKIIGSL</Hsp_hseq>
      <Hsp_midline>I LI  L+   +   PD   +   H   +  + +  +    QL    +  + ++++ +PG+ +L  +DQ  L Q + + L V  L +R+   +    L F    +L+  +    SF      + +  +    L++    F C+  L L+      GLR   + E+++   I  L</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>494</Hit_num>
  <Hit_id>pdb|2H79|A</Hit_id>
  <Hit_def>Crystal Structure of human TR alpha bound T3 in orthorhombic space group [Homo sapiens]</Hit_def>
  <Hit_accession>2H79_A</Hit_accession>
  <Hit_len>269</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>31.9574</Hsp_bit-score>
      <Hsp_score>71</Hsp_score>
      <Hsp_evalue>0.826735</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>172</Hsp_query-to>
      <Hsp_hit-from>88</Hsp_hit-from>
      <Hsp_hit-to>205</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>121</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYI</Hsp_qseq>
      <Hsp_hseq>VVDFAKKLPMFSELPXEDQIILLKGCCMEIMSLRAAVR-YDPES-DTLTLSGEMAVKREQLKNGGLGVVSDAIFELGKSLSAFNLDDTEVALLQAVLLMST-DRSGLLXVDKIEKSQEAYL</Hsp_hseq>
      <Hsp_midline>VV ++K LP F  L  +DQI L++   M +M      R Y   S   L  + ++ +  +++K      +   ++++ +      +   E   ++ +LL++T    GL    + E+ + +Y+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>495</Hit_num>
  <Hit_id>pdb|3UVV|A</Hit_id>
  <Hit_def>Crystal Structure of the ligand binding domains of the thyroid receptor:retinoid X receptor complexed with 3,3&apos;,5 triiodo-L-thyronine and 9-cis retinoic acid [Gallus gallus]</Hit_def>
  <Hit_accession>3UVV_A</Hit_accession>
  <Hit_len>265</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>31.9574</Hsp_bit-score>
      <Hsp_score>71</Hsp_score>
      <Hsp_evalue>0.834988</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>186</Hsp_query-to>
      <Hsp_hit-from>84</Hsp_hit-from>
      <Hsp_hit-to>215</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>27</Hsp_identity>
      <Hsp_positive>60</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>135</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYIRELIKAIGLRQKGV</Hsp_qseq>
      <Hsp_hseq>VVDFAKKLPMFSELPCEDQIILLKGCCMEIMSLRAAVR-YDPES-ETLTLSGEMAVKREQLKNGGLGVVSDAIFDLGKSLSAFNLDDTEVALLQAVLLMSS-DRTGLICVDKIEKCQETYLLAFEHYINYRKHNI</Hsp_hseq>
      <Hsp_midline>VV ++K LP F  L  +DQI L++   M +M      R Y   S + L  + ++ +  +++K      +   ++ + +      +   E   ++ +LL+++    GL    + E+ + +Y+      I  R+  +</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>496</Hit_num>
  <Hit_id>pdb|3HZF|A</Hit_id>
  <Hit_def>Structure of TR-alfa bound to selective thyromimetic GC-1 in C2 space group [Homo sapiens]</Hit_def>
  <Hit_accession>3HZF_A</Hit_accession>
  <Hit_len>269</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>31.9574</Hsp_bit-score>
      <Hsp_score>71</Hsp_score>
      <Hsp_evalue>0.841747</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>172</Hsp_query-to>
      <Hsp_hit-from>88</Hsp_hit-from>
      <Hsp_hit-to>205</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>121</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYI</Hsp_qseq>
      <Hsp_hseq>VVDFAKKLPMFSELPXEDQIILLKGCCMEIMSLRAAVR-YDPES-DTLTLSGEMAVKREQLKNGGLGVVSDAIFELGKSLSAFNLDDTEVALLQAVLLMST-DRSGLLXVDKIEKSQEAYL</Hsp_hseq>
      <Hsp_midline>VV ++K LP F  L  +DQI L++   M +M      R Y   S   L  + ++ +  +++K      +   ++++ +      +   E   ++ +LL++T    GL    + E+ + +Y+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>497</Hit_num>
  <Hit_id>pdb|3ILZ|A</Hit_id>
  <Hit_def>Structure of TR-alfa bound to selective thyromimetic GC-1 in P212121 space group [Homo sapiens] &gt;pdb|3JZB|A Crystal Structure of TR-alfa bound to the selective thyromimetic TRIAC [Homo sapiens] &gt;pdb|4LNW|A Crystal structure of TR-alpha bound to T3 in a second site [Homo sapiens] &gt;pdb|4LNX|A Crystal structure of TR-alpha bound to T4 in a second site [Homo sapiens]</Hit_def>
  <Hit_accession>3ILZ_A</Hit_accession>
  <Hit_len>267</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>31.9574</Hsp_bit-score>
      <Hsp_score>71</Hsp_score>
      <Hsp_evalue>0.845972</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>172</Hsp_query-to>
      <Hsp_hit-from>86</Hsp_hit-from>
      <Hsp_hit-to>203</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>3</Hsp_gaps>
      <Hsp_align-len>121</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQFEEMRSSYI</Hsp_qseq>
      <Hsp_hseq>VVDFAKKLPMFSELPXEDQIILLKGCCMEIMSLRAAVR-YDPES-DTLTLSGEMAVKREQLKNGGLGVVSDAIFELGKSLSAFNLDDTEVALLQAVLLMST-DRSGLLXVDKIEKSQEAYL</Hsp_hseq>
      <Hsp_midline>VV ++K LP F  L  +DQI L++   M +M      R Y   S   L  + ++ +  +++K      +   ++++ +      +   E   ++ +LL++T    GL    + E+ + +Y+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>498</Hit_num>
  <Hit_id>pdb|5Q0L|A</Hit_id>
  <Hit_def>Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens] &gt;pdb|5Q0L|C Ligand binding to FARNESOID-X-RECEPTOR [Homo sapiens]</Hit_def>
  <Hit_accession>5Q0L_A</Hit_accession>
  <Hit_len>233</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>31.5722</Hsp_bit-score>
      <Hsp_score>70</Hsp_score>
      <Hsp_evalue>0.877064</Hsp_evalue>
      <Hsp_query-from>41</Hsp_query-from>
      <Hsp_query-to>151</Hsp_query-to>
      <Hsp_hit-from>48</Hsp_hit-from>
      <Hsp_hit-to>153</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>26</Hsp_identity>
      <Hsp_positive>56</Hsp_positive>
      <Hsp_gaps>7</Hsp_gaps>
      <Hsp_align-len>112</Hsp_align-len>
      <Hsp_qseq>LNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLT-MWQIPQEFVKLQVSQEEFLCMKVLLLLN</Hsp_qseq>
      <Hsp_hseq>LTEXATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAXFL----RSAEIFNKKLPSGHSDLL--EARIRNSGISDEYITPXFSFYKSIGELKXTQEEYALLTAIVILS</Hsp_hseq>
      <Hsp_midline>L +     +  +V+++K LPGF+ L  +DQI L++ S +         RS +  + ++     DL+  E R++ S      +T  +   +   +L+ +QEE+  +  +++L+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>499</Hit_num>
  <Hit_id>pdb|5Z1F|A</Hit_id>
  <Hit_def>Structure of atOSCA3.1 channel [Arabidopsis thaliana] &gt;pdb|5Z1F|B Structure of atOSCA3.1 channel [Arabidopsis thaliana]</Hit_def>
  <Hit_accession>5Z1F_A</Hit_accession>
  <Hit_len>724</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>31.9574</Hsp_bit-score>
      <Hsp_score>71</Hsp_score>
      <Hsp_evalue>0.966782</Hsp_evalue>
      <Hsp_query-from>28</Hsp_query-from>
      <Hsp_query-to>95</Hsp_query-to>
      <Hsp_hit-from>118</Hsp_hit-from>
      <Hsp_hit-to>175</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>20</Hsp_identity>
      <Hsp_positive>32</Hsp_positive>
      <Hsp_gaps>10</Hsp_gaps>
      <Hsp_align-len>68</Hsp_align-len>
      <Hsp_qseq>NTKPDTSSSLLTSLNQLGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVS</Hsp_qseq>
      <Hsp_hseq>NTKNATDTTSKGTFSQLDNLSMANITKKSSRLWAF----------LGAVYWISLVTYFFLWKAYKHVS</Hsp_hseq>
      <Hsp_midline>NTK  T ++   + +QL    + ++ K S  L  F          L    W+SL+ +   W++YKHVS</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
<Hit>
  <Hit_num>500</Hit_num>
  <Hit_id>pdb|4OZT|E</Hit_id>
  <Hit_def>crystal structure of the ligand binding domains of the Bovicola ovis ecdysone receptor EcR/USP heterodimer (PonA crystal) [Pediculus humanus corporis]</Hit_def>
  <Hit_accession>4OZT_E</Hit_accession>
  <Hit_len>238</Hit_len>
  <Hit_hsps>
    <Hsp>
      <Hsp_num>1</Hsp_num>
      <Hsp_bit-score>30.8018</Hsp_bit-score>
      <Hsp_score>68</Hsp_score>
      <Hsp_evalue>1.95277</Hsp_evalue>
      <Hsp_query-from>52</Hsp_query-from>
      <Hsp_query-to>235</Hsp_query-to>
      <Hsp_hit-from>62</Hsp_hit-from>
      <Hsp_hit-to>235</Hsp_hit-to>
      <Hsp_query-frame>0</Hsp_query-frame>
      <Hsp_hit-frame>0</Hsp_hit-frame>
      <Hsp_identity>36</Hsp_identity>
      <Hsp_positive>80</Hsp_positive>
      <Hsp_gaps>14</Hsp_gaps>
      <Hsp_align-len>186</Hsp_align-len>
      <Hsp_qseq>VVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAPDLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIP--LEGLRSQTQFEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRALSVEFPEMMSEV</Hsp_qseq>
      <Hsp_hseq>IVEFAKRLPGFDKLLREDQIALLKACSSEVMMLRMARRY--DVGSDSILFANNQPYTRDSYSLAGMGETVDDLLRFCRQMYGMKVDNAEYALLTAIVIFSERPSLIEGWK----VEKIQEIYLEALKVYVDNRRKP--ASGTIFAKLLSVLTELRTLGNLNSEMCFSLKLKNKKL----PPFLAEI</Hsp_hseq>
      <Hsp_midline>+V+++K LPGF  L  +DQI L++     +M+  +  R    V    + FA +          +        + +  ++   ++V   E+  +  +++ +  P  +EG +     E+++  Y+  L   +  R+K   +S   F +L  +L  L  L       C +  ++++ L    P  ++E+</Hsp_midline>
    </Hsp>
  </Hit_hsps>
</Hit>
</Iteration_hits>
  <Iteration_stat>
    <Statistics>
      <Statistics_db-num>130881</Statistics_db-num>
      <Statistics_db-len>34844698</Statistics_db-len>
      <Statistics_hsp-len>103</Statistics_hsp-len>
      <Statistics_eff-space>3268685115</Statistics_eff-space>
      <Statistics_kappa>0.041</Statistics_kappa>
      <Statistics_lambda>0.267</Statistics_lambda>
      <Statistics_entropy>0.14</Statistics_entropy>
    </Statistics>
  </Iteration_stat>
</Iteration>
</BlastOutput_iterations>
</BlastOutput>

